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	Abstract	
	
Bluetongue	virus	(BTV)	is	an	arbovirus	of	the	Reoviridae	family	and	causes	major	economic	impact	due	
to	the	haemorrhagic	presentation	of	Bluetongue	disease	in	ruminants.		Target	cells	of	BTV	infection	are	
endothelial	and	immune	cells	in	the	mammalian	hosts	(bovine	and	ovine)	and	the	midgut	and	salivary	
gland	cells	of	the	insect	host	(Culicoides	spp.),	which	is	the	known	vector	 in	the	transmission	of	BTV.		
Little	 is	 known	 about	 BTV	 entry	 and	 replication	 in	 host	 derived	 cells.		 This	 thesis	 investigates	 the	
endocytosis	 mechanisms	 used	 by	 BTV	 in	 bovine	 endothelial	 (BFA)	 cells	 and	 (KC)	 cells	 derived	 from	
Culicoides	spp.		Using	a	combination	of	confocal	microscopy	and	flow	cytometry,	endocytosis	pathways	
were	 dissected	 by	 using	 pharmacological	 inhibitors,	 siRNA	 and	 dominant-negative	 (DN)	 protein	
expression	 which	 inhibit	 cellular	 factors,	 allowing	 discrimination	 between	 distinct	 endocytosis	
pathways.		 It	 was	 found	 that	 BTV-1	 entry	 and	 trafficking	 to	 acidic	 endosomes	 was	 relatively	 slow,	
consistent	 with	 a	 non-clathrin	 uptake	 pathway	 in	 BFA	 cells.	 During	 entry,	 BTV	 appeared	 to	 induce	
global	rearrangements	of	the	actin	cytoskeleton	and	disruption	of	F-actin	filaments	with	Cytochalasin	D	
inhibited	BTV-1	 infection	by	preventing	an	early	step	 in	 infection.	Furthermore,	preliminary	evidence	
suggests	that	BTV-1	may	induce	actin	rearrangements	and	uptake	by	 initiating	Rho	protein	signalling.	
Infection	was	inhibited	by	EIPA	and	IPA-3	which	target	sodium-proton	exchanger	1	and	p21	activated	
kinases	 respectively,	which	 are	 cellular	 factors	 required	 for	macropinocytosis.	 Taken	 together,	 these	
results	suggest	that	BTV	is	utilizing	macropinocytosis	for	entry	in	BFA	cells.		Furthermore,	expression	of	
DN	 eps15	 and	 treatment	with	 an	 inhibitor	 of	 CME	 (Pitstop	 2)	 did	 not	 inhibit	 BTV-1	 infection	 of	 BFA	
cells.	Interestingly,	treatment	of	KC	cells	with	Pitstop-2	appeared	to	inhibit	BTV-1	infection,	indicating	
that	infection	may	be	clathrin	dependent	in	KC	cells.	Additionally,	treatment	of	BFA	and	KC	cells	with	
Methyl-β-cyclodextrin	 did	 not	 inhibit	 infection,	 indicating	 infection	 is	 cholesterol-independent.	
Treatment	of	BFA	cells	with	a	dynamin	inhibitor,	Dyngo4a,	siRNA	targeting	dynamin-2	and	expression	
of	DN	dynamin-2	splice	variant	ba	all	inhibited	BTV-1	infection	and	Dyngo4a	was	shown	to	inhibit	BTV-1	
entry.	In	addition,	dynamin	inhibitors	Dynasore	and	Dyngo4a	also	inhibited	BTV-1	infection	in	KC	cells.	
This	suggests	that	the	endocytosis	pathway	used	by	BTV-1	in	BFA	and	KC	cells	is	dynamin-dependent.	
This	 thesis	provides	evidence	 that	entry	of	BTV-1	 is	determined	 in	part	by	 the	 target	 cell	 and	uses	a	
dynamin-dependent	macropinocytosis-like	pathway	to	enter	mammalian	cells	and	CME	in	insect	cells.	
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1.1 Bluetongue	virus	
	
	
Bluetongue	 virus	 (BTV)	 is	 the	 aetiological	 agent	 of	 Bluetongue	 disease,	 a	 haemorrhagic	
disease	 of	wild	 and	 domestic	 ruminants	 and	 camelids	 (Verwoerd,	 2004).	 BTV	 is	 the	 type	
species	of	 the	genus	Orbivirus	of	 the	 family	Reoviridae,	a	virus	 family	of	both	human	and	
veterinary	 importance	 (Mertens,	 2005).	 The	 reoviruses	 are	 characterised	 by	 segmented	
double-stranded	 RNA	 (dsRNA)	 genomes,	 encased	 in	 a	 multi-layered	 protein	 capsid	
structure	(Roy,	1992).		Viruses	within	the	family	Reoviridae	are	divided	into	9	genera,	four	
of	 which	 infect	 humans	 and	 animals	 (Orthoreovirus,	 Coltivirus,	 Rotavirus	 and	 Orbivirus)	
while	the	remaining	5	infect	plants,	insects	and	fish	(Albert,	1996).	
	
	
	
Orbiviruses	 include	a	number	of	 important	and	emerging	diseases	 including	 those	of	high	
veterinary	 importance	 such	 as	 African	 horse	 sickness	 virus	 (ASHV),	 BTV,	 Peruvian	 horse	
sickness	virus	(PHSV),	Equine	encephalosis	virus	(EEV)	and	Epizootic	haemorrhagic	disease	
virus	 (EHDV).	 Newly	 emerging	 orbiviruses	 are	 constantly	 being	 discovered	 such	 as	 the	
emergence	 of	 a	 novel	 orbivirus	 discovered	 in	 Tibet,	 China,	 which	 was	 isolated	 from	
Anopholes	maulatus	designated	the	Tibet	Orbivirus	(TBOV),	with	an	unknown	host	(Li	et	al.,	
2014)	and	Muko	virus	isolated	from	ixodid	ticks	in	Japan,	with	migratory	birds	as	hosts	(Ejiri	
et	al.,	2015).	There	are	currently	22	species	recognised	 in	the	Orbivirus	genus	 (Table	1.1).	
Arthropod	vectors	are	required	for	transmission	of	all	Orbiviruses	known	to	date,	with	the	
exception	 of	 newly	 discovered	 BTV	 strains	 (BTV-25	 and	 BTV-26),	 which	 have	 so	 far	 no	
identified	vector.	
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BTV	 is	 an	 arbovirus	 (arthropod-borne)	 transmitted	 by	 certain	 species	 of	 biting	 midge,	
Culicoides	spp	(Mellor	et	al.,	2000).	There	are	currently	27	serotypes	of	BTV	that	have	been	
documented,	 3	 (serotype	 25,	 26	 and	 27)	 of	 which	 have	 been	 identified	 in	 recent	 years	
(Jenckel	et	al.,	2015,	Maan	et	al.,	2011,	Hofmann	et	al.,	2008).	
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Table	1.1		Current	ICTV	list	of	recognized	Orbivirus	species	
Virus	species	 Host	species	 Vector	species	
African	horse	sickness	virus	
(ASHV)	
Horses,	dogs,	camels,	cattle,	
sheep,	goats,	elephants,	
predatory	carnivores	and	in	
rare	circumstances	humans.	
Culicoides	spp.	
Bluetongue	virus	(BTV)	 Cattle,	sheep,	goats,	camels,	
elephants,	predatory	
carnivores	
Culicoides	spp.	
Changuinola	virus	(CGLV)	 Humans,	rodents,	sloths	 Phlebotomine	flies	and	
mosquitoes	
Cheuda	virus	(CNUV)	 Seabirds	 Ticks:	Argas,	Ornithodoros	
Chobar	Gorge	virus	(CGV)	 Bats	 Ticks:	Ornithorodoros	
Corriparta	virus	(CORV)	 Humans,	rodents	 Culicine	mosquitoes	
Epizootic	haemorrhagic	disease	
virus	(EHDV)	
Cattle,	sheep,	deer,	camels,	
llamas,	wild	ruminants,	
marsupials	
Culicoides	spp.	
Equine	encephalosis	virus	(EEV)	 Horses	 Culicoides	spp.	
Eubanangee	virus	(EUBV)	 Unknown	 Culicoides	spp.	and	Anopheline,	
Culicine	mosquitoes	
Ieri	virus	(IERIV)	 Birds	 Culex	mosquitoes	
Great	Island	virus	(GIV)	 Seabirds,	rodents,	humans	 Ticks:Argas,	Ornithodoros	and	
Ixodes	
Lebombo	virus	(LEBV)	 Humans,	rodents	 Culicine	mosquitoes	
Orungo	virus	(ORUV)	 Humans,	camels,	cattle,	goats,	
sheep,	monkeys	
Culicine	mosquitoes	
Palyam	virus	(PALV)	 Cattle,	sheep	 Culicoides	spp	and	Culicine	
mosquitoes	
Umatilla	virus	(UMAV)	 Birds	 Culicine	mosquitoes	
Wad	Medani	virus	(WMV)	 Domestic	animals	 Ticks:	Boophilus,	Rhipicephalus,	
Hyalomma,	Argas	
Wallal	virus	(WALV)	 Marsupials	 Culicoides	spp.	
Warrego	virus	(WARV)	 Marsupials	 Culicoides	spp.	and	Anopheline,	
Culicine	mosquitoes	
Wongorr	virus	(WGRV)	 Cattle,	macropods	 Culicoides	spp.	and	mosquitoes	
St	Croix	river	virus	(SCRV)	 Deer	 Ticks	
Peruvian	horse	sickness	virus	
(PHSV)	
Cattle	 Mosquitoes	
Yunnan	Orbivirus	(YUOV)	 Unknown	 Culex	tritaaeniorhynchus	
		 mosquitoes	 	
Table	1.1		Current	ICTV	list	of	recognized	Orbivirus	species	
	
This	table	shows	22	named	species	identified	in	the	Orbvirus	genus	along	with	host	and	vector	
species.		Information	obtained	from:	
	
http://www.ictvonline.org/virusTaxonomy.asp?src=NCBI&ictv_id=20074304	
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Bluetongue	disease	was	 first	described	 in	South	Africa	 in	 the	 late	eighteenth	century	and	
was	denoted	as	‘tong-sikte’	by	Francois	de	Vaillant.	It	was	first	postulated	that	Bluetongue	
disease	was	 transmitted	 through	a	parasite	 and	 therefore	 the	disease	was	 referred	 to	as	
‘malarial	 catarrhal	 fever’	 (Hutcheon,	 1902).	 However,	 the	 full	 clinical	 presentation	 of	 the	
disease	was	 not	 fully	 described	 until	 1905,	where	 symptoms	were	 listed	 as	 being	 a	 high	
fever	 between	 7-10	 days	 after	 infection,	 the	 appearance	 of	 lesions	 in	 the	 mouth	 and	
tongue	 and	 lastly	 an	 indicative	 cyanotic	 tongue.	 It	 was	 from	 this	 description	 that	 the	
disease	 then	became	known	as	 ‘Blaauwtong’,	which	was	given	by	Dutch	citizens	 in	South	
Africa	and	the	direct	translation	was	used	by	Spreull	to	name	the	disease,	‘Bluetongue’	as	
the	 causative	 agent	 was	 unknown	 (Spreull,	 1905).	 It	 was	 also	 in	 this	 paper	 where	 the	
suggestion	 of	 a	 biting	 insect	 transmitting	 the	 pathogen	 was	 first	 documented	 (Spreull,	
1905).	
	
	
	
Since	the	first	identified	case,	BTV	has	become	endemic	in	areas	of	optimal	vector	activity	
within	 the	 global	 latitudes	 of	 45	 to	 50°N	 and	 35°S,	 which	 includes	 the	 regions	 of	 the	
Mediterranean	Europe,	North	and	South	America,	Africa,	India,	Australia	and	China,	(Mellor	
and	 Leake,	 2000).	 Historically,	 the	 global	 distribution	 of	 BTV	 has	 had	 a	 northern	 latitude	
limit	of	50°N,	however,	recent	incursions	in	Europe	since	1998	have	seen	the	virus	spread	
to	more	northern	European	regions	that	were	previously	free	of	BTV	(Purse	et	al.,	2005).	In	
2006,	 BTV	 (BTV-8)	 reached	 North-west	 Europe	 (Germany,	 Netherlands,	 Belgium,	 France	
and	 Luxembourg)	 for	 the	 first	 time,	 expanding	 its	 distribution	 further	 north	 in	 2007	 and	
resulted	in	the	first	outbreak	in	the	UK	(Wilson	and	Mellor,	2008).	Whilst	the	UK	promptly	
controlled	the	outbreak	by	an	aggressive	vaccination	campaign	 in	2008,	 it	took	until	2011	
for	the	last	case	of	BTV-8	to	be	eliminated	from	Sardinia,	Italy	(Niedbalski,	2015).	However,	
on	 21st		August	 2015,	 a	 single	 sheep	 was	 diagnosed	 with	 BTV-8	 in	 France,	 Allier	 region,	
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Central	 France.	 Preliminary	 investigations	 into	 the	 outbreak	 have	 identified	 a	 further	 7	
holdings	with	the	virus	and	suggestions	are	that	this	 is	not	a	new	incursion	but	perhaps	a	
result	of	unreported	circulation	of	the	virus	in	France	since	the	last	reported	case	in	2010	or	
perhaps	an	indication	of	a	problem	with	the	vaccine.	
	
(https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/460582/	
	
poa-bluetongue-btv8-france.pdf).		It	has	been	suggested	that	the	spread	of	BTV	to	northern	
	
latitudes	are	influenced	by	climate	change	(Purse	et	al.,	2005)	and	the	emergence	and	re-	
emergence	 of	 BTV	 in	 Northern	 Europe	 will	 be	 an	 increasing	 concern	 as	 global	 warming	
continues.	
	
	
	
1.2 Clinical	symptoms	and	disease	
	
	
Clinical	 signs	 of	 Bluetongue	 are	 most	 commonly	 observed	 in	 sheep	 and	 some	 wild	
ruminants,	 whereas	 infection	 in	 cattle	 and	 goats	 are	 predominantly	 asymptomatic.		
Severity	of	clinical	signs	also	vary	widely	between	breeds	as	well	as	individuals	of	the	same	
host	 species,	 indicating	 a	 wide	 range	 of	 differences	 in	 susceptibilities.	 Acute	 symptoms	
include	fever,	malaise,	anorexia,	respiratory	distress,	excessive	salivation,	haemorrhages	in	
the	mucous	membranes	of	the	oral	or	nasal	cavities,	oral	erosions	and	lesions,	oedema	of	
the	head	and	neck	and	on	rare	occasions,	a	swollen	cyanotic	tongue	(Spreull,	1905).	
	
	
	
Mortality	rates	ranges	from	0-30%	but	some	virulent	outbreak	strains	in	highly	susceptible	
sheep	 can	 reach	 higher	 mortality	 rates.	 Acute	 severe	 infection	 predominantly	 leads	 to	
death	within	14	days	of	infection.				Survivors	endure	a	prolonged	convalescence	that	
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includes	 emaciation	 and	 deterioration	 in	 body	 condition.	 Productivity	 in	 these	 animals	 is	
seriously	hampered	with	many	succumbing	to	secondary	infections,	such	as	pneumonia.	
	
	
	
Paradoxically,	 despite	 having	 differential	 clinical	 presentations	 and	 severity,	 the	
pathogenesis	of	BTV	in	sheep	and	cattle	is	similar.	Infection	in	the	mammalian	host	begins	
with	 cutaneous	 transfer	 of	 the	 virus	 from	 the	 bite	 of	 the	 insect	 vector.	 Viral	 Replication	
most	likely	begins	in	target	cells	in	the	skin	and	the	nearest	regional	lymph	node	followed	
by	 virus	 dissemination	 throughout	 the	 body,	 and	 further	 replication	 primarily	 in	
microvascular	 endothelial	 cells	 and	 leukocyte	 subsets	 of	 numerous	 organs	 (Pini,	 1976,	
Mahrt,	1986,Darpel,	2012	).	
	
	
	
Replication	of	BTV	in	endothelial	cells	results	in	tissue	injury	and	necrosis;	this	is	reflected	in	
the	formation	of	lesions	(Drew	et	al.,	2010a).	However,	the	exact	mechanism	by	which	this	
occurs	 is	 unknown	 as	 the	 directly	 observed	 viral	 induced	 endothelial	 cell	 death	 cannot	
account	for	the	extent	of	vascular	 leakage	observed	(Maclachlan	et	al.,	2009).	The	clinical	
manifestations	 of	 severe	 disease	 in	 susceptible	 sheep	 typically	 presents	 with	 excessive	
bleeding	 and	 coagulopathy.	 In	 addition,	 infection	 in	 ruminant	 vascular	 endothelium	 is	
relatively	 restricted	 and	 transient	 but	 its	 pathology	 has	 many	 similarities	 to	 the	 human	
haemorrhagic	 viral	 fever,	 Ebola.	Mainly	 this	 similarity	 is	 presented	 in	 the	 permeability	of	
capillaries	 causing	 vascular	 leakage	 in	 infected	 tissues	 potentially	 mediated	 by	 tissue	
necrosis	factor	(TNF)	of	macrophages	or	other	local	cellular	immune	responses	(Drew	et	al.,	
2010b,	DeMaula	et	al.,	2002a,	DeMaula	et	al.,	2002b).	
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1.3 Transmission,	overwintering	and	persistence	
	
	
The	principle	transmission	route	for	BTV	is	vector-borne	transmission	through	an	arthropod	
vector,	 specifically	 via	 the	biting	midge	Culicoides	 spp	 (Mellor	et	 al.,	 1984a,	Mellor	et	 al.,	
1984b).	 However,	 BTV	 has	 also	 been	 documented	 to	 be	 transmitted	 via	 alternative	
transmission	 routes,	 such	 as	 transplacental	 and	 oral	 transmission	 (Menzies	 et	 al.,	 2008,	
Darpel	 et	 al.,	 2009,	 Backx	 et	 al.,	 2009,	 Calvo-Pinilla	 et	 al.,	 2010).	 Recently,	 a	 serotype	 of	
BTV,	 BTV-26,	 has	 been	 identified	 as	 being	 transmitted	 via	 direct	 contact	 transmission	 in	
goats	and	that	the	virus	was	unable	to	be	transmitted	via	Culicoides	spp.	bite	(Batten	et	al.,	
2014,	 Batten	 et	 al.,	 2013).	 This	 highlights	 the	 possibility	 that	 genetic	 recombination	 of	
genome	 segments	 and	 evolution	 could	 allow	 the	 virus	 to	 adopt	 alternative	 transmission	
strategies.	
	
	
	
Viral	 persistence	 of	 BTV	 in	 its	 host,	 mammalian	 or	 insect,	 has	 been	 deemed	 the	 critical	
factor	 for	 the	 viruses	 ability	 to	 ‘overwinter’	 in	 temperate	 climates	 and	 reappear	 the	
following	year.	Overwintering	 is	 a	 term	coined	by	Nevill	 in	1971	 (Nevill,	 1971)	where	 the	
same	virus	strains	reappear	the	following	year,	despite	unfavourable	climates	in	the	winter	
affecting	 the	adult	vector.	 It	has	been	discussed	 that	BTV	might	be	able	 to	persist	during	
vector-free	 periods	 via	 three	 mechanisms.	 Theoretically	 Bluetongue	 could	 potentially	
persist:	 (1)	 In	 the	 vector	 population,	 (2)	 In	 the	 host	 population,	 or	 (3)	 via	 an	 alternative	
transmission	cycle.	A	diagram	depicting	possible	persistence	and	overwintering	 strategies	
can	be	seen	in	Figure	1.1.	
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Species	of	Culicoides	spp.	found	in	the	northern	hemisphere	survive	winters	in	their	larvae	
stage	and	so	the	theoretically	the	most	likely	mechanism	for	the	virus	overwintering	in	the	
vector	would	be	 transovarial	 transmission	of	 the	virus	within	 infected	vectors.	One	 study	
identified	the	presence	of	BTV	RNA	in	Culicoides	spp.	 larvae,	however,	no	viable	virus	was	
able	to	be	rescued	(White	et	al.,	2005).	
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Figure	1.1	
	
	
	
	
Figure	1.1	Proposed	models	of	alternative	transmission	and	persistence	strategies	to	allow	BTV	to	
overwinter	
The	diagram	shows	the	principle	transmission	route	via	a	vector	bite	on	the	left,	which	occurs	during	
optimal	 vector	 temperatures	 in	 the	 summer	 and	 the	 progression	 to	 proposed	 alternative	
transmission	routes	in	the	winter,	such	as	transplacental	transmission,	transovarial	transmission	and	
possible	persistence	mechanisms	 in	 the	vector	or	mammalian	hosts	 that	may	allow	BTV	to	survive	
vector-free	periods.		Adapted	from	(Wilson	et	al.,	2008)	
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Alternatively,	despite	being	less	tolerant	of	low	temperatures	than	Culex	spp.	mosquitoes,	
the	 adult	 Culicoides	 spp.	may	 be	 able	 to	 survive	mild	 winters	 (Mellor	 and	 Leake,	 2000).	
Laboratory	studies	have	recreated	this	scenario	and	have	elucidated	that	the	lifespan	of	the	
Culicoides	 spp.	 vector	 could	 be	 extended	 from	 10-20	 days	 to	 up	 to	 three	months	 if	 the	
temperature	remained	at	10°C	(Lysyk	and	Danyk,	2007).	
	
	
	
Supporting	 this	potential	mechanism	of	overwintering	of	 the	Culicoides	spp.	vector,	 there	
were	 reports	 of	 Culicoides	 spp.	 being	 captured	 during	 the	 mild	 winter	 of	 2006-2007	 in	
Europe	 (Zimmer	 et	 al.,	 2008).	 This	 identified	 the	 potential	 of	 infected	 Culicoides	 spp.		
vectors	surviving	mild	winters	and	infecting	mammalian	hosts	the	following	year.	However,	
although	 some	 adult	 Culicoides	 spp.	might	 survive	 longer	 in	mild	 winter	 conditions,	 it	 is	
currently	unclear	if	they	would	remain	active	and	continue	to	blood-feed.	The	possibility	of	
additional	 behaviour	 changes,	 such	 as	 adult	 Culicoides	moving	 indoors	 and	 maintaining	
host	seeking	activity	inside	animal	accommodations	are	still	under	investigation	(Wilson	et	
al.,	2008).	
	
	
	
There	 is	 also	 potential	 for	 persistence	 of	 BTV	 in	 the	 ruminant	 host.	 Typically,	 infectious	
virus	 is	 not	 recovered	 from	 the	 blood	 of	 ruminant	 hosts,	 beyond	 60	 days	 post	 infection	
(Barratt-Boyes	 and	MacLachlan,	 1994,	 Heidner	 et	 al.,	 1988,	 Luedke,	 1969,	 Luedke	 et	 al.,	
1969,	MacLachlan	et	al.,	1992,	Richards	et	al.,	1988),	but	paradoxically,	have	shown	to	be	
PCR	positive	 for	more	 than	200	days	 (MacLachlan	 et	 al.,	 1994).	However	 the	 isolation	of	
infectious	virus	from	the	skin	of	a	sheep	6	weeks	post	infection	in	the	absence	of	infectious	
virus	 in	the	blood	has	been	reported	(Takamatsu	et	al.,	2003).	 It	has	also	previously	been	
shown	that	ovine	γδT-cells	can	remain	persistently	infected	with	BTV	in	the	absence	of	
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visible	cytopathic	effect	when	cultured	ex	vivo	(Stott	et	al.,	1990,	Takamatsu	et	al.,	2003),	
and	 this	 has	 been	 suggested	 as	 a	 potential	 mechanism	 by	 which	 the	 host	 could	 remain	
latently	 infected	 (Takamatsu	 et	 al.,	 2003).	However,	 similar	 studies	 carried	out	 by	 others	
could	not	replicate	the	finding	of	 infectious	virus	 in	the	skin	beyond	detectable	 infectious	
viraemia	(Melville	et	al.,	2004,	White	and	Mecham,	2004,	Lunt	et	al.,	2006).	
	
	
	
BTV	transplacental	transmission	in	ruminants	was	initially	reported	in	the	1950s,	when	the	
vaccination	 of	 pregnant	 ewes	 with	 live	 attenuated	 BTV	 vaccines	 resulted	 in	 losses	 of	
newborn	 lambs	 (Schultz	 and	 Delay,	 1955).	 Later,	 it	 was	 observed	 that	 transplacental	
transmission	 was	 dependent	 on	 the	 stage	 of	 pregnancy	 that	 the	 ruminant	 host	 was	
infected	(Gibbs	et	al.,	1979).	The	ability	of	BTV	strains	to	cross	the	ruminant	placenta	had	
long	been	associated	with	 the	attenuation	and	modification	of	viral	 strains	 through	serial	
cell	culture	passage	in	the	laboratory	(Kirkland	and	Hawkes,	2004).	
	
	
	
However	 more	 recently,	 transplacental	 transmission	 of	 the	 newly	 emerged	 BTV-8	 strain	
was	observed	during	the	Bluetongue	outbreak	in	Europe	(Darpel	et	al.,	2009,	Backx	et	al.,	
2009,	Worwa	 et	 al.,	 2009).	 Therefore	 some	wild-type	 strains	 of	 BTV	might	 also	 have	 the	
capability	to	infect	ruminant	offspring	in	utero.	
	
	
	
Nonetheless,	to	this	date	it	 is	still	unclear	how	BTV	can	survive	long	absences	of	the	adult	
vector	insects	and	re-merge	in	favourable	seasons,	as	a	definite	and	efficient	overwintering	
mechanism	has	yet	to	be	confirmed.	
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1.4 BTV	genome	
	
	
BTV	has	a	linear	double	stranded	RNA	(dsRNA)	genome,	which	comprises	19,200	base	pairs	
(bp),	 forming	 ten	 discrete	 segments.	 Until	 recently,	 each	 segment	 was	 believed	 to	 be	
monocistronic,	 however,	 at	 least	 two	 segments	 have	 cistronic	 open	 reading	 frames	
(Belhouchet	 et	 al.,	 2011,	 Ratinier	 et	 al.,	 2011,	 Stewart	 et	 al.,	 2015).	 The	 ten	 dsRNA		
segments	 are	 numbered	 1	 to	 10	 and	 each	 codes	 for	 a	 single	 polypeptide,	 with	 the	
exception	 of	 the	 two	 smallest	 segments	 (9	 and	 10),	 which	 encode	 VP6	 and	 NS4,	 and	
NS3/NS3A	and	NS5	respectively	 (Mertens	et	al.,	1984,	Belhouchet	et	al.,	2011,	Stewart	et	
al.,	2015,	Ratinier	et	al.,	2011).	Table	1.2	details	what	protein	each	segments	encodes	and	
their	known	functions.	
	
	
	
Recent	 studies	 have	 investigated	 how	 BTV	 packages	 its	 genome	 and	 has	 identified	 that	
structural	motifs	at	the	3’	and	5’	ends	of	segment	4	of	BTV-9	and	segment	8	of	BTV-1	are	
critical	 for	 packaging	 as	 the	 motifs	 alone	 are	 able	 to	 package	 unrelated	 sequences	
(Burkhardt	et	al.,	2014).	Additionally,	cell	free	RNA-RNA	interaction	studies	have	suggested	
that	 packaging	 is	 initiated	with	 the	 untranslated	 region	 (UTR)	 of	 the	 smallest	 of	 the	 ten	
segments,	segment	10,	which	then	interacts	with	RNA	from	other	segments,	recruiting	first	
medium	and	then	 large	segments	 (Sung	and	Roy,	2014).	Additionally,	mutation	of	certain	
nucleotides	within	the	UTR	of	5’	and	3’	of	segment	10,	were	shown	to	alter	RNA	secondary	
structure	 and	 subsequently	 render	 the	 virus	 unviable	 due	 to	 insufficient	 RNA	 packaging	
(Boyce	and	McCrae,	2015).	
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The	structural	organisation	of	the	viral	dsRNA	may	further	aid	transcription	of	the	genomic	
information,	as	the	template	will	be	able	to	function	effectively	without	getting	tangled	and	
halting	the	transcriptase	activity	(Diprose	et	al.,	2001).	
		Table	1.2		BTV	genome	segments	and	the	proteins	they	encode	 	
Genome	
Segment	
No.	of	
bp	
Proteins	 Location	 Function	
1	 3954	 VP1	 Inner	Sub-	
Core	
RNA	dependent	RNA	Polymerase	
2	 2926	 VP2	 Outer	Capsid	
Shell	
Type	Specific	Structural	Protein	
Haemaglutinin	
A	role	in	Cell	Entry	
3	 2772	 VP3	 Sub-Core	 Structural	Protein,	forms	Scaffold	for	VP7	
Trimers	–	required	for	virion	assembly	
4	 2011	 VP4	 Inner	Sub-	
Core	
mRNA	capping	enzyme	–	
guanylytransferase/	methyltransferase	
5	 1639	 VP5	 Outer	Capsid	
Shell	
Structural	Protein	
A	role	in	Cell	Permeabilisation	
6	 1770	 NS1	 Non-	
Structural	
Tubules	–	An	Unknown	Function	
7	 1156	 VP7	 Core	Surface	 Structural	Protein	–	possible	role	in	cell	entry	
of	vector	cells	
8	 1123	 NS2	 Non-	
Structural	
Forms	VIB	matrix,	binds	ssRNA	
9	 2046	 VP6	
NS4	
Inner	Sub-	
Core	
Binds	ssRNA	&	dsRNA,	Helicase	activity	
Possible	protective	function	against	DNA	
degredation	
10	 822	 NS3/	
		 NS3A/	NS5	 	
Non-	
Structural	 	
Glycoproteins,	aids	virus	release	
Table	1.2	This	table	identifies	function,	protein	expressed	and	location	of	dsRNA	segments	post	
translation.		Adapted	from	(Mertens	et	al.,	1984).	
Chapter	1:		Understanding	the	early	events	in	Bluetongue	virus	cell	entry	
29	
	
	
	
	
1.5 Virion	structure	
	
	
The	mature	virion	consists	of	a	non-enveloped,	3	layered	(outer	capsid,	core	and	sub-core)	
icosahedral	capsid	structure	(Hewat	et	al.,	1992b)	that	is	approximately	80nm	in	diameter.	
Within	this	structure	lies	the	segmented,	dsRNA	genome		(Gouet		et		al.,		1999).	The	virion	
is	 made	 out	 of	 seven	 structural	 proteins	 known	 as	 VP1	 to	 VP7,	 which	 include	 3	 minor	
structural	 proteins	 VP1,	 VP4	 and	 VP6.	 Within	 infected	 cells,	 5	 distinct	 non-	 structural	
proteins	are	also	expressed,	NS1,	NS2,	NS3/	NS3A,	NS4	and	NS5	(Belhouchet	et	al.,	2011,	
Ratinier	et	al.,	2011,	Stewart	et	al.,	2015).	A	schematic	illustration	of	the	virion	can	be	seen	
in	Figure	1.2.	
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Figure	1.2	
	
	
	
	
	
Figure	1.2		Schematic	diagram	of	BTV	structure	
Diagram	 shows	 a	 schematic	 structure	 of	 BTV	with	 outer	 capsid	 proteins	 shown	 in	 blue	 (VP2)	 and	
yellow	(VP5),	core	protein	 in	green	(VP7)	and	sub-core	protein	 in	red	(VP3).	Transcriptase	complex	
proteins	and	dsRNA	genome	can	be	seen	located	inside	the	sub-core.	Adapted	from	(Mertens	et	al.,	
2004)	
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1.5.1 Outer	capsid	proteins:		VP2	and	VP5	
	
The	outer	capsid	proteins,	VP2	and	VP5	cover	the	core	particle,	which	is	formed	by	VP3	and	
VP7.	 The	 BTV	 outer	 capsid	 is	 formed	 by	 60	 trimers	 (180	 copies)	 of	 VP2,	 which	 forms	
triskelion	structures	and	120	trimers	(360	copies)	of	the	globular	protein	VP5	(Hewat	et	al.,	
1992b,	 Burroughs	 et	 al.,	 1995).	 VP2	 has	 a	 trimeric	 structure,	 which	 protrudes	 from	 the	
outer	capsid	(Hyatt	et	al.,	1993).	Being	the	most	exposed	viral	protein	of	the	mature	virion,	
VP2	 binds	 to	 the	 cellular	 receptor	 prior	 to	 cell	 entry	 (which	 will	 be	 discussed	 in	 further	
detail	in	section	1.13.1)	(Huismans,	1983,	Eaton	and	Crameri,	1989,	Hassan	and	Roy,	1999),	
contains	haemagluttinating	activity	 (Cowley	and	Gorman,	1987)	and	 specific	 epitopes	are	
recognised	 by	 neutralising	 antibodies	 of	 the	 infected	 host’s	 immune	 response	 	 (Marshall	
and	Roy,	1990,	Urakawa	et	al.,	1994,	Pierce	et	al.,	1995).	As	the	most	variable	viral	protein	
and	 the	 target	 of	 the	 hosts’	 neutralising	 antibodies,	 VP2	 also	 dictates	 the	 virus	 serotype	
(Mertens	 et	 al.,	 1989,	 White	 and	 Eaton,	 1990)	 and	 so	 is	 often	 used	 in	 diagnostics	 to	
determine	outbreak	strains	 (Mertens	et	al.,	2007).	 In	addition,	VP2	has	been	 found	to	be	
closely	associated	to	vimentin	within	the	cell	and	is	suggested	to	be	involved	in	virus	egress	
(Bhattacharya	et	al.,	2007,	Beaton	et	al.,	2002,	Wirblich	et	al.,	2006,	Hyatt	et	al.,	1993).	
	
	
	
The	 other	 outer	 capsid	 protein,	 VP5	 has	 been	 found	 to	 have	 membrane	 fusion	 activity,	
which	 aids	 cell	 entry	 of	 BTV	 (Forzan	 et	 al.,	 2004,	 Hassan	 et	 al.,	 2001)	 (which	 will	 be	
discussed	in	further	detail	in	section	1.13.2).	
1.5.2 Sub-Core	and	core	proteins:	VP3	and	VP7	
	
	
	
The	 sub-core	 layer	 is	 formed	 by	 120	 copies	 of	 the	 VP3	 protein,	 arranged	 as	 60	 dimers	
organised	into	an	icosahedral	lattice.	Five	sets	of	VP3	dimers	are	arranged	as	decamers		and	
twelve	of	these	interact	to	form	the	final	VP3	sub-core	layer	(Grimes	et	al.,	1998).			VP3	
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is	 highly	 conserved	 and	 studies	 have	 indicated	 that	 it	 plays	 an	 important	 role	 in	 virus	
assembly.	Mutated	 forms	 of	 VP3,	which	 lacked	 a	 ‘dimerisation’	 domain,	 failed	 to	 initiate	
the	formation	of	the	sub-core	particle.	However,	the	ability	to	form	dimers	and	decamers	
were	retained	(Kar	et	al.,	2004).	
	
X-ray	 crystallography	 studies	 identified	 grooves	 on	 the	 inside	 of	 the	 VP3	 layer	 that	may	
potentially	be	used	to	organise	the	dsRNA	genome	(Mertens	and	Diprose,	2004).	VP3	has	
also	been	shown	to	be	associated	with	the	enzymatically	active	core	proteins.	In	particular,	
VP1	 and	 VP4	 have	 been	 demonstrated	 to	 associate	 with	 VP3	 decamers	 and	 it	 has	 been	
suggested	that	the	assembly	of	the	sub-core	particle	is	initiated	by	the	association	of	these	
three	proteins	(Blois	et	al.,	1992,	Nason	et	al.,	2004).	
	
The	outer	layer	of	the	core	particle	is	comprised	of	260	VP7.	Cryo-EM	studies	have	shown	
that	the	VP7	trimers	are	positioned	below	the	VP2	triskelion	structures	and	interactions	are	
observed	between	 the	uppermost	part	of	 the	VP7	protein	and	VP2,	whereas	 the	sides	of	
the	 VP7	 protein	 mainly	 make	 contact	 with	 other	 VP7	 molecules	 and	 the	 globular	 VP5	
trimers	(Hewat	et	al.,	1992a,	Nason	et	al.,	2004).	
	
	
	
The	 BTV	 core	 particle	without	 VP2	 and	 VP5	 retains	 infectivity	 for	Culicoides	 (KC)	 cells	 or	
adult	 Culicoides	 spp.,	 whilst	 core	 particles	 lose	 infectivity	 in	 mammalian	 cell	 systems	
(Mertens	 et	 al.,	 1996).	 This	 suggests	 that	 VP7	 plays	 a	 role	 in	 cell	 entry	 in	 the	 vector	
Culicoides	 cells	 (which	 will	 be	 discussed	 in	 further	 detail	 in	 section	 1.13.3).	 Tan	 and	
colleagues	 created	Core	 Like	Particles	 (CLPs)	 using	native	 and	mutated	 forms	of	VP7	 and	
native	VP3	proteins.	These	CLPs	were	confirmed	to	be	structurally	and	biochemically	similar	
to	the	viral	core	particle.	
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1.5.3 Minor	BTV	Proteins:	VP1,	VP4	and	VP6	
	
	
	
Release	of	the	virus	from	endosomal	compartments,	removes	the	outer	capsid	proteins	and	
triggers	 the	core	particle	 to	become	transcriptionally	active	 (Mertens	and	Diprose,	2004).	
The	proteins	responsible	for	the	formation	of	the	replicase	complex	are	VP1	(polymerase),	
VP4	 (mRNA	 capping	 enzyme)	 and	 VP6	 (helicase).	 These	 proteins	 all	 play	 a	 role	 in	
synthesizing	capped	viral	messenger	RNA	 (vmRNA),	which	 is	extruded	 from	the	viral	 core	
into	the	cell	cytoplasm.	
	
	
	
The	 largest	 of	 the	minor	 proteins,	 VP1,	 is	 the	 viral	 RNA-dependent	 RNA	 polymerase	 and	
synthesizes	dsRNA/mRNA	from	a	plus	strand	RNA	(see	section	1.6	for	more	detail).	
	
	
	
VP4	has	been	 shown	 to	generate	 the	cap	 structure	 for	authentic	BTV	 transcripts	by	both	
guanylyltransferase	 and	 two	 distinct	methyltransferase	 reactions	 (Ramadevi	 et	 al.,	 1998,	
Blois	et	al.,	1992).	
	
	
	
Through	the	development	of	a	reverse	genetics	system	for	BTV,	the	role	of	VP6	in	the	viral	
replication	 cycle	 was	 investigated.	 It	 was	 shown	 that	 VP6	 exhibits	 activity	 in	 early	
replication	of	the	virus	and	associates	with	viral	inclusion	bodies	(VIBs)	formed	by	NS2	and	
is	believed	to	form	an	essential	component	of	the	primary	replication	complex	along	with	
VP1,	 VP3	 and	 VP4	 (Matsuo	 and	 Roy,	 2009).	 Previous	 studies	 found	 that	 VP6	 has	 RNA	
dependent	 ATPase	 	 and	 	 helicase	 	 properties	 	 (Kar	 	 and	 	 Roy,	 	 2003,	 	 Stauber	 	 	 et	 	 	 al.,			
1997).		Therefore,	VP6	is	implicated	in	unwinding	the	dsRNA	of	the	genome	in			preparation	
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for	transcription.	
	
1.5.4 Non-structural	proteins:	NS1,	NS2,	NS3/3A,	NS4	and	NS5	
	
	
	
Characteristic	formation	of	cytoplasmic	tubular	structures	or	‘tubules’	during	BTV	and	other	
Orbivirus	infections	is	resultant	of	expression	of	non-structural	protein	1	(NS1),	which	is	the	
largest	 of	 the	 non-structural	 proteins	 at	 64kDa	 (Lecatsas,	 1968,	 Murphy	 et	 al.,	 1971,	
Thomas	and	Miller,	1971,	Tsai	and	Karstad,	1970).	
	
	
	
NS1	 is	 the	 most	 abundantly	 expressed	 viral	 protein	 during	 infection	 (Van	 Dijk	 and	
Huismans,	1988),	although	the	functional	properties	of	the	tubules	are	unknown,	however,	
there	 is	 some	 suggestion	 that	 they	may	be	 involved	 in	 virus	 pathogenicity	 and	 regulated	
viral	 protein	 synthesis	 (Boyce	 et	 al.,	 2012,	 Owens	 et	 al.,	 2004).	 Expression	 of	 this	 highly	
conserved	protein	occurs	early	in	replication	(Hwang	et	al.,	1993,	Whetter	et	al.,	1990)	and	
is	predominantly	located	in	the	cell	cytoplasm,	with	some	association	with	VIBs	(Brookes	et	
al.,	 1993,	 Eaton	 et	 al.,	 1988).	 Infected	 animals	 elicit	 strong	 antibody	 responses	 to	 NS1	
(Richards	et	al.,	1988,	Roy	et	al.,	1990),	likely	due	to	its	cytoplasmic	abundance.	Therefore,	
detection	of	NS1	antibodies	is	considered	as	a	potential	candidate	for	BTV	diagnostic	ELISA	
(Anderson	et	al.,	1993).	
	
	
	
The	non-structural	protein-2	 (NS2)	 is	 the	major	component	of	VIB’s	 (Brookes	et	al.,	1993,	
Thomas	et	al.,	1990),	which	are	believed	to	be	the	site	of	replication	and	assembly.		NS2	has	
been	shown	to	bind	to	the	N-terminus	of	single	stranded	RNA	(ssRNA)	(Fillmore	et	al.,	2002,	
Lymperopoulos	et	al.,	2003,	Lymperopoulos	et	al.,	2006,	Theron	and	Nel,	1997,	Zhao	et	al.,	
1994).	VIBs	are	rich	in	ssRNA	and	all	viral	core	proteins	but	lack	ribosomes	(Brookes	
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et	al.,	1993,	Thomas	et	al.,	1990).	As	NS2	is	an	ssRNA	binding	protein,	it	may	play	a	vital	role	
in	RNA	genome	assembly	 (Lymperopoulos	et	 al.,	 2003,	 Lymperopoulos	et	 al.,	 2006).	
	
NS2	has	also	been	found	to	attract	core	protein	VP3	but	only	interacts	with	VP7	when	NS2	is	
in	complex	with	VP3,	however,	sub-core	and	core-like	particles	can	be	formed	by	VP1,	VP4,	
VP3	and	VP7	independent	of	NS2	and	so	NS2	is	not	required	for	the	early	stages	of	assembly	
(Kar	et	al.,	2007).	
	
	
	
Segment	10	of	the	BTV	genome	encodes	three	non-structural	proteins;	NS3/NS3A	and	NS5	
(Mertens	 et	 al.,	 1984,	 Stewart	 et	 al.,	 2015).	 The	 first	 open	 reading	 frame	 codes	 for	
NS3/NS3A,	whereas	 a	 second	 translation	 initiation	 site	 produces	 the	NS3A	 and	 a	 second	
open	reading	frame	codes	for	the	NS5	protein.	
	
	
	
NS3	 and	NS3A	 are	 often	 associated	with	 secretory	 pathway	 organelles	 such	 as	 the	Golgi	
apparatus,	 smooth	 surfaced	 vesicles	 and	 at	 the	 plasma	 membrane	 during	 viral	 egress	
(Hyatt	et	al.,	1991,	Wu	et	al.,	1992).	 It	has	been	suggested	that	NS3/NS3A	is	expressed	to	
higher	levels	in	insect	cells	compared	to	mammalian	cells	and	therefore	may	play	a	critical	
role	during	virus	egress	 in	 insect	cells	 (Guirakhoo	et	al.,	1995,	Hyatt	et	al.,	1993,	Van	Dijk	
and	Huismans,	1988).	Studies	using	reverse	genetics	have	shown	that	in	mammalian	cells,	
viruses	with	only	NS3	and	not	NS3A	propagate	efficiently,	whereas,	viruses	with	only	NS3A	
are	 severely	 attenuated	 (Celma	 and	 Roy,	 2011).	 Mutation	 studies	 of	 NS3	 highlighted	 a	
similar	 effect	 whereby	 virus	 particles	 were	 not	 released	 effectively	 due	 to	 a	 lack	 of
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interaction	 with	 S100A10/p11	 (calcium	 binding	 protein),	 indicating	 that	 the	 N-terminal	
region	of	NS3	plays	a	role	of	viral	release	in	mammalian	cells	(Celma	and	Roy,	2011).	This	
was	compared	to	viral	propagation	and	release	in	insect	cells	and	it	was	identified	that	both	
NS3	 and	NS3A	were	 required	 for	 viral	 release	 (Celma	 and	 Roy,	 2011).	 However,	 there	 is	
evidence	that	NS3/NS3A	are	not	essential	in	mammalian	cell	replication	(van	Gennip	et	al.,	
2014)	but	NS3/NS3A	knockout	viruses	were	unable	to	replicate	or	disseminate	in	Culicoides	
sorensis,	indicating	that	these	viral	proteins	are	essential	for	virus	propagation	in	the	vector	
(Feenstra	 et	 al.,	 2015).	 NS3	 has	 also	 been	 implicated	 as	 a	 type	 1	 interferon	 system	
antagonist	in	mammalian	cells	(Chauveau	et	al.,	2013,	Ftaich	et	al.,	2015).	
	
	
	
A	second	overlapping	open	reading	frame	(ORF)	has	recently	been	identified	in	segment	10,	
which	means	as	well	as	coding	for	NS3	and	NS3A,	the	second	ORF	also	allows	expression	of	
a	further	non-structural	protein	called	NS5	(Stewart	et	al.,	2015).	NS5	is	a	small	protein	50-	
59	 residues	 in	 length	 that	 appears	 to	 localise	 in	 the	 nucleoli	 (Stewart	 et	 al.,	 2015).	 NS5	
deleted	viruses	do	not	 appear	 to	have	altered	 replication	kinetics	 compared	 to	wild	 type	
(wt)	 viruses	 but	 viruses	without	NS5	were	 highly	 pathogenic	 in	mice,	 possibly	 suggesting	
that	NS5	plays	a	role	controlling	virus	pathogenicity	(Stewart	et	al.,	2015).	
	
	
	
A	 further	 overlapping	 reading	 frame	 was	 identified	 within	 segment	 9,	 which	 appears	 to	
encode	 a	 fourth	 non-structural	 protein	 (NS4),	 which	 is	 77	 to	 79	 amino	 acids	 in	 length	
(Belhouchet	 et	 al.,	 2011,	 Ratinier	 et	 al.,	 2011).	 Protein	 expression	 analysis	 and	 confocal	
fluorescent	 microscopy	 has	 identified	 NS4	 aggregates	 throughout	 the	 cytoplasm	 and	
nucleus	in	both	BHK	and	KC	cells	(Belhouchet	et	al.,	2011).	However,	NS4	is	localised	in	the	
nucleoli	during	early	infection		(Ratinier		et		al.,		2011).				Uncertainty	surrounds	the	NS4	
Chapter	1:		Understanding	the	early	events	in	Bluetongue	virus	cell	entry	
37	
	
	
	
protein	 function	 but	 preliminary	 data	 suggests	 NS4	 has	 a	 protective	 function	 from	 DNA	
degradation	 by	 DNase,	 however	 the	 exact	 purpose	 of	 this	 is	 yet	 to	 be	 identified		
(Belhouchet	 et	 al.,	 2011)	 and	 expression	 of	 NS4	 conferred	 an	 advantage	 to	 BTV-8		
replication	in	cells	in	an	anti-viral	state	(Ratinier	et	al.,	2011).	
	
	
	
1.6 Replication	Cycle	
	
	
The	 replication	 cycle	 of	 BTV	 begins	 with	 the	 virion	 binding	 to	 the	 outer	 surface	 of	 a	
susceptible	cell	by	interactions	between	the	VP2	outer	capsid	protein	and	cellular	receptors	
(Huismans,	1983,	Eaton	and	Crameri,	1989,	Hassan	and	Roy,	1999).	The	virus	is	then	taken	
up	by	the	cell	via	endocytosis	(Forzan	et	al.,	2007,	Gold	et	al.,	2010).	Within	endosomes,	the	
virion	 is	 exposed	 to	 a	 low	 pH	 environment,	which	 causes	 the	 virus	 to	modify	 or	 lose	 its	
outer	capsid	layer	(VP2	and	VP5)	(Hassan	et	al.,	2001,	Forzan	et	al.,	2004).	The	core	is	then	
released	into	the	host	cell	cytoplasm,	via	an	unknown	mechanism.	
	
	
	
Transcription	 of	 the	 BTV	 genome	 occurs	 within	 the	 cell	 cytoplasm,	 however,	 this	 takes	
place	within	the	intact	core	particle	in	order	to	evade	activation	of	the	host-cells	anti-viral	
defence	 responses	 to	 dsRNA	 (Jacobs	 and	 Langland,	 1996,	 Gitlin	 and	 Andino,	 2003).	
Transcriptase	functions	are	activated	after	the	outer	capsid	layer	is	removed	and	the	RNA	is	
transcribed	 and	 extruded	 out	 of	 the	 viral	 core	 particle	 (Van	 Dijk	 and	 Huismans,	 1980,	
Mertens	and	Diprose,	2004).	The	dsRNA	is	replicated	in	two	steps.	Following	unwinding	of	
the	 dsRNA	 by	 the	 viral	 helicase	 VP6,	 plus-stranded	 mRNAs	 are	 transcribed	 from	 the	
negative	 RNA	 strand	 (the	 template)	 by	 the	 polymerase	 (VP1).	 Newly	 synthesised	mRNAs	
are	 capped	 by	 VP4	 and	 leave	 the	 viral	 core	 for	 subsequent	 protein	 translation	 by	 the	
cellular	translation	machinery	(Diprose	et	al.,	2001,	Gouet	et	al.,	1999,	Grimes	et	al.,		1998,	
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Mertens	and	Diprose,	2004).	Plus	stranded	RNAs	are	later	packed	into	the	nascent	progeny	
sub-viral	 particles	 where	 they	 act	 as	 templates	 to	 synthesize	 new	 minus-strand	 RNAs	
(Mertens	et	al.,	2004).	
	
	
	
The	 BTV	 proteins	 are	 synthesized	 and	 VIBs	 are	 formed	 as	 the	 principal	 sites	 of	 RNA	
synthesis	 and	particle	assemble	 (Kar	et	 al.,	 2007).	 The	VIB	matrix	protein,	NS2,	 is	 initially	
dispersed	throughout	the	cytoplasm	but	forms	inclusion	sites	when	at	least	one	of	the	two	
phosphorylation	sites	are	phosphorylated	(Modrof	et	al.,	2005).	
	
	
	
Aside	 from	phosphorylation,	 no	other	 viral	 factors	 are	 required	 for	 assembly	 of	NS2	 into	
aggregate	structures	similar	to	VIBs	(Modrof	et	al.,	2005).	As	infection	progresses	VIBs	have	
been	shown	to	move	along	microtubules	to	the	perinuclear	region	of	the	cell	(Eaton		et	al.,	
1990,	 Mellor,	 2009)	 The	 ability	 of	 NS2	 to	 bind	 to	 ssRNA	 indicates	 a	 probable	 role	 in	
assembly,	replication	and	genome	packaging	of	BTV	(Fillmore	et	al.,	2002,	Lymperopoulos	
et	al.,	2003,	Lymperopoulos	et	al.,	2006,	Theron	and	Nel,	1997,	Zhao	et	al.,	1994).	
	
	
	
Newly	assembled	virions	are	trafficked	through	the	cell	and	are	eventually	released	out	of	
the	 cell	 by	 a	 budding	 mechanism	 or	 through	 destabilisation	 of	 the	 cell	 membrane,	
facilitated	by	non-structural	protein	NS3	and	potentially	NS1	(Guirakhoo	et	al.,	1995,	Hyatt	
et	al.,	1993,	Van	Dijk	and	Huismans,	1988,	Owens	et	al.,	2004).	
	
	
The	non-structural	protein	NS1,	which	forms	tubules,	 is	observed	as	early	as	2	hours	post	
infection	and	infection.	 Little	is	known		about		this		protein		and		what		its		role		is		in		BTV	
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infection	but	a	better	understanding	of	the	role	played	by	viral	tubules	may	be	obtained	
now	a	BTV	reverse	genetics	systems	has	been	developed	(Boyce	et	al.,	2008).	
	
	
	
Following	virion	release	from	infected	cells,	the	replication	cycle	is	then	repeated	in	
neighbouring	cells	(see	Figure	1.3).	
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Figure	1.3	
	
	
	
	
	
Figure	1.3		Schematic	diagram	of	BTV	replication	cycle	
A	schematic	drawing	representing	the	lytic	replication	cycle	of	BTV,	showing	the	major	steps	in	the	
cycle.		Adapted	from	(Patel	and	Roy,	2014).	
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1.7 Infectious	BTV	Particles	
	
Infectious	 BTV	 virions	 exist	 as	 at	 least	 three	 different	 particle	 types:	 whole	 virions,	
infectious	sub-viral	paricles	(ISVPs)	and	core	particles	(Verwoerd	et	al.,	1972,	Mertens	et	al.,	
1987).	Whole	 virions	 contain	all	 viral	proteins	described	 in	 section	1.5.	Core	particles	 are	
generated	 after	 the	 loss	 of	 outer	 capsid	 proteins,	 VP2	 and	 VP5,	 during	 uncoating	 in	
response	 to	 a	 low	pH	environment	 (Mertens	 et	 al.,	 1987).	 Core	particles	 are	 reported	 to	
have	a	5	 log	reduction	 in	 infectivity	for	BHK	cells	compared	to	whole	virions	but	maintain	
high	 infectivity	 for	 KC	 cells	 (Mertens	 et	 al.,	 1996).	 Generation	 of	 ISVPs	 occur	 during	
proteolytic	 cleavage	 of	 the	 outer	 capsid	 protein	 VP2	 with	 trypsin	 and	 chymotrypsin	
enzymes	(Mertens	et	al.,	1987,	Mertens	et	al.,	1989).	The	cleaved	products	of	VP2	remain	
in	 association	 with	 the	 viral	 particle	 (Mertens	 et	 al.,	 1987,	 Mertens	 et	 al.,	 1989).	 These	
enzymes	are	also	known	to	exist	in	Culicoides	spp.	saliva	and	exposure	of	whole	virions	to	
saliva	 results	 in	 the	 generation	 of	 ISVPs	 (Darpel	 et	 al.,	 2011).	 Other	 viruses	 undergo	
cleavage	 of	 their	 outer	 capsid	 glycoproteins,	 which	 often	 aids	 virus	 entry.	 For	 example	
Middle	 East	 Respiratory	 Syndrome	 coronavirus	 (MERS	 CoV),	 spike	 (attachment)	 protein	
undergoes	a	two-step	cleavage	by	furin,	which	then	facilitates	membrane	fusion	(Millet	and	
Whittaker,	 2014).	 	Whilst	 membrane	 fusion	 is	 unlikely	 in	 a	 non-enveloped	 virus	 such	 as	
BTV,	 the	 cleavage	 of	 VP2	 may	 influence	 virus	 entry	 and	 subsequently	 affect	 the	 virus	
infectivity.	
	
	
	
ISVPs	 generated	 from	 cell	 culture	 adapted	 BTV-1	 rSArrrr/01	 were	 observed	 as	 having	 a	
similar	 titre	on	BHK-21	cells	as	whole	virions	but	higher	 titres	on	KC	cells	 (Mertens	et	al.,	
1996,	Darpel	et	al.,	 2011).	However,	all	 studies	of	 these	particles	 to	date	have	only	been	
with	purified	core	particles	and	ISVPs		generated	from		BHK-21		cell	culture	adapted			 BTV-1	
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and	 infectivity	 of	 these	particles	may	differ	when	generated	 from	 field	 isolate	 strains	 	 of	
BTV.	
1.8 BTV	Cell	targets	
	
	
BTV	can	infect	and	replicate	in	ruminants	as	well	as	insect	hosts.	Infection	in	the	ruminant	
host	is	characterized	by	its	acute	hemorrhagic	pathology	observed	in	sheep,	which	suggests	
that	 the	 virus	 has	 an	 endothelial	 cellular	 target	 (see	 Chapter	 1,	 section	 1.2).	 Various	
techniques,	 such	 as	 PCR	 and	 in-situ	 hybridization	 and	 immunofluorescence	 microscopy	
have	 identified	 the	 presence	 of	 BTV	 in	 vascular	 endothelial	 tissues	 (Brodie	 et	 al.,	 1998).	
Cytopathic	 effect	 has	 also	 been	 observed	 in	 bovine	 and	 ovine	 primary	 endothelial	 cells	
derived	from	the	pulmonary	artery	and	lung	microvasculature	(Takamatsu	and	Jeggo,	1989,	
Barratt-Boyes	et	al.,	1992,	DeMaula	et	al.,	2001).	However,	replicating	virus	in	endothelial	
cells	has	only	been	confirmed	by	using	confocal	microscopy	using	antibodies	that	were	able	
to	distinguish	between	structural	and	non-structural	viral	proteins	(Darpel	et	al.,	2012).	
	
	
Specific	subsets	of	 leukocytes	have	been	shown	to	be	infected	with	BTV	(Barratt-Boyes	et	
al.,	 1992)	 and	 it	 is	 thought	 that	 the	 virus	 disseminates	 by	 infecting	 lymphocytes,	
macrophages,	 neutrophils,	 dendritic	 and/or	 monocytes	 (Barratt-Boyes	 et	 al.,	 1992,	
Takamatsu	and	Jeggo,	1989,	Stott	et	al.,	1990,	Maclachlan	et	al.,	2009).	Replication	of	the	
virus	 in	 leukocyte	 subsets	 of	 infected	 sheep	 has	 also	 been	 confirmed	 by	 confocal	
microscopy	 (Darpel	 et	 al.,	 2012),	 and	 although	 cellular	 subsets	 could	 not	 be	 conclusively	
identified	 they	 phenotypically	 resembled	 monocytes,	 dendritic	 cells	 and	 lymphocytes.	
Within	 the	 midge,	 BTV	 disseminates	 from	 the	 midgut	 cells	 following	 ingestion	 of	 an	
infected	blood-meal	by	a	susceptible	insect	host.	This	occurs	via	the	insects’	haemoceol	to	
the		fat	body	cells,	before	finally		replicating		in	the		salivary	glands.			Only	those				 individual	
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Culicoides	in	which	the	virus	reaches	the	salivary	gland	can	transmit	BTV	during	subsequent	
blood-feeding	to	susceptible	hosts	(Mellor,	2009).	
	
	
	
1.9 Virus	Cell	Entry	
	
	
	
Viruses	can	be	broadly	categorized	into	those,	which	are	surrounded	by	a	lipid	membrane	
derived	 from	 the	 host	 cell	 (enveloped	 viruses)	 and	 others,	 which	 lack	 a	 lipid	membrane	
(non-enveloped	 viruses).	 The	 first	 step	 of	 viral	 entry	 is	 attachment	 to	 the	 target	 cell	
(Philipson	et	al.,	1968).	The	specific	 interactions	of	a	virus	with	a	cellular	 receptor	dictate	
virus	 tropism	 and	 host	 range	 (Wise,	 1975).	 Both	 enveloped	 and	 non-enveloped	 viruses	
share	 the	 same	 basic	 steps	 of	 virus	 cell	 entry	 of	 attachment	 and	 delivery	 of	 the	 viral	
genome	 to	 the	 cell	 cytoplasm.	 The	 subsequent	 steps	 after	 cellular	 attachment	 can	 be	
divided	into	endocytic	routes	and	non-endocytic	routes.	
	
	
	
The	 non-endocytosis	 route	 occurs	 by	 direct	 penetration	 of	 the	 plasma	membrane	 and	 is	
used	by	enveloped	viruses.	Endocytosis	 routes	can	be	utilized	by	enveloped	viruses	as	an	
alternative	entry	mechanism	but	are	primarily	used	by	non-enveloped	viruses	(Devadas	et	
al.,	 2014,	Walker	 et	 al.,	 2015).	 Viruses	 can	 subvert	many	 different	 endocytosis	 pathways	
including	 clathrin-mediated	 endocytosis	 (CME),	 caveolae-dependent	 endocytosis,	
macropinocytosis	 (MPC),	 CLIC-GLEEC	 endocytosis	 and	 flotillin-dependent	 endocytosis,	 to	
name	but	a	few.	
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1.10 Non-endocytosis	entry	routes	
	
	
	
Enveloped	viruses	include	some	of	the	most	deadly	viruses,	such	as,	Ebola	(EBOV),	Human	
Immunodeficiency	 Virus	 (HIV),	 Chikungunya	 (CHIKV)	 and	 Middle	 East	 Respiratory	
Coronavirus	 (MERS	 CoV).	 These	 viruses	 employ	 simplistic	 but	 effective	 cellular	 entry	
strategies	by	 fusing	the	envelope	of	 the	virus	with	the	plasma	membrane	of	 the	host	cell	
(Plemper,	 2011).	 Membrane	 fusion	 of	 enveloped	 viruses	 is	 facilitated	 by	 glycoproteins	
(Knowles	and	Person,	1976),	which	protrude	out	of	outer	surface	of	the	virion,	(e.g.	spike	
proteins).	
	
	
	
Independent	 of	 the	 classification	 of	 glycoproteins,	 two	 basic	 steps	 in	 membrane	 fusion	
have	emerged	as	conserved	among	enveloped	viruses	(Sieczkarski	and	Whittaker,	2002).	In	
summary,	 the	 first	 step	 involves	 a	 conformational	 change	 of	 the	 fusogenic	 spike	
glycoprotein	upon	attachment	to	the	target	cell	that	results	 in	the	membrane	insertion	of	
hydrophobic,	membrane	 attack	 domains	 (fusion	 peptide	 or	 fusion	 loops).	 	 This	 results	 in		
the	 formation	 of	 a	 pre-hair-pin	 intermediate	 that	 leads	 to	 the	 engagement	 of	 the	 viral	
envelope	 with	 the	 host	 cell	 membrane	 (Plemper,	 2011).	 The	 next	 step	 results	 in	 the	
refolding	of	 the	 trimeric	 fusogenic	complex	 into	a	 trimeric	hairpin	structure,	which	brings	
the	 donor	 and	 target	 membranes	 into	 close	 proximity	 (Pelkmans	 et	 al.,	 2002,	 Dimitrov,	
2000,	 Rawat	 et	 al.,	 2003,	 Takeda	 et	 al.,	 2003,	 Waarts	 et	 al.,	 2002,	 Kielian	 et	 al.,	 2000,	
Igakura	et	al.,	2003).	Others	propose	a	theory	whereby	the	membranes	progress	towards	
each	other	through	the	formation	of	a	lipid	funnel	(Lowy	et	al.,	1990),	which	allows	merging	
of	the	curved	outer	regions	on	the	leaflets,	known	as	a	hemi-fusion	step	(Lakadamyali	et	al.,	
2003,	Dimitrov	et	al.,	1992).		The	inner	leaflets	then	fuse	to	form	a	pore	
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(Waarts	 et	 al.,	 2002,	 Kielian	 et	 al.,	 2000,	 Hogle,	 2002),	which	 allows	 delivery	 of	 the	 viral	
genome	into	the	cell	cytoplasm.	
	
	
	
1.11 Endocytosis	entry	routes	
	
	
Many	 viruses	 enter	 cells	 by	 exploiting	 ‘normal’	 endocytosis	 pathways	 (Mercer	 et	 al.,	
2010b).	 Endocytosis	 is	 a	 cellular	 process	 by	 which	 molecules	 and	 surface	 receptors	 are	
internalised	(Alberts,	2002).	There	are	many	different	pathways	of	endocytosis	that	operate	
in	mammalian	cells,	many	of	which	have	not	been	fully	characterised,	that	deliver	cargo	to	
distinct	 intracellular	 locations.	 Numerous	 studies	 have	 identified	 a	 number	 of	 different	
endocytic	pathways	that	viruses	utilize	for	entry	and	for	trafficking	to	different	parts	of	the	
cell	 (Pelkmans	 and	 Helenius,	 2003,	 Grove	 and	Marsh,	 2011)	 and	 often	 a	 given	 virus	 can	
utilize	 several	 different	 pathways.	 Distinct	 endocytic	 pathways	 are	 characterised	 by	 the	
cellular	factors	required	for	them	to	operate	(examples	outlined	in	Table	1.3.)	
.	
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Table	1.3		Endocytosis	pathways	and	their	cellular	factors	
Endocytic	
Pathway	 Cellular	Factors	
	 Clathrin-mediated	Endocytosis	
Coat	proteins	 Clathrin	heavy	chain,	clathrin	light	chain	
Adaptors	 AP2,	eps15,	epsin	1	
Scission	factors	 Dynamin-2	
Regulatory	
factors	 PI(3,4)P,	PI(4,5)P2,	cholesterol,	cortactin,	Arp2/3	
Cytoskeleton	 Actin,	microtubules	
Trafficking	 Rab5,	Rab7,	Rab4,	Rab11,	Rab22	
	 Macropinocytosis	
Coat	proteins	 None	
Scission	factors	 Unknown	
Regulatory	
factors	
Tyrosine	kinases,	PAK1,	PI(3)Kinase,	PKC,	Ras,	Rac1,	Cdc42,	Rab34,	CtBP1,	
NHE1,	cholesterol	
Cytoskeleton	 Actin,	microtubules,	myosin	II	
Trafficking	 Rab5,	Rab7,	Arf6	
	 Caveolae-dependent	
Coat	proteins	 Caveolin-1	
Scission	factors	 Dynamin-2	
Regulatory	
factors	 Tyrosine	kinases,	phosphatases,	PKC,	RhoA,	cholesterol	
Cytoskeleton	 Actin,	microtubules	
Trafficking	 Rab5	
	 Lipid	Raft	
Coat	proteins	 None	
Scission	factors	 Unknown	
Regulatory	
factors	 Tyrosine	kinases,	RhoA,	cholesterol	
Cytoskeleton	 Actin	
Trafficking	 Unknown	
	 IL-2	pathway	
Coat	proteins	 None	
Scission	factors	 Dynamin-2	
Regulatory	
factors	 RhoA,	lipid	rafts,	ubiquitination	
Cytoskeleton	 Actin	
Trafficking	 Rab5,	Rab7	
	 GEEC	pathway	
Coat	proteins	 Unknown,	GRAF1	
Scission	factors	 Unknown	
Regulatory	
factors	 Arf1,	ARHGAP10,	Cdc42,	lipid	rafts	
Cytoskeleton	 Actin	
Trafficking	 Rab5,	PI(3)K	
	 Flotillin	pathway	
Coat	proteins	 Flotillin-1	
Scission	factors	 Unknown	
Regulatory	
factors	 Fyn	kinase	
Cytoskeleton	 Unknown	
Trafficking	 Rab5,	PI(3)K	
	 Arf6	pathway	
Coat	proteins	 None	
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Scission	factors	 Unknown	
Regulatory	
factors	 PIP5K,	Arf6,	Arf1,	PI(4,5)P,	PI(3)K,	Cholesterol,	actin	
Cytoskeleton	 Actin	
Trafficking	 Rab5,	Rab7	(degredation),	Rab11,	Rab22	(recycling	only)	
	 Phagocytosis	
Coat	proteins	 None	
Adaptors	 AP2	
Scission	factors	 Dynamin-2	
Regulatory	
factors	 Tyrosine	kinases,	PI(3)K,	PKC,	Ras,	RhoA,	RhoG,	Rac1,	Cdc42,	Arf6,	cholesterol	
Cytoskeleton	 Actin,	microtubules,	myosins	
Trafficking	 Rab5,	Rab7	
Abbreviations:	 Arf1/Arf6,	 ADP-Ribosylation	 factor-1	 and	 6;	 ARHGAP10,	 Rho	 	 GTPase-activating	
protein	1;	Arp2/3,	actin	related	proteins	2	and	3;	Cdc42,	cell	division	control	protein	42;	CtBP1,	C-	
terminal	 binding	 protein	 1;	 PI(3)K,	 phosphoinositide	 3-kinase;	 PI(3,4)P,	 Phosphoinositol-3,4	
phosphate;	 PI(4,5)P2,	 Phosphoinositol-3,4	 biphosphate;	 PIP5K,	 Phosphoinositol-4-phosphate	 5	
kinase;	PKC,	protein	kinase	C;	Rab4,	-5,	-7,	-11,	-22,	Rabankyrin	4,	-5,	-7,	-11,	-22;	Rac1,	Ras-related	
C3	botulinum	toxin	substrate	1;	Ras,	Rat	sarcoma	viral	oncogene	homolog;	RhoA,	Ras	homolog	gene	
family	member	A;	RhoG,	Ras	homolog	gene	family	member	G.	
	
Table	adapted	from	(Mercer	et	al.,	2010b).	
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1.11.1 Clathrin-mediated	endocytosis	
	
	
CME	 is	 a	well-studied	 endocytic	 pathway.	 Clathrin-coated	 vesicles	 package	 and	 transport	
cargo	 from	 the	 plasma	membrane	 to	 early	 endosomes.	 There	 are	 five	 stages	 of	 clathrin-	
coated	vesicle	 formations	 (See	 Figure	1.4).	 These	are	nucleation,	 cargo	 selection,	 clathrin	
coat	 assembly,	 vesicle	 scission	 and	 uncoating,	 and	 clathrin	 component	 recycling		
(McMahon,	2011,	McMahon	and	Boucrot,	2011).	The	first	step	(nucleation)	typically		begins	
by	the	invagination	of	the	plasma	membrane	to	form	a	pit.	Recent	studies	have	shown	that	
a	number	of	nucleation	proteins	(FCHO	proteins,	Epidermal	Growth	Factor	Receptor	(EGFR)	
pathway	 substrate	 15	 (eps15)	 and	 Intersectins)	 bind	 to	 phosphatidylatidylinositol-4,5-
bisphosphate	 (PtdIns	 (4,5)P2)	 and	 define	 the	 site	 of	 clathrin	 recruitment	 and	 vesicle	
budding	(Stimpson	et	al.,	2009,	Henne	et	al.,	2010).	Depletion	of	FCHO	proteins,	eps15	or	
intersectins	 inhibits	 clathrin	 recruitment,	 showing	 that	 these	 proteins	 are	 essential	 in	
clathrin	 coated	 pit	 formation.	 In	 the	 second	 stage	 of	 CME	 (cargo	 selection)	 the	 adaptor	
protein	 2	 (AP2)	 and	 other	 cargo-specific	 adaptor	 proteins	 are	 recruited	 to	 the	 site	 of	
nucleation	 where	 they	 recruit	 specific	 receptors.	 Following	 this	 interaction,	 cargo	 is	
selected	 and	 thereby	 prompts	 the	 assembly	 of	 the	 clathrin	 coat.	 Clathrin	 triskelia	 are	
assembled	 and	 organised	 around	 the	 pit	 and	 polymerization	 of	 clathrin	 is	 thought	 to	
mediate	bending	of	the	membrane	as	the	coated	pit	 invaginates	(Hinrichsen	et	al.,	2006).	
Next	dynamin	is	recruited	by	BAR-domain	containing	proteins	at	the	neck	of	the	curvature	
of	 the	 vesicle	 (Ferguson	 et	 al.,	 2009).	 Dynamin	 undergoes	 a	 GTP	 hydrolysis	 dependent	
conformational	 change	 that	 initiates	 vesicle	 scission	 and	 release	 of	 the	 cargo-	 containing	
clathrin-coated	vesicle	 into	 the	 cell	 cytoplasm.	Dynamin	 scission	 is	 also	 common	 in	other	
endocytic	 pathways	 such	 as	 Caveloale-dependent,	 phagocytosis	 and	 IL-2	 dependent	
endocytosis.	The	ATPase	heat	shock	cognate	70	(HSC70)	and	its	cofactor	auxillin	or	cyclin	G-
associated	kinase	(GAK)	aid	the	disassembly	of	the	clathrin	coat,	the	final	
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stage	 of	 vesicle	 formation,	 which	 essentially	 ‘uncoats’	 the	 vesicle.	 The	 uncoated	 vesicles	
deliver	 cargo	 to	 early	 endosomes	 by	 a	 fusion	 event	where	 they	 are	 sorted	 for	 transport	
either	to	recycling-endosomes	or	to	late	endosomes/lysosomes	for	degradation	(McMahon	
and	Boucrot,	2011).	
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Figure	1.4.	
	
	
	
	
Figure	1.4	Diagram	depicting	cellular	requirements	and	mechanics	of	clathrin-mediated	
endocytosis	
A	diagram	showing	the	five	stages	of	clathrin	pit	formation.	Adapted	from	(McMahon	and	Boucrot,	
2011)	
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1.11.2 Cholesterol-dependent	endocytosis	
	
	
Endocytic	 pathways	 are	 fundamentally	 divided	 into	 clathrin-dependent	 and	 or	 clathrin-	
independent.	There	are	a	plethora	of	clathrin-independent	pathways,	which	 include	 lipid-	
dependent	pathways	such	as	caveolin-dependent	and	lipid-raft	dependent	endocytosis.	
	
	
	
The	 caveolae-dependent	 endocytosis	 pathway	 is	 probably	 the	 best-studied	 clathrin-	
independent	pathway.	Caveolae	are	 flask-shaped	 invaginations	of	 the	plasma	membrane,	
void	 of	 a	 clathrin	 coat	 and	 are	 instead	 comprised	 of	 cholesterol	 and	 glycosphigolipids,	
known	as	lipid	rafts	(Pelkmans	and	Helenius,	2002).	The	major	protein	components	of	these	
flasks	are	caveolins	and	the	recently	described	cavins	(Hansen	et	al.,	2011).	Stability	of	the	
caveolae	is	achieved	by	the	essential	protein	caveolin	(Fra	et	al.,	1995a,	Fra	et	al.,	1995b).	
Caveolae	 are	 found	 on	 many	 cell	 types	 in	 particular	 endothelium,	 smooth	 muscle,	 and	
fibroblasts	 (Parton	 and	 Simons,	 2007).	 Caveolae	 are	 thought	 to	 play	 a	 role	 in	 signal	
transduction	 events	 due	 to	 the	 presence	 of	 receptor	 and	 non-receptor	 tyrosine	 kinases	
(Sargiacomo	et	al.,	1993,	Lisanti	et	al.,	1993).	The	cellular	cytoskeleton	comprised	of	actin	is	
disrupted	 as	 caveolae	 are	 internalized	 and	 dynamin	 is	 found	 at	 the	 neck	 of	 the	 caveolar	
vesicle	(Oh	et	al.,	1998,	Henley	et	al.,	1998).	Dynamin	is	present	to	aid	vesicle	scission	as	it	
does	during	CME.	 Internalization	of	 caveolae	 requires	 ligand	binding	 in	order	 to	 trigger	a	
phosphorylation	cascade,	which	induces	the	downstream	trafficking	of	the	caveolar	vesicle	
(Williams	and	Lisanti,	2004).	SV40,	cholera	toxin	b,	shiga	toxin	and	many	others	are	known	
to	 be	 endocytosed	 via	 the	 caveolar	 pathway.	 However,	 variations	 in	 the	 internalization	
process	between	different	 ligands	mean	that	 it	 is	difficult	to	describe	a	common	pathway	
employed	by	all	ligands.	
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1.11.3 Macropinocytosis	
	
	
Early	 publications	 suggested	 macropinocytosis	 (MPC)	 was	 an	 indiscriminate	 fluid-phase	
uptake	 mechanism	 primarily	 used	 to	 internalise	 large	 volumes	 of	 fluid	 and	 membranes	
(Swanson	 and	Watts,	 1995).	However,	 there	 is	 growing	 evidence	 that	MPC	 is	 a	 triggered	
cellular	 mechanism,	 where	 multiple	 forms	 of	 the	 pathway	 exist	 (Mercer	 and	 Helenius,	
2008,	Mercer	and	Helenius,	2010,	Mercer	et	al.,	2010a,	Hetzenecker	et	al.,	2015).	MPC	 is	
driven	by	actin	polymerisation	and	complex	signalling	cascades	(Yarden,	2001)	that	initiate	
increased	 fluid-phase	 uptake	 and	 temporarily	 alter	 cellular	 behaviour	 (Mercer	 and	
Helenius,	2012).	
	
	
	
There	 are	 a	 number	 of	 characteristic	 features	 of	 MPC	 that	 define	 this	 pathway.	 MPC	
involves	 formation	of	 large	uncoated	 ruffles	 at	 the	plasma	membrane,	which	 close	up	 to	
form	 fluid-filled	 vacuoles	 known	 as	 macropinosomes	 (reviewed	 in	 (Swanson,	 2008)).	
External	 stimuli	 can	 be	 required	 for	 the	 activation	 of	 MPC	 and	 often	 involves	 growth	
factors,	which	activate	receptor	tyrosine	kinases	(RTK)	(Hubbard	and	Miller,	2007,	Bryant	et	
al.,	 2007).	 However,	 some	 viruses	 are	 also	 known	 to	 directly	 initiate	 MPC	 (Mercer	 and	
Helenius,	 2008,	 Locker	 et	 al.,	 2000,	 Huang	 et	 al.,	 2008).	 Small	 guanine	 triphosphotases	
(GTPases)	 play	 a	 critical	 role	 in	MPC	 (Van	 den	 Broeke	 et	 al.,	 2014,	 Begum	 et	 al.,	 2004).	
Activation	 of	 Ras	 GTPases	 by	 receptor	 tyrosine	 kinase	 (RTK)	 initiates	 three	 arms	 of	 the	
signalling	 pathway,	 involving	 Ras-related	 C3	 botulinum	 toxin	 substrate	 1	 (Rac1),	 ADP-	
Ribosylation	factor	6	(Arf6),	Ras	related	protein	Rab5	(Rab	5)	and	Phosphatidylinositol-4,5-
bisphosphate	3-	 kinase	 (PI3	Kinase)	 (Bar-Sagi	 and	 Feramisco,	 1986,	Bar-Sagi	 et	 al.,	 1987).	
These	 GTPases	 modulate	 membrane	 ruffling,	 macropinosome	 closure	 and	 membrane	
trafficking.	 For	 example,	 Rac1	 potentiates	 all	 three	 types	 of	membrane	 ruffling	 (circular,	
lamellipodia			 and	
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blebs)	 (Ridley	 and	 Hall,	 1992a,	 Ridley	 et	 al.,	 1992,	 Mercer	 and	 Helenius,	 2008),	 Rab	 5	
associates	with	circular	ruffles	and	facilitates	trafficking	to	early	endosomes	(Lanzetti	et	al.,	
2004,	Schnatwinkel	et	al.,	2004)	and	Arf6	is	involved	in	endocytic	membrane	trafficking	and	
plasma	membrane	 remodelling	 (Donaldson,	2005,	 Svensson	et	al.,	 2006,	 Lundmark	et	al.,	
2008b,	Radhakrishna	et	al.,	1999,	Radhakrishna	et	al.,	1996).	
	
	
	
Downstream	 to	 Ras	 GTPases,	 the	most	 important	 kinase	 in	MPC,	 p21	 activated	 kinase	 1	
(PAK1)	 is	activated	by	Rac1	(Parrini	et	al.,	2005,	Dharmawardhane	et	al.,	2000).	Dynamics	
and	motility	of	 the	 cytoskeleton	 is	 regulated	by	 the	 serine/threonine	kinase,	PAK1	and	 is	
required	 at	 all	 stages	 during	 MPC	 (Galisteo	 et	 al.,	 1996).	 PAK1	 relocates	 to	 the	 plasma	
membrane	upon	activation	and	potentiates	several	effectors	needed	for	the	generation	of	
membrane	 ruffles,	 blebs	 and	macropinosome	 formation	 (Dharmawardhane	 et	 al.,	 1999).	
PAK1	 also	 drives	 macropinosome	 closure	 by	 activating	 carboxy terminal-binding	
protein 1/brefeldin	 A ADP	 ribosylated	 substrate	 (CtBP-1)	 (Liberali	 et	 al.,	 2008).	
Therefore,	 PAK1	 is	 needed	 from	 initiation	 of	 plasma	 membrane	 rearrangements	 to	
macropinosome	formation	and	closure	(Parrini	et	al.,	2005,	Dharmawardhane	et	al.,	2000,	
Liberali	et	al.,	2008).	In	addition	to	PAK1,	a	number	of	other	kinases	also	play	a	role	in	the	
stimulation	of	membrane	 ruffling	and	MPC.	These	 include	protein	kinase	C	 (PKC)	and	Src	
Family	Kinase	(SFK)	(Miyata	et	al.,	1989,	Sandilands	et	al.,	2004,	Donepudi	and	Resh,	2008).	
Other	 cellular	 factors	 are	 also	 involved	 in	 MPC,	 such	 as,	 Sodium-Proton	 Exchanger	 1	
(NHE1),	which	are	 also	 known	 to	be	 involved	 in	membrane	 ruffle	 formation	 (West	 et	 al.,	
1989).	
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Detachment	of	macropinosomes	from	the	plasma	membrane	allows	them	to	move	deeper	
into	 the	 cytoplasm	 where	 they	 undergo	 acidification	 (West	 et	 al.,	 1989,	 Hewlett	 et	 al.,	
1994).	Trafficking	of	macropinosomes	appears	to	be	dependent	on	cell	type	and	the	type	of	
induction	(Mercer	and	Helenius,	2009).	Many	viruses	have	been	identified	as	utilising	MPC,	
either	directly	for	productive	infection	or	indirectly	to	assist	penetration	of	virions.	There	is	
mounting	 evidence	 that	 viruses	 can	 activate	 different	 combinations	 of	 cellular	 factors	
required	 for	MPC.	 Some	 viruses	 that	 use	MPC	 for	 entry	 also	 require	 dynamin,	 a	 GTPase	
(Gold	et	al.,	2010)	that	was	previously	thought	to	be	only	required	for	CME.	In	addition,	it	
appears	that	some	viruses	that	use	MPC	require	myosin	II,	whilst	others	do	not	(Mercer	and	
Helenius,	 2009).	 A	 diagram	 demonstrating	 macropinocytosis	 complex	 signalling	 pathway	
can	be	seen	in	Figure	1.5.	
	
1.11.4 Other	endocytosis	pathways	
	
	
Some	 of	 the	 lesser-described	 endocytosis	 pathways	 include	 Clathrin-independent	
carriers/GPI	 enriched	 early	 endosomal	 compartments	 (CLIC-GLEEC)	 endocytosis,	 Arf6	
dependent	 endocytosis,	 Flotillin-mediated	 endocytosis	 and	 phagocytosis	 (Conner	 and	
Schmid,	 2003,	 Mayor	 and	 Pagano,	 2007,	 Sandvig	 et	 al.,	 2008,	 Stagg	 et	 al.,	 2007).	
Morphology	 of	 endocytic	 intermediates	 at	 the	 plasma	 membrane	 aids	 identification	 of	
endocytic	 processes.	 The	 formation	 of	 invaginations	 at	 the	 plasma	membrane	 are	 often	
coated	 in	 either	 –clathrin	 (CME),	 caveolin	 (Caveolae-dependent	 endocytosis),-	 or	 flotillin.		
Flotillin	 are	membrane	proteins	which	 form	microdomains	 at	 the	 plasma	membrane	 and	
have	been	associated	in	a	number	of	processes	that	include	endocytosis	(flotillin	acts	as	a	
scaffolding	 protein	 within	 calveolar	 membranes,	 which	 form	 calveolae	 or	 calveolae-like	
vesicles)	or	they	have	distinct	membrane	formations	such	as	membrane	ruffling	seen	with	
MPC	(Hansen	and	Nichols,	2009),	signal	transduction	and	the	regulation	of	the	cytoskeleton	
(Otto	and	Nichols,	2011).	Phagocytosis	shares	similarities	to	marcopinocytosis	but	requires	
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AP2	 and	 is	 usually	 restricted	 to	 specialized	 cells	 such	 as	macrophages	 (Araki	 et	 al.,	 1996,	
Gold	 et	 al.,	 1999,	Heinsbroek	 et	 al.,	 2009).	 	 Flotillin-mediated	 endocytosis	 appears	 to	 be	
independent	 of	 both	 clathrin	 and	 dynamin	 and	 results	 in	 the	 formation	 of	 flask-shaped,	
flotillin	 decorated	 pits	 which	 are	 known	 to	 traffic	 to	 the	 early	 endosomes	 (Frick	 et	 al.,		
2007).	 CLIC-GLEEC	 endocytosis	 forms	 GTPase	 regulator	 associated	 with	 focal	 adhesions	
kinase	(GRAF1)	coated	tubular	 invaginations	at	the	plasma	membrane	and	is	regulated	by	
lipid	 raft	 domains	 and	 facilitated	 by	 actin	 (Lundmark	 et	 al.,	 2008a).	 Other	 endocytosis	
mechanisms	are	summarised	in	Table	1.3.	
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Figure	1.5	
	
	
	
	
	
Figure	1.5		Diagram	of	signaling	cascade	during	macropinocytosis	activation	
Diagram	shows	signaling	molecules	required	during	each	step	of	macropinocytosis	from	virus/ligand	
binding	to	vesicle	trafficking.		Adapted	from	(Mercer	and	Helenius,	2012).	
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1.11.5 Viruses	that	utilize	endocytosis	for	cell	entry	
	
	
Viruses	are	commonly	used	as	a	tool	to	study	cellular	endocytosis	mechanisms	as	they	can	
often	be	 fluorescently	 tagged	or	 antibody	 labelled	 (Pelkmans	 and	Helenius,	 2003),	which	
has	 allowed	many	 viruses	 entry	mechanisms	 to	 be	 elucidated.	 The	 first	 virus	which,	was	
shown	 to	 use	 CME	 for	 cellular	 infection	 was	 Semliki	 Forest	 virus	 (SFV)	 (Helenius	 et	 al.,	
1980).	It	was	identified	that	SFV	employed	a	stepwise	endocytic	entry	pathway.	The	outer	
surface	of	SFV	firstly	binds	via	multiple	sites	to	the	cell	surface	via	receptors.	The		virus	then	
laterally	diffuses	in	the	plane	of	the	membrane	and	is	sequestered	into	clathrin	coated	pits,	
which	once	internalised	via	CME,	form	clathrin	coated	vesicles.	Vesicles	are	then	trafficked	
to	early	endosomes,	where	low	pH	allows	penetration	through	the	endosomal	membrane	
via	viral	spike	glycoproteins,	a	process	which	is	mediated	by	membrane	fusion	that	allows	
delivery	of	the	virus	to	the	cell	cytosol	(Helenius	et	al.,	1980).	Similarly	 it	has	been	shown	
that	FMDV	utilize	CME	which	is	 initiated	by	binding	to	the	receptor;	 intergrin	αVβ6	and	is	
trafficked	 to	 early	 endosomes	 (Berryman	 et	 al.,	 2005).	 The	 mechanism	 of	 release	 from	
endosomal	 compartments	 is	 yet	 to	 be	 fully	 elucidated	 but	 may	 occur	 via	 a	 similar	
mechanism	 as	 the	 related	 Human	 Rhinovirus	 whereby	 the	 myristoylated	 viral	 capsid	
protein,	VP4	induces	membrane	permeability	via	the	formation	of	a	pore	(Panjwani	et	al.,	
2014).	
	
	
	
The	 first	 virus	 to	 be	 confirmed	 as	 entering	 cells	 via	 caveolae	 is	 the	 non-enveloped	 DNA	
virus,	 Simian	 virus	 40	 (SV40)	 (Hummeler	 et	 al.,	 1970,	 Anderson	 et	 al.,	 1996,	 Stang	 et	 al.,	
1997,	Mackay	 and	 Consigli,	 1976).	 Caveolae	 is	 a	 triggered	 endocytosis	mechanism	which	
initialises	 clustering	 of	 lipid	 raft	 components	 such	 as	 glycosylphosphatidylinositol	 (GPI)-	
anchored	proteins	and	Major	Histocompatibility	Complex	(MHC)	class	I	molecules	at	the	
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plasma	membrane	(Pelkmans	and	Helenius,	2002,	Stang	et	al.,	1997,	Verkade	et	al.,	2000,	
Anderson	et	al.,	1998,	Simons	and	Toomre,	2000).	SV40	binds	to	the	cell	surface	via	MHC	
class	 I	 and	 migrates	 laterally	 along	 the	 plasma	 membrane	 until	 they	 reside	 in	 caveolae	
(Anderson	et	al.,	1998,	Pelkmans	et	al.,	2001).	Once	inside	caveolae	initiation	of	signalling	
via	 tyrosine	 phosphorylation	 triggers	 depolymerisation	 of	 the	 actin	 cytoskeleton	 and	
production	 of	 PtdIns	 (4,5)P2.	 Upon	 scission	 via	 dynamin,	 virus	 loaded	 caveolae	 are	
internalised	 into	 the	 cytosol	 (Pelkmans	 et	 al.,	 2002).	 Caveolae	 were	 first	 believed	 to	 be	
trafficked	to	organelles	known	as	caveosomes	(Pelkmans	et	al.,	2001),	which	were	later	to	
be	disregarded	as	experimental	artifacts	and	SV40	is	now	believed	to	be	trafficked	directly	
to	 the	 early	 endosomes	 (Pelkmans	 and	 Zerial,	 2005,	 Pelkmans	 et	 al.,	 2004,	 Hayer	 et	 al.,	
2010).	 In	 addition	 to	 SV40,	 Echovirus	 1	 has	 also	 been	 shown	 to	 utilise	 a	 caveolae	 entry	
mechanism	 after	 binding	 to	 integrins	which	 subsequently	 initiates	 downstream	 signalling	
(Marjomaki	et	al.,	2002).	
	
	
	
Many	viruses	have	been	identified	to	use	macropinocytosis	for	productive	infection	either	
as	 a	 direct	 entry	 mechanism	 or	 as	 an	 assisted	 entry	 mechanism	 (Mercer	 and	 Helenius,	
2009).	 	 Mature	 virions	 of	 Vaccinia	 virus	 (VV)	 use	 a	 macropinocytic	 entry	 mechanism	 in		
tissue	 culture	 cells	 by	 mimicking	 apoptotic	 bodies	 which	 are	 internalised	 by	 cells	 via	
macropinocytosis	 (Mercer	 and	 Helenius,	 2008,	 Locker	 et	 al.,	 2000,	 Huang	 et	 al.,	 2008).	
Studies	revealed	that	macropinocytosis	seems	to	be	the	predominant	entry	mechanism	of	
VV	 (with	membrane	 fusion	as	a	minor	entry	mechanism)	and	virions	are	 internalised	 into	
large	 uncoated	 vacuoles	 that	 fuse	 at	 low	pH	 (Townsley	 et	 al.,	 2006).	 VV	 also	 initiates	 an	
increase	 in	 fluid	 phase	 uptake	 and	 the	 virus	 has	 been	 shown	 to	 trigger	 actin	
rearrangements	 and	 Rac1	 signalling	 (Mercer	 and	 Helenius,	 2008,	 Locker	 et	 al.,	 2000).	
Additional		inhibitor	studies		identified	requirements	for		several		serine/threonine	 tyrosine	
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and	 phosphatidylinositol	 kinases	 (PAK1,	 PKC	 and	 PI3	 kinase),	 sodium-proton	 exchangers,	
myosin	 II	 and	 cholesterol	 (Locker	 et	 al.,	 2000,	Mercer	 and	 Helenius,	 2008,	 Chung	 et	 al.,	
2005).	 The	 virus	 was	 also	 shown	 as	 colocalising	 with	 fluid-phase	 markers	 and	 triggering	
blebbing	 at	 the	 plasma	 membrane,	 characteristics	 which	 typify	 macroinocytosis	 (Lucas,	
2008).	Group	B	coxsackieviruses	(CVB)	are	also	believed	to	enter	cells	via	macropinocytosis	
at	epithelia	tight	junctions	and	are	internalised	in	macropinosomes	that	are	dependent	on	
Rab5,	Ras,	Rab34,	sodium-proton	exchangers	and	PKC	(Coyne	et	al.,	2007).	
	
	
	
1.12 Dynamin	
	
	
	
Dynamins	 are	 guanine	 triphosphatases	 (GTPases)	 that	 are	 members	 of	 a	 protein	
superfamily	 that	 includes	 classical	 dynamins,	 dynamin-like	 proteins,	 OPA1,	 Mx	 proteins,	
mitofusins	and	guanylate-binding	proteins/atlastins	(Praefcke	and	McMahon,	2004,	Schmid	
and	Frolov,	2011).	One	member	of	this	family	is	a	GTPase	known	as	Dynamin	(Schmid	and	
Frolov,	 2011).	 Dynamin	 was	 first	 identified	 in	 the	 temperature	 sensitive	 Drosophila	
dynamin	Shibire	mutant	(Kosaka	and	Ikeda,	1983)	and	later	it	was	identified	that	dynamin	
played	 a	 role	 in	 scission	 of	 clathrin	mediated	 pits	 (van	 der	 Bliek	 and	Meyerowitz,	 1991,		
Chen	 et	 al.,	 1991).	 Dynamin	 assembles	 into	 helical	 structures	 at	 the	 neck	 of	 budding	
vesicles.	Hydrolysis	of	GTP	promotes	a	conformational	change	 in	dynamin,	which	aids	the	
action	of	vesicle	scission	(Marks	et	al.,	2001).	The	elucidation	of	the	action	of	this	mechano-
chemical	enzyme	using	energy	from	hydrolysis	of	GTP	to	GDP	to	mediate	fission	of	clathrin	
coated	pits	from	the	membrane	(Hinshaw	and	Schmid,	1995)	were	then	described	to	form	
structures	 around	 the	 necks	 of	 the	 clathrin	 coated	 pit	 prior	 to	 scission	 (De	 Camilli	 et	 al.,	
1995,	Takei	et	al.,	1995).								However,	the	precise	mode	of	action	of	dynamin	
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has	not	 yet	 been	determined.	As	well	 as	 scission	mechanisms	 in	 endocytosis,	 dynamin	 is	
also	 involved	 in	 a	 number	 of	 other	 cellular	 processes,	 such	 as	 cell	 signalling,	 trafficking	
events	and	budding	from	the	golgi	in	the	secretory	pathway	(Urrutia	et	al.,	1997,	Cao	et	al.,	
1998,	McNiven	et	al.,	2000a).	
	
	
There	 are	 three	 isoforms	 of	 dynamin;	 dynamin-1,	 dynamin-2	 and	 dynamin-3	which	 have	
differential	 tissue	 distributions	 (Cao	 et	 al.,	 1998).	 Dynamin-2	 is	 generally	 ubiquitously	
expressed	in	tissues	(Cook	et	al.,	1994)	but	dynamin-1	is	highly	expressed	in	neuronal	cells	
(Ferguson	 et	 al.,	 2007,	 Nakata	 et	 al.,	 1991)	while	 dynamin-3	 is	 predominantly	 located	 in	
brain	and	testis	(Cao	et	al.,	1998,	Raimondi	et	al.,	2011).	It	has	been	reported	that	different	
dynamin	 isoforms	 have	 different	 protein-protein	 interactions	 and	 this	 may	 affect	 lipid	
binding	and	membrane	 fission	activity	 (Xue	et	 al.,	 2011,	Bodmer	et	 al.,	 2011,	Gray	et	 al.,	
2003).	Furthermore,	each	isoform	of	dynamin	contains	multiple	splice	variants	(Cao	et	al.,	
1998).	Dynamin-1	has	been	reported	to	have	8	splice	variants	and	dynamin-3	is	thought	to	
have	13	splice	variants	(Cao	et	al.,	1998).	Dynamin-2	has	had	four	splice	variants	identified,	
which	are	termed	dynamin-2	aa,	dynamin-2	bb,	dynamin-2	ba	and	dynamin-2	ab	(Cao	et	al.,	
1998).	 Dynamin-2	 splice	 variants	 have	 been	 reported	 to	 be	 involved	 predominantly	 in	
different	endocytosis	pathways	such	as	clathrin-mediated	endocytosis,	caveolae-mediated	
endocytosis	and	macropinocytosis	(Cao	et	al.,	2007).	
	
	
Dynamins	 comprise	 of	 five	 domains.	 The	 domain	 responsible	 for	 GTP	 binding	 and		
hydrolysis	known	as	the	G	domain,	the	pleckstrin	homology	(PH)	domain	which	is	involved	
in	cell	signalling	and	cellular	compartment	membrane	targeting,	a	middle	domain,	which	is	
responsible	 for	dynamin’s	 tetrameric	structure	and	plays	a	critical	 role	 in	self-assembly	at	
the		necks	of	vesicles		(Ramachandran		et		al.,	2007).			The	GTPase		effector	domain				(GED),	
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which	 is	also	needed	for	assembly	 (Marks	et	al.,	2001)	and	the	proline	rich	domain	 (PRD)	
required	 for	protein-protein	 interactions	which	are	 facilitated	by	the	ability	of	 the	PRD	to	
bind	to	SH3	domains	found	in	other	proteins	(Kessels	et	al.,	2001,	Mise-Omata	et	al.,	2003,	
Lai	 et	 al.,	 1999,	 McNiven	 et	 al.,	 2000b,	 Ringstad	 et	 al.,	 1997,	 Wigge	 et	 al.,	 1997).	 	 A	
schematic	representation	of	the	functional	domains	of	dynamin	can	be	seen	in	Figure	1.6.	
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Figure	1.6	
	
	
	
	
	
	
	
Figure	1.6		Diagram	of	Dynamin	functional	domains	
Diagram	shows	the	five	functional	domains	of	dynamin	and	the	schematic	location	on	the	protein.	
Adapted	from	(Faelber	et	al.,	2012).	
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1.13 BTV	Cell	Entry	
	
There	has	been	limited	research	in	BTV	cell	entry	and	all	research	to	date	has	been	with	cell	
culture	adapted	viruses	and	non-host	derived	cells.	
1.13.1 The	BTV	Receptor	and	the	Role	of	VP2	in	Cell	Attachment	
	
	
	
	
The	cellular	receptor	that	BTV	engages	with	prior	to	entry	has	not	been	fully	characterised.	
However,	there	have	been	a	number	of	putative	receptors	identified	that	may	interact	with	
virions	 at	 the	 cell	 surface.	Glycoproteins	 aided	by	 sialic	 acid	 acting	 as	 a	 co-receptor	have	
been	 proposed	 to	 interact	 with	 BTV	 in	 mouse	 L929	 cells	 and	 VP2	 has	 been	 shown	 to	
strongly	bind	to	Glycophorin	A	in	erythrocytes	((Eaton	and	Crameri,	1989,	Hassan	and	Roy,	
1999)).	There	 is	 limited	evidence	that	 the	pre-binding	of	BTV	with	heparan	sulphate	 (HS),	
subsequently	reduces	virus	binding	to	cells	((Mecham	and	McHolland,	2010))	suggesting	HS	
as	a	possible	receptor.	
	
	
	
The	cellular	attachment	protein	of	BTV	has	been	identified	as	the	protruding	outer	capsid	
protein,	 VP2	 (Huismans	 and	 Erasmus,	 1981,	 Eaton	 and	 Crameri,	 1989,	 Hassan	 and	 Roy,	
1999).	Removal	of	VP2	from	the	virions	has	shown	the	virus	particle	as	incapable	of	binding	
to	 BHK-21	 cells,	 which	 suggest	 that	 VP2	 is	 the	 primary	 attachment	 protein	 of	 the	 virus	
(Huismans	and	Erasmus,	1981).	VP2	has	been	shown	to	share	structural	similarities	to	Class	
I	fusion	proteins	of	enveloped	viruses	(Forzan	et	al.,	2004).		VP2	is	susceptible	to	cleavage	
by	 proteases	 such	 as	 chymotrypsin	 and	 trypsin,	 which	 can	 be	 found	 in	 midge	 saliva	
(Mertens	 et	 al.,	 1996,	 Darpel	 et	 al.,	 2011).	 Cleavage	 steps	 of	 viral	 attachment	 	 	 proteins			
often			facilitate			virus			entry,		particularly			in			enveloped				 viruses	
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(Millet	 and	 Whittaker,	 2014,	 Krzyzaniak	 et	 al.,	 2013,	 Follis	 et	 al.,	 2006),	 however,	 this	
scenario	 has	 not	 currently	 been	 investigated	 for	 BTV.	 Membrane	 bound	 BTV	 has	 been	
detected	 upon	 virus	 egress	 from	 cells	 (Mertens,	 2011),	 and	 cleavage	 of	 VP2	 may	 be	
required	to	facilitate	fusion	entry	in	membrane	bound	virions,	however	due	to	the	inability	
of	purifying	membrane	bound	virions,	this	has	not	been	studied.	
	
	
	
1.13.2 Role	of	VP5	in	BTV	Cell	Entry	
	
	
	
	
Class	I	fusion	proteins	of	several	enveloped	virus	share	structural	similarities	to	VP5	of	BTV	
(Forzan	et	al.,	2004).	VP5	has	been	shown	to	have	membrane	permeabilisation	properties,	
which	 are	 hypothesised	 as	 being	 required	 for	 virus	 release	 from	 the	 endosomal	
compartments	after	activation	from	the	low	pH	environment	(Forzan	et	al.,	2004,	Hassan	et	
al.,	 2001).	 The	 predicted	 structure	 of	 VP5	 is	 a	 C-terminal	 globular	 domain	 and	 an	 N-	
terminal	 coiled	 coil	 domain,	 linked	 by	 a	 hinge	 region	 (Hassan	 et	 al.,	 2001,	 Forzan	 et	 al.,	
2004).	 The	 predicted	 amphipathic	 helices	 at	 the	 N-terminus	 of	 VP5	 show	 structural	
similarities	to	those	of	the	fusion	proteins	of	enveloped	viruses	and	VP5	is	thought	to	play	a	
major	 role	 in	 the	 penetration	 of	 cellular	membranes.	 A	 recombinant	 VP5	 expressed	 as	 a	
fusion	 protein	 with	 Glutathione	 S-transferase	 was	 shown	 to	 bind	 and	 permeabilise	
mammalian	and	Culicoides	cells	and	mutant	 forms	of	VP5	which	 lack	amphiphatic	helices	
were	 shown	 not	 to	 exhibit	 binding	 and	 penetration	 activity.	 This	 confirmed	 that	 these	
structures	are	essential	for	fusion	activity	and	cellular	membrane	destabilisation	(Hassan	et	
al.,	 2001).	 The	 fusion	 activity	 of	 VP5	 is	 thought	 to	 be	 responsible	 for	 the	 formation	 of	
syncytium	 in	 infected	 cells	 (Forzan	 et	 al.,	 2004).	 In	 addition,	 VP5	was	 shown	 to	 co-purify	
with	lipid	raft	domains	and	a	motif	with	similarities	to	a	soluble	N-ethylmaleimide-sensitive	
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fusion	attachment	protein	receptor	(SNARE)	domain	was	identified	in	VP5	and	was	shown	
to	associate	with	lipid	rafts	(Bhattacharya	and	Roy,	2008).	
	
	
1.13.3 Role	of	VP7	in	BTV	Cell	Entry	
	
	
	
	
The	 structural	 protein,	VP7,	which	 forms	 the	outer	 surface	of	 the	BTV	 core	particle	have	
been	shown	to	confer	infectivity	in	Culicoides	spp.	and	KC	cells,	a	phenomenon	which	is	not	
shared	 with	 mammalian	 cells	 (Mertens	 et	 al.,	 1987,	 Mertens	 et	 al.,	 1996,	 Mellor	 et	 al.,	
2000).	 	This	 is	suggestive	that	core	particles	may	partake	 in	alternative	entry	mechanisms		
to	whole	virions	in	insect	cells	(Tan	et	al.,	2001).	
	
	
	
An	 arginine-glycine-aspartate	 (RGD)	 tripeptide	 has	 been	 identified	 in	 the	 VP7	 protein	 of	
BTV.	 This	 motif,	 located	 at	 amino	 acid	 (aa)	 residues	 168	 to	 170	 has	 been	 shown	 to	 be	
exposed	on	the	exterior	of	core	particles,	suggesting	a	possible	role	in	cell	entry	(Grimes	et	
al.,	1998).	RGD	tripeptides	have	been	shown	to	interact	with	the	integrin	family,	as	similar	
mechanism	as	seen	with	FMDV	(Jackson	et	al.,	1997,	 Jackson	et	al.,	2004).	The	externally	
exposed	nature	of	the	RGD	motif	may	indicate	a	role	in	attachment	with	insect	cells.	(Xu	et	
al.,	 1997,	 Tan	 et	 al.,	 2001).	 Whilst	 monoclonal	 antibodies	 to	 the	 RGD	 peptide	 blocked	
binding	of	core	particles	to	KC	cells	(Tan	et	al.,	2001),	BTV	cores	were	shown	not	to	interact	
with	integrin	αVβ3	(Arnaout	et	al.,	2002).	Glycosaminoglycans	(GAGs)	have	been	shown	to	
inhibit	 binding	of	 core	particles	 to	KC	 cells	where	potency	of	binding	 correlated	with	 the	
increased	sulphination	of	the	GAGs	and	therefore	negative	charge.	(Hutchinson.,	1999).	
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1.13.4 BTV	and	Endocytosis	
	
	
	
	
Two	 different	 endocytosis	 pathways	 have	 been	 independently	 proposed	 as	 cell	 entry	
mechanisms	of	BTV.	The	first	identified	pathway,	CME	used	non-purified	virus	and	culture-	
adapted	 BTV-10	 and	 endocytosis	 mechanisms	 were	 investigated	 in	 HeLa	 and	 Vero	 cells	
(Forzan	et	al.,	2007).	The	second	pathway	 identified,	MPC,	employed	purified	BHK-21	cell	
culture-adapted	 BTV-1	 and	 BHK-21	 cells	 (Gold	 et	 al.,	 2010).	 Both	 studies	 agree	 that	 BTV	
entry	 requires	 a	 low	 pH	 dependent	 step,	 indicating	 that	 virus	 delivery	 to	 an	 acidic	
compartment	 facilitates	 productive	 infection.	 Both	 observations	 are	 consistent	 with	 the	
virus	 using	 receptor-mediated	 endocytosis	 as	 a	 mechanism	 of	 cellular	 internalisation	
(Forzan	et	al.,	2007,	Gold	et	al.,	2010).	
	
	
CME	 was	 proposed	 as	 the	 internalisation	 mechanism	 used	 by	 BTV-10	 by	 Forzan	 and	
colleagues	 (2007).	A	macropinocytosis-like	 cell	 entry	mechanism	was	proposed	 for	 BTV-1		
by	Gold	et	al.,	(Gold	et	al.,	2010).	The	first	study	showed	reduced	virus	internalization	and	
infection	 when	 clathrin-dependent	 endocytisis	 was	 inhibited	 by	 small	 interfering	 RNA	
(siRNA)	 which	 target	 the	 μ2	 subunit	 of	 the	 clathrin-AP2	 adaptor	 complex	 in	 HeLa	 cells	
(Forzan	et	al.,	2007).	 In	addition,	 virus	appeared	 to	co-localise	with	 fluorescently	 labelled	
transferrin	 at	 the	 cell	 surface,	 and	 treatment	 of	 Vero	 cells	 with	 clathrin	 inhibitor,	
Chlorpromazine	 reduced	 virus	 infectivity	 (Forzan	 et	 al.,	 2007).	 The	 study	 also	 found	 that	
treatment	 of	 cells	 with	 Nystatin,	 a	 cholesterol	 inhibitor	 had	 no	 impact	 on	 BTV	 infection	
(Forzan	et	al.,	2007).	However,	as	the	virus	used	in	this	study	was	not	purified,	it	is	possible	
that	 components	 in	 the	 cell	 lysate,	 such	 as	 growth	 factors	 and	 cytokines	 could	 activate	
certain	endocytosis	mechanisms	(Bryant	et	al.,	2007).	
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In	contrast,	BTV	uptake	and	 infection	were	not	 inhibited	 in	BHK-21	cells	by	expression	of		
DN	mutants	of	AP180	(a	protein	required	for	CME)	or	the	DN	dynamin-2	isoform	‘aa’,	all	of	
which	have	been	shown	to	inhibit	CME	(Gold	et	al.,	2010).	Instead,	BTV	internalisation	was	
inhibited	by	the	MPC	inhibitors	EIPA	and	Cytochalasin-D	and	virus	was	shown	to	co-localise	
	
with	a	known	marker	for	MPC,	dextran	(Gold	et	al.,	2010).	
	
	
	
Paradoxically,	inhibition	of	BTV	entry	was	observed	in	cells	treated	with	dynamin	inhibitor,	
Dynasore	 in	 two	 independent	 studies	 (Du	et	 al.,	 2014,	Gold	et	 al.,	 2010).	However,	upon	
over	expression	of	DN	dynamin-2	 ‘aa’,	no	 inhibition	 in	 infection	was	observed.	Therefore,	
further	investigation	in	to	the	role	of	dynamin	in	BTV	infection	and	entry	is	required.	
	
	
	
As	each	study	had	a	number	of	experimental	differences,	such	as	virus	purification	status,	
virus	serotype	and	cell	 type	used	to	study	endocytosis	mechanisms,	 it	 is	possible	that	the	
differences	observed	 in	the	endocytosis	mechanism	utilised	by	BTV	 is	 influence	by	one	or	
several	of	these	factors.	
	
	
	
1.13.5 BTV	Trafficking	
	
	
	
	
Until	recently,	attempts	at	fluorescently	tagging	BTV	have	failed	due	to	incorrect	assembly,	
however,	 the	 generation	 of	 a	 tetracysteine-tagged	 BTV	 allowed	 visualisation	 of	 virus	
trafficking	(Du	et	al.,	2014).	Live	cell	 imaging	of	 the	tagged	BTV-10	revealed	that	VP2	and	
VP5	segregate	after	15	minutes	of	internalisation	after	trafficking	from	the	early	endosome	
to		the		late		endosome		(Du		et		al.,		2014).				However,		previous		attempts		using			antibody	
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labelling	of	 virus,	 identified	BTV-1	 localised	with	 late	endosomal	 compartments	after	120	
minutes	 of	 entry	 (Gold	 et	 al.,	 2010).	 Again,	 the	 reported	 variation	 in	 the	 rate	 of	 BTV	
internalisation	could	reflect	differences	in	endocytosis	mechanisms	used	by	different	virus	
strains	and/or	be	a	result	of	the	specific	target	cells	utilised.	
	
	
	
1.14 Aims	
	
	
	
The	 aim	 of	 this	 thesis	 is	 to	 elucidate	 the	 endocytosis	 mechanisms	 employed	 by	 a	 low	
passage,	 field-	 isolate	 strain	 of	 BTV-1	 GIB2007/01	 in	 host-derived	 cells.	 	 Previous	 work	
investigating	BTV	endocytosis	mechanisms	have	used	cell	culture	adapted	BTV	in	cell	types	
that	are	not	naturally	infected	by	the	virus.		The	objectives	of	this	study	are:	
• To	purify	field	isolate	BTV-1	GIB2007/01	from	Culicoides	spp.	cells	to	retain	a	field-
type	phenotype	by	not	adapting	the	virus	to	mammalian	cell	culture.	
• 	To	 investigate	 entry	 mechanisms	 in	 bovine	 foetal	 aorta	 endothelial	 (BFA)	 cells	
(endothelial	cells	are	a	natural	cellular	target	during	infection).	
• To	 investigate	 entry	mechanisms	 in	 Culicoides	 spp.	 (KC)	 cells	 (cell	 types	 that	 are	
naturally	targeted	during	infection	in	the	field).			
	
The	information	from	this	study	will	contribute	by	improving	understanding	understanding	
the	endocytosis	mechanism	BTV	uses	in	host	cells	and	may	aid	the	development	of	future	
drug	therapeutics.	
	
	
Specifically	this	thesis	is	investigating	the	following	hypothesis:	
	
“Bluetongue	virus	cellular	entry	mechanisms	are	influenced	by	target	host	cell”	
		
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Chapter	2	–	
Materials	and	Methods	
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2.1 Cells	and	Viruses	
	
	
2.1.1 Cell	Lines	
	
	
	
An	embryonic	cell	line	isolated	from	larvae	of	Culicoides	(variipennis)	sonorensis,	known	as	
KC	cells,	were	kindly	supplied	by	Sally	Wechsler,	USDA	to	the	Pirbright	Institute	~	15	Years	
ago.	KC	cells	were	propagated	at	28°C	in	Schneiders	insect	media	with	L-glutamine	(Sigma)	
containing	 10%	 foetal	 bovine	 serum	 (FBS)	 (Sigma)	 and	 1%	 penicillin/streptomycin	 (Life	
Technologies).	
	
	
	
Baby	 Hamster	 Kidney-21	 (clone	 13)	 (BHK-21)	 cells	 (Public	 Health	 England,	 European	
Collection	of	Cell	Cultures	(ECACC))	were	propagated	grown	at	37°C	in	Glasgows	Minimum	
Essential	Medium	(GMEM)	(Sigma)	containing	10%	foetal	bovine	serum	(FBS)	(Sigma),	1%	L-	
Glutamine	(Sigma)	and	1%	penicillin/streptomycin	(Life	Technologies).	
	
	
	
Bovine	Aorta	Endothelial	Foetal	 (BFA)	cells	 (Public	Health	England,	European	Collection	of	
Cell	 Cultures	 (ECACC))	 were	 propagated	 at	 37°C	 in	 Nutrient	 Mixture	 F12-Hams	 media	
(Sigma)	containing	10%	foetal	bovine	serum	(FBS)	(Sigma),	1%	L-Glutamine	(Sigma)	and	1%	
penicillin/streptomycin	(Life	Technologies).	
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2.1.2 Cell	counting	
	
	
	
Cells	 were	 diluted	 1	 in	 10	 in	 Dulbecco’s	 phosphate	 buffered	 saline	 (D-PBS)	 (Sigma).	 Cell	
suspensions	(100µl)	were	then	loaded	on	to	cassettes	of	the	Moxi	Flow	(Orflo)	system	and	
cell	number	was	determined	as	per	manufacturers’	instructions.	
2.1.3 Viruses	
	
	
	
BTV,	Serotype	1,	originated	from	a	sheep	in	the	Gibraltar	outbreak	in	2007	was	isolated	by	
the	non-vesicular	reference	laboratory	(NVRL)	by	incubation	of	sheep	blood	in	C	sonorensis	
(KC)	cells.	The	 isolate	was	designated	BTV-1	GIB2007/01	KC1	 (The	Pirbright	 Institute,	BTV	
Reference	Collection),	passaged	twice	more	in	KC	cells	and	used	for	virus	purification	(see	
section	 2.2)	 and	 all	 subsequent	 experiments.	 Purified	 virus	 was	 stored	 at	 4°C	 as	 it		
Infectivity	reduces	during	freeze-thawing.	
	
	
	
2.2 Virus	Purification	
	
	
Purification	 of	 the	 BTV-1	 GIB2007/01	 KC1	 isolate	 was	 achieved	 by	 largely	 following	 the	
protocol	described	by	(Mertens	et	al.,	1987).	However,	as	this	was	a	field	strain	virus	and	
the	 experiments	 in	 this	 thesis	 required	 that	 the	 virus	 was	 not	 mammalian	 cell	 culture	
adapted,	 virus	was	propagated	 in	2	extra	passages	of	KC	 cells,	 instead	of	BHK-21	 cells	 as	
described	(Mertens	et	al.	1987).	
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The	BTV	purification	method	by	Mertens	et	al.	(1987)	was	adapted	in	a	number	of	ways	to	
allow	purification	of	BTV,	solely	generated	in	insect	cell	cultures.		The	first	adaptation	was	
to	 infect	 KC	 cell	 cultures	 in	 T175	 tissue	 culture	 flasks,	 as	 opposed	 to	 the	 originally	 used	
roller	bottles.	BTV-infected	BHK-21	cells	typically	dislodge	from	plastic	tissue	culture	flasks	
by	approximately	48	hours	post	infection	(hpi),	which	makes	collection	of	cells	from	roller	
bottles	 relatively	 straightforward.	 This	 procedure	 is	 more	 suited	 in	 T175	 tissue	 culture	
flasks	than	roller	bottles	as	cells	are	grown	on	an	easily	accessible	flat	surface.	As	KC	cells	
perpetually	 grow	on	 top	of	 one	 another	 (subject	 to	 nutrient	 resources),	 as	 opposed	 to	 a	
monolayer,	 it	 meant	 the	 number	 of	 flasks	 infected	 could	 be	 reduced.	 Additionally	 this	
method	 reduced	 infected	 waste	 while	 still	 maintaining	 a	 high	 enough	 cell	 density	 to	
generate	a	 suitable	concentration	of	virus	needed	 for	 the	purification	procedure.	Enough	
KC2	passage	virus	was	propagated	in	order	to	infect	x55	T175	tissue	culture	flasks	required	
for	virus	purification,	meaning	the	final	purified	virus	had	undergone	three	passages	in	KC	
cells	in	total.	
	
	
	
Secondly,	most	of	the	replicated	virus	is	found	within	infected	KC	cells.		Virus	recovery	was	
maximised	 by	 collection	 of	 non-adherent	 cells	 by	 pipetting	 as	 well	 as	 adherent	 cells	 by	
mechanical	 scraping.	As	 this	purification	procedure	had	never	previously	 	been	 tested	on		
KC	cells,	it	was	unknown	as	to	whether	the	lysis	step	in	the	procedure	would	be	sufficient	
to	 release	 the	 virus	 from	 intact	 KC	 cells.	 Effectiveness	 of	 the	 lysis	 step	 was	 analysed	 by	
sodium	 dodecyl	 sulphate	 polyacrylamide	 gel	 electrophoresis	 (SDS	 PAGE)	 (see	 chapter	 3,	
section	3.3.1,	Figure	3.2).	
Chapter	2:		Understanding	the	early	events	in	Bluetongue	virus	cell	entry	
74	
	
	
	
	
Thirdly,	due	to	the	lack	of	cpe	produced	by	BTV	in	infected	KC	cells,	a	quantitative	reverse-	
transcriptase	PCR	(qRT-PCR)	was	carried	out	during	the	virus	propagation	steps	to	ensure	
sufficient	 virus	was	 present	 prior	 to	 proceeding	with	 the	 virus	 purification	 (qRT-PCR	was	
carried	 out	 in	 collaboration	 with	 Karin	 Darpel	 and	 Marc	 Guimera).	 Table	 2.1	 shows	 an	
example	of	the	cycle	threshold	(ct)	values	for	each	passage	through	KC	cells.	
	
Table	2.1		Cycle	threshold	results	from	BTV	passage	in	KC	cells	
	
Virus	Passage	 Initial	
inoculum	ct	
value	
Days	 post	
infection	
Threshold	
(dRdn)	
qRT-PCR	ct	value	
BTV-1	 GIB2007/01	
(KC1)	
n.d	 n.d.	 n.d.	 n.d.	
BTV-1	 GIB2007/01	
(KC2)	
21.4	 5	 0.2047	 13.72	
BTV-1	 GIB2007/01	
(KC3)	
20.91	 5	 0.2047	 13.46	
Uninfected	control	 No	ct	 5	 0.2047	 No	ct	
	
	
	
In	 the	method	 described	 by	Mertens	 et	 al.	 (1987)	 BTV	 particles	 are	 purified	 using	 three	
sequential	sucrose	gradients	after	propagating	virus	in	BHK-21	cells	((Mertens	et	al.,	1987)).	
In	 the	KC	cell	modified	method,	 three	distinct,	 viscous,	opaque	bands	were	present	after	
the	 first	 gradient	 step,	 as	opposed	 to	 a	 single	 solid	disc	described	 for	BHK-21	 cells.	 Virus		
was	 located	 at	 the	 expected	 interface	 between	 40%	 and	 66%	 sucrose.	 In	 order	 to	
successfully	 collect	purified	virus,	 the	 sucrose	above	and	below	 the	purified	viscous	band	
was	 removed	prior	 to	being	 layered	on	 to	a	 further	 two	sucrose	gradients.	 Following	 the	
second	 sucrose	 gradient,	 instead	 of	 a	 firm	 disc,	 a	 fluffy	 distinct	 band	was	 located	 at	 the	
interface	(between	the	40%	and	66%	sucrose).	This	band	was	collected	and	passed		through	
a	final	gradient	containing	40%	sucrose	with	0.1%	N-Lauroylsarcosine	sodium	salt	(NLS)	as	
the	top	layer	and	a	66%	sucrose	cushion	as	the	bottom	layer.	At	the	final	sucrose	gradient	a	
single	 distinct,	 blue/white	 band	 was	 located	 at	 the	 expected	 position	 at	 the	 sucrose	
interface	(between	the	40%	and	66%	sucrose),	which	can	be	observed	in	Figure	2.1.	
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This	band	was	harvested	and	stored	in	40%	sucrose	supplemented	with	0.1%	NLS	at	4°C	
and	called	purified	BTV-1.	
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Figure	2.1	
	
	
	
Figure	2.1	Purified	BTV-1	on	final	sucrose	gradient	of	virus	purification	
	
A	 photograph	 showing	 the	 third	 and	 final	 sucrose	 gradient	 of	 the	 purification	 of	 the	 field	 strain	
BTV1GIB2007	 KC3.	 Purified	 KC	 cell	 derived	 virus	 is	 identified	 by	 the	 blue/white	 band	 which	 is	
positioned	 at	 the	 sucrose	 interface	 between	 40%/66%	 sucrose	 on	 the	 gradient,	 indicated	 by	 the	
white	arrow.	
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2.3 Virus	Assays	
	
	
2.3.1 Measuring	virus	infectivity	using	Fluorescent	TCID50s	
	
	
	
Ninety-six-well	flat-bottomed	tissue	culture	plates	were	seeded	either	with	BHK-21	or	BFA	
cells	the	day	prior	to	TCID50	experiments	to	ensure	that	cells	were	confluent	on	the	day	of	
the	experiment;	or	with	KC	cells,	which	were	 seeded	on	 the	day	of	 the	experiment.	Ten-	
fold	 virus	 dilutions	were	 set	 up	 and	 100	µL	was	 added	 to	wells	 in	 at	 least	 quadruple	 for	
each	dilution.	Cells	were	incubated	for	3	days	at	37°C	or	28°C	for	BHK-21	and	BFA	cells	or	
KC	cells	respectively.	Cells	were	then	fixed	in	4%	paraformaldehyde	(PFA)	(Sigma)	for	1	hour	
washed	 in	 D-PBS	 3	 times	 before	 a	 final	 addition	 of	 D-PBS	 to	 each	 plate.	
Immunofluorescence	labelling	was	carried	out	after	permeabilising	cells	with	0.2%	Triton	X-	
100	 (Sigma)	 for	 20	minutes	 at	 room	 temperature.	 Cells	 were	 incubated	 with	 guinea	 pig	
anti-BTV	 antibody	 (Orab279)	 (The	 Pirbright	 Institute)	 diluted	 1	 in	 2000	 in	 0.5%	 Bovine	
serum	albumin	(BSA)	(Melford)/D-PBS	(Sigma)	for	1	hour	at	room	temperature,	followed	by	
three	 washes	 with	 D-PBS	 and	 incubation	 with	 AlexaFluor-488	 conjugated	 to	 goat	 anti-	
guinea	pig	secondary	antibody	(1:200	in	0.5%BSA/D-PBS)	for	1	hour	at	room	temperature.	
Finally,	 cells	were	 then	washed	with	D-PBS	 (Sigma)	3	 times	and	either	examined	under	a	
fluorescent	 microscope	 (Leica)	 or	 with	 the	 fluorescent	 Enzyme-Linked	 ImmunoSpot	
(ELISPOT)	reader	(AID	Elispot).	Green	cells	were	counted	as	positive	for	virus,	i.e.	green	cells	
within	 a	 well	 (above	 background	 controls),	 were	 scored	 as	 positive	 for	 tissue	 culture	
infective	dose	50	(TCID50)	calculation.	TCID50’s	were	calculated	using	the	Spearman-Karber	
formula:	
	
Log10Median	Dose	=	X0		–	d/2	+	d*(Σ	r/n)	
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This	method	allowed	cells	that	do	not	show	cpe	to	be	compared	to	those	that	display	lytic	
effects	of	the	virus.	
2.3.2 Virus	Infection	Assays	
	
	
	
Many	 experiments	 within	 this	 thesis	 investigate	 the	 effect	 of	 specific	 inhibitory	 factors	
against	cellular	components	and,	as	a	result,	their	effect	on	BTV-1	infection.	After	treating	
cells	 with	 pharmacological	 inhibitors	 (see	 section	 2.9.1),	 small-interfering	 (siRNA)	 (see	
section	 2.5.14)	 or	 dominant-negative	 (DN)	 proteins	 (see	 section	 2.5.13),	 cells	 were	 then	
infected	with	0.12µg/mL	purified	BTV-1	GIB2007/01	KC3	which	had	been	diluted	in	serum	
free	GMEM	(Sigma)	for	BFA	cells	or	serum	free	Schneiders	media	(Sigma)	for	KC	cells.	Virus	
was	first	allowed	to	adsorb	to	the	cells	by	allowing	virus	to	attach	at	37°C	for	BFA	cells	or	
28°C	for	KC	cells	for	one	hour.	After	adsorption,	cells	were	washed	3	times	with	cell	culture	
media	and	replaced	with	fresh	GMEM	(Sigma)/Schneiders	media	(Sigma)	containing	1%/5%	
foetal	 bovine	 serum	 (FBS)	 (Sigma)	 and	1%	penicillin/streptomycin	 for	 the	duration	of	 the	
remaining	11	hour	infection,	continued	at	the	appropriate	temperature	for	each	cell	type.	
Following	 infection,	 cells	 were	 either	 processed	 for	 flow	 cytometry	 analysis	 (see	 section		
2.7)	or	confocal	microscopy	(see	section	2.8).	
	
2.3.3 Passaging	viruses	
	
	
	
One	hundred	µL	of	the	 initial	BTV1	GIB2007/01	KC1	inoculum	was	used	to	 infect	KC	cells.	
After	the	second	passage	on	KC	cells	(KC2),	cells	were	dislodged	from	the	flask	and	pelleted	
at	 1000	 rpm	 for	 3	 minutes.	 One	 ml	 of	 infectious	 supernatant	 was	 diluted	 in	 35	 ml	 of	
complete	cell	culture	medium	and	subsequently	used	to	infect	T175	flasks	seeded	with	
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BFA,	 BHK-21	 or	 KC	 cells.	 Virus	was	 passaged	 in	 BFA	 or	 BHK-21	 cells	 upon	 appearance	 of	
cytopathic	effect	 (cpe).	Due	to	 the	slow	replication	cycle	and	 lack	of	cpe	 in	KC	cells,	virus	
was	passaged	every	seven	days	to	ensure	virus	budding	had	taken	place.	This	was	repeated	
until	passage	6	in	each	cell	line	was	reached.	
	
	
	
2.3.4 Virus	Uptake	Assays	
	
	
	
Cells	 (BFA	and	KC),	which	had	been	treated	with	 inhibitors,	as	well	as	control	cells,	which	
had	been	treated	with	equivalent	 inhibitor	diluent	 (see	section	2.9.1)	were	used	 for	virus	
entry	 experiments.	 Cells	 were	 infected	 with	 6µg/ml	 BTV-1	 GIB2007/01	 KC3	 (diluted	 in	
serum	free	media,	as	described	in	section	2.3.2)	and	incubated	on	ice	for	one	hour	on	ice	to	
allow	adsorption	of	 virus	 and	 synchronisation	of	 virus	 entry.	After	 adsorption	of	 virus	on	
ice,	cells	were	washed	3	times	with	serum	free	cell	culture	media	and	warmed	to	37°C	for	
BFA	cells	or	28°C	 for	KC	cells	 for	durations	of	30	minutes,	1	hour,	90	minutes	or	2	hours	
post	virus	attachment.	Cells	were	then	processed	for	confocal	microscopy	(see	section		2.8).	
	
	
	
2.4 Protein	Analysis	
	
	
2.4.1 SDS	PAGE	
	
	
	
SDS	PAGE	gels	were	used	to	analyse	viral	proteins	with	a	method	adapted	from	(Laemmli,	
1970)	method.	 Eight	%	 resolving	 gels	 and	 5%	 stacking	 gels	were	 prepared	 (see	 standard	
solutions	 in	Appendix	 9-A)	 and	polymerised	gels	were	 loaded	with	20µL	of	pre-prepared	
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denatured	samples.	Samples	were	prepared	by	adding	3x	SDS	loading	buffer	(New	England	
Biolabs)	 together	 with	 12.5mM	 DTT	 (New	 England	 Biolabs)	 and	 boiled	 at	 96°C	 for	 5	
minutes.	All	 samples	were	 loaded	 in	parallel	with	a	Precision	Plus	Protein	 ladder	 (Biorad)	
and	run	in	Tris-glycerine	running	buffer	at	90V	until	the	dye	front	just	runs	off	the	gel.	
	
	
	
2.4.2 Coomasie	and	Silver	Staining	
	
	
	
SDS-PAGE	gels	were	stained	for	analysis	with	Coomasie	Brilliant	Blue	stain	(Sigma)	or	Pierce	
Silver	Stain	(Thermo	Scientific)	as	per	manufacturers’	instructions.	
	
	
	
2.4.3 Dynamic	Light	Scattering	
	
	
	
The	zetasizer	µV	(Malvern)	was	used	to	size	purified	virus	particles.	Virus	was	diluted	1	 in		
10	in	40%	sucrose	containing	1%	NLS	in	a	100µL	volume	and	placed	in	a	disposable	optically	
clear	 cuvette	 (BioRad).	 	 Samples	 were	 read	 either	 direct	 from	 4°C	 storage	 or	 heating	 at		
37°C	 for	 5	 hours.	 Settings	 were	 adjusted	 according	 to	 sample	 diluent;	 hence	 the	 40%	
sucrose	 setting	 was	 selected	 prior	 to	 reading.	 Samples	 were	 read	 for	 40	 reads	 at	 40		
seconds	 each	 in	 order	 to	 gather	 accurate	 information	 for	 sample	 size	 composition.	 The	
zetasizer	µV	was	always	calibrated	by	 running	arc	beads	 (Life	Technologies)	and	 in-house	
prepared	liposomes,	which	have	a	known	size,	prior	to	sample	reading.	
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2.4.4 Bio-Rad	protein	assay	
	
	
	
The	 Bio-Rad	 protein	 assay	 (based	 on	 the	 Bradford	 method)	 was	 used	 to	 quantify	 	 the	
protein	content	of	purified	BTV,	as	per	manufacturers’	 instructions.	Albumin	standards	of	
known	 protein	 concentrations	 were	 used	 to	 generate	 a	 standard	 curve.	 Optical	 Density		
(OD)	readings	were	obtained	via	the	Spectramax	plate	reader.	
	
2.4.5 The	bicinchoninic	acid	(BCA)	assay	
	
	
	
The	Pierce	BCA	protein	assay	kit	(Life	Technologies)	was	used	to	quantify	protein	content	of	
whole	 cell	 lysates	 for	 western	 blot	 analysis,	 as	 per	manufacturers’	 instructions.	 Albumin	
standards	were	supplied	within	the	kit	and	used	to	generate	a	standard	curve	for	protein	
concentration	inference.		OD	readings	were	obtained	via	the	Spectramax	plate	reader.	
	
	
	
2.4.6 Making	protein	lysates	
	
	
	
Cell	 lysates	 were	 prepared	 by	 resuspending	 cells	 in	 1%	 Triton	 X-100	 (Sigma)	 containing	
protease	 inhibitors,	 ProteoBlock,	 a	 protease	 cocktail	 inhibitor	 (Fermentas)	 at	 a	 final	 1x	
concentration.	
	
	
	
2.4.7 Western	Blots	
	
	
	
Proteins	 that	 had	 been	 separated	 previously	 by	 SDS	 PAGE	 were	 transferred	 by	
electrophoresis			from			SDS			PAGE			gels			on			to			a			nitrocellulose			membrane	 (Amersham	
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biosciences	 Ltd)	 at	 100V	 for	 1	 hour	 in	 transfer	 buffer.	 After	 transfer,	 membranes	 were	
blocked	 for	 1	 hour	 to	 prevent	 non-specific	 binding	 of	 primary	 antibodies	 by	 incubating	
membranes	 in	 D-PBS	with	 5%	milk	 (Marvel)	 and	 0.05%	 tween	 (Sigma).	 Primary	 antibody	
was	diluted	 in	D-PBS	with	5%	milk	 (Marvel)	and	0.05%	tween	(Sigma)	at	a	dilution	of	1	 in	
1000	 (0.5ug/ml)	 for	 anti-Dynamin	 Hudy	 1	 (Millipore),	 or	 1	 in	 1000	 for	 anti-BTV	Orab276	
(The	Pirbright	Institute	orbivirus	reference	antibody	collection)	or	anti-Actin	(Millipore)	and	
then	 incubated	 with	 the	 membrane	 overnight	 at	 4°C	 whilst	 gently	 shaking.	 Membranes	
were	 then	 washed	 three	 times	 for	 10	 minutes	 each	 in	 D-PBS	 and	 0.05%	 tween	 (Sigma)	
followed	by	incubation	with	a	secondary	IgG	HRP	goat	anti-mouse	(diluted	as	1	in	5000	in	
block	buffer)	for	1.5hrs	at	room	temperature	whilst	shaking.	The	membranes	were	washed	
3	times	in	D-PBS	and	0.05%	tween	(Sigma),	followed	by	4	to	5	changes	in	deionised	water	
(dH2O)	 changes.	 Finally	 membranes	 were	 developed	 using	 the	 Super	 Signal,	 West	 Pico	
Chemoluminescent	 Substrate	 (Thermo	 Scientific)	 as	 per	 manufacturers’	 instructions.	
Western	 blots	 were	 then	 either	 imaged	 using	 films	 or	 the	 Kodak	 Image	 Station	 4000R		
Digital	Imaging	System	operated	by	Molecular	Imaging	Software	v	5.3.4.17821	(Carestream	
health	inc.).	
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2.5 DNA	and	RNA	analysis	
	
	
2.5.1 Viral	RNA	Extraction	
	
	
	
Viral	RNA	was	extracted	from	infected	cell	culture	supernatant	using	the	Qiamp	viral	RNA	
mini	kit	(Qiagen),	as	per	manufacturers’	instructions.							Viral	RNA	was	stored	short	term	at	
+4C	or	at	-20C	for	subsequent	analysis	by	qRT-PCR.	
	
	
	
	
2.5.2 Messenger	RNA	extraction	
	
	
	
Messenger	 RNA	 (mRNA)	 was	 extracted	 using	 Dynabeads™	 mRNA	 Direct	 extraction	 kit	
(Ambion	 from	Life	Technologies)	as	per	manufacturers’	 instructions.	The	extracted	mRNA	
was	 used	 to	 confirm	 KC	 cell	 dynamin-2	 sequence	 by	 PCR,	which	was	 identified	 from	 the	
Culicoides	spp.	Genome	project	(see	section	2.5.5/2.5.6/2.5.9).	
	
2.5.3 RT-PCR	
	
	
	
qRT-PCR	carried	out	using	extracted	viral	RNA	(section	2.5.1)	was	carried	out	by	colleagues	
at	The	Pirbright	Institute,	using	the	method	described	either	by	(Shaw	et	al.,	2007,	Maan	et	
al.,	 2015)	which	amplify	either	 segment	1	or	 segment	9	of	 the	BTV	genome	 respectively.	
qRT-PCR	was	carried	out	to	confirm	whether	virus	has	successfully	replicated	in	KC	cells	as	
inferred	by	a	decrease	of	ct	values	(increase	in	RNA)	from	the	initial	inoculum	taken	on	day	
0	to	the	sample	taken	on	day	5	post	infection.	(see	Table	2.1).	
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2.5.4 Quantifying	DNA	or	RNA	
	
	
	
One	 µl	 of	 purified	 DNA	 or	 RNA	was	 loaded	 on	 to	 the	NanoDrop1000	 (Thermo	 scientific)	
spectrophotometer	after	blanking	with	molecular	grade	water.	Results	were	interpreted	as	
per	manufacturers’	instructions.	
2.5.5 Reverse	transcription	
	
	
Extracted	mRNA	 (5μl)	was	 reverse	 transcribed	 into	 complementary	DNA	 (cDNA)	 by	 using	
first	 strand	 Superscript	 III	 Reverse	 Transcription	 kit	 (Life	 Technologies)	 to	 allow	 for	 PCR	
amplification	of	 KC	 cell	 dynamin-2	 gene.	 The	mRNA,	 complementary	DNA	was	 generated	
from	annealing	random	hexamers	or	one	of	two	reverse	primers,	which	were	based	on	KC	
cell	 dynamin-2	 scaffold	 sequence	 generated	 from	 the	Culicoides	 spp.	Genome	project,	 as	
detailed	below:	
	
‘Reverse	primer	3	–	AATAGGGCAAAGGTGTGTCG’	
‘Reverse	primer	2	–	CAACCTCGTCTGCAGTCTCA’	
Two	μl	primer	or	random	hexamer	(2μM)	was	added	to	5μl	mRNA	and	1μl	10mM	dNTP’s	
and	3μl	 nuclease	 free	water.	 The	mixture	was	 incubated	 at	 65°C	 for	 5	minutes	 and	 then	
placed	on	ice	for	2	minutes.	
	
	
	
After	annealing	primers	or	random	hexamers,	fragments	were	synthesized	by	the	addition	
of	 the	 following	 components	 to	 the	 reaction	mix:	 10X	 reaction	 buffer,	 4μl	 25mM	MgCl2,	
0.1M	DTT	and	1μl	RNase	OUT	(40U/	μl),	1uL	superscript	III	RT	enzyme	(except	for	the	mRNA	
plus	no	RT	enzyme	for	the	negative	negative	control)	and	the	mixture	was	incubated	
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at	50°C	for	45	minutes.	Template	cDNA	was	then	used	to	amplify	KC	cell	dynamin-2	(see	
section	2.5.6).	
2.5.6 Polymerase	Chain	Reaction	
	
	
	
Amplification	 of	 fragments	 of	 the	 KC	 cell	 Dynamin-2	 gene	 was	 carried	 out	 in	 order	 to	
determine	 the	 Culicoides	 spp.	 Dynamin-2	 sequence	 proposed	 by	 the	 Culicoides	 spp.	
Genome	project.	 Five	 primers	were	manually	 designed	 used	 in	 different	 combinations	 in	
order	to	amplify	overlapping	fragments	of	the	gene.		These	primers	were:	
	
Forward	1	(F1)	–	5’TTGCTGTAGTGGGTGGACAA3’	(starts	at	bp	position	83)	
Forward	2	(F2)	–	5’TGCGTGATCGACTTCAAAAG3’	(starts	at	bp	position	872)	
Reverse	1	(R1)	–	5’GCACCACCCGATAACTCATT3’	(starts	at	bp	position	1048)	
Reverse	2	(R2)	–	5’CAACCTCGTCTGCAGTCTCA3’	(starts	at	bp	position	1804)	
Reverse	3	(R3)	–	5’AATAGGGCAAAGGTGTGTCG3’	(starts	at	bp	position	1729)	
The	following	combinations	of	primers	were	used	to	amplify	the	proposed	Dynamin-2	gene	
from	 the	 cDNA	 generated	 using	 reverse	 primer	 2	 (see	 section	 2.5.5),	 as	 this	 was		
determined	as	being	the	best	quality	cDNA:		F1	-	R1,	F2	–	R2,	F2	–	R1	and	F2	–	R3.	
Fragments	were	amplified	using	KOD	polymerase	(Novagen,	USA).	The	following	reaction	
condition	were	used	on	an	Eppendorf	vapo-protect	mastercycler	thermocycler.	
Denaturation:	95	°C	for	2	minutes	
	
	
The	below	conditions	were	run	for	30	cycles	in	total:	
Denaturation:		95	°C	for	20	seconds	
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Annealing:	 55	°C	for	10	seconds	
Elongation:	 70	°	C	for	50	seconds	
PCR	products	were	analysed	using	gel	electrophoresis	and	sanger	sequencing	(see	section	
2.5.7/2.5.9).	
	
	
	
2.5.7 Gel	electrophoresis	
	
	
	
For	1%	agarose	gels,	1	g	agarose	(Sigma)	was	heated	in	100ml	tris-borate	EDTA	(TBE)	buffer	
until	dissolved.	After	cooling	 for	5	minutes,	3	µL	Ethidium	bromide	 (Sigma)	was	added	 to	
the	dissolved	agarose	and	poured	into	a	gel	cast	with	a	comb	and	left	to	set.	The	agarose	
gel	was	placed	 into	 a	 gel	 tank	with	 TBE	buffer	 and	 samples	were	 loaded	with	1x	 loading	
buffer	(New	England	Biolabs).	Gels	were	run	at	100	V	for	approximately	1	hour	and	imaged	
using	Biorad	gel	doc	(Biorad).	
	
	
	
2.5.8 DNA	purification	
	
	
	
In	 order	 to	 sequence	 the	 amplified	 DNA	 fragments,	 DNA	was	 purified	 from	 PCR	 product	
using	PCR	Clean	up	kit	from	Qiagen	(Qiagen)	following	manufacturers’	instructions.	
	
2.5.9 Sanger	sequencing	
	
	
	
Sanger	 sequencing	 was	 carried	 out	 on	 purified	 amplified	 KC	 cell	 dynamin-2	 gene	 PCR	
products	(see	section	2.5.6)	to	determine	sequence	similarity	to	sequences	generated	from	
the		Culicoides		spp.		Genome		project.							BigDye®		Terminator		v3.1		cycle		sequencing				kit	
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(Applied	 Biosystems	 UK)	 and	 was	 used	 to	 sequence	 purified	 DNA	 as	 per	manufacturers’	
instructions.	Sample	reactions	were	precipitated	with	ethanol	and	resuspended	with	25	μl	
HI-DI	 formamide	 before	 being	 placed	 on	 ABI	 3730	 Analyser	 to	 determine	 sample	
sequences.	
	
2.5.10 Ecoli	Transformation	
	
	
	
Plasmid	DNA	 (1μl	of	 either	WT	or	DN	dynamin-2	 (obtained	 from	McNiven	 Laboratory)	or	
Eps15	plasmids	(obtained	from	Benmerah	Laboratory,	Cochin	Institute,	Paris)	was	added	to	
50μl	 DH5α	 competent	 cells	 (Invitrogen)	 and	 incubated	 on	 ice	 for	 30	 minutes.	 The	 cell-	
plasmid	mix	was	then	heat	shocked	at	42°C	for	40	seconds	and	then	placed	back	on	ice	for		
2	 minutes	 before	 adding	 1	 ml	 S.O.C	 media	 (Life	 Technologies).	 Transformed	 cells	 were	
incubated	at	37°C	for	one	hour	in	a	shaking	incubator	and	then	plated	on	to	Luria	broth	(LB)	
agar	plates	(The	Pirbright	Institute)	containing	kanamycin	(Gibco).	
	
2.5.11 Plasmids	
	
A	number	of	plasmids	were	used	 for	 this	 thesis	 to	enable	expression	of	both	wild-
type	 (WT)	 and	 dominant-negative	 (DN)	 proteins	 within	 the	 cell	 lines	 used	 in	 this	
study	 (see	 section	 2.1.1).	 	 Firstly,	 DN	 and	 WT	 dynamin-2	 (DNM2)	 splice	 variant	
constructs	(encoding	DNM2	splice	variants	-aa,	-bb	and	–ba)	were	obtained	from	the	
Mc	Niven	laboratory	(Mayo	Clinic,	Rochester,	USA).		Furthermore,	DN	and	WT	eps15	
constructs	 (DIII	 and	 EH29)	 and	 control	 plasmid	 (D3Δ2)	were	 supplied	by	Alexandra	
Benmerah	 (Universté	 Paris	 Descarte,	 Paris,	 France).		 Control	 plasmid	 peGFP	 were	
purchased	from	Clonetech.			See	table	2.2.							
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Table	2.2		Plasmid	function	and	construction		
Construct	name	 Protein	
encoded	
Protein	
function	
Publication	
detailing	
construction	
and	 sequence	
details	
peGFP-
WTDNM2aa	
WT	Dynamin-2	
aa	(GFP	fusion)	
GTP	binding	
protein	
Cao	et	al.,	1998	
peGFP-
DNDNM2aa	
DN	Dynamin-2	
aa	(GFP	fusion)	
Inhibits	GTP	
binding	protein	
DNM2aa	
Cao	et	al.,	1998	
peGFP-
WTDNM2ba	
WT	Dynamin-2	
ba	(GFP	fusion)	
GTP	binding	
protein		
Cao	et	al.,	1998	
peGFP-
DNDNM2ba	
DN	Dynamin-2	
ba	(GFP	fusion)	
Inhibits	GTP	
binding	protein	
DNM2ba	
Cao	et	al.,	1998	
peGFP-
WTDNM2bb	
WT	Dynamin-2	
bb	(GFP	fusion)	
GTP	binding	
protein	
Cao	et	al.,	1998	
peGFP-
DNDNM2bb	
DN	Dynamin-2	
bb	(GFP	fusion)	
Inhibits	GTP	
binding	protein	
bb	
Cao	et	al.,	1998	
peGFP-DIII	 Eps15	with		
COOH	terminal	
domain	
removed	(i.e.	
has	AP2	binding	
domain	
removed)	(GFP	
fusion)	
Inhibits	eps15	
function	
Benmerah	et	
al.,	1998	
peGFP-D32	 EPS15	with	EH	
and	AP2	binding	
domain	
removed	(GFP	
fusion)	
Mimics	WT	
eps15	function,	
no	inhibition	
observed.	Acts	
as	a	control	
plasmid	
Benmerah	et	
al.,	1998	
peGFP-EH29	 Eps15	with	
537nt	deletion	
at	position	288-
825	(i.e.	has	EH	
domain	
removed)	(GFP	
fusion)	
Inhibits	eps15	
function	
Benmerah	et	
al.,	1999	
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2.5.12 Plasmid	Purification	
	
	
All	plasmids	were	purified	using	Qiagen	Plasmid	Maxi	kit	as	per	manufacturers’	instructions	
(Qiagen).	
	
	
	
2.5.13 Restriction	enzyme	digest	
	
	
	
Diagnostic	 restriction	 enzyme	 digests	 were	 carried	 out	 on	 purified	 plasmids	 to	 identify	
whether	 the	 correct	 sized	 inserts	were	 present.	 EcoRI	 (New	 England	 Biolabs)	 and	HindIII	
(New	England	Biolabs)	restriction	sites	were	used	for	Dynamin-2	plasmids	and	BamHI	 (New	
England	 Biolabs)	 and	 XbaI	 (New	 England	 Biolabs)	 were	 used	 for	 Eps15	 plasmids.	 Double	
enzyme	digests	were	carried	out	as	per	manufacturers’	instructions.	
2.5.14 Transfection	of	plasmid	DNA	
	
	
	
Transfection	of	BFA	cells	with	plasmid	DNA	proved	to	be	challenging.	After	trialling	several	
optimisation	conditions	and	different	transfection	reagents,	it	was	found	that	Xtreme-Gene	
9	 transfection	 reagent	 (Roche)	 with	 a	 6:1	 (transfection	 reagent:DNA)	 ratio	 led	 to	 the		
highest	number	of	cell	transfected	cells	and	subsequently	expressing	the	encoded	proteins.	
Manufacturers’	instructions	were	followed	for	transfection	of	plasmid	DNA	and	transfected	
cells	were	allowed	to	express	the	protein	for	6	to	48	hours	(experiment	dependent).	
	
Dominant-negative	(DN)	and	wild-type	(WT)	dynamin-2	(DNM2)	splice	variant	constructs	(-
aa,	-bb	and	–ba)	were	supplied	by	the	Mc	Niven	laboratory	(Mayo	Clinic,	Rochester,	USA).		
DN	and	WT	eps15	constructs	(DIII	and	EH29)	and	control	plasmid	(D3Δ2)	were	supplied	by	
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Alexandra	 Benmerah	 (Universté	 Paris	 Descarte,	 Paris,	 France).		 Control	 plasmid	 peGFP	
(Clonetech)	 was	 transfected	 along	 with	 plasmids	 described	 above	 using	 XtremeGene	 9	
(Roche)	 in	 a	 6:1	 (reagent:plasmid)	 ratio	 as	 per	 manufacturers’	 instructions.		 Cells	 were	
transfected	for	a	total	of	16	hours	prior	to	infecting	cells.	
	
2.5.15 Transfection	of	siRNA	
	
	
	
siRNA	 targets	 was	 designed	 against	 the	 published	 bovine	 dynamin-2	 gene	 (Accession	
number:	NM_001099369.1)	 using	 the	 ThermoFischer	 siRNA	 selection	 tool.	 Ten	 promising	
hits	were	 generated,	 one	 of	which,	 siRNA141	 –	 5’GCTCTGTGCTCGAGAACTT3’	 (targets	 bp	
position	 141),	 had	 previously	 been	 published	 and	 validated	 (Dhaminka	 et	 al.,	 2008;	
Dhaminka	 et	 al.,	 2007)).	 This	 siRNA	 target	 along	 with	 an	 additional	 siRNA	 that	 was	 not	
located	 in	 the	 region	 of	 splicing	 siRNA657	 –	 5’GGGATGTCCTGGAGAACAA3’	 (targets	 bp	
position	 657)	 were	 selected	 for	 this	 study.	 Scrambled	 sequences	 for	 each	 of	 the	 bovine	
dynamin-2	targeting	siRNA’s	were	also	purchased	and	used	as	controls.	
	
	
	
Transfection	of	20pmol	 (unless	otherwise	 stated)	of	 two	Dynamin-2	 targeting	 siRNAs	and	
scrambled	 controls,	 as	 single	 or	 duplex	 transfections	were	 carried	 out	 using	 transfection	
reagent		Dharmafect		4		(Dharmacon		GE		Healthcare)		as		per		manufacturers’			instructions.	
siRNA’s	 were	 transfected	 for	 48	 hours	 prior	 to	 BTV	 infection	 or	 control	 ligand	 uptake	
experiments.	Cells	were	 then	 infected	or	allowed	 to	 take	up	control	 ligand.	 Infected	cells	
would	have	been	 transfected	 for	 a	 total	 of	 70	hours.	 siRNA	 transfection	 conditions	were	
optimised	as	detailed	in	chapter	4,	section	4.2.1.	
	
2.5.16 Preparation	of	dsRNA	for	BTV	genome	amplification	
	
	
	
Double	stranded	RNA	genome	was	prepared	by	using	TRIZOL	reagent	and	the	guanidinium	
isothiocyanate	procedure	described	by	(Attoui	et	al.,	2000).	
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2.5.17 Amplification	of	dsRNA	BTV	genome	segments	
	
	
	
Full-length	amplification	of	cDNA	(FLAC)	technique	was	used	to	amplify	BTV	dsRNA	genome	
segments,	as	described	by	(Maan	et	al.,	2007).	Briefly,	the	method	works	by	ligating	an	self-
priming	 anchor	 primer	 5’	 p-GAGGATTCTAAAC/iSp9/TCCAGTTTAGAATCC-OH	 3’	 to	 the	
TRIZOL	extracted	dsRNA,	 this	 allows	 each	 segment	 to	be	 attached	 to	 this	 anchor	primer.	
This	 is	 then	 run	 on	 an	 agarose	 gel	 and	 segments	 are	 cut	 out	 and	 recovered	 using	 silica	
binding	 methods.	 cDNA	 is	 generated	 by	 carrying	 out	 first	 strand	 reverse	 transcriptase	
reaction,	 using	 the	 anchor	 primer	 to	 generate	 the	 sequence.	 Segments	 were	 then	
sequenced	as	described	in	section	2.5.9.	
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2.6		Sequence	Analysis	
	
	
2.6.1		Pipeline	for	Sequence	Alignments	
	
	
	
Bovine	 splice	 variants	 of	 dynamin-2	 were	 identified	 by	 aligning	 all	 published	 cDNA		
transcript	 sequences	 against	 the	 full	 length	 Dynamin-2	 gene.	 Bovine	 (Bos	 taurus)	 cDNA	
Dynamin-2	(DNM2)	transcripts	were	identified	and	extracted	from:	
http://www.ncbi.nlm.nih.gov/projects/mapview/map_search.cgi?taxid=9913&query=DNM	
	
2	
	
	
Sequences	were	then	opened	 in	BioEdit	v7.0.5.3	and	duplicate	sequences	were	removed.	
Using	PuTTY	as	a	 shell	and	Filezilla	 to	move	 files	a	 reference	sequence	 for	 full-length	Bos	
Taurus	DNM2	 gene	was	 built	 (Accession	 number:	NM_001099369.1),	 using	 python	 script	
(see	Appendix	D).	All	cDNA	transcript	sequences	were	then	aligned	to	reference	sequence	
using	SAMtools	to	create	.sam	files,	which	were	subsequently	converted	to	.bam	files	using	
BAMtools.	These	.bam	files	were	then	sorted	and	indexed	before	viewing	the	alignment	on	
Intergrative	 Genomics	 Viewer	 (IGV).	 cDNA	 transcript	 sequences	 accession	 numbers	 are	
listed	in	(Chapter	4,	Table	4.1).	
Sequence	 data	 generated	 to	 confirm	 KC	 Dynamin-2	 sequence	 was	 also	 processed	 and	
analysed	using	the	same	pipeline	and	packages	as	described	above.	
Sequence	 analysis	 of	 BTV	 whole	 genome	 sequences	 were	 carried	 out	 using	 BioEdit	
Sequence	Alignment	Editor	v7.2.5.	
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2.7 Flow	Cytometry	
	
	
2.7.1 Cell	preparation	
	
	
	
Cells	 were	 treated	 with	 pharmacological	 inhibitors	 or	 transfected	 with	 DN	 	 proteins	 	 or	
siRNA	as	described	 in	sections	2.5.13	or	2.5.14	or	2.9.1	and	then	 infected	as	described	 in	
section	2.3.2.	Following	 infection,	 cells	were	stained	with	1	μL	of	Near-IR	Live/Dead	stain	
(Life	technologies)	for	10	minutes	at	37°C	for	BFA	cells	or	28°C	for	KC	cells.	Cells	were	then	
detached	 from	 the	 plastic	 either	with	 Accutase	 (Sigma)	 for	 BFA	 cells	 or	with	 serum	 free	
Schneiders	 media	 (Sigma)	 for	 KC	 cells.	 Following	 this,	 cells	 were	 transferred	 to	 a	 u-	
bottomed	96-well	plate	(Fischer	Scientific)	and	pelleted	at	1000rpm	(233	g)	for	3	minutes.	
Cells	 were	 fixed	 by	 resuspended	 in	 4%	 PFA	 (Sigma)	 for	 1	 hour	 before	 pelleting	 again	 at	
1000rpm	(233	g)	for	3	minutes	and	then	resuspending	in	D-PBS	(Sigma).	Infected	cells	were	
then	labelled	for	BTV	proteins	(see	section	2.7.2)	before	analysing	on	the	BD	LSR	Fortessa	
(Becton	 Dickinson),	 laser	 configurations	 can	 be	 found	 in	 the	 appendices	 (Appendix	 B).	
Cytometer	Setup	and	Tracking	(C,S	&	T)	beads	(Becton	Dickinson)	were	used	prior	to	every	
experiment	 to	 ascertain	 the	 cytometer’s	 initial	 baseline	 status	 (to	 set	 laser	 delays)	 and	
variation	 for	 each	 fluorescence	 detector,	 allowing	 algorithms	 to	 automatically	 determine	
PMT	 gains	 allowing	 application	 settings	 to	 be	 used	 and	 reproducibility	 between	
experiments.	Compensation	and	cytometer	 laser	setup/settings	are	shown	 in	Appendix	B.	
After	 data	 collection,	 data	was	 analysed	 using	 FCS	 Express	 v5	 (De	 Novo)	 and	 graphically	
represented	using	GraphPad	Prism	 v6	with	 statistical	 analysis	 carried	out	 in	Minitab	 v16.	
The	gating	strategy	can	be	visualised	in	section	2.7.3.	
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2.7.2 Intracellular	labelling	of	BTV	infection	for	flow	cytometry	
	
	
	
After	 fixation,	 cells	 were	 permeabilised	 with	 150μL	 of	 0.2%	 Saponin	 (Sigma)	 in	 1%	 BSA	
(Sigma)	in	PBS	(Sigma),	which	will	be	referred	to	as	‘saponin	block	buffer’	throughout	for	5	
minutes.	 Cells	 were	 pelleted	 for	 3	minutes	 at	 1000rpm	 (233	 g),	 resuspended	 in	 50μL	 of	
primary	antibody,	Orbivirus	 reference	antibody	 (Orab)	276	 (The	Pirbright	 Institute)	which	
was	raised	 in	Rabbit	 (IAH)	and	diluted	at	1	 in	4000	(determined	by	antibody	titration,	see	
Appendix	C)	in	saponin	block	buffer.	This	was	the	detected	using	goat	anti-rabbit	IgG	Alexa	
Fluor	 647	 (Life	 Technologies)	 secondary	 antibody	 used	 at	 1	 in	 200	 and	 incubated	 for	 30	
minutes.	Antibody	Orab276	was	 identified	as	detecting	BTV	VP5,	VP6	and	VP7	 in	western	
blot	 (see	 Appendix	 C).	 Orab	 276	 polyclonal	 serum	 had	 been	 previously	 raised	 against	
purified	BTV1	in	rabbits	and	the	detection	of	structural	proteins	VP5,	VP7	and	VP6	by	this	
antibody	was	confirmed	by	western	blot.	Subsequently	cells	were	pelleted	for	3	minutes	at	
1000rpm	 (233	 g)	 and	 then	 resuspended	 with	 saponin	 block	 buffer	 and	 incubated	 with	
agitation	 for	 5	minutes	before	pelleting	 for	 3	minutes	 at	 1000rpm	 (233	g).	 This	 step	was	
repeated	a	 further	2	 times	 to	 remove	unbound	non-specific	binding	of	primary	antibody.	
Cells	 were	 then	 pelleted	 for	 3	 minutes	 at	 1000rpm	 (233	 g)	 and	 incubating	 in	 50μL		
secondary	antibody,	goat	anti-rabbit	alexa-fluor	647	(Life	Technologies)	diluted	1	in	200	in	
saponin	block	buffer	for	30	minutes	in	the	dark.	Cells	were	washed	three	times	in	saponin	
block	buffer	 as	described	and	 then	 resuspended	 in	350μL	D-PBS	and	 transferred	 to	 FACS	
tubes	(BD	Biosciences)	for	analysis	on	the	LSR	Fortessa	(BD	Biosciences).	
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2.7.3 Flow	cytometry	analysis	
	
	
	
Data	 collected	 on	 the	 BD	 LSR	 Fortessa	 using	 FacsDiva	 software	 was	 exported	 as	 flow	
cytometry	 standard	 (FCS)	 files.	 This	 data	 was	 analysed	 with	 Denovo,	 FCS	 Express	 v5	
software.	 Cell	 populations	 were	 gated	 to	 isolate	 single,	 live	 cells	 for	 further	 analysis.	
Examples	of	gating	strategies	are	shown	in	figures,	which	demonstrate	the	gating	strategy	
for	 quantifying	 BTV	 infection	 in	GFP-fusion	 protein	 transfections	 (Figure	 2.2),	 quantifying	
control	 ligand	 uptake	 in	 GFP-fusion	 protein	 transfections	 (Figure	 2.3),	 quantifying	 BTV	
infection	 in	 drug	 inhibitor	 experiments	 or	 siRNA	 transfected	 cells	 (Figure	 2.4)	 and	
quantifying	 control	 ligand	 uptake	 in	 drug	 inhibitor	 exposure	 or	 siRNA	 transfected	 cells	
(Figure	2.5).	The	percentage	of	cells	 labelled	for	viral	proteins	were	used	as	a	measure	of	
BTV-1	infection.	The	threshold	for	the	detection	of	cells	positive	for	viral	proteins	were	set	
by	 using	 uninfected	 cells,	which	were	 treated	 in	 the	 same	manner	 and	 labelled	with	 the	
same	 primary	 and	 secondary	 antibodies	 used	 for	 detecting	 virus.	 The	 mean	 fluorescent	
intensity	(mfi)	was	used	as	a	measure	for	quantifying	the	uptake	of	control	ligands	in	a	cell	
population.	The	background	 threshold	was	set	by	using	cells	 that	were	exposed	 to	 ligand	
but	only	at	4°C	(to	prevent	uptake	of	ligand)	as	a	baseline.	Numerical	data	generated	from	
analysis	 of	 flow	 cytometry	 data	 were	 then	 statistically	 analysed	 using	 Minitab	 v17	 and	
graphically	represented	using	GraphPad	Prism	v6	(see	section	2.10).	
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Figure	2.2	
	
	
	
	
Figure	2.2		Gating	strategy	for	detection	of	BTV	infection	in	transfected	cells	
	
Flow	cytometry	data	was	analysed	using	FCS	Express	v5.	Density	plots	were	used	to	gate	on	single	
cells,	 gate	 1	 (A),	 live	 cells,	 gate	 2	 (B)	 and	 BTV	 infection	 was	 detected	 in	 GFP	 positive	 and	 GFP		
negative	cells	by	using	 the	background	control	 to	 set	 the	background	gate	positions	 (C).	Panel	 (D)	
shows	GFP-fusion	protein	transfected	cells	that	have	been	infected	as	an	example.	
A	 B	
C	 D	
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Figure	2.3	
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Figure	2.3	Gating	strategy	for	quantifying	control	ligand	uptake	in	GFP	and	non-GFP	expressing	
cells	
	
Flow	cytometry	data	was	analysed	by	gating	on	single	cells	(A)	in	gate	1,	live	cells	(B)	in	gate	2	and	
then	dividing	the	resulting	population	by	gating	on	GFP-expressing	population,	gate	3,	and	non-GFP	
expressing	population,	gate	4,	as	shown	in	panel	(C).	The	mean	fluorescent	intensity	of	transferrin-	
AF647	uptake	was	then	measured	in	GFP	positive	cells	(D)	and	GFP	negative	cells	(E).	An	overlay	of	
histograms	representing	plots	(D)	and	(E)	is	shown	in	panel	(F)	for	easy	comparison	of	differences	in	
mean	fluorescent	intensity	with	GFP	negative	cells	seen	in	the	blue	histogram	plot	and	GFP	positive	
cells	shown	in	the	black	histogram	plot.	
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Figure	2.4	
	
	
	
Figure	2.4	Gating	strategy	for	quantifying	BTV	infection	in	inhibitor	treated	or	siRNA	transfected	
cells	
	
Flow	 cytometry	 data	 was	 analysed	 by	 looking	 at	 single	 cells	 (A),	 gate	 1,	 live	 cells	 which	 	 were	
detected	by	an	amine	reactive	dye	(B),	gate	2,	and	then	using	uninfected	cells	labelled	with	primary	
and	secondary	antibodies	to	set	infection	background	threshold	(C)	as	indicated	by	gate	3.	Panel	(D)	
shows	 an	 example	 of	 control	 treated	 and	 BTV	 infected	 cells	 with	 33.14%	 of	 the	 cell	 population	
expressing	detectable	levels	of	BTV	viral	proteins	
A	 B	
C	 D	
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Figure	 2.5	
	
	
	
Figure	2.5	Gating	strategy	for	quantifying	ligand	uptake	in	inhibitor	treated	or	siRNA	transfected	
cells	
	
Flow	 cytometry	 data	 was	 analysed	 by	 isolating	 single	 cell	 populations,	 gate	 1	 (A),	 live	 cell	
populations,	 gate	 2	 (B)	 and	 using	 background	 controls	 (cells	 exposed	 to	 ligand	 but	 kept	 at	 4°C	 to	
minimise	 ligand	uptake)	 to	use	 to	set	 threshold	of	 ligand	positive	and	 ligand	negative	cells,	gate	3		
(C).	Panel	(D)	gives	an	example	of	a	sample	were	the	majority	of	the	cells	have	taken	up	the	control	
ligand.		Control	ligand	uptake	is	measured	as	mean	fluorescent	intensity	(mfi)	of	cell	populations.	
A	 B	
C	 D	
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2.8 Microscopy	
	
	
2.8.1 Confocal	Microscopy	
	
	
BFA	cells	were	seeded	on	to	sterile	glass	coverslips	the	day	prior	to	infection,	while	KC	cells	
were	 seeded	 onto	 poly-L-Lysine	 (Sigma)	 coated	 coverslips	 on	 the	 day	 of	 infection.	 Cells	
were	exposed	to	0.12ug/mL	of	purified	virus	 (see	section	2.3.2)	 for	virus	 infection	studies		
or	6ug/mL	(see	section	2.3.4)	for	virus	entry	studies.	Following	infection	or	uptake	studies,	
cells	were	placed	on	ice	and	fixed	with	4%	PFA	for	1	hour	and	then	washing	and	replacing	
fixative	with	D-PBS.	Internalized	and	replicating	virus	was	detected	using	anti-BTV	Orab276	
(The	 Pirbright	 Institute)	 used	 at	 1	 in	 1000,	which	was	 raised	 in	 Rabbit	 (IAH),	 and	 labeled	
with	a	goat	anti-rabbit	IgG	Alexa	Fluor	568	(Life	Technologies)	secondary	antibody	used	at	1	
in	200	or	anti-BTV	antibody	/Orab279,	raised	in	guinea	pigs	(The	Pirbright	Institute)	used	 at	
1	 in	 1000	 and	 then	 detected	 with	 goat	 anti-guinea	 pig	 IgG	 Alexa	 Fluor	 568	 (Life	
Technologies)	 secondary	 antibody	 used	 at	 1	 in	 200.	 Infectious	 sub-viral	 particles	 (ISVP’s)	
were	 labelled	with	polyclonal	 rabbit	 serum	Orab109	or	 110	 (raised	 against	 purified	BTV1	
ISVPs)	 used	 at	 1	 in	 1000	 and	 detected	 with	 goat	 anti-rabbit	 IgG	 Alexa	 Fluor	 568	 (Life	
Technologies)	 secondary	antibody	used	at	1	 in	200.	All	 coverslips	were	stained	with	4',6-	
Diamidino-2-Phenylindole	DAPI	stain	(Life	technologies)	at	1	in	10000	and	virus	uptake	
experiments	 were	 also	 stained	 with	 phalloidin-488	 (Life	 technologies)	 at	 1	 in	 25.	 Virus	
uptake	 or	 infection	 was	 visualized	 using	 the	 Leica	 SP2	 Scanning	 Confocal	Microscope	 or	
Leica	TCS	SP8	Confocal	 laser	scanning	Microscope.	Virus	uptake	studies	used	the	Hybrid	3	
settings	 in	order	 to	detect	 low	fluorescent	single	virions	 in	 the	552	 laser	channel	and	the	
488	channel	in	order	to	not	bleach	phalloidin-488	staining	
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2.8.2 Image	analysis	
	
	
Z-stacked	images	were	compiled,	rendered,	3D-cell	reconstructed	and	analysed	using	
IMARIS	image	analysis	software.	
	
	
	
2.9 Biochemical	Analysis	
	
	
2.9.1 Pharmaceutical	inhibitors	
	
	
Several	pharmaceutical	inhibitors	were	used	throughout	this	thesis	either	to	pre-treat	cells	
for	 30	minutes	prior	 to	 infection/	 control	 ligand	uptake	or	 treat	 cells	 at	 time	 points	 post	
infection,	which	are	specified	in	figure	legends	in	results	chapters.	A	table	listing	inhibitors,	
stock		concentrations,	working	concentrations,	diluent		and	suppliers	can	be	seen	in				Table	
2.3.	Inhibitors	were	further	diluted	to	working	stock	concentrations	using	serum	free		
GMEM	(Sigma).	
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Table	2.3		Pharmacological	inhibitors	of	endocytosis	and	diluents	
	
Inhibitor	Name	 Inhibitor	Target	 Inhibitor	
Diluent	
Stock	
Concentration	
Working	
Concentration	
Supplier	
Dynasore	 Dynamin	I	and	II	
inhibitor	-	unknown	
mode	of	action	
noncompetitive	
inhibition	
DMSO	 5mg	 100µM	 Abcam	
Dyngo4a	 Dynamin	I	and	II	
inhibitor	GTPase	
allosteric	site	
DMSO	 5mg	 30μM	 Abcam	
MiTMAB	 Dynamin	I	and	II	PH	
lipid	binding	domain	
competitive	with	lipid	
noncompetitive	with	
GTP	
DMSO	 1mg	 16µM	 Abcam	
Dynole	34-2	 Dynamin	I	and	II	GTPase	
Allosteric	Site	
uncompetitive	with	GTP	
DMSO	 1mg	 20μM	 Abcam	
Chlorpromazine	
Hydrochloride	
Clathrin	 Deionised	
water	
5mg	 10µg/mL	 Abcam	
Pitstop2	 Clathrin	 DMSO	 5mg	 25μM/30µM	 Abcam	
Methyl-β-	
cyclodextrin	
Cholesterol	 GMEM	 5mg	 5mM	 Sigma	
EIPA	 Sodium-proton	
exchanger	1	
DMSO	 25mg	 100µM	 Sigma	
IPA-3	 p21-activated	kinase	1	
(PAK1)	
DMSO	 25mg	 100μM	 Calbiochem	
Cytochalasin	D	 Actin	polymerization	 DMSO	 1mg	 10μg/mL	 Life	
Technologies	
C3	Toxin	
	
From	Clostridium	
botulinum	
Rho	proteins	 Deionised	
water	
100µg/mL	 1μg/mL	 Calbiochem	
Wortmannin	 PI3Kinase	 DMSO	 5mg	 200nM	 Sigma	
Blebbistatin	 Myosin	II	 DMSO	 1mg	 50µM	 Abcam	
AmCl2	 Neutralizes	endosomal	
pH	
SFM	 1M	 25mM	 Fluka	
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2.9.2 Control	ligands	
	
	
Control	ligand	experiments	were	carried	out	on	serum-starved	cells	which	had	either	been	
treated	with	drug	 inhibitors	or	 control	 treatments	 (see	 section	2.9.1)	 or	 transfected	with	
DNA	 or	 siRNA	 (see	 section	 2.5.13/2.5.14).	 Two	 control	 ligands	 were	 used	 in	 this	 thesis,	
which	 were	 transferrin,	 an	 established	 marker	 in	 mammalian	 cell	 systems	 for	 clathrin-	
mediated	endocytosis	((Harding	et	al.,	1983,	Harding	and	Stahl,	1983,	Hanover	et	al.,	1984,	
Hopkins,	 1985,	 Hopkins	 et	 al.,	 1985))	 and	 dextran,	 an	 established	marker	 for	 fluid-phase	
uptake/macropinocytosis	(Klein	and	Satre,	1986).	Cells	were	serum	starved	for	45	minutes,	
with	 three	washes	with	 serum	 free	media,	Glasgow’s	Minimum	Essential	Media	 (GMEM)	
(Sigma),	every	15	minutes.	Cells	were	then	exposed	to	10μg/mL	transferrin	Alexa-Fluor	647	
(Life	technologies)	or	0.5mg/mL	dextran	Alexa-Fluor	647	(Life	technologies)	for	15	minutes	
and	 then	placed	on	 ice.	Cells	were	 then	processed	 for	either	 flow	cytometry	 (see	 section	
2.7)	or	confocal	microscopy	(see	section	2.8).	
	
	
	
Control	 ligand	 described	 above	 was	 slightly	 adapted	 for	 fluid	 phase	
uptake/macropinocytosis	 stimulation	 experiment	 (See	 Chapter	 5,	 section	 5.5.7).	 For	 this	
experiment,	 cells	 were	 serum	 starved	 as	 described	 above	 and	 then	 exposed	 to	 either	
1μg/mL	 phorbol	 12-myristate	 13-acetate	 (PMA)	 (Sigma)	 or	 0.3μg/mL	 	 purified	 	 BTV-1	
(diluted	in	serum	free	GMEM)	for	15	minutes.	After	15	minute	stimulation,	cells	were	then	
exposed	 to	 0.5mg/mL	 dextran	 (Life	 Technologies)	 and	 were	 incubated	 at	 37°C	 for	 15	
minutes	to	allow	ligands	to	be	internalized.	Cells	were	then	placed	on	ice	and	prepared	for	
flow	cytometry	(see	section	2.7).	
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2.9.3 Cytotoxicity	Assay	
	
	
Cells	were	 seeded	onto	 optically	 clear	 bottom,	white-sided	plates	 (Perkin	 Elmer)	 the	 day	
before	 the	 assay.	 When	 cells	 were	 80%	 confluent,	 cells	 were	 treated	 with	 a	 range	 of	
concentrations	 of	 the	 pharmacological	 inhibitors	 tested	 (see	 section	 2.9.1).	 Cells	 were	
incubated	 with	 inhibitors	 for	 12.5	 hours.	 The	 cell	 titre	 substrate	 and	 buffer	 were	 then	
mixed	 after	 defrosting	 and	 equilibrating	 to	 room	 temperature	 and	 100uL	 of	 the	
substrate/buffer	mix	were	added	 to	 cells	 for	10	minutes,	whilst	being	gently	 rocked.	 The	
luminescence	 of	 the	 cells,	were	 then	 read	 using	Hidex	 chameleon	 luminometer.	 Viability	
was	 determined	 by	 luminescence	 readings	 where	 high	 luminescence	 corresponds	 to	
healthy,	viable	cells	and	 low	 luminescence	corresponds	to	metabolically	 inactive	cells	 (i.e.	
cytotoxicity).	
	
	
	
2.10 Statistical	Analysis	
	
	
General	 Linear	 Model	 (randomised	 factors	 –	 date	 of	 experiment,	 fixed	 factors	 being	
treatment)	 ANOVA	 with	 Tukey’s	 correction	 was	 carried	 out	 for	 all	 flow	 cytometry	 data	
using	Minitabv17.	Data	from	GFP-fusion	transfection	experiments	were	first	normalised	to	
account	 for	 transfection	efficiency	before	 then	being	analysed	as	described	above.	To	do	
this,	expressing	populations	(GFP	positive)	that	were	infected	were	normalised	by	dividing	
the	total	%	cells	of	the	total	expressing	population,	this	was	repeated	with	the	uninfected	
population	and	the	same	process	was	carried	out	with	the	non-expressing	populations	(GFP	
negative).	All	experimental	data	was	 in	 triplicate	with	at	 least	 two	repeated	experiments.	
Data	 from	 repeated	 experiments	 were	 combined	 prior	 to	 statistical	 analysis.	 	 Flow	
cytometry	data	was	graphically	represented	by	presenting	all	experiment	data	as	dot	plots	
with	 each	 experiment	 identified	 by	 a	 different	 symbol	 and	 each	 treatment	 in	 different	
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colours.	 	 The	 decision	 on	 the	 graphical	 representation	 was	 to	 openly	 show	 inherent	
variability	between	experiments	but	to	also	show	that	each	experiment	showed	the	same	
trend	and	indicated	where	possible	if	the	trends	were	significant	by	the	use	of	‘*’,	where	*	
is	p	=	<0.05,	**	is	p	=	<0.005	and	***	is	p	=	<0.0005.	
		
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Chapter	3	-	
	
Purification	and	characterisation	of	
the	adaptation	of	BTV	to	cell	culture	
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3.1 Introduction	
	
	
Laboratory	adaptation	of	viruses	through	multiple	passaging	in	cell	culture	often	results	in	
viruses	 that	 are	 genetically	 and	 phenotypically	 different	 from	 the	 original	 field	 isolates	
(Krug	 et	 al.,	 2015,	 Kaul	 et	 al.,	 2009,	 Roedig	 et	 al.,	 2011).	 It	 has	 been	 demonstrated	 that	
these	 adaptations	 can	 affect	 virus	 entry,	 as	 is	 seen	 with	 Foot-and-Mouth	 Disease	 Virus	
(FMDV)	where	cell	 culture	adaptation	alters	 virus-receptor	 interactions	allowing	 the	virus	
to	enter	and	replicate	 in	cells	that	were	previously	non-permissive	to	 infection	(Berryman	
et	al.,	2013,	Chamberlain	et	al.,	2015,	Jackson	et	al.,	1996,	Sa-Carvalho	et	al.,	1997).	
	
	
	
Previous	 publications	 investigating	 BTV	 cell	 entry	 used	 highly	 mammalian	 cell	 culture	
adapted	strains	(Forzan	et	al.,	2007,	Gold	et	al.,	2010).	This	chapter	investigates	cell	culture	
adaptation	of	a	 field	 isolate	of	BTV	through	serial	passaging	 in	mammalian	and	 insect	cell	
culture.	 The	 sequences	 of	 the	 viral	 genomes	 were	 determined	 and	 the	 effect	 on	 virus	
infectivity	 on	 mammalian	 and	 insect	 cells	 compared.	 In	 addition,	 a	 method	 of	 virus	
purification	 which	 requires	minimal	 virus	 passaging	 without	mammalian	 cell	 culture	 was	
developed	by	modifying	 a	 previously	 published	BTV	purification	protocol	 (Mertens	 et	 al.,	
1987).	
	
	
	
For	 this	 study,	 a	 field	 isolate	of	BTV-1	 (BTV-1GIB2007/01)	was	used.	 This	 virus	originated	
from	a	sheep	in	the	Gibraltar	outbreak	(which	took	place	in	2007)	and	was	isolated	at	the	
time	 by	 one	 passage	 in	 insect	 cells	 (Culicoides	 spp.	 (KC)	 cells)	 and	 stored	 in	 the	 BTV	
reference		collection	designated		as		BTV-1GIB2007/01		without	propagation		in	mammalian	
Chapter	3:		Understanding	early	events	in	Bluetongue	virus	cell	entry	
106	
	
	
	
	
cells.	This	chapter	characterises	the	purified	BTV	particles	using	the	modified	protocol	 for	
insect	cell	generated	BTV	and	investigates	particle	purity	and	viability.	
	
	
	
Previous	 BTV	 cell	 entry	 publications	 also	 used	 different	 virus	 preparations;	 Forzan	 et	 al.,	
used	non-purified	virus	in	cell	culture	supernatant	(Forzan	et	al.,	2007),	whereas	Gold	et	al.,	
used	purified	virus	(Gold	et	al.,	2010).	It	is	documented	that	cytokines,	growth	factors	and	
other	 cellular	 factors	 can	 activate	 endocytosis	 pathways.	 For	 example,	 macropinocytosis	
can	be	activated	by	receptor	tyrosine	kinases,	transmembrane	receptors	that	are	activated	
by	 ligands	 such	 as	 growth	 factors,	 which	 can	 be	 found	 in	 tissue	 culture	 supernatants	
(Maruyama,	 2014,	 Hubbard	 and	 Miller,	 2007,	 Bryant	 et	 al.,	 2007).	 In	 addition,	 certain	
cytokines	can	play	a	role	in	the	activation	(IL-4	and	IL-13)	and	suppression	(IL-10	and	IFN-γ)	
of	 fluid-phase	uptake	 in	macrophages	 (Montaner	 et	 al.,	 1999).	 It	 has	 also	been	observed	
that	 pro-inflammatory	 cytokines	 IL-1,	 IL-6	 and	 IL-8,	 are	 released	 from	 BTV	 infected	
endothelial	cells	and	are	known	to	modulate	the	course	of	BTV	 infection	(DeMaula	et	al.,	
2002b).	To	avoid	the	potential	influence	of	cellular	factors	on	BTV	entry	the	studies	carried	
out	in	this	thesis	used	purified	virus.	
	
	
	
This	chapter	will	describe	purification	and	characterisation	of	whole	virion	particles	of	BTV-	
1	(BTV-1	GIB2007/01)	from	KC	cells	and	evaluate	the	significance	of	cell	culture	adaptation.	
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3.2 Phenotypic	and	genotypic	effects	of	serial	passaging	of	BTV-1	
	
	
3.2.1 Effects	of	serial	passaging	on	BTV-1	infectivity	
	
	
The	field	isolate	of	BTV-1	(BTV-1	GIB2007/01)	was	initially	passaged	twice	in	KC	cells	(KC2)	
and	then	a	further	6	times	in	BHK-21	(KC2/BHK6)	or	BFA	cells	(KC2/BFA6),	or	a	further	four	
times	in	KC	cells	(KC6).	Viruses	from	passages	2	(KC2)	and	6	(KC6,	KC2/BHK6	and	KC2/BFA6)	
for	 each	 cell	 line	 were	 analysed	 for	 infectivity.	 For	 each	 virus,	 infectivity	 was	 quantified	
using	3	cell	lines	(KC,	BHK	and	BFA	cells)	using	a	fluorescent	TCID50	method	(see	Chapter	2,	
section	2.3.1).	
For	each	virus/cell	 combination	 investigated	 the	TCID50/mL	were	determined	3	 times	and	
carried	 out	with	 a	minimum	of	 quadruple	 replicates.	 Figure	0.1	 shows	 the	 titre	 for	 KC2,	
KC6,	 KC2/BHK6	 and	 KC2/BFA6	 viruses	 on	 all	 3	 cell	 lines.	 The	 virus	 generated	 from	 the	
second	passage	in	KC	cells	(KC2)	was	taken	as	the	closest	virus	to	the	field	isolate	and	this	
was	compared	to	all	other	viruses.	
	
	
	
The	first	observation	to	note	was	a	significant	increase	in	viral	titre	in	KC6	(light	blue	bars	in	
Figure	0.1)	virus	compared	to	KC2	virus	(dark	blue	bars	in	Figure	0.1)	when	titrated	in	KC	
cells	 (ANOVA,	 p	 =	 0.01)	 indicating	 that	 KC6	 has	 enhanced	 infectivity	 in	 insect	 cells.	
Additionally,	both	KC	cell	derived	viruses	(KC2	and	KC6)	had	significantly	lower	infectivity	on	
both	mammalian	cell	 lines	 (BFA	and	BHK-21	cells)	 compared	 to	 the	 titre	on	KC	cells	 (KC2	
viruses	comparing	titres	observed	in	BFA	and	BHK-21	cells,	ANOVA	p	=	0.001	and	p	=	0.005,	
respectively.	 KC6	 viruses	 comparing	 to	 BFA	 and	 BHK-	 21	 cells,	 ANOVA	 p	 =	 <0.0005,	 p	 =	
<0.0005,	respectively).	This	suggests	that	during	passage		
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in	KC	cells,	changes	that	might	improve	virus	growth	in	mammalian	cells	are	avoided	and	the	virus	
retains	 its	 field-like	 phenotype.	 The	 results	 also	 demonstrate	 that	 the	 viruses	 (KC2/BFA6	 and	
KC2/BHK6)	prepared	using	mammalian	cells	have	similar	titres	on	all	3	cell	lines	(KC,	BFA	and	BHK)	
suggesting	 that	 passage	 through	mammalian	 cells	 does	 result	 in	 adaptation	 to	mammalian	 cell	
culture	 and	enhanced	 replication	 in	mammalian	 cell	 likes.	 Taken	 together	 these	 results	 suggest	
that	to	study	entry	of	a	virus	with	a	field	phenotype	it	should	not	be	prepared	using	mammalian	
cells.	
Chapter	3:		Understanding	early	events	in	Bluetongue	virus	cell	entry	
109	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	3.1	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	3.1		Infectivity	of	BTV-1GIB2007/01	after	serial	passage	in	three	different	cell	lines	
	
Field	 isolate	 BTV-1	 GIB2007/01	was	 serially	 passaged	 either	 in	 BHK-21,	 BFA	 or	 KC	 cells	 after	 two	
initial	passages	 in	KC	cells.	The	second	passage	 in	KC	cells	 (KC2)	and	the	sixth	passaged	virus	 from	
each	 cell	 line	 (KC6,	 KC2BHK6	 and	 KC2BFA6)	were	 titrated	 on	 each	 of	 the	 indicated	 cell	 lines.	 The	
TCID50	was	 determined	3	 times	 and	 carried	out	with	 a	minimum	of	 quadruplet	wells.	 Analysis	 of	
variance	 (ANOVA)	with	 Tukey’s	 correction	was	 carried	out	 to	 compare	 virus	 titre	between	 viruses	
and	 both	within	 and	 between	 cell	 lines.	 *	 =	 p<0.05,	 **	 =	 p	 <0.005,	 ***	 =	 p	 <0.0005,	where	 bars	
indicate	the	viral	titres	which	differ	statistically	significant	
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3.2.2 Effects	of	serial	passaging	of	BTV-1	in	cell	culture	of	genome	sequence	
	
	
	
The	whole	genomes	of	the	KC2,	KC6	and	KC2BFA6	viruses	were	sequenced	(carried	out	 in	
collaboration	with	 Kyriaki	Nomikou	 from	 the	Arbovirus	Molecular	 Research	 group	 at	 The	
Pirbright	 Institute)	and	compared	to	 identify	sequence	differences.	For	KC6	and	KC2BFA6,	
each	 segment	 was	 aligned	 against	 the	 corresponding	 segment	 from	 the	 KC2	 virus	 to	
compare	both	nucleotide	and	amino	acid	sequences	(Alignments	can	be	seen	in	Appendix	
E).		Differences	in	the	sequences	are	summarised	in	Table	3.1.	
	
	
	
Synonymous	nucleotide	changes	were	seen	in	segments	1	and	6	when	comparing	KC2	virus	
with	 KC6	 or	 KC2/BFA6	 viruses.	 Three	 non-synonymous	 nucleotide	 (nt)	 changes	 were	
detected	in	the	KC6	virus	compared	to	KC2	virus;	two	in	segment	9	and	one	in	segment	3	
which	encode	VP6	(the	viral	helicase)	and	VP3	(the	core	scaffolding	protein),	respectively.	
These	 resulted	 in	 a	 Lysine	 (K)	 to	 Asparagine	 (N)	 (changes	 at	 residue	 184	 in	 VP3,	 and	
Arginine	(R)	to	Glutamate	(E)	and	Glycine	(G)	to	Glutamate	(E)	changes	at	residues	24	and	
121	in	VP6.		One	of	the	changes	in	segment	9	(at	nt	377)	also	alters	residue	66			 (Glutamate	
(E)	to	Lysine	(K))	within	NS4	as	the	reading	frames	for	VP6	and	NS4	overlap.	The	KC6	virus	
also	 had	 a	major	 deletion	 (18	 nt;	 1180-1197)	 in	 segment	 2	 resulting	 in	 the	 loss	 of	 6	 aa	
(residue	 388-393)	 in	 VP2	 which	 as	 the	 outer	 most	 protein	 is	 the	 target	 for	 neutralising	
antibodies	and	responsible	 for	cell-attachment.	The	KC2/BFA6	virus	had	the	same	change		
in	VP3	as	seen	in	the	KC6	virus	and	two	other	unique	non-synonymous	nucleotide	changes	
(compared	 to	 the	KC2	virus).	These	were	at	nucleotide	1508	 in	segment	2	 resulting	 in	an	
Isoleucine	 (I)	 to	Methionine	 (M)	 changes	 at	 residue	 497	 of	 VP2,	 and	 at	 nucleotide	 30	 in	
segment	9	that	resulted	in	an	Isoleucine	(I)	to	Methionine	(M)	change	at	residue	5	in	VP6.	
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Interestingly,	 no	 changes	 were	 detected	 in	 viral	 genes	 coding	 for	 VP4	 (mRNA	 capping	
enzyme),	 VP5	 (Outer	 capsid	 fusion	 protein),	 VP7	 (Inner	 core	 structural	 protein)	 and	non-	
structural	proteins	NS2	(forms	viral	inclusion	body	matrix)	and	NS3/NS3A	(involved	in	virus	
egress).	
	
	
3.3 Purification	of	field	isolate	BTV-1	from	KC	cells	
	
	
Adaptations	 to	 the	 published	 BTV-1	 purification	 protocol	 were	 made	 to	 overcome	 the	
requirement	for	mammalian	cell	culture	and	the	potential	adaptation	of	BTV-1	GIB2007/01	
during	purification.	Essentially,	the	virus	was	propagated	by	limited	passage	in	KC	cells	and	
purifying	virus	directly	from	homogenised	KC	cells	(as	Chapter	2,	section	2.2).	
3.3.1 Analysing	BTV-1	purity	
	
	
The	purity	of	the	virus	preparations	was	assessed	by	SDS	PAGE.	SDS	PAGE	gels	 for	one	of	
the	 virus	 preparations	 are	 shown	 in	 Figure	 3.2	 and	 were	 stained	 with	 either	 Coomasie	
brilliant	blue	stain	(Figure	3.2	(A))	or	silver	stain	(Figure	3.2	(B)).	Three	different	volumes	of	
the	purified	virus	sample	were	analysed	in	lanes	1	(14µL	of	sample),	lane	2	(7µL	of	sample)	
and	lane	3	(5µL	of	sample).	All	expected	viral	proteins	were	present	in	lanes	1-3,	with	little	
to	no	cellular	contamination	(Figure	3.2).	
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Figure	3.2	
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Figure	3.2		SDS	Page	of	purified	BTV-1GIB2007/01	from	KC	Cells	
	
SDS	 PAGE	 gels	 present	 viral	 proteins	 from	 purified	 BTV-1	 GIB/2007/01.	 (A)	 Gel	 stained	 with		
Coomasie	stain.	(B)	Gel	stained	with	Pierce	Silver	Stain.	Three	volumes	of	purified	virus	from	KC	cells	
can	be	seen	in	Lanes	1	(14uL),	2	(7uL)	and	3	(5uL)	of	both	gels	(A)	and	(B).	All	major	viral	structural	
proteins	can	be	identified	in	the	silver	stained	PAGE	(B)	while	cellular	proteins	cannot	be	detected.	
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3.3.2 Analysing	BTV-1	infectivity	
	
	
The	 infectivity	 (TCID50)	 of	 the	 purified	 virus	was	 determined	 by	 viral	 titration	 on	 KC,	 BFA		
and	 BHK-21	 (Chapter	 2,	 section	 2.3.1).	 The	 mean	 TCID50/ml	 for	 3	 separate	 virus		
purifications	 is	 shown	 in	Table	3.2.	The	TCID50/ml	on	BFA	and	BHK-21	cells	were	 similar,	
however,	the	TCID50/mL	were	greater	for	all	three,	virus	purifications	on	KC	cells,	a	finding	
that	is	consistent	with	mammalian	cell	culture	adapted	BTV-1	titrated	on	KC	cells	(Mertens	
et	al.,	1987,	Mertens	et	al.,	1996)	(see	Table	3.2).	
	
	
Table	3.2		Purified	virus	titres	on	three	different	cell	lines	
	
Cell	Line	 	 Mean	TCID50/mL	
	 Purification	1	 Purification	2	 Purification	3	
KC	 109.3	 109.23	 108.25	
BFA	 106.7	 106.5	 106.5	
BHK-21	 107	 106.6	 n.d.	
	
	
	
	
3.3.3 Aggregation	of	BTV-1	virions	
	
	
Purified	preparations	of	BTV	have	 a	 tendency	 to	 aggregate	which	 can	be	 reduced	by	 the	
addition	of	0.1%	NLS	(Mertens	et	al.,	1987).	Therefore	purified	viruses	were	stored	 in	the	
presence	of	0.1%	NLS.		The	aggregation	status	of	the	purified	viruses	was	evaluated	by	DLS.	
Figure	3.3	shows	DLS	data	for	BTV-1	whole	virions	and	ISVPs	from	purification	3.	Previous	
publications	 suggest	 ISVPs	 are	 not	 prone	 to	 aggregation	 (Mertens	 et	 al.,	 1987)	 and	 so	
purified	 ISVP	 was	 used	 as	 a	 marker	 for	 disaggregated	 virus.	 The	 trace	 identifies	 a	
heterogenous	population	of	particle	sizes,	which	are	distributed	between	40nm	and	800nm	
for	whole	virus	and	45nm	and	1100nm	for	ISVPs	(Figure	3.3	(A)).		In	the	whole	virus			 trace,	
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a	shoulder	can	be	seen	(red	trace	panel	(a)),	which	appears	to	peak	at	70-90nm,	consistent	
with	 the	 presence	 of	 individual	 virions.	 The	 main	 peak	 can	 be	 seen	 at	 approximately	
250nm,	 suggestive	 of	 some	 virus	 aggregation,	 which	 potentially	 indicates	 that	 virus	 is	 in	
small	 aggregates	of	 approximately	 3	 virions.	 The	main	peak	 for	 ISVPs	 (green	 trace,	 panel	
(a)),	 however,	 is	 approximately	150nm,	which	 could	 indicate	 small	 aggregates,	 consistent	
with	2	virions.	For	comparison,	panel	(b)	shows	virus	that	was	stored	at	4°C	for	12	months	
and	 appears	 to	 show	 extensive	 virus	 aggregation,	 with	 two	 peaks	 shown	 at	 150nm	 and	
1050nm.	As	virus	aggregates	over	 time,	 freshly	purified	virus	was	used	for	all	 subsequent	
virus	entry	experiments.	
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Figure	3.3	
	
	
	
Figure	3.3	Dynamic	Light	Scattering	of	freshly	purified	BTV-1	whole	virions,	 ISVP’s	and	1	year	old	
purified	BTV-1	whole	virions.	
	
	
Particle	size	was	measured	using	the	Malvern	µ	zetasizer	of	freshly	purified	BTV-1	GIB2007/01	whole	
virions	(shown	in	red)	and	ISVP’s	(shown	in	green)	as	shown	in	figure	(A)	and	compared	to	purified	
BTV-1	GIB2007/01	whole	virions	that	have	been	stored	at	4°C	for	one	year,	as	shown	in	figure	(B).	
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3.3.4 Analysing	whole	genome	sequencing	of	purified	BTV	
	
	
In	section	3.3.2,	a	number	of	genomic	changes	were	 identified	upon	repeated	passage	of	
BTV	 in	cell	 culture.	The	aim	of	 this	project	 is	 to	purify	BTV	whilst	 retaining	genotypic	and	
phenotypic	 characteristics	 of	 the	 field	 isolate.	 Therefore,	whole	 genome	 sequencing	was	
carried	out	on	 low	KC	passaged	purified	virus	and	compared	 to	 the	KC2	virus	 in	order	 to	
identify	 whether	 any	 genetic	 changes	 have	 occurred	 prior	 to	 virus	 purification.	 After	
alignment	 of	 all	 BTV	 segments	 from	 purified	 virus	 with	 the	 KC2	 virus	 sequence,	 it	 was	
identified	 that	only	 a	 single	polymorphic	 site	 in	 segment	9	 at	 nucleotide	position	17	was	
detected	 (see	 Appendix	 F).	 As	 this	 was	 consensus	 sequencing,	 the	 site	 coded	 in	 	 the	
majority	of	the	population	for	a	G	(75%	population)	but	25%	of	the	population	coded	for	T.	
This	change	altered	the	amino	acid	from	Methionine	(M)	to	Arginine	(R).	As	this	site	was	in	
the	helicase,	it	is	unlikely	this	mutation	would	impact	cell	entry.	
	
	
	
3.4 Quantifying	BTV-1	infection	using	flow	cytometry	
	
	
A	 method	 was	 developed	 to	 quantify	 BTV	 infection	 using	 flow	 cytometry.	 A	 number	 of	
available	 antibodies	 (produced	 at	 TPI)	 were	 screened	 for	 their	 suitability	 to	 identify		
infected	cells.	All	of	the	antibodies	tested		detected	viral	proteins	in	BFA	cells,	compared	to	
a	 low	 background	 signal	 seen	 in	 the	 uninfected	 controls	 or	with	 infected	 cells	 incubated	
with	only	the	secondary	antibodies	(no	first	antibody	controls)	(Figure	3.4).	The	polyclonal	
antibody	 orab276	 (raised	 in	 rabbit	 against	 BTV-1	 whole	 virus)	 gave	 the	 best	 signal	 to	
background	 ratio	 (Figure	 3.4)	 and	was	 therefore	 selected	 for	 BTV	 viral	 protein	 detection	
analysed	by	flow	cytometry.	
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Figure	3.4	
	
	
Figure	3.4	Testing	anti-BTV-1	antibodies	that	quantify	infection	in	flow	cytometry	and	confocal	
applications	
	
	
Anti-BTV	 antibodies	 were	 tested	 in	 infected	 and	 uninfected	 BFA	 cells	 for	 their	 suitability	 for	
detecting	BTV-1	GIB2007/01	infection	by	flow	cytometry	and	confocal	microscopy.	(A)	BTV	infection	
was	detected	using	flow	cytometry	following	12h.p.i.	 	All	antibodies	tested	detected	viral	 infection		
by	 flow	 cytometry,	with	 little	 background	 seen	 in	 uninfected	 cells,	 antibodies	Orab276,	Orab	 277		
and	 Orab	 114	 were	 tested.	 Panel	 (B)	 shows	 confocal	 microscopy	 of	 anti-BTV	 antibody	 Orab276	
labelling	 on	 uninfected	 cells.	 Panel	 (C)	 shows	 anti-BTV	 antibody	 Orab276	 tested	 on	 18h	 infected	
cells.	Panel	(D)	shows	anti-BTV	antibody	Orab114	tested	on	18h	infected	cells.	Panel	(E)	shows	anti-	
BTV	 antibody	 Orab277	 tested	 on	 cells	 18h	 infected	 cells.	 All	 confocal	 images	 show	 blue	 staining	
which	is	DAPI	and	red	staining	which	is	BTV.		Scale	bars	=	15	µM.	
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The	 same	 antibodies	 were	 also	 tested	 for	 their	 ability	 to	 detect	 infection	 by	 confocal	
microscopy	 (Figure	 3.4	 (b),	 (c)	 and	 (d)).	 The	 antibodies	 generated	 good	 fluorescent	
intensity	with	little	to	no	non-specific	background	binding.	The	level	of	 infection	observed	
using	confocal	microscopy,	agreed	with	what	was	shown	using	flow	cytometry,	which	gave	
confidence	 that	 flow	cytometry	would	be	a	 good	quantitative	 technique	 to	measure	BTV	
infection.	
	
To	determine	the	specificity	and	sensitivity	of	the	flow	cytometry	assay	for	detecting	BTV	
infection,	BFA	cells	were	infected	with	different	amounts	of	virus	(Figure	3.5	(A))	and	left	
for	1	or	16	hours	for	each	virus	dilution.	A	small	percentage	(<2%)	of	cells	were	detected	as	
positive	 for	 viral	protein	 labelling	above	background	when	 the	 cells	were	 labelled	1	hour	
post	 infection	presumably	as	 the	 result	of	detecting	 input	virus	 inoculum.	However,	after		
16	hours	of	infection	5-28%	of	the	cell	population	was	positive	for	viral	proteins,	indicating	
that	the	antibody	is	detecting	active	BTV-1	infection	(Figure	3.5	(A)).	
Figure	 3.5	 (B)	 shows	 an	 infection	 time	 course	 to	 evaluate	 the	 ability	 of	 the	 antibody	 to	
detect	virus	 infection	 in	KC	cells	 (Figure	3.5	 (B)).	Cells	were	BTV-1	 infected	and	 incubated	
for	 1,	 16,	 20	 and	 24	 hours	 before	 being	 processed	 for	 flow	 cytometry	 (see	 Chapter	 2,	
section	 2.7).	 An	 increase	 in	 infection	 can	 be	 seen	 in	 KC	 cells	 as	 the	 length	 of	 infection	
increases	 (Figure	 3.5	 (B)),	 indicating	 that	 the	 antibody	 used	 for	 detection	 of	 infection	 is		
both	specific	and	sensitive	for	detecting	viral	protein	generation	during	virus	replication	in	
both	BFA	and	KC	cells.	
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Figure	3.5	
	
Figure	3.5		Quantifying	BTV-1	infection	using	flow	cytometry	
	
BTV-1	 infection	 was	 detected	 using	 anti-BTV	 antibody	 (Orab276)	 and	 secondary	 goat-anti	 rabbit	
AlexaFluor-647.	Panel	 (A)	 shows	BFA	cells	 infected	with	a	dilution	 series	of	BTV-1	and	details	 viral	
protein	 expression	 levels	 at	 1	 and	 16	 hours	 post	 infection.	 Panel	 (B)	 shows	 KC	 cells	 infected	with	
BTV-1	 (1	 in	 500	dilution)	 and	 a	 time	 course	of	 infection	 from	1	 to	 24	hours	 post	 infection.	Graph	
displays	raw	data.		Single,	live	cell	populations	were	analysed.	
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3.5 Discussion	
	
	
Serial	passaging	of	viruses	at	 low	multiplicity	of	 infection	(m.o.i.)	 in	cell	culture	effectively	
forces	 viruses	 to	 pass	 through	 repeated	 evolutionary	 bottlenecks,	 which	 in	 turn	 can	
significantly	 impact	the	genetic	 landscape	of	 the	virus	 (Woo	and	Reifman,	2014).	This	can	
force	 viruses	 to	 adapt	 to	 the	 cellular	 environment	 to	 improve	 virus	 growth.	 Significantly,	
this	 can	 result	 in	 virus	 with	 altered	 receptor	 preferences,	 which	 could	 change	 the	
endocytosis	 pathway	 used	 for	 entry.	 Furthermore,	 viruses	 passaged	 at	 high	 m.o.i.		
introduce	a	larger	viral	diversity	in	the	virus	population	after	each	passage	(Domingo	et	al.,	
2012).	 Therefore,	 this	 may	 cause	 viruses	 at	 the	 undetectable	 sub-consensus	 level	 to	
become	 detectable	 after	 repeated	 passaging,	 if	 selective	 pressures	 allow	 it	 to	 become	 a	
dominant	virus	sequence	in	the	population.	
	
	
	
This	chapter	describes	the	effects	of	serial	passage	on	BTV	infectivity	and	genome	sequence	
during	passage	of	a	field	isolate	of	BTV	in	mammalian	and	insect	cells.	A	field	isolate	of	BTV	
was	passed	6	times	through	KC	cells	(KC6)	or	twice	through	KC	cells	followed	by	a	further	6	
passages	through	BFA	or	BHK	cells	(KC2/BFA6	and	KC2/BHK6,	respectively).	The	infectivity	
of	the	KC2,	KC6,	KC2/BFA6	and	KC2/BHK6	viruses	for	KC,	BFA	or	BHK-21	cells	show	that	the	
KC6	virus	appears	 to	have	higher	 infectivity	 for	KC	cells	 than	 the	KC2	virus.	 Sequences	of	
these	viruses	 identified	amino	acid	changes	 in	 the	viral	helicase	 (VP6),	 core	protein	 (VP3)	
and	 NS4.	 Interestingly,	 the	 KC6	 virus	 also	 had	 a	 major	 deletion	 in	 the	 cell	 attachment	
protein	(VP2).	It	is	not	known	if	any	of	the	changes	result	in	improved	growth	in	KC	cells	or	
if	some	of	the	changes	are	required	in	combination	and	so	further	work	will			be	needed	to	
determine	the	effects	of	these	changes	on	virus	growth	in	KC	cells.	
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The	results	of	this	analysis	also	show	that	the	viruses	passaged	in	KC	cells	have	a	lower	titre	
for	 mammalian	 cells,	 suggesting	 that	 virus	 propagation	 in	 KC	 cells	 avoids	 changes	
associated	with	adaptation	to	growth	in	mammalian	cell	culture.	
	
	
	
This	conclusion	was	supported	by	the	observation	that	the	viruses	passaged	in	mammalian	
cells	(KC2/BFA6	and	KC2/BHK6)	had	higher	titres	on	mammalian	cells	compared	to	the	KC2	
virus,	 suggesting	 adaptation	 had	 occurred.	 Sequences	 of	 the	 KC2/BFA6	 virus	 identified	
changes	 that	could	account	 for	 improved	growth	 in	mammalian	cells	but	as	stated	above	
confirmation	of	this	will	require	future	work.	
	
	
	
All	viruses	had	relatively	high	infectious	titres	in	midge	cells.	This	suggests	that	replication	
of	BTV	in	midge	cells	is	robust	and	that	genetic	changes	driven	by	selective	pressure	within	
mammalian	cells	may	not	impede	infection	in	Culicoides	spp.	derived	KC	cells.	It	is	possible	
that	 this	 is	 a	 viral	 survival	 strategy	 that	 has	 evolved	 to	 allow	 the	 virus	 to	 continue	 to	
replicate	successfully	in	the	vector.	
	
	
	
VP2	 is	 the	 cell	 attachment	 protein.	 The	 virus	 KC6	 has	 a	 deletion	 of	 6	 amino	 acids	 (aa)	
(residues	 388	 –	 393)	 in	VP2,	which	does	not	 appear	 in	 the	KC2/BFA6	 virus.	 This	 deletion	
could	 influence	 the	 functionality	 of	 the	 attachment	 protein,	 such	 as	 altering	 receptor	
binding	and	attachment	of	entry.	Furthermore,	the	KC2/BFA6	also	had	a	non-synonymous	
nucleotide	 change	 in	 VP2	 (I497M),	 which	 could	 influence	 virus	 entry.	 The	 fact	 that	 a	
reduction	 in	 viral	 titre	 is	 observed	 in	 the	 KC6	 virus	 in	 BFA	 cells,	 could	 suggest	 that	 this	
deletion	may	alter	receptor-binding		preference		at		the		point		of		attachment,		perhaps	to	
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enhance	 receptor	 binding	 in	 insect	 cells	 by	 removing	 a	 less	 efficient	 binding	 	 site	 	 in	 the	
virus.	 It	 is	 known	 that	 the	 RGD	 tripeptide	 in	 VP7	 can	 mediate	 binding	 to	 integrins	 and	
attachment	 to	 Culicoides	 spp.	 cells	 (Tan	 et	 al.,	 2001)	 and	 so	 this	 deletion	 may	 alter	
conformation	of	VP2	and	may	expose	the	RGD	peptide	to	allow	binding	through	that	site.	
However,	to	confirm	this	hypothesis,	further	functional	analysis	of	this	virus	is	required.	
	
	
	
Consensus	sequencing	identifies	the	dominant	sequence	in	a	population.	However,	in	virus	
population	 (particularly	 RNA	 viruses),	 large	 viral	 diversities	 can	 exist.	 Therefore,	 when	
carrying	 out	 consensus	 sequencing	 in	 BTV	 population,	 the	 consensus	 sequence	 usually	
reflect	a	change	in	the	dominant	virus	sequence	in	the	population	(Domingo	et	al.,	2012).	
Therefore	 changes	 in	 the	dominant	 sequence,	may	 reflect	 selective	pressure	allowing	 for	
cell	culture	adaptation.	Whilst	changes	 in	sequences	will	be	described	as	 ‘synonymous’	or	
‘non-synonymous	changes’	from	this	point	forward,	it	may	be	reflective	in	a	change	in	viral	
sequence	 dominance	 due	 to	 selection	 or	 a	 polymorphic	 site	 due	 to	 adaptation.	 Deep	
sequencing	would	reveal	which	possibility	is	likely.	
	
	
	
Interestingly,	there	were	two	changes	in	the	same	position	identified	in	both	the	KC6	and	
the	 KC2/BFA6	 viruses,	 one	 of	which	was	 non-synonymous.	 The	 synonymous	 substitution	
resided	 in	 VP1,	 G	 to	 A	 at	 bp	 position	 3497,	 and	 the	 non-synonymous	 substitution	 was	
identified	 in	 VP3,	 K184N.	 As	 the	 same	 changes	 were	 identified	 in	 both	 the	 KC	 and	 BFA	
passaged	viruses,	these	residues	could	indicate	a	general	cell	culture	adaptation.	
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Two	 additional	 non-synonymous	 mutations	 were	 observed	 in	 the	 KC6	 virus	 within	 VP6	
(segment	9),	R24E	and	G121E,	the	viral	helicase	and	a	further	mutation	in	the	second	open	
reading	 frame	 of	 segment	 9,	 which	 codes	 for	 NS4,	 E66K.	 In	 addition,	 another	 non-	
synonymous	 substitution	 was	 also	 observed	 in	 VP6	 of	 the	 KC2/BFA6	 virus,	 I5M.	 Non-	
synonymous	substitutions	within	viral	proteins	such	as	the	viral	helicase	and	non-structural	
proteins	 in	 both	 of	 these	 viruses	 could	 influence	 viral	 replication.	 In	 addition,	 non-	
synonymous	 mutations	 in	 the	 attachment	 protein	 could	 possibly	 affect	 virus	 cell	
attachment	and/or	entry.	It	is	interesting	that	there	is	a	shared	non-synonymous	mutation	
in	the	VP3	of	both	cell	culture	passaged	viruses,	a	core	scaffold	protein,	the	significance	of	
which	is	difficult	to	determine	without	further	investigation.	
	
	
	
Whilst	 it	 is	 unclear	 from	 this	 study	 whether	 the	 mutations	 identified	 in	 this	 chapter	
observed	 in	 serial	 passaged	 viruses	 would	 be	 recurrent,	 it	 does	 demonstrate	 that	 serial	
passaging	of	BTV	in	cell	culture	can	influence	the	viral	genome	sequence,	which	then	might	
affect	 viral	 cell	 entry	 and/or	 replication.	 Similar	 observations	 have	 been	 made	 in	 other	
studies	where	serial	passaged	viruses	have	shown	polymorphic	variation	such	as	that	seen	
in	 SARS	 coronavirus,	 Ebola,	 HIV-1,	 Hepatitis	 C,	 Rotavirus	 and	 FMDV	 some	 of	which	 have	
also	 reported	 functional	 effects	 on	 the	 virus	 (Agrawal-Gamse	 et	 al.,	 2009,	 Pugach	 et	 al.,	
2004,	Volchkova	et	al.,	2011,	Poon	et	al.,	2005,	Mohan	and	Atreya,	2001,	Helle	et	al.,	2013).	
Therefore,	 it	 is	 important	 for	 studies	 that	 require	 purified	 virus	 to	 use	 a	 purification	
method,	which	retains	a	viral	genome	with	close	sequence	 identity	 to	that	of	 the	original	
seed	virus.	
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Previous	 studies	 into	 BTV	 endocytosis	 have	 used	 laboratory	 adapted	 strains	 that	 have	
undergone	multiple	passages	in	mammalian	cell	culture,	such	as	the	BTV-1	rSArrrr/01	strain	
which	has	undergone	serial	passaging	in	BHK-21	cells	(Gold	et	al.,	2010)	and	BTV-10	strain	
which	has	undergone	serial	passage	in	BSR	cells	(Forzan	et	al.,	2007).	Preservation	of	wild-	
type	virus-host	dynamics	is	important	when	studying	cell	entry	of	viruses	as	adaptation	for	
the	utilization	of	 alternative	 receptors	 and/or	 endocytosis	mechanisms	 is	 possible.	 In	 the	
case	 of	 arboviruses,	 such	 as	 BTV,	 serial	 passaging	 in	 mammalian	 cell	 culture	 could	
potentially	adapt	 the	virus	 to	 the	mammalian	cell	 type	and	could	 lose	 the	natural	vector-	
host	dynamic.	
	
Studies	of	virus	endocytosis	often	require	high	titre	purified	viruses	in	order	to	conduct	cell-	
based	assays.	Purification	of	 the	virus	 is	needed	to	allow	confidence	that	 the	endocytosis	
mechanism	being	used	is	that	which	is	triggered	by	the	virus	itself	and	not	by	cytokines	or	
cellular	 growth	 factors	 (Hubbard	and	Miller,	 2007,	Maruyama,	2014,	Bryant	et	 al.,	 2007).	
Adaptation	 of	 the	 Mertens	 et	 al	 (1987)	 protocol	 by	 replacement	 of	 BHK-21	 cells	 for	
propagating	 the	 virus	 to	 KC	 cells,	 a	 Culicoides	 spp.	 cell	 line,	 meant	 that	 a	 number	 of	
adaptations	to	the	purification	procedure	were	required	to	grow	virus,	confirm	growth	of	
the	 virus	 and	 lysis	 of	 the	 virus	 from	 these	 cells	which	 become	 persistently	 infected	with	
BTV.	Analysis	of	 the	purity	and	 infectivity	of	virus	purified	from	KC	cells	revealed	that	the	
adaptation	to	the	purification	was	successful.	Furthermore,	sequencing	of	the	purified	virus	
identified	 only	 a	 single	 polymorphic	 site	 in	 segment	 9	 (VP6	 -	 helicase)	 of	 the	 genome.	
Indicating	 that,	 any	 adaptation	 of	 the	 purified	 virus	 has	 not	 resulted	 in	 adaptations	 that	
could	impact	BTV	cell	entry.	The	results	show	that	the	purification	of	the	field	isolate	virus	
generated	in	KC	cells	was	successful.	
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It	 has	 been	 documented	 that	 BTV	 often	 has	 a	 tendency	 to	 aggregate	 after	 purification,	
except	 in	 the	 presence	 of	 0.1%	 N-Lauoryl	 sarcosine	 (Mertens	 et	 al.,	 1987).	 This	 study	
showed	that	whilst	particles	consistent	with	the	size	of	single	virions	could	be	observed	in	
the	purified	samples	of	whole	virions	and	ISVPs,	sizes	which	correlate	to	both	doublet	and	
triplet	cells	could	also	be	identified.	This	was	demonstrated	by	dynamic	light	scattering	of	
the	 sample	which	 identified	a	heterogenous	 sized	 virus	population	and	 singlets,	 doublets	
and	also	 triplets	of	 the	 sample	 and	 this	 could	 also	be	 seen	when	 looking	 at	 transmission	
electron	 micrographs	 of	 the	 purified	 virus	 particles	 (not	 shown).	 The	 DLS	 analysis	 also	
showed	 that	 purified	 virus	 stocks	 could	 not	 be	 stored	 for	 prolonged	 periods.	 Virus	 entry	
studies	 requires	 freshly	 purified	 virus.	 In	 order	 to	 characterise	 both	 viral	 growth	 and	
endocytosis	mechanisms	used	by	BTV,	a	 flow	cytometry	assay	was	developed	 to	quantify	
viral	infection	in	both	BFA	and	KC	cells.	
	
	
	
In	summary,	this	chapter	has	described	that	BTV	can	successfully	be	purified	from	KC	cells	
with	 limited	 adaptation	 to	 cell	 culture	 and	 retains	 both	 genotypic	 and	 phenotypic	
characteristics	 of	 field	 isolate	 BTV.	 Furthermore,	 development	 of	 a	 flow	 cytometry	 assay	
was	successful	and	can	be	used	to	quantify	BTV	infection	for	aid	of	study	BTV	endocytosis.	
		
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Chapter	4	 -	
	
The	role	of	dynamin	in	BTV	entry	and	
infection	
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4.1 Introduction	
	
	
The	 molecular	 mechanisms,	 which	 govern	 BTV	 entry	 into	 cells	 remain	 largely	 unknown.	
Only	two	studies	have	specifically	investigated	cell	entry	of	BTV	and	both	used	cell	culture	
adapted	 strains	of	 the	virus	and	cell	 lines	derived	 from	animals	not	normally	 targeted	by	
BTV	 (Gold	 et	 al.,	 2010,	 Forzan	 et	 al.,	 2007).	 In	 one	 of	 these	 studies,	 dynamin	 	 was		
implicated	 as	 being	 required	 for	 BTV	 cell	 entry	 (Gold	 et	 al.,	 2010).	 Dynamin	 is	 a	 GTPase	
known	to	act	as	a	vesicle	scission	protein	in	many	endocytosis	pathways	and	is	believed	to	
exist	 as	 at	 least	 four	 splice	 variants	 (Cao	 et	 al.,	 2007,	 Cao	 et	 al.,	 1998)	 (see	 Chapter	 1,	
section	1.12).	 (Gold	et	al.,	2010)	 showed	 that	a	pharmacological	 inhibitor	 (Dynasore™)	of	
dynamin	inhibited	BTV	entry	suggesting	a	role	for	dynamin	in	the	entry	process.	In	contrast,	
the	same	study	showed	that	 transient	expression	of	DN	dynamin-2	 (the	aa	splice	variant)	
did	not	 inhibit	BTV	entry	or	 infection	 (Gold	et	al.,	2010)	which	appears	 to	 	contradict	 the	
results	obtained	by	Dynasore.	
	
	
	
The	 main	 aim	 of	 this	 chapter	 is	 to	 investigate	 whether	 there	 is	 a	 role	 for	 dynamin	 in	
infection	of	host	derived	cells	(bovine	endothelial	(BFA)	cells	and	Culicoides	spp.	(KC)	cells)	
by	 a	 field	 isolate	of	BTV-1	and	whether	different	dynamin-2	 splice	 variants	play	different	
roles	in	infection.	
	
	
	
The	 role	 of	 dynamin	 in	 BTV	 entry	 and	 infection	 was	 investigated	 using	 three	 different	
approaches.	 The	 first	 used	 pharmacological	 inhibitors	 of	 dynamin.	 The	 second	 utilised		
siRNA	to	selectively	deplete	cells	of	Dynamin-2	while	the	third,	was	to	investigate	the	role	
Chapter	4:		Understanding	early	events	in	Bluetongue	virus	cell	entry	
129	
	
	
	
	
of	 different	 dynamin-2	 splice	 variants	 in	 BTV	 infection	 by	 using	 over	 expression	 of	 DN	
dynamin-2	splice	variants:	aa,	ba	and	bb	(see	Chapter1,	section	1.12).	
	
	
	
At	 the	start	of	 this	study,	 the	Culicoides	spp.	genome	was	not	available.	Therefore,	siRNA	
could	not	be	used	to	target	the	Dynamin-2	gene,	nor	could	splice	variants	be	identified	in	
the	 insect	host.	Consequently,	pharmacological	 inhibitors	of	dynamin	alone	were	used	 to	
investigate	the	role	of	dynamin	in	the	Culicoides	spp.	host.	
	
	
	
4.2 The	effects	of	Dynamin	inhibitors	on	BTV	entry	and	infection	in	BFA	
cells	
	
Dynamin	is	a	large	GTPase	and	acts	as	a	scission	protein	that	facilitates	release	of	endocytic	
vesicles	 from	the	plasma	membrane	 (Hinshaw	and	Schmid,	1995,	McNiven	et	al.,	2000a).	
The	 conundrum	 that	 Dynasore	 (a	 dynamin	 inhibitor)	 but	 not	 DN	 dynamin-2	 aa	 inhibited	
BTV	entry	(Gold	et	al.,	2010)	prompted	further	investigation	into	the	role	of	dynamin	in	BTV	
infection.	
	
	
	
4.2.1					Toxicity	of	dynamin	inhibitors	for	BFA	cells	
	
	
	
Many	 endocytosis	 inhibitors	 can	 cause	 cellular	 toxicity	 (Vercauteren	 et	 al.,	 2010).	 To	
establish	 if	 dynamin	 inhibitors	 are	 toxic	 for	 BFA	 cells,	 the	 cells	 were	 incubated	 for	 12.5	
hours	 with	 different	 concentrations	 of	 the	 inhibitors	 and	 cell	 viability	 determined	 using	
Promega	 Cell	 ToxGlo	 assay,	 which	 quantifies	 cellular	 ATPase	 activity	 within	 cells.	
Reductions	in	cellular	ATPase	readings	correlates	to	high	cellular	toxicity	and	therefore,	 the	
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toxic	effects	of	pharmacological	 inhibitors	on	 the	cell	 lines	of	 interest	could	be	measured	
(see	Chapter	2,	section	2.9.3).	
	
	
	
Initially	 four	 dynamin	 inhibitors;	 Dynasore™,	 Dyngo-4a™,	 MiTMAB™	 and	 Dynole	 	 34-2™	
were	screened	for	toxicity	over	12.5	hours.	All	four	dynamin	inhibitors	displayed	cytotoxic	
effects	when	cells	were	exposed	to	high	concentrations	of	drug	 (Figure	4.1).	Three	of	 the	
four	inhibitors	appeared	to	not	affect	cellular	ATPase	activity	at	concentrations	reported	to	
give	effective	dynamin	inhibiton	in	other	cell	lines	(Robertson	et	al.,	2014,	Gold	et	al.,	2010,	
Forzan	et	al.,	2007,	Berryman	et	al.,	2005,	Schelhaas	et	al.,	2012).	
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Figure	4.1	
	
	
	
	
	
Figure	4.	1		Toxicity	of	Dynamin	drug	inhibitors	on	BFA	cells	
	
Cellular	ATPase	activity	was	measured	using	a	luminescent	assay	in	BFA	cells	treated	with	different	
concentrations	each	carried	out	 in	 triplicate	of	one	of	 four	dynamin	 inhibitors	 for	 the	duration	of	
12.5	 hours.	 Panel	 (A)	 displays	 toxicity	 data	 for	 cells	 treated	 with	 increasing	 concentrations	 	 of		
Dyngo4a,	 panel	 (B)	 shows	 toxicity	 data	 for	 cells	 treated	with	 increasing	 concentrations	 of	Dynasore,	
panel	(C)	shows	toxicity	data	for	cells	treated	with	different	concentrations	of	Dynole	34-2	and	lastly	
toxicity	data	for	BFA	cells	treated	with	multiple	concentrations	of	MiTMAB	can	be	seen	in	panel	(D).	
Untreated	cells	 are	displayed	 in	 red	and	drug	 treated	cells	 are	displayed	 in	blue.	Dynole	34-2	 and	
MITMAB	have	the	highest	toxicity.	
A	 B	
C	 D	
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Dynasore	 showed	 a	 maximum	 non-toxic	 concentration	 of	 100µM	 (Figure	 4.1	 B),	 for	
Dyngo4a	the	maximum	non-toxic	concentration	was	120µM	(Figure	4.1	A)	and	for	Dynole	
34-2	 it	 was	 40µM	 (Figure	 4.1	 C).	 MiTMAB	 displayed	 high	 toxicity	 to	 BFA	 cells	 and	 the	
maximum	 non-toxic	 concentration	 was	 only	 8µM.	 As	 MiTMAB	 is	 reported	 to	 be	 an		
effective	dynamin	inhibitor	at	32µM,	this	was	not	included	in	further	studies	(Figure	4.1	D).	
Dyngo4a	 exhibited	 the	 least	 cytotoxic	 effects	 on	 BFA	 cells	 and	 was	 selected	 for	 further	
studies	at	a	concentration	of	30µM.	Initial	viability	assays	using	ToxGlo	indicated	Dynasore	
(100μM)	 and	 Dynole	 34-2	 (40μM)	 appeared	 to	 not	 effect	 cellular	 ATPase	 activity	 at	
concentrations,	 which	 have	 been	 reported	 by	 others	 to	 effectively	 inhibit	 dynamin	
(Schelhaas	et	al.,	2012).	However,	when	cells	were	treated	with	100µM	Dynasore	or	40µM	
Dynole	34-2	(but	not	Dyngo-4a),	the	live/dead	amine	reactive	stain	used	for	flow	cytometry	
assays	 identified	 cells	 as	 non-viable	 after	 12.5	 hours	 (data	 not	 shown),	 which	 was	 an	
observation	consistent	with	what	was	seen	by	Gold	in	BHK-21	cells	(Gold,	2010).		Therefore,	
Dyngo-4a™	 was	 selected	 as	 the	 pharmacological	 inhibitor	 of	 choice	 to	 use	 for	 all	
subsequent	experiments	on	BFA	cells.	
	
	
	
4.2.2				Effects	of	dynamin	inhibitor	Dyngo-4a	on	BTV-1	infection	of	BFA	cells	
	
	
The	inhibitory	activity	of	Dyngo-4a™	towards	dynamin	was	further	investigated	in	BFA	cells.	
BFA	cells	were	pre-treated	with	Dyngo-4a™	and	incubated	with	AlexaFluor-647	conjugated	
transferrin	(see	Chapter	2,	sections	2.9.1/2.7.1/2.7.3),	as	transferrin	is	known	to	enter	cells	
via	 the	dynamin-dependent	endocytosis	pathway	of	CME	 (see	Chapter	1,	 section	1.11.1).	
This	pathway	should	be	disrupted	if	dynamin	is	successfully	inhibited.	Upon	treatment	with	
Dyngo-4a™		(30µM)		BFA		cells		displayed		a		statistically		significant		reduction	 in	transferrin	
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uptake	(Figure	4.2	A)	compared	to	control	treated	cells	(i.e.	cells	treated	with	the	
equivalent	drug	diluent	(see	Chapter	2,	section	2.9.1,	Table	2.2).	
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A	 B	
Figure	4.	2	The	effects	of	Dyngo4a	on	control	ligand	uptake	and	BTV	infection	
	
BFA	 cells	 were	 treated	 with	 either	 30µM	 Dyngo4a	 or	 an	 equivalent	 dilution	 of	 the	 drug	 diluent		
DMSO	either	30	minutes	before	transferrin	uptake	or	before	infection	or	after	infection	was	initiated	
(1,	2,	3	or	6	hours	post	infection).	Empty	symbols	indicate	experiment	1	with	3	replicates	and	solid	
symbols	 indicate	 experiment	 2	 with	 3	 replicates.	 Panel	 (A)	 shows	 the	 effects	 of	 Dyngo4a	 on	
transferrin,	uptake.	BFA	cells	pre-treated	with	Dyngo4a	exhibit	a	significant	inhibition	of	transferrin	
uptake	 compared	 to	 both	 the	 drug	 diluent	 control	 and	 untreated	 cells	 (One-way	 ANOVA,	 tukey’s	
correction,	 p	 =	 <0.005,	 p	 =	 <0.005,	 respectively).	 Panel	 (B)	 shows	 the	 effect	 of	 Dyngo4a	 on	 BTV	
infection.	 Inhibition	 of	 infection	 was	 seen	 in	 cells	 treated	 with	 Dyngo4a	 pre-infection	 (One-Way	
ANOVA	p	=	<0.005)	but	not	when	added	after	the	start	of	infection.	
Figure	4.2	
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BFA	 cells	were	 also	 pre-treated	with	 30µM	Dyngo-4a™	 and	 infected	with	 BTV	or	 treated	
with	 Dyngo-4a™	 at	 certain	 time	 points	 post	 infection.	 BFA	 cells	 pre-treated	with	 Dyngo-		
4a™	showed	a	significant	inhibition	of	infection	compared	to	the	control	treatment,	which	
is	a	dilution	of	the	drug	diluent	equivalent	to	the	drug	concentration	(see	Chapter	2,	section	
2.9.1)	 (One-way	ANOVA,	Tukey’s	correction	p	=	<0.005)	but	no	 inhibition	of	 infection	was	
observed	in	cells	treated	at	1,	2,	3	or	6	hours	post	infection	(Figure	4.2	B)	suggesting	a	role	
for	dynamin	during	cell	entry.	
	
	
	
As	Dyngo-4a™	caused	an	inhibition	of	BTV	infection	only	when	added	prior	to	infection,	the	
role	 of	 dynamin	 during	 BTV	 entry	 was	 further	 explored.	 BFA	 cells	 were	 seeded	 on	 to	
coverslips	 and	 either	 treated	 with	 Dyngo-4a™	 or	 control	 treatment	 (DMSO)	 before	
incubation	with	 BTV	 at	 4°C	 for	 1	 hour	 to	 allow	 virus	 to	 adsorb,	 after	 3	washes	with	 cell	
culture	media,	cells	were	incubated	for	2	hours	at	37°C	to	allow	virus	internalisation.	Cells	
were	 then	 fixed	 and	 labelled	 for	 BTV	 proteins	 (red)	 using	 appropriate	 antibodies	 (see	
Chapter	2,	 section	2.8.1).	The	actin	 cytoskeleton	 (green)	was	 stained	with	Alexa-Fluor488	
labelled	 phalloidin	 and	 fluorescence	 detected	 using	 confocal	microscopy	 (see	 Chapter	 2,	
section	2.8.1).	On	the	figure	the	green	intensity	was	set	to	show	the	actin	rich	cortex	that	
lies	 just	 deep	 of	 the	 plasma	 membrane	 to	 help	 identified	 internalised	 virus.	 Panel	 (A)		
(Figure	 4.3)	 show	 uninfected	 control	 cells	 labelled	 in	 the	 absence	 of	 BTV	 and	 panel	 (B)	
shows	 infected	 cells	 labelled	with	 secondary	 antibody	 only	 to	 demonstrate	 that	 no	 non-	
specific	 fluorescent	 labelling	 using	 Orab	 276	 polycolonal	 anti-BTV1	 serum	 or	 secondary	
antibody	 can	be	detected.	Panels	 (C),	 (E)	 and	 (G)	 show	control	 treated	 (drug	diluent,	 see	
Chapter	 2,	 section,	 2.9.1,	 Table	 2.2)	 cells	 after	 2	 hours	 post	 virus	 entry	 and	 viral	 protein	
labelling	can	be	seen	within	the	cytosol.		Additionally,	panels	(D),	(F)	and	(H)	show	cells	pre-	
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treated	with	Dyngo4a	for	30	minutes	and	viral	proteins	can	be	seen	remaining	at	the	cell	
surface	after	2	hours	of	uptake	(Figure	4.3)	
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Figure	4.3	
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4.3				The	effect	of	siRNA	targeting	dynamin-2	on	BTV	infection	
	
	
Dynamin	 inhibitors	 target	all	 isoforms	of	dynamin;	dynamin-1,	dynamin-2	and	dynamin-3.	
Dynamin-2	 is	 ubiquitously	 expressed	 in	 all	 cells,	whereas	dynamin-1	 and	dynamin-3	have	
tissue	specific	expression	(Cao	et	al.,	1998)	(see	Chapter	1,	section	1.12).	Therefore,	for	BFA	
cells	 it	 was	 likely	 that	 the	 isoform	 dynamin-2	 would	 be	 involved	 in	 BTV	 endocytosis.	
Consequently,	siRNA	targeting	bovine	dynamin-2	was	designed	and	the	effect	of	dynamin-2	
depletion	on	BTV	infection	investigated.	
	
	
	
4.3.1				Effects	of	dynamin-2	targeting	siRNA	on	BTV-1	infection	of	BFA	cells	
	
	
	
Initially,	 transfection	 of	 siRNA	 into	 BFA	 cells	 was	 optimised	 through	 testing	 of	 different	
ratios	of	transfection	reagent	to	a	fluorescently	tagged	control	siRNA	(called	siGlo-green™)	
at	 different	 cell	 densities	 for	 24	 and/or	 48	 hours	 before	 fixing	 the	 cells	 and	 quantifying	
transfection	efficiency	by	flow	cytometry	and	confocal	microscopy.	 Increasing	numbers	of	
transfected	 cells	 were	 observed	 as	 the	 ratio	 of	 transfection	 reagent	 to	 siRNA	 increased,	
while	 cell	 density	 showed	 little	 effect	 on	 transfection	 efficiency	 (Figure	 4.4	 A	 and	 B).	
Analysing	 transfected	cells	by	confocal	microscopy,	 it	was	observed	 that	by	48	hours	and	
using	 1μL	 transfection	 reagent	 to	 (20pmol)	 siRNA,	 nearly	 all	 cells	 were	 transfected	 and	
began	to	show	nuclear	localisation	of	the	siRNA	(Figure	4.4	C-H).	
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Figure	4.	4		Optimisation	of	siRNA	transfections	in	BFA	cells	using	the	siGlo	control	
	
BFA	cells	were	transfected	with	5μM	of	a	fluorescently	tagged	siRNA	known	as	siGlo	in	combination	
with	 4	 concentrations	 of	 the	 transfection	 reagent	 (Dharmafect)	 for	 24	 or	 48h.	 	 Transfection	
efficiency	 was	 quantified	 using	 flow	 cytometry	 and	 cellular	 location	 of	 transfected	 siRNA	 was	
observed	 using	 confocal	microscopy.	 Panel	 (A)	 shows	 transfection	 efficiency	 quantified	 using	 flow	
cytometry	on	BFA	cells	that	were	80%	confluent.	Transfection	efficiency	shows	a	steady	increase	in	
efficiency	 from	 low	 concentrations	 of	 the	 transfection	 reagent	 to	 high	 concentrations.	 A	 similar	
trend	 is	 also	observed	 in	panel	 (B),	which	 shows	 the	 transfection	efficiency	 in	BFA	cells	 that	were	
50%	confluent.	Little	difference	 in	transfection	efficiency	 is	observed	for	cells	that	were	80	or	50%	
confluent.	Mock	transfected	cells	were	treated	in	the	same	manner	with	transfection	reagent	minus	
siGlo.	Panels	(C-H)	shows	confocal	images	of	cells	transfected	with	siGlo	(24h	transfections	are	seen	
in	Panels	C,	Dharmafect	at	0.25μL	(scale	bar	=	14μM),	E,	Dharmafect	at	0.5μL	(scale	bar	=	22μM)	and	
G,	Dharmafect	at	1μL	(scale	bar	=	22μM))	or	48h	transfections	(Panels	D,	0.25μL	Dharmafect	(scale	
bar	 =	 22μM),	 F,	 0.5μL	 Dharmafect	 (scale	 bar	 =	 15μM)	 and	 H,	 1μL	 Dharmafect	 (scale	 bar	 21μM)).	
Again	 an	 increase	 in	 transfection	 efficiency	 is	 observed	 in	 cells	 transfected	 using	 a	 high		
concentration	of	the	transfection	reagent	‘Dharmafect’.	
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siGlo	is	shown	to	target	the	nucleus	in	cells	transfected	for	48h	using	1μL	of	Dharmafect	(panel	H).	
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In	order	to	confirm	that	neither	the	transfection	reagent	nor	the	siRNA	 itself	was	causing	
cellular	 toxicity,	 live	 cells	 were	 distinguished	 by	 adding	 a	 live/dead	 stain,	 followed	 by	
quantification	of	 live	 cells	using	 flow	cytometry.	Untreated	 cells	were	 compared	 to	mock	
transfected	 cells	 (which	were	 exposed	 to	 transfection	 reagent)	 and	 it	was	 identified	 that	
transfection	 reagent	 alone	 had	 no	 significant	 impact	 on	 cell	 viability	 after	 a	 12	 hour	
incubation	with	the	reagent.	However,	mean	27.3%	(±	9.87	Standard	Deviation)	reduction		
in	cell	viability	was	observed	in	cells	transfected	with	a	scrambled	siRNA,	while,	transfected	
fluorescently	tagged	siRNA	(siGlo)	had	no	impact	on	cell	viability	(Figure	4.5).	
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Figure	4.5	
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Figure	4.	5		The	effects	of	siRNA	transfection	on	cell	viability	
Cells	were	either	transfected	with	scrambled	siRNA	or	SiGlo	for	48h,	 treated	with	transfection	reagent	or	 left	
untreated.	Cells	were	then	labelled	with	a	Live/Dead	cell	viability	stain	before	quantifying	the	proportion	of	live	
cells	using	 flow	cytometry.	 Little	negative	effect	was	observed	 in	 cell	 viability	under	any	conditions	except	 in	
cells	that	were	transfected	with	scrambled	siRNA	141,	which	showed	a	mean	27.3%	(±	9.87	Standard	Deviation)	
reduction	in	cell	viability.	
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Two	 siRNA’s	 designed	 to	 target	 bovine	 dynamin-2	 were	 named	 siRNA	 141	 and	 657,	
respective	of	the	nt	position	on	the	dynamin-2	sequence	that	they	target.	Both	siRNAs	also	
had	a	scrambled	counterpart	to	use	as	control	siRNAs,	which	were	named	scrambled	141	
and	 657.	 Three	 separate	 siRNA	 experiments	 were	 carried	 out	 and	 the	 effect	 on	 BTV	
infection,	 transferrin	 uptake	 and	 Dynamin-2	 protein	 production	 were	 investigated.	 BFA	
cells	 were	 transfected	 for	 48	 hours	 and	 cell	 lysates	 were	 quantified	 for	 total	 protein	
content	 and	 18µg	 of	 protein	 analysed	 for	 each	 sample	 by	 western	 blot	 for	 dynamin-2	
presence.	 Actin	 was	 visualised	 within	 the	 same	 samples	 on	 the	 same	 blot	 to	 act	 as	 a		
loading	 control;	 the	 western	 blot	 from	 siRNA	 experiment	 3	 is	 shown	 in	 Figure	 4.6	 (A).	
Densitometry	 was	 carried	 out	 on	 quantify	 detected	 protein	 expression	 by	 western	 blot.	
Background	 levels	 (an	 area	 of	 blank	 film)	 were	 subtracted	 and	 dynamin	 protein	 levels	
normalised	 against	 the	 internal	 actin	 loading	 control	 for	 each	 sample,	 mock	 control	
treatment	 was	 taken	 as	 1	 and	 ech	 treatment	 as	 a	 proportion	 of	 the	 mock	 control	
treatment.	 Normalised	 densitometry	 data	 is	 presented	 in	 Figure	 4.6	 (B).	 The	 dynamin	
antibody	 identified	 2	 different	 size	 proteins	 by	 the	western	 blot	 and	 they	were	 analysed	
and	 quantified	 separately.	 Comparing	 scrambled	 controls	 with	 the	 paired	 siRNA,	 it	 was	
identified	that	there	was	little	difference	in	Dynamin-2	production	in	scrambled	141	(Figure	
4.4A	Lane	2)	compared	with	siRNA	141	(Lane	7).	A	reduction	in	dynamin	protein	was	seen	
for	siRNA	657	(Lane	8)	compared	to	scrambled	657	(Lane	3).	In	addition,	double	transfected	
samples	containing	20pmol	of	each	siRNA	(Lane	9)	and	another	sample	containing	10pmol	
of	 each	 siRNA	 (Lane	 10)	 also	 observed	 a	 reduction	 in	 dynamin	 compared	 to	 the	 double	
transfected	scrambled	20pmol	control	(Lane	4).	Statistical	analysis	could	not	be	carried	out	
due	 to	 limited	 sample	 number	 but	 the	 trends	 indicate	 that	 there	 was	 a	 reduction	 in	
Dynamin-2	 production	 in	 3	 out	 of	 the	 4	 transfection	 conditions	 (siRNA	 657	 and	 the	 two	
double	transfected	siRNA	141	and	657	at	concentration	20pmol	and	10pmol).	
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The	 effect	 of	 dynamin-2	 depletion	 on	 BTV	 infection	 was	 also	 analysed	 for	 all	 three	
experiments	using	flow	cytometry	and	the	results	are	shown	in	(Figure	4.7	A).	Statistically	
significant	inhibition	in	infection	was	observed	for	3	out	of	4	siRNA	combinations	compared	
with	 the	 paired	 scrambled	 control	 and	 the	 reduction	 of	 infectivity	 coincided	 with	 those	
transfections	 conditions,	 which	 had	 also	 resulted	 in	 successful	 reduction	 in	 Dynamin-2.	
These	were	siRNA	657	compared	to	scrambled	657	(One-way	ANOVA,	tukey’s	correction			p	
=	<0.005)	and	the	double	transfected	siRNA’s	141	and	657	at	both	concentrations	(20pmol	
each	 and	 10pmol	 each)	 compared	 to	 the	 scrambled	 controls	 (One-way	 ANOVA,	 tukey’s	
correction	p	=	<0.0005	and	p	=	<0.0005,	respectively).	
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Figure	 4.6	
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Figure	4.7	
	
Figure	4.	7	Effects	of	dynamin-2	targeting	siRNA	on	BTV	infection		
	
BFA	 cells	 were	 transfected	 with	 siRNA	 targeting	 Dynamin-2	 or	 the	 scrambled	 siRNA	 control	
counterpart	for	48h.	Cells	were	then	infected	with	BTV	for	12h.	Cells	were	fixed	and	then	analysed	
for	BTV	viral	protein	expression	using	flow	cytometry.	The	graph	shows	the	effect	of	siRNA	on	BTV	
infection	 from	 3	 experiments,	 empty	 symbols	 represent	 experiment	 1,	 solid	 symbols	 represent	
experiment	 2	 and	 half-filled	 symbols	 are	 from	 experiment	 3.	 Statistically	 significant	 reductions	 in		
BTV	 infection	 are	 seen	 in	 cells	 treated	with	 siRNA	 657	 (p	 =	 <	 0.005)	 compared	 to	 scrambled	 657	
control,	 cells	 double	 transfected	 with	 siRNA	 141	 and	 657	 at	 double	 concentration	 (20pmol	 +		
20pmol)	displayed	a	significant	decrease	in	infection	compared	to	corresponding	scrambled	control	
(p	=	<0.0005)	and	in	addition	to	single	concentration	siRNA	and	scrambled	siRNA	(10pmol	+	10pmol)	
(p	=	<0.005).	
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4.4				The	role	of	dynamin-2	splice	variants	in	BTV	infection	
	
	
Alternate	 splicing	 of	 dynamin-2	 has	 been	 reported	 to	 exist	 (Cao	 et	 al.,	 1998,	 Cao	 et	 al.,	
2007).	 In	 the	 rat	 genome,	 it	 has	 been	 confirmed	 that	 four	 splice	 variants	 exist	 called	
dynamin-2	aa,	bb,	ba	and	ab.	Next,	 the	 role	of	different	dynamin-2	splice	variants	 in	BTV	
infection	 was	 investigated	 by	 transiently	 expression	 of	 dominant	 negative	 mutants	 of	
dynamin-2	splice	variants	(aa,	bb	and	ba)	and	determining	the	effect	on	BTV	infection	
	
4.4.1	 Effects	 of	 dynamin-2	 splice	 variants	 on	 positive	 control	 ligand	 uptake	 in	
BFA	cells	
	
	
The	effects	of	 transient	expression	of	GFP-tagged,	WT	and	DN	dynamin-2	splice	variants	 (aa,	ba	
and	bb)	on	endocytosis	was	 investigated	using	BFA	cells	and	Alexa-Fluor-647	labelled	transferrin	
(a	marker	of	CME)	(Harding	et	al.,	1983,	Harding	and	Stahl,	1983,	Hanover	et	al.,	1984,	Hopkins	et	
al.,	1985)	and	Alexa-Fluor-647	labelled	dextran	(a	marker	of	fluid	phase	uptake/macropinocytosis)	
(Oliver	et	al.,	1984).	BFA	cells	were	transfected	for	12	hours.	The	cells	were	then	serum	starved	
and	 allowed	 to	 internalise	 transferrin	 or	 dextran	 for	 15	 minutes,	 followed	 by	 staining	 with	
live/dead	stain,	fixation	(see	Chapter	2,	section	2.7.3)	and	analysis	using	flow	cytometry.	For	each	
splice	variant,	two	independent	experiments	were	carried	each	in	triplicate	(Figure	4.8).		For	each	
transfection	 GFP	 positive	 (expressers)	 and	 GFP	 negative	 (non-expressers)	 populations	 were	
analysed	separately.	The	data	shown	in	(Figure	4.8)	compares	transferrin/dextran	uptake	for	WT	
and	DN	dynamin-2	for	the	GFP	positive	populations.	Expression	of	dominant-negative	dynamin-2	
aa	 and	 bb	 resulted	 in	 an	 inhibition	 of	 transferrin	 uptake	 compared	 to	 cells	 expressing	 the	
corresponding	WT	Dynamin-2				 (Figure	4.8		panels	A		and		C).			In	contrast,	the	DN		dynamin-2		ba		
splice	did	not	inhibit	 	transferrin	uptake	and	an	increase	in	transferrin	uptake	compared	to	wild-
type	expressers	was	seen	(Figure	4.8	E).	None	of	the	dominant-negative	splice	variants	(aa,	bb	and	
ba)	affected	dextran	uptake	(Figure	4.8	B,	D	and	F).	
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Figure	4.8	
	
	
	
	
	
Figure	4.	8	The	effect	of	DN	dynamin-2	splice	variants	on	transferrin	and	dextran	uptake	
	
Each	 dynamin-2	 splice	 variant	 was	 transfected	 into	 BFA	 cells	 and	 their	 effect	 on	 transferrin	 and	
ligand	uptake	were	evaluated.	Data	 is	 from	two	 independent	experiments	carried	out	 in	 triplicate.	
Empty	symbols	refer	to	data	from	experiment	1	and	solid	symbols	refer	to	data	from	experiment	2.	
Blue	symbols	indicate	WT-dynamin-2	expressing	populations	and	red	symbols	reflect	DN	Dynamin-2	
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expressing	populations.	The	effect	of	DN	Dynamin-2	aa	expression	on	 	 transferrin	 	uptake	can	 	be	
seen	in	panel	(A).	The	effect	of	DN	Dynamin-2	aa	expression	on	dextran	uptake	can	be	seen	in	panel	
(B).	DN	Dynamin-2	bb	effect	on	transferrin	uptake	can	be	seen	 in	panel	 (C).	Dextran	uptake	 in	DN	
dynamin-2	 bb	 expressing	 populations	 can	 be	 seen	 in	 panel	 (D).	 Lastly,	 transferrin	 uptake	 in	 DN	
dynamin-2	ba	expressing	populations	 can	be	 seen	 in	panel	 (E)	 and	 its	 effect	on	dextran	uptake	 in	
panel	 (F).	 Each	 experiment	 was	 analysed	 using	 ANOVA	 with	 Tukey’s	 correction.	 Statistical	
significance	was	only	observed	 in	 transferrin	uptake	experiments,	where	DN	Dynamin-2	aa	and	bb	
had	an	inhibitory	effect	on	transferrin	uptake	compared	to	WT	Dynamin-2	aa	and	bb	(p	=	<	0.05,	p		=	
<0.0005,	respectively)	and	DN	dynamin-2	ba	enhanced	transferrin	uptake	compared	to	WT	dynamin-	
2	ba	(p	=	<0.05).	
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4.4.2				Effects	of	dynamin-2	splice	variants	on	BTV-1	infection	in	BFA	cells	
	
	
The	effect	of	expression	of	dominant	negative	dynamin-2	splice	variants	on	BTV	 infection	
was	 investigated	next.	 BFA	 cells	were	 transfected	with	 the	GFP-dynamin	 constructs	 (wild	
type	and	dominant	negative)	or	with	a	construct	expressing	GFP	alone	(peGFP)	for	12	hours	
and	then	infected	for	a	further	12	hours	before	adding	live/dead	stain	and	carrying	out	cell	
fixation.	 The	 cells	were	 permeabilised	 and	 intracellular	 viral	 proteins	 labelled	 using	 Anti-	
BTV	 Antibody	 Orab	 276	 and	 goat-anti	 rabbit	 647	 and	 the	 GFP-positive	 cells	 and	 GFP-	
negative	cell	populations	analysed	for	infection	using	flow	cytometry.	
	
	
	
For	 both	 dynamin	 constructs	 of	 the	 dynamin	 aa	 splice	 variant	 (wt	 and	 DN	 mutant	
respectively),	a	significant	reduction	in	infection	was	seen	when	the	level	of	 infection	was	
compared	 between	 the	 GFP-positive	 (expressing)	 and	 GFP	 negative	 (non-expressing)	 cell	
populations	 (Figure	4.10	A).	This	was	also	 seen	 for	 the	peGFP	plasmid.	This	 suggests	 that	
DNA	transfection	had	an	 inhibitory	effect	on	BTV	 infection.	 	This	effect	was	also	seen	 for		
the	 bb	 and	 ba	 splice	 variants	 (Fig	 4.10	 E	 and	 E).	 Analysing	 the	 level	 of	 BTV	 protein	
expression	in	GFP-positive	cells	only	(expressing	populations)	revealed	that	the	expression	
of	 the	 DN	 mutant	 of	 the	 ba	 splice	 variants	 (Figure	 4.10,	 panels	 (C)	 and	 (D))	 (One-Way	
ANOVA,	Tukey’s	correction,	p	=	<0.005,	p	=	<0.005,	respectively),	but	not	the	aa	or	bb	splice	
variants,	 had	 a	 significant	 inhibitory	 effect	 on	 the	 %	 of	 cells	 expressing	 BTV	 proteins	
suggesting	that	the	dynamin-2	splice	variant	ba	may	play	a	role	in	BTV	infection.	
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Figure	4.9	
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Figure	4.	9	The	effects	of	over	expression	of	dominant	negative	dynamin-2	splice	variants	on	BTV	
infection	
	
Each	DN	and	WT	dynamin-2	(GFP-fusion)	splice	variant	was	over	expressed	in	BFA	cells	for	12h	and	
then	 cells	 were	 infected	 with	 BTV	 for	 a	 	 further	 12h.	 	 All	 panels	 represent	 flow	 cytometry	 data.		
Empty	 symbols	 indicate	 experiment	 1,	 solid	 symbols	 represent	 experiment	 2,	 half-filled	 symbols	
identify	 experiment	 3.	GFP	 expressing	 and	 non-expressing	 populations	 from	 the	 same	 sample	 are	
identified	 by	 the	 same	 coloured	 symbols.	 Expressing	 and	 non-expressing	 cell	 populations	 were	
normalised	to	account	for	transfection	efficiency.	Panels	(A),	(C)	and	(E)	show	all	experimental	data	
including	 controls.	 Panels	 (B),	 (D)	 and	 (F)	 represent	mean	 ±	 SEM	 data	 from	 construct	 expressing	
populations	 only.	 Panels	 (A)	 and	 (B)	 shows	 data	 from	 splice	 variant	 dynamin-2	 aa	 experiments,	
panels	(C)	and	(D)	exhibits	data	from	splice	variant	dynamin-2	bb	experiments.		Lastly	panel	(E)			 and	
(E) details	 data	 from	 splice	 variant	 dynamin-2	 ba	 experiments.	 All	 data	 indicated	 the	 level	 of	 BTV	
infection	 in	 %	 cells	 infected.	 Only	 DN	 dynamin-2	 ba	 splice	 variant	 inhibited	 BTV	 infection	 when	
compared	 to	 control	 plasmids	 peGFP	 backbone	 and	 WT	 dynamin-2	 ba	 (ANOVA	 with	 Tukey’s	
correction,	 p	 =	 <0.005,	 p	 =	 <0.005,	 respectively).	 In	 addition,	 expressing	 populations	 expressing	
control	and	DN	plasmids	had	an	inhibitory	effect	on	BTV	infection	compared	to	non-expressing	cell	
populations.	Statistical	significance	is	indicated	by	stars,	where	*	=	p	<0.05,	**	=	p<0.005	and	***	=	
p<0.0005.	
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4.5 Identification	of	bovine	dynamin-2	splice	variants	
	
	
To	date	splice	variants	of	Dynamin-2	have	only	been	confirmed	in	the	rat	genome	(Sontag	
et	al.,	1994,	Cao	et	al.,	1998)	and	the	wild	type	and	dominant	negative	constructs	used	in	
this	 study	 were	 based	 on	 rat	 sequences.	 As	 the	 DN	 mutants	 of	 rat	 dynamin-2	 	 splice		
variants	 showed	 differential	 effects	 on	 BTV	 infection,	 it	 was	 investigated	 whether	 splice	
variants	of	dynamin-2	exist	in	the	bovine	genome.	
	
	
	
This	 was	 approached	 by	 identifying	 all	 published	 cDNA	 transcripts	 for	 bovine	 dynamin-2	
(accession	numbers	 shown	 in	Table	4.0.1)	 and	aligning	 the	 sequences	against	 full-length	
bovine	(Bos	taurus)	dynamin-2	gene	(accession	number	NM001099369.1).	 	The	alignment	
of	the	transcripts	 identified	polymorphic	regions,	of	which,	two	regions	were	of	particular	
interest	 as	 two	 or	 more	 transcripts	 shared	 the	 same	 sequence	 but	 were	 polymorphic	
compared	 to	 the	 full-length	 gene	 sequence.	 The	 alignment	 can	 be	 seen	 in	 Figure	 4.10,	
polymorphic	 sites	 are	 identified	 by	 coloured	 bands	 (showing	 Single	 Nucleotide	
Polymorphisms	(SNPs)),	horizontal	black	bars	(showing	deletions)	and	black	dots	(showing	
insertion	 sites).	 On	 closer	 inspection	 of	 the	 two	 polymorphic	 regions	 of	 interest	 (Figure	
4.10),	the	two	sites	aligned	against	the	two	splicing	sites	identified	in	the	rat	genome.	The	
first	region,	which	will	now	be	referred	to	as	splicing	region	1	(SR1)	and	is	identified	by	the	
red	 box	 in	 Figure	 4.10	 and	 the	 second	 region,	 which	will	 now	 be	 referred	 to	 as	 splicing	
region	 2	 (SR2)	 is	 identified	 by	 the	 blue	 box	 in	 Figure	 4.10.	 The	 differences	 in	 transcript	
sequence	of	SR1	can	be	seen	in	Figure	4.11	and	SR2	in	Figure	4.12.	
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Table	4.	1	Accession	numbers	of	bovine	cDNA	transcripts	used	to	identify	bovine	
dynamin-2	splice	variants	
	
Species	 Accession	Number	 Sequence	type	
Bos	taurus	 NM001099369.1	 Full	length	mRNA	
Bos	taurus	 EE340240.1	 cDNA	clone	mRNA	
Bos	taurus	 EE389969.1	 cDNA	clone	mRNA	
Bos	taurus	 EE958683.1	 cDNA	clone	5’	mRNA	
Bos	taurus	 BC146259.1	 Dynamin-2	mRNA	cDNA	clone	–	complete	cds	
Bos	taurus	 BC104493.1	 Dynamin-2	mRNA	cDNA	clone	–	partial	cds	
Bos	taurus	 EE963014.1	 cDNA	clone	3’	mRNA	
Bos	taurus	 EE366824.1	 cDNA	clone	mRNA	
Bos	taurus	 EE367623.1	 cDNA	clone	mRNA	
Bos	taurus	 EE352223.1	 cDNA	clone	mRNA	
Bos	taurus	 EE344930.1	 cDNA	clone	mRNA	
Bos	taurus	 EE219542.1	 cDNA	clone	mRNA	
Bos	taurus	 DY043303.1	 cDNA	clone	5’	mRNA	
Bos	taurus	 DY076811.1	 cDNA	clone	5’	mRNA	
Bos	taurus	 DV873240.1	 cDNA	clone	5’	mRNA	
Bos	taurus	 EE334735.1	 cDNA	clone	mRNA	
Bos	taurus	 DV869354.1	 cDNA	clone	5’	mRNA	
Bos	taurus	 DY221732.1	 cDNA	clone	5’	mRNA	
Bos	taurus	 DV873768.1	 cDNA	clone	5’	mRNA	
Bos	taurus	 EE367078.1	 cDNA	clone	mRNA	
Bos	taurus	 EE891406.1	 cDNA	clone	5’	mRNA	
Bos	taurus	 DV880688.1	 cDNA	clone	5’	mRNA	
Bos	taurus	 DV88709.1	 cDNA	clone	5’	mRNA	
Bos	taurus	 DV893792.1	 cDNA	clone	5’	mRNA	
Bos	taurus	 DV917678.1	 cDNA	clone	5’	mRNA	
Bos	taurus	 DY058753.1	 cDNA	clone	5’	mRNA	
Bos	taurus	 DY062966.1	 cDNA	clone	5’	mRNA	
Bos	taurus	 DY084976.1	 cDNA	clone	5’	mRNA	
Bos	taurus	 EE368090.1	 cDNA	clone	5’	mRNA	
Bos	taurus	 EE377256.1	 cDNA	clone	mRNA	
Bos	taurus	 EE388620.1	 cDNA	clone	mRNA	
Bos	taurus	 EE890911.1	 cDNA	clone	mRNA	
Bos	taurus	 EE958684.1	 cDNA	clone	5’	mRNA	
Bos	taurus	 EE963013.1	 cDNA	clone	3’	mRNA	
Bos	taurus	 DV819451.1	 cDNA	clone	5’	mRNA	
Bos	taurus	 DV881284.1	 cDNA	clone	5’	mRNA	
Bos	taurus	 DY648018.1	 cDNA	clone	5’	mRNA	
Bos	taurus	 DY096354.1	 cDNA	clone	5’	mRNA	
Bos	taurus	 DY084734.1	 cDNA	clone	5’	mRNA	
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by	the	red	box	and	splice	region	2	(SR2),	indicated	by	the	blue	box.	The	‘*’	indicates	transcripts	that	span	through	splicing	region	one	and	tw
o	and	so	their	splice	variant		
can	be	determ
ined.	
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than	expected	size	and	thick	purple	horizontal	bars	represent	sm
all	insertion	sites.	The	figure	show
n	identifies	a	region	of	high	variation,	w
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ultiple	transcripts	share	
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All	bovine	cDN
A	transcripts	that	m
atch	DN
M
2	gene	found	on	genbank	w
ere	collected	and	aligned	against	full-length	bovine	DN
M
2	gene.	Pipeline	for	alignm
ent	is	described	in	
m
ethods.		Each	grey	arrow
	represents	an	individual	cDN
A	transcript.		This	alignm
ent	show
s	thick	red	bars,	w
hich	represents	a	larger	than	expected	insertion	site.		The		
figure	show
n	identifies	a	larger	than	expected	insertion	site	at	the	sam
e	position	in	4	cDN
A	transcripts	and	could	indicate	a	second	splicing	region	in	the	bovine	DN
M
2	gene	
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These	two	potential	 regions	were	then	compared	to	the	two	splicing	regions	 identified	 in	
the	 rat	 genome.	 In	 the	 first	 splicing	 region	 in	 the	 rat,	 two	 variants	 have	 been	 identified,	
variant	a	and	b.	 The	alignment	of	 the	bovine	 sequences	also	 identified	 two	 sequences	 in		
this	 first	 region,	 which	 were	 common	 in	 at	 least	 two	 or	 more	 transcripts.	 The	 two	
sequences	identified	in	the	bovine	genome	were	then	aligned	against	variant	a	and	variant	
b	 in	the	first	splicing	region	 in	the	rat	genome.	Figure	4.13	shows	a	schematic	diagram	of	
the	dynamin-2	gene	with	splicing	regions	1	and	2	 identified	 in	blue.	The	bovine	sequence	
for	variants	a	and	b	in	splicing	region	1	can	be	seen	in	Figure	4.13	(A)	and	rat	sequence	in	
Figure	4.13	(B).	The	amino	acid	residues	which	differ	between	species	is	highlighted	in	red	
in	the	sequence,	of	which	two	residues	differed	between	species	 in	variant	a	and	a	single	
residue	 differed	 between	 species	 in	 variant	 b.	 This	 analysis	was	 repeated	 for	 the	 second	
region	of	 interest	on	the	bovine	genome	and	this	was	aligned	against	 the	second	splicing	
region	 of	 the	 rat	 genome.	 Splicing	 region	 2	 of	 the	 rat	 genome	 also	 has	 two	 	 possible		
variants	 termed	 variant	 a	 or	 variant	 b.	 It	 was	 identified	 that	 after	 aligning	 the	 bovine	
sequences	 with	 these	 two	 variants,	 identical	 sequences	 were	 shared	 with	 both	 rat	 and	
bovine	 variant	 sequences	 in	 this	 region,	 also	 shows	 in	 Figure	 4.13.	 This	 shows	 that	 two	
splicing	regions	were	able	to	be	 identified	 in	the	bovine	genome	and	the	sequences	after	
analysis	only	differed	by	single	or	double	residues	 in	 the	two	splice	variants	 form	splicing	
region	 1	 and	 both	 splice	 variants	 were	 identical	 in	 splicing	 region	 2	 between	 the	 two	
species.	
	
	
	
Six	 transcripts	 spanned	 through	 both	 splicing	 regions	 and	 so	 the	 splice	 variants	 can	 be	
determined	for	 these	transcripts.	Of	 the	six	 transcripts,	 two	splice	variants	were	found	to		
be	 variant	 bb,	 two	 were	 found	 to	 be	 variant	 ab	 and	 two	 were	 found	 to	 be	 variant	 ba	
(transcripts	are	identified	by	a	star	in	Figure	4.10.		This	gives	evidence	that	at	least	three		of	
Chapter	4:		Understanding	early	events	in	Bluetongue	virus	cell	entry	
164	
	
	
	
	
the	possible	four	splice	variants	can	be	found	in	the	bovine	genome,	although	variant	aa	is	
likely	to	exist	but	a	targeted	investigation	is	needed	to	identify	this	variant.	
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Figure	4.	13	Schematic	representation	of	bovine	and	rat	dynamin-2	showing	splice	variant	amino	
acid	differences	
	
Dynamin-2	 has	 been	 confirmed	 to	 have	 2	 splicing	 regions	 (shown	 in	 panel	 B)	 in	 the	 rat,	 as		
highlighted	 by	 blue	 (Cao	 et	 al.,	 1998).	 Through	 sequence	 alignments	 of	 all	 published	 cDNA		
transcripts	 for	 bovine	 dynamain-2	 similar	 splicing	 regions	 to	 that	 of	 the	 rat	 has	 been	 identified.		
Panel	 A,	 shows	 a	 schematic	 representation	 of	 the	 two	 splicing	 regions	 identified	 (SR1)	 and	 (SR2).	
Each	of	these	splicing	regions	have	been	identified	as	having	one	of	2	variants,	as	shown	in	panel	A.	
Bovine	variant	a	in	SR1	identified	2	amino	acid	differences	compared	to	the	rat	variant	a,	as	shown	
by	red	bold	amino	acid	resides.	Bovine	variant	b	showed	a	single	amino	acid	difference	compared	to	
the	 rat	 variant	 b	 at	 splicing	 region	 1.	 Neither	 variant	 a	 or	 b	 had	 a	 single	 amino	 acid	 difference	
compared	 to	 the	 rat	 at	 splicing	 region	 2.	 Panel	 B	 shows	 each	of	 the	 rat	 splice	 variants	 at	 splicing	
region	1	and	2	with	amino	acid	differences	compared	to	bovine	splice	variants	shown	by	red	bold	
text	in	the	amino	acid	sequences.	Yellow	represents	GTP	binding	sites,	red	rectangle	represents	the	
pleckstrin	homology	(PH)	and	the	green	rectangle	represents	proline	rich	domains	(PRD).	
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4.6 The	effects	of	Dynamin	inhibitors	on	BTV	infection	in	KC	cells	
	
	
Results	presented	in	this	chapter	so	far	suggest	that	dynamin	is	involved	in	BTV	infection	of	
BFA	cells	 (Chapter	4,	 sections	4.2	 to	4.5).	 Therefore,	 the	 role	dynamin	plays	 in	Culicoides	
spp.	 infection	 in	vitro	was	investigated	next	to	 identify	whether	the	virus	utilises	a	shared	
endocytosis	mechanisms	in	the	mammalian	and	insect	host.	
	
4.6.1 KC	cell	toxicity	upon	treatment	with	pharmacological	dynamin	inhibitors	
	
	
	
Cytotoxicity	 of	 dynamin	 inhibitors	 on	 KC	 cells	were	 assessed	 by	 incubated	with	 dynamin	
inhibitors	 for	12.5	hours	and	then	staining	cells	with	an	amine	reactive	dye	to	distinguish	
live	and	dead	cells.	Cells	were	analysed	by	flow	cytometry	and	analysed	by	gating	on	live,	
single	cells	(see	Chapter	2,	section	2.7.3).	
	
	
	
Control	 treated	cells	 (cells	 treated	with	equivalent	concentration	of	drug	diluent)	showed	
the	 viability	 compared	 to	 untreated	 cells.	 Cells	 treated	 with	 either	 100µM	 Dynasore	 or	
30µM	Dyngo4a	 showed	a	 small	 reduction	 in	 cell	 viability	 compared	 to	 control	 treated	or	
untreated	cells;	however	the	reduction	was	not	significant.	Therefore,	both	Dynasore	and	
Dyngo4a	were	 investigated	for	their	effects	on	BTV	 infection	and	control	 ligand	uptake	 in		
KC	cells.	
4.6.2 Effects	of	pharmacological	dynamin	inhibitors	on	transferrin	uptake	in	KC	cells	
	
	
	
The	 effects	 of	 Dynasore	 on	 transferrin	 uptake	 and	 BTV-1	 infection	 were	 investigated.	 A	
small	reduction	(but	not	statistically	significant)	in	transferrin	uptake	was	observed	in	cells	
treated		with		100µM		Dynasore		compared		to		control		treated		cells.				Figure		4.14		B.		 The	
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effects	of	Dyngo4a	on	transferrin	uptake	was	also	investigated,	however,	due	to	technical	
difficulties	the	experiment	did	not	produce	reliable	results	and	is	therefore	not	presented		
in	this	chapter.	
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Figure	4.14	
	
	
	
	
	
Figure	4.	14	Effects	of	dynamin	inhibitors	on	BTV	infection	in	KC	cells	
	
The	effects	of	dynamin	 inhibitors	Dynasore	and	Dyngo4a	on	BTV	 infection	were	 investigated	 in	KC	
cells.	Cell	viability	was	measured	using	an	amine	reactive	live/dead	stain	which	was	detected	using	
flow	cytometry.	The	effects	of	the	drugs	after	incubating	with	KC	cells	for	12.5h	can	be	seen	in	panel	
(A).	The	effects	of	dynasore	on	transferrin	uptake	can	be	seen	in	panel	(B).	Data	in	panel	(B)	is	from	
two	experiments,	empty	symbols	depict	experiment	1	and	solid	symbols	experiment	2.	The	effects		
of	Dynasore	 on	BTV	 infection	 is	 detailed	 in	 panel	 (C).	 Pre-treatment	 and	 treatment	 at	 1	 and	 2hpi		
with	Dynasore	saw	a	significant	decrease	 in	BTV	 infection	compared	 to	control	 treated	cells	 (One-	
way	ANOVA,	Tukeys	correction,	p	=	<0.0005,	p	=	<0.0005,	p	=	0.0005,	respectively).							 Data	in	panel	
(C)	 is	 from	 two	 experiments,	 empty	 symbols	 are	 from	 experiment	 1	 and	 solid	 symbols	 from	
experiment	2.	The	effects	of	Dyngo4a	on	BTV	 infection	can	be	seen	 in	panel	 (D).	Highly	significant	
inhibition	in	infection	can	be	seen	in	Dyngo4a	pre-treated	cells	compared	to	control	treatment	(One-	
way	ANOVA,	 Tukey’s	 correction,	 p	 =	 <0.0005)	 but	 treatments	 post	 infection	 had	 no	 effect.	 Graph	
represents	 data	 from	 four	 experiments,	 empty	 symbols	 are	 from	experiment	 1,	 solid	 symbols	 are	
from	experiment	2,	half-filled	symbols	from	experiment	3	and	crossed	symbols	are	from	experiment	
4.	
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4.6.3 Effects	of	pharmacological	dynamin	inhibitors	on	BTV	infection	in	KC	cells	
	
	
	
To	 determine	 whether	 BTV	 infection	 in	 KC	 cells	 is	 dynamin-dependent,	 two	 dynamin	
pharmacological	 inhibitors,	 Dynasore	 and	 Dyngo4a,	were	 used.	 KC	 cells	 were	 either	 pre-	
treated	with	dynamin	inhibitors	or	control	treatment	(dilution	of	drug	diluent	at	equivalent	
concentration	to	drug)	and	then	infected	or	treated	with	the	inhibitor	1,	2	or	3	hours	post	
infection.	
	
	
	
Pre-treatment	of	KC	cells	with	Dynasore	appeared	to	have	a	strong	inhibitory	effect	on	BTV	
infection	 compared	 to	 matched	 control	 treatment	 Figure	 4.15,	 C	 (One-Way	 	 ANOVA,		
Tukey’s	 correction,	p	=	<0.0005).	However,	when	cells	were	 treated	with	Dynasore,	post-	
infection,	 BTV	 infection	 was	 also	 inhibited	 to	 similar	 levels	 and	 statistical	 significance,	
suggesting	 the	drug	may	be	 impacting	on	post	 entry	 replication	mechanisms.	 To	 confirm	
the	need	of	dynamin	in	BTV	infection,	an	alternative	dynamin	inhibitor,	Dyngo-4a,	was	also	
investigated.	 Four	 independent	 experiments	 showed	 that	 pre-treatment	 with	 Dyngo-4a	
resulted	 in	 statistical	 significant	 inhibition	 of	 BTV	 infection	 compared	 to	 the	 matched	
control	 treatment.	 Furthermore	 the	 inhibitory	 effect	 of	 Dyngo-4a	 on	 BTV	 infection	 in	 KC	
cells	 was	 much	 more	 pronounced	 when	 the	 drug	 was	 added	 prior	 to	 infection	 when	
compared	 to	 drug	 treatments	 post	 infection	 where	 no	 significant	 difference	 in	 infection		
was	observed	(Figure	4.15	D).	These	observations	are	similar	to	those	made	in	BFA	cells	in	
section	4.2.2.	
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4.6.4 Identification	of	dynamin	gene	in	the	Culicoides	sorensis	spp	genome	
	
	
	
The	existence	of	a	dynamin	gene	in	the	Culicoides	genome	is	unknown.	However,	there	is	
some	evidence	 for	dynamin	existence	 in	 insect	 cells	 (Chen	et	al.,	1991,	van	der	Bliek	and	
Meyerowitz,	 1991,	 Sontag	 et	 al.,	 1994,	Gass	 et	 al.,	 1995).	 The	Culicoides	genome	project	
began	 during	 the	 course	 of	 this	 study,	 which	 gave	 an	 opportunity	 to	 interrogate	 the	
genome	 for	 the	presence	of	 a	dynamin	gene	 (carried	out	 in	 collaboration	with	Mark	 Fife	
and	Ramiro	Morales-Hojas).	Alignments	of	the	Culicoides	sorensis	spp.	genome	against	the	
coding	 sequence	 of	Anopholese	 gambiae	 (AGAP003018-RA)	 dynamin	 gene	 identified	 two	
scaffold	 sequences	 which	 showed	 good	 identity	 against	 the	 5’	 and	 3’	 ends	 of	 the	 A.	
gambiae	 dynamin	 sequence	 (Figure	 4.15).	 A	 blast	 search	 identified	 100	 hits,	 all	 hits	
excluding	 predicted	 sequences	 identified	 69	 –	 75%	 sequences	 similarity	 to	 other	
invertebrates,	with	 some	 identified	 as	 known	dynamin	 or	 dynamin-like	 genes	 (see	 Table	
4.0.1).	Using	the	two	scaffold	sequences	as	a	guide	for	a	Culicoides	spp	dynamin	sequence,	
primers	were	designed	to	target	the	sequence	in	order	to	confirm	the	sequence	within	KC	
cells.	mRNA	was	 extracted	 from	 KC	 cells	 and	 after	 a	 reverse	 transcription	 reaction	 using	
either	specific	gene	primers	or	random	hexamers,	sequences	were	amplified	using	specific	
primers	designed	against	the	proposed	Culicoides	dynamin	gene.	PCR	products	were	then	
purified	 and	 cloned	 in	 to	 a	 TOPO	 vector.	 Five	 out	 of	 seven	 cloned	 PCR	 fragments	 were	
identified	as	having	the	correct	sized	insert.	From	these	cloned	fragments,	four	out	of	five	
clones	 gave	 good	 quality	 sequencing	 reads	 in	 both	 forward	 and	 reverse.	 Forward	 and	
reverse	reads	of	all	 four	clones	were	aligned	against	the	Culicoides	scaffold	sequence	and	
identified	as	a	dynamin	candidate.	
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(Figure	 4.15).	 The	 alignment	 identified	 regions	 of	 good	 sequence	 identity	 but	 	 also		
identified	SNPs	that	were	common	in	two	out	of	four	clones	and	a	trinucleotide	region	that	
has	been	deleted	 in	all	 four	clones.	Mismatched	bases	could	be	seen	 in	the	5’	end	of	 the	
sequence,	which	could	indicate	a	region	of	high	variability.	
	
Table	4.1	BLAST	results	from	Culicoides	spp.	predicted	dynamin	gene	sequence	scaffold	
	
Scientific	name	
of	species	
Common	
name	 of	
species	
Known	gene	 Complete	or	
partial	
mRNA/cds	
%	Sequence	
Identity	
Accession	
Number	
Drosophila	
willistoni	
Fruit	fly	 n/a	 mRNA	 75%	 XM	
002071190.1	
Aedes	aegypti	 Yellow	 fever	
mosquito	
Dynamin	 Partial	mRNA	 74%	 XM	
001652620.1	
Aedes	aegypti	 Yellow	 fever	
mosquito	
Dynamin	 Partial	mRNA	 74%	 XM	
001652619.1	
Drosophila	
ananassae	
Fruit	fly	 GF20511	 mRNA	 73%	 XM	
001963621.1	
Drosophila	
mojavensis	
Fruit	fly	 G121715	 mRNA	 73%	 XM	
002010723.1	
Pediculus	
humanus	
corporis	
Human	body	
louse	
Dynamin	 Putative	
mRNA	
73%	 XM	
002430397.1	
Drosophila	
grimshawi	
Fruit	fly	 GH12050	 mRNA	 73%	 XM	
001991414.1	
Droshophila	
virillis	
Fruit	fly	 GJ15580	 mRNA	 73%	 XM	
002058240.1	
Anopholes	
gambiae	
African	
malaria	
mosquito	
AGAP003018	 mRNA	
complete	cds	
72%	 XM	563079.4	
Anopholes	
gambiae	
African	
malaria	
mosquito	
AGAP003018	 mRNA	
complete	cds	
72%	 XM	
003436307.1	
Brugia	malayi	 Filarial	
nematode	
worm	
Dynamin	 Partial	mRNA	 69%	 XM	
001891778.1	
Caenorhabditis	
briggsae	
Roundworm	 CBR-Dynamin-	
1	
mRNA	
complete	cds	
69%	 XM	
002645906.1	
Drosophila	
persimilis	
Fruit	fly	 GL21454	 mRNA	 74%	 XM	
002028985.1	
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4.7 Discussion	
	
	
Dynamin	 is	 a	 conserved	 enzyme	 that	 is	 known	 to	 be	 involved	 in	 many	 endocytosis		
pathways	utilized	by	pathogens	 to	 gain	entry	 to	 cells	 (Reviewed	 in	 (Harper	et	 al.,	 2013)).	
Previously,	BTV	entry	and	infection	of	BHK-21	cells	was	shown	to	be	blocked	by	Dynasore	(a	
pharmacological	inhibitor	of	dynamin)	but	not	by	the	expression	of	DN	Dynamin-2	aa	(Gold	
et	al.,	2010).	Some	studies	have	found	that	entry	of	a	virus	could	be	influenced	by	the	cell	
type	 it	 is	entering,	as	 is	seen	with	Adenoviruses	(Bartlett	et	al.,	2000,	Nonnenmacher	and	
Weber,	 2011).	 Therefore	 this	 study	used	 two	 cell	 lines,	BFA	and	KC	 cells,	which	are	both	
natural	 host	 target	 cells	 for	 BTV	 to	 identify	 whether	 the	 replication-competent	 entry	
pathway	used	by	BTV	is	dynamin-dependent.	
	
	
	
This	 chapter	 has	 identified	 that	 inhibition	 of	 dynamin-1,	 -2	 and	 -3	 by	 treatment	 with	
pharmacological	inhibitor	Dyngo4a	in	BFA	cells	resulted	in	inhibition	of	BTV-1	infection	and	
entry.	Furthermore,	treatment	of	KC	cells	with	dynamin	inhibitors,	Dyngo4a	and	Dynasore,	
also	 resulted	 in	 inhibition	 of	 BTV-1	 infection.	 Expression	 of	 siRNA	 targeting	 Dynamin-2,	
successfully	knocked	down	expression	of	Dynamin-2	in	BFA	cells	 in	3	out	of	4	transfection	
conditions	 tested.	 Cells	 that	 observed	 knockdown	 of	 dynamin-2	 expression	 also	 saw	 a	
significant	inhibition	in	infection,	suggesting	that,	Dynamin-2	is	required	for	BTV	infection.	
Additionally,	 expression	 of	 DN	 dynamin-2	 ba	 but	 not	 dynamin-2	 aa	 or	 bb	 in	 BFA	 cells	
subsequently	 inhibited	 BTV	 infection,	 suggesting	 that	 dynamin-2	 ba	 splice	 variant	 is	
required	 for	 BTV	 entry	 and	 infection.	 Expression	 of	 DN	 dynamin-2	 ba	 did	 not	 result	 in	
inhibition	 of	 transferrin	 uptake.	 However,	 expression	 of	 DN	 dynamin-2	 aa	 and	 bb	 did,	
hinting	 that	 BTV	 is	 using	 a	 dynamin-dependent	 entry	mechanism	 that	 is	 independent	 of	
clathrin.	
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Inhibition	of	 infection	was	observed	 in	BFA	cells	pre-treated	with	Dyngo4a™	but	 infection	
was	not	 inhibited	 in	cells	 treated	with	Dyngo4a™	post	 infection.	Dyngo4a™	also	 inhibited	
uptake	of	transferrin,	indicating	that	dynamin	has	been	successfully	inhibited	and	that	BTV	
infection	requires	dynamin	at	an	early	stage	of	infection	(within	the	first	hour	of	a	cell	being	
infected)	 in	 BFA	 cells.	 In	 contrast,	 a	 more	 prolonged	 and	 highly	 significant	 inhibition	 of	
infection	was	observed	in	KC	cells	that	were	treated	pre-	and	post-infection	with	Dynasore.	
Further	 investigation	 also	 inhibited	 dynamin	 with	 Dyngo4a	 and	 identified	 a	 statistical	
significant	inhibition	of	infection	in	cells	pre-treated	with	the	drug	but	not	in	post	infection	
treatments	 in	 KC	 cells.	 In	 addition,	 the	 effect	 of	 Dynasore™	 on	 control	 ligand	 uptake	
showed	 that	 treatment	 of	 KC	 cells	 with	 these	 drugs	 showed	 little	 effect	 on	 uptake	 	 of	
control	 ligand,	 transferrin,	 which	 uses	 CME	 in	 mammalian	 cells,	 whilst	 an	 increase	 in	
dextran	 uptake	 was	 observed	 in	 Dynasore™	 treated	 KC	 cells	 (data	 not	 shown).	 This		
indicates	 that	 if	 these	dynamin	 inhibitors	are	 successfully	blocking	dynamin	 in	KC	 cells,	 it	
may	also	cause	an	up-regulation	 in	fluid	phase	uptake.	The	 increase	 in	fluid	phase	uptake	
observed	in	these	drug	treated	KC	cells,	could	indicate	that	any	effect	on	the	CME	pathway	
utilised	 by	 transferrin	 may	 be	 masked	 if	 non-specific	 fluid	 phase	 uptake	 is	 triggered.	
Furthermore	 it	 is	 also	possible	 that	as	 these	pharmacological	 inhibitors	were	designed	 to	
target	 mammalian	 dynamin	 and	 that	 their	 effect	 in	 insect	 cells	 is	 not	 as	 specific.	 It	 is		
equally	possible	that	transferrin	may	not	utilise	the	CME	pathway	in	insect	cells.	Therefore,	
interpretation	 of	 the	 effects	 of	 dynamin	 inhibitors	 in	 insect	 cells	 must	 be	 conservative	
without	the	presence	of	an	 insect	cell	characterised	positive	uptake	control.	Nonetheless,	
these	 results	 suggest	 that	 BTV	 infection	 may	 require	 dynamin	 in	 KC	 cells	 but	 further	
characterisation	of	endocytosis	 and	 identification	of	 adequate	positive	uptake	 controls	 in	
insect	cells	is	required.	
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Taken	together,	results	obtained	for	the	mammalian	cell	line	demonstrated	that	dynamin	is	
required	at	an	early	stage	of	infection	in	BFA	cells.	Confocal	microscopy	of	BTV	entry	with	
dyngo4a	 or	 control	 treated	 BFA	 cells	 identified	 that	 after	 2	 hours	 of	 uptake,	 virus	 was	
clearly	visible	in	the	cytosol	of	control	treated	cells	but	could	only	be	visualised	at	the	cell	
periphery	 in	 dyngo4a	 treated	 cells.	 This	 indicated	 that	 entry	 of	 the	 virus	 required	 a	
dynamin-dependent	 step	 in	BFA	cells.	 Several	endocytosis	pathways	 require	dynamin	but	
this	 information	 allows	 the	 endocytosis	mechanism	 utilised	 by	 the	 virus	 to	 be	 narrowed	
down.	 However,	 a	 recent	 study	 using	 cells	 that	 have	 had	 all	 three	 dynamin	 isoforms	
knocked	out	(dynamin-1,	2	and	3),	identified	dynamin	inhibitors	Dynasore™	and	Dyngo4a™	
inhibited	 fluid	 phase	 endocytsosis	 and	 peripheral	 membrane	 ruffling	 ,	 which	 were	 not	
impaired	by	the	lack	of	dynamin.	This	indicates	that,	both	Dynasore™	and	Dyngo4a™	could	
impact	dynamin-independent	pathways	as	well	as	dynamin-dependent	pathways	((Park	et	
al.,	2013)).	Therefore,	dynamin-dependence	of	BTV	entry	and	replication	must	be	assessed	
using	multiple	methods.	
	
	
	
To	 investigate	dynamin-dependence	 in	more	detail,	siRNA	was	used	to	down-regulate	the	
translation	 of	 the	 dynamin-2	 protein,	 therefore,	 inhibiting	 GTPase	 activity	 and	 protein-	
protein	 interactions.	 Transfection	 of	 single	 siRNAs	 have	 been	 known	 to	 cause	 off	 target	
effects	 by	 triggering	 cellular	 immune	 responses	 but	 transfection	 of	 siRNA	 pools	 negates	
unwanted	off	target	effects	((Hannus	et	al.,	2014)),	so	to	navigate	this	pitfall,	 transfection		
of	dual	siRNAs	with	the	same	protein	target	but	differing	target	sequence	was	used	in	this	
investigation.	 Three	 experiments	 using	 siRNA	 to	 target	 dynamin	 were	 described	 in	 this	
chapter.	Each	experiment	showed	combinations	of	single	and	double	siRNA	transfections.	
The	first	siRNA	experiment	showed	transfection	of	the	single	siRNA	657	and	a	combination	
of	dual	transfection	of	siRNA	657	and	141,	successfully	knocked	down	dynamin-2	protein	
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production	compared	to	the	scrambled	controls.	 Inhibition	 in	 infection	was	also	observed		
in	the	same	siRNA	transfected	conditions	that	observed	dynamin-2	knockdown,	 indicating	
that	even	a	small	reduction	in	dynamin-2	protein	production	has	a	significant	effect	on	BTV	
infection.	These	experiments	identify	that	upon	successful	inhibition	of	dynamin-2	protein	
production,	 BTV	 infection	 can	 also	 be	 inhibited.	 This	 demonstrates	 that	 there	 is	 a	
requirement	of	dynamin-2	in	BTV	infection.	
	
	
	
The	complexity	that	dynamin	exists	in	at	least	3	isoforms	and	each	of	these	isoforms	have	
been	 found	 to	 have	 multiple	 splice	 variants,	 raises	 the	 question,	 if	 these	 dynamins	 are	
redundant	or	do	they	have	distinct	cellular	functions.	The	interplay	between	CME	and	fluid	
phase	 endocytosis,	 particularly	 macropinocytosis,	 has	 been	 controversially	 argued.	
However,	studies	using	dynamin-1	and	dynamin-2	knock	out	cells	revealed	that	dynamin-2	
involvement	in	CME	and	fluid	phase	endocytosis	is	mechanistically	distinct	(Liu	et	al.,	2008).	
Previous	 studies	 suggested	 otherwise	 but	were	 reliant	 upon	 over	 expression	 of	 dynamin	
isoforms	and	not	 the	 removal	of	endogenous	dynamins,	which	are	 in	 some	cases	able	 to	
compensate	if	one	isoform/splice	variant	is	suppressed	(Altschuler	et	al.,	1998).	
The	multi-faceted	 approach	 of	 investigating	 the	 role	 of	 dynamin	 in	 BTV	 infection	 in	 this	
chapter	 has	 highlighted	 that,	 at	 least	 for	 Dynamin-2,	 splice	 variants	 are	 likely	 to	 have	
distinct	functions	in	endocytosis	and	intracellular	trafficking.	
	
	
	
Each	of	the	three	dynamin-2	splice	variants	had	alternate	ligand	uptake	profile.	Dominant	
negative	 dynamin-2	 aa	 and	 dynamin-2	 bb	 inhibited	 transferrin	 uptake,	 however	 did	 not	
inhibit	dextran	uptake.	Whereas,	the	dominant-negative,	dynamin-2	ba	constructs	did	not	
inhibit	dextran	or	transferrin	uptake.		In	fact,	expression	of	DN	dynamin-2	ba	splice		 variant	
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significantly	 increased	 transferrin	 uptake,	 which	 suggests	 inhibition	 of	 dynamin-2	 ba	
enhances	 CME.	 This	 could	 possibly	 reflect	 that	 splice	 variant	 ba	 may	 be	 involved	 in	 an	
alternative	 endocytosis	 mechanism	 and	 inhibition	 of	 this	 pathway	may	 upregulate	 CME.	
The	differences	 in	the	 ligand	uptake	profiles	of	these	constructs	 indicate	that	they	exhibit	
functional	 differences	 in	 endocytosis.	 This	 is	 further	 strengthened	by	 the	 fact	 that	only	 a	
single	 dominant-negative	 construct,	 dynamin-2	 ba,	 inhibits	 BTV	 infection,	 indicating	 that,	
dynamin-2	 splice	 variants	 have	 specificity	 in	 their	 function.	 This	 is	 the	 first	 time	 that	
evidence	 of	 a	 single	 splice	 variant	 has	 been	 found	 to	 be	 implicated	 to	 be	 required	 for	
infection	 by	 a	 pathogen.	 This	 opens	 up	 the	 opportunity	 of	 a	more	 targeted	 approach	 of	
therapeutics,	which	 are	 able	 to	 target	 the	 splice	 variant	 specifically	 involved	 in	 pathogen	
infection	 and	 thus	 reducing	 the	 potential	 of	 unwanted	 off	 target	 effects.	 Dynamin		
inhibitors	 are	 already	 being	 trialled	 for	 cancer	 therapy	 and	 Dynasore™	 has	 	 successfully	
been	trialled	in	mice	to	treat	Athleroscerosis	(Chen	et	al.,	1991,	Chircop	et	al.,	2011a,	Joshi	
et	 al.,	 2011,	 Chircop	 et	 al.,	 2011b).	 This	 demonstrates	 that	 the	 use	 of	 dynamin	 splice	
variants	 as	 a	 target	 for	 the	 treatment	 of	 disease	 could	 be	 plausible	 and	 may	 negate	
development	of	resistance	that	 is	often	generated	against	drugs	that	target	the	pathogen	
directly.	
An	 interesting	 observation	 made	 from	 the	 effects	 of	 DN	 dynamin-2	 splice	 variant		
expression	on	BTV	 infection	was	 that	 expression	of	 any	DNA,	 in	 cells	 appeared	 to	 inhibit	
BTV	 infection.	 It	 is	 possible	 that	 the	 inhibitory	 effect	 on	 BTV	 infection	 observed	may	 be	
indicative	 of	 transfected	 DNA	 triggering	 innate	 antiviral	 defences	 (Unterholzner	 et	 al.,	
2010).	
Dynamin-2	splice	variants	have	only	been	published	within	the	rat	genome	(Sontag	et	al.,	
1994,	Cao	et	al.,	1998).	However,	 it	 is	 likely	that	other	splice	variants	are	present	in	other	
mammals.							 In	order	to	confirm	the	existence	of	dynamin-2	splice	variants	in	bovine	cells,	
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published	cDNA	transcripts	from	bovine	dynamin-2	were	analysed	with	the	view	to	identify	
dynamin-2	 splice	 variants	 that	may	be	present	 in	 the	bovine	 genome.	Multiple	 sequence	
alignment	 of	 all	 transcripts	 against	 the	 full-length	 bovine	 gene,	 identified	 two	 splicing	
regions	 in	the	same	sequence	position	as	found	in	the	rat	genome.	These	splicing	regions	
had	one	of	 two	possible	 sequences,	which	 are	 able	 to	 give	 rise	 to	 4	 splice	 variants,	 as	 is		
seen	in	the	rat	genome.	Closer	comparison	revealed	a	2	amino	acids	difference	in	variant	a	
in	splicing	region	1	between	bovine	and	rat	genome	and	a	single	amino	acid	change	is	seen	
in	variant	b	in	splicing	region	1.	No	amino	acid	differences	are	seen	in	either	variant	a	or	b		
in	splicing	region	2	compared	to	the	rat	genome.	By	examining	transcripts	which	spanned	
splicing	 region	1	and	2	 in	 the	bovine	dynamin-2	gene,	 it	was	possible	 to	 identify	3	of	 the	
possible	4	splice	variants	as	being	present	in	the	bovine	genome.	The	forth	splice	variant	is	
likely	to	exist	but	a	targeted	study	is	needed	to	confirm	variant	aa’s	presence	in	the	bovine	
genome.	As	sequences	of	the	splice	variants	only	have	minor	differences	as	those	seen	in	
the	 rat	 splice	 variants,	 it	 is	 likely	 that	 the	 splice	 variants	 expressed	 in	 this	 study	 share		
similar	biological	functions	to	the	bovine	splice	variants	which	have	been	identified.	
	
	
	
The	 shibire	 gene	 in	 the	Drosophila	 spp.	 genome	 (Swanson	 and	 Poodry,	 1981)	 has	 been	
identified	as	sharing	66%	identity	with	both	mammalian	dynamin-1	and	dynamin-2	(Sontag	
et	 al.,	 1994)	 and	 was	 shown	 to	 have	 dynamin-like	 functionality	 (van	 der	 Bliek	 and	
Meyerowitz,	 1991).	 This	 suggested	 that	 dynamin	 existed	 in	 invertebrates	 as	 well	 as	
vertebrates.	 Since	 then,	 single	 dynamin	 genes	 have	 been	 annotated	 in	 	 Aedes	 	 aegypti,	
Culex	quinquefasciatus	and	Anopholes	gambiae	genomes	and	functional	studies	looking	at	
dynamin-dependence	 in	virus	entry	studies	 in	mosquitoes	have	also	 found	mosquito	cells	
to	have	dynamin	functionality	(Lee	et	al.,	2013,	Acosta	et	al.,	2011).		As	there	has	not	been		
a	Culicoides	genome	available,	until	now,	 it	was	unknown	as	 to	whether	a	dynamin	gene	
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existed	 in	 the	 Culicoides	 spp	 genome.	 Interrogation	 of	 the	 Culicoides	 sorensis	 genome	
sequences	 currently	 being	 generated	 at	 The	 Pirbright	 Institute,	 has	 identified	 scaffold	
sequences	 that	 share	 high	 sequence	 identifity	 (69-75%)	 to	 dynamin	 genes	 located	 in	 the	
mosquito	 and	 Drosophila	 spp	 genomes.	 These	 scaffold	 sequences	 were	 then	 used	 to	
confirm	a	region	of	the	dynamin-like	sequences	in	KC	cells	by	reverse	transcription	PCR	of	
extracted	 mRNA	 from	 KC	 cells	 and	 cloning	 PCR	 products	 for	 sequencing	 purposes.	
Complimentary	 bioinformatics	 suggest	 the	 presence	 of	 dynamin-2	 splice	 variants	 in	 the	
bovine	 genome	 and	 also	 the	 presence	 of	 a	 dynamin	 gene	 in	 the	Culicoides	 spp	genome.		
The	 clones	 identified	 a	 trinucleotide	 that	was	missing	 in	 all	 four	 clones	 compared	 to	 the	
scaffold	sequence	and	common	SNPs	that	are	present	in	some	but	not	all	clone	sequences.	
Some	 regions	 were	 found	 to	 be	 identical	 to	 that	 of	 the	 scaffold	 sequence	 from	 the	
Culicoides	genome	project	and	indicated	this	is	likely	a	dynamin-like	gene	but	functionality	
needs	 confirmation.	 In	 addition,	 identification	 of	 sequence	 variation	 between	 the	 clones	
indicated	 that	 there	may	be	 splice	 variants	 in	 invertebrate	dynamin	genes	 too.	However,	
this	 needs	 further	 investigation	 but	 as	Drosophila	 spp.	has	 been	 shown	 to	 have	multiple	
dynamin	 isoforms	 (Chen	 et	 al.,	 1991),	 it	 is	 likely	 that	 multiple	 variants	 also	 exist	 in	 the	
Culicoides	spp.	genome.	
	
	
	
To	 conclude,	 this	 chapter	 has	 identified	 a	 role	 for	 dynamin	 in	 an	 early	 event	 in	 BTV		
infection	 of	 host	 derived	 BFA	 and	 KC	 cells.	 Dynamin-2	 splice	 variant	 ba	 but	 not	 splice	
variants	aa	and	bb	was	implicated	as	playing	a	role	in	BTV	infection.	Complementary	ligand	
uptake	 profiles	 of	 the	 dynamin-2	 splice	 variants	 also	 provided	 evidence	 that	 whilst	 BTV	
infection	 of	 BFA	 cells	 is	 dynamin-dependent,	 it	 occurs	 independent	 of	 clathrin.	
Bioinformatic	 analysis	 also	 identified	 splice	 variants	 in	 the	 bovine	 dynamin-2	 gene.	 This	
chapter		also	confirmed	the		presence	of	a	dynamin-2		gene	in	the		Culicoides	spp.			genome	
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project	and	provides	preliminary	evidence	that	splice	variants	may	also	exist	in	the	midge	
dynamin-2.	
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Investigating	the	entry	mechanisms	
utilized	by	BTV	in	BFA	cells	
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5.1 Introduction	
	
	
Previous	studies	investigating	entry	mechanisms	utilized	by	BTV	have	used	mammalian	cell	
culture	adapted	viruses	and	standard	tissue	culture	cell	lines	such	as	BSR,	BHK	or	VERO	cells	
which	 are	 not	 derived	 from	 the	 natural	 hosts	 or	 the	 cell	 type	 normally	 targeted	 by	 BTV	
(Gold	et	al.,	2010,	Forzan	et	al.,	2007).	These	studies	concluded	that	BTV-10	enters	cells	via	
CME	 in	 BSR	 cells	 (Forzan	 et	 al.,	 2007)	 whereas	 BTV-1	 uses	 a	 non-classical	 dynamin-	
dependent	 macropinocytosis-like	 mechanism	 in	 BHK-21	 cells	 (Gold	 et	 al.,	 2010).	 This	
chapter	 investigates	 the	 entry	 mechanism	 utilised	 by	 a	 field	 isolate	 of	 BTV-1	 (BTV-1	
GIB2007/01	KC3),	 to	 infect	a	bovine	 foetal	aorta	endothelial	 cell	 line	 (BFA)	as	endothelial	
cells	 are	 a	 natural	 cell	 targeted	 during	 BTV	 infection	 of	 cattle	 and	 sheep	 in	 vivo.	
Furthermore	 the	 BTV-1	 strain	was	 also	 purified	 to	 generate	 a	 homogenous	 virus	 particle	
preparation	while	avoiding	the	influence	of	cellular	or	“free”	viral	proteins	present	in	tissue	
culture	supernatant	preparations.	
	
	
	
In	chapter	4,	 it	was	confirmed	that	BTV	requires	dynamin-2	for	 infection	and	entry	in	BFA	
cells	 and	 is	 likely	 to	 be	 required	 for	 infection	 of	 KC	 cells	 (see	 Chapter	 4).	 Furthermore,	
experiments	 with	 DN	mutants	 of	 different	 dynamin-2	 splice	 variants	 suggested	 that	 the	
specific	 variant	needed	 for	BTV	 infection	 is	Dynamin-2	ba.	Overall,	dynamin-2	 is	essential	
for	 many	 endocytic	 pathways	 such	 as:	 CME,	 caveolae-mediated	 endocytosis,	 IL2R	
endocytosis,	phagocytosis,	Arf6	mediated	endocytosis	and	synaptic	vesicle	recycling	and	is	
also	 necessary	 for	 some	 forms	 of	 macropinocytosis.	 Dynamin-2	 is	 not	 required	 for	
CLIC/GLEEC	 endocytosis	 and	 other	 dynamin	 independent	 pathways	 such	 as	 dynamin-	
independent	macropinocytosis	(Reviewed	in	(Harper	et	al.,	2013)).								 This	chapter	aims	to	
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identify	 the	dynamin-dependent	endocytosis	pathway	utilized	by	a	 field	 isolate	of	BTV	 to	
enter	BFA	cells.	
Entry	 mechanisms	 were	 studied	 using	 transient	 expression	 of	 DN	 proteins	 and	
pharmacological	 inhibitors	of	cellular	endocytosis	pathways.	The	 inhibitors	were	screened	
for	cytotoxicity	and	validated	using	control	ligands;	transferrin	(an	established	CME	marker)	
and	dextran	 (an	established	marker	 for	 fluid	phase	uptake,	particularly	macropinocytosis)	
prior	to	investigating	the	effect	of	the	inhibitors	of	BTV	uptake	and	infection.	
	
	
	
5.2 Investigating	the	requirement	of	acidic	endosomes	in	BTV	infection	and	
the	rate	of	trafficking	to	acidic	compartments	
	
	
Previous	 publications	 have	 suggested	 BTV	 requires	 a	 low	 pH-dependent	 step	 in	 order	 to	
initiate	infection	(Gold	et	al.,	2010,	Forzan	et	al.,	2007).	To	confirm	this	observation	for	the	
BTV-1	field	isolate	and	BFA	cells,	the	effects	of	using	ammonium	chloride	on	BTV	infection	
was	investigated.	
	
	
	
Ammonium	chloride	is	a	lysosomotropic	weak	base	and	raises	endosomal	pH	by	acting	as	a	
buffer	 in	 the	 acidic	 environment	 within	 endosomes	 (Baxt,	 1987,	 Carrillo	 et	 al.,	 1984,	
Martin-Acebes	et	 al.,	 2007).	 	 BFA	 cells	were	pre-treated	with	25mM	ammonium	chloride		
for	 30	 minutes	 and	 infected	 with	 BTV.	 The	 cells	 were	 fixed	 after	 16	 hours	 of	 infection,	
labelled	for	virus	protein	and	analysed	for	the	population	of	cells	expressing	viral	proteins	
using	 flow	 cytometry	 (see	 Chapter	 2,	 section	 2.7.1).	 In	 cells	 pre-treated	with	 ammonium	
chloride	 infection	 was	 significantly	 less	 compared	 to	 untreated	 cells	 indicating	 that	 BTV	
requires	a	pH	dependent	step	to	initiate	infection	(Figure	5.1).	
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The	 rate	 of	 delivery	 of	 a	 pH-dependent	 virus	 to	 acidic	 compartments	 provides	 clues	 to	
which	 endocytosis	mechanism	 is	 used.	 For	 example,	 viruses	 and	 natural	 ligands	 that	 use	
CME	 usually	 reach	 early	 endosomes	within	 5	 to	 10	minutes	 post-entry	 (Berryman	 et	 al.,	
2005,	Baxt	 and	Bachrach,	 1982).	 Therefore,	 in	order	 to	determine	 the	 rate	of	 delivery	of	
BTV	 to	 acidic	 compartments	 the	 cells	 were	 also	 treated	 with	 ammonium	 chloride	 at	
different	time	points	post	infection	(Figure	5.1).	
	
	
	
When	ammonium	chloride	was	added	to	cells	1	hour	post	infection,	a	significant	decrease	
of	 virus	 infected	 cells	 was	 observed	 compared	 to	 untreated	 cells.	 When	 added	 at	 later	
times	 post	 infection	 there	 was	 a	 small	 but	 statistically	 not	 significant	 reduction	 in	 the	
number	 of	 infected	 cells.	 The	 data	 shown	 in	 Figure	 5.1	 suggests	 that	 at	 1	 hour	 post	
infection	 approximately	 50%	 of	 the	 virus	 has	 reached	 an	 acidic	 compartment	 consistent	
with	 a	 relatively	 slow	 rate	 of	 delivery	 to	 acidic	 compartments	 suggesting	 a	 clathrin-	
independent	entry	mechanism.	
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Figure	5.1	
	
Figure	5.1		Delivery	kinetics	of	BTV	to	acidic	compartments	
BFA	cells	were	infected	with	BTV-1	GIB2007/01	KC3	for	16	hours.	Ammonium	chloride	(25mM)	was	
added	 to	 cells	 at	different	 time	points	during	 infection:	pre-treatment	or	1,	 2,	 4,	 6,	 8,	 12	h.p.i.	 or	
during	 the	 last	 5	minutes	 of	 infection.	 Cells	 were	 fixed	 and	 labelled	 with	 Orab	 276	 prior	 to	 flow	
cytometry	 analysis.	 Data	was	 obtained	 by	 gating	 on	 single,	 live	 cells.	 The	 graph	 shows	 combined		
data	from	two	repeated	experiments	each	carried	out	in	triplicate.	The	data	are	shown	as	the		mean	
%	cells	infected	and	±SEM.	ANOVA	and	Tukey’s	analysis	identified	a	statistically	significant	inhibition	
in	 infection	 between	 untreated	 cells	 and	 cells	 pre-treated	 and	 treated	 at	 1h.p.i	 with	 25mM	
Ammonium	chloride	 (p	=	<0.0005).	After	1	hour	of	 internalisation,	approximately	50%	of	virus	has	
been	delivered	to	an	acidic	compartment.	
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5.2.1	 Field	 isolate	 BTV-1	 entry	 kinetics	 in	 Bovine	 Foetal	 Aorta	 Endothelial	
Cells	
	
	
Entry	 of	 the	 BTV-1	 field	 isolate	 was	 also	 investigated	 for	 BFA	 cells	 using	
immunofluorescence	confocal	microscopy.	Entry	was	synchronised	by	pre-binding	virus	on	
ice	 for	 1	 hour.	 Cells	 were	 then	 washed	 with	 pre-warmed	 media	 and	 entry	 initiated	 by	
warming	 to	 37°C.	 At	 the	 indicated	 time	 points	 the	 cells	 were	 fixed	 with	 4%	 PFA	 and	
processed	for	confocal	microscopy.	Viral	proteins	were	labelled	using	an	anti-BTV	antibody	
(see	Appendix	C).	The	actin	cytoskeleton	 (green)	and	nucleus	 (blue)	were	visualised	using	
respective	dyes	(see	Chapter	2,	section	2.8.1).	To	allow	visualisation	of	BTV-1	entering	the	
cell,	 high	viral	particle	 to	 cell	 ratio	was	 required	and	 so	 confocal	entry	experiments	were	
carried	out	with	6μg	purified	BTV-1	compared	to	0.12µg	used	for	infection	studies.	
	
	
	
Before	warming,	virus	labelling	(red)	was	seen	at	the	cell	surface,	which	is	marked	by	actin	
(shown	 in	 green)	 (Figure	5.2).	An	actin	 rich	 cortex	 can	be	 seen	at	 the	 cell	 periphery,	 just	
deep	of	the	plasma	membrane,	with	filopodia-like	actin	structures	projecting	from	the	cell	
periphery.	 Some	 labelling	 for	 BTV	 was	 seen	 in	 association	 with	 the	 apical	 tips	 of	 the	
projected	 actin	 structures.	 After	 30	minutes	 uptake,	 (Figure	 5.3)	 BTV	 labelling	 was	 seen	
embedded	within	 the	 actin	 rich	 cortex	but	 virus	 still	 appears	 to	 be	predominantly	 at	 the	
periphery	 of	 the	 cell.	 After	 an	 hour	 of	 uptake,	 most	 BTV	 labelling	 remained	 at	 the	 cell	
periphery	 but	 appeared	 to	 have	 accumulated	 in	 more	 intensely	 labelled	 puncta.	
Furthermore,	the	majority	of	cells	showing	positive	BTV	labelling	appeared	to	show	a	global	
actin	 reorganisation.	 Actin	was	 no	 longer	 seen	 as	 a	 rich	 cortex	 at	 the	 cell	 periphery	 but	
instead	 appeared	 as	 low	 intensity	 labelling	 in	 the	 cell	 cytoplasm	 (Figure	 5.4).	 This	 was	
observed	for	the	majority	(approx.	70%)	of	cells	that	were	positive	for	BTV	labelling.				After	
		
	
	
90	minutes	of	uptake,	BTV	labelling	was	seen	within	the	cell	cytoplasm	(Figure	5.5).	At	this	stage,	actin	
labelling	 was	 also	 mostly	 seen	 in	 the	 cytoplasm.	 These	 results	 are	 consistent	 with	 the	 ammonium	
chloride	experiments	and	suggest	a	slow	rate	of	BTV-1.	
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5.3 Investigating	the	requirement	of	CME	in	BTV	infection	
	
	
The	 best-characterised	 dynamin-dependent	 endocytosis	 mechanism	 is	 CME.	 As	 previous	
investigations	 implicated	 CME	 as	 a	 BTV	 entry	 mechanism	 ((Forzan	 et	 al.,	 2007)),	 the	
requirement	 for	 CME	 was	 investigated	 using	 pharmacological	 inhibitors	 and	 transient	
expression	of	a	DN	mutants	of	eps15	(eps15	is	an	initiation	factor	required	for	clathrin	pit	
formation).	
	
	
	
5.3.1 Chlorpromazine	 is	 ineffective	 at	 inhibiting	 CME	 in	 BFA	 cells	 but	
inhibits	BTV	infection	
	
	
The	 pharmacological	 inhibitor,	 Chlorpromazine	 is	 reported	 to	 inhibit	 CME	 by	 inhibiting	
adaptor	 protein	 2	 (AP-2)	 binding	 to	 the	 clathrin	 lattice	 and	 thus	 preventing	 formation	 of	
clathrin-coated	pits	(Wang	et	al.,	1993).	
	
	
	
Initially	a	 range	of	 concentrations	of	Chlorpromazine	 (from	1.25µg/ml	 to	320μg/ml)	were	
tested	for	toxicity	on	BFA	cells	by	incubation	for	12.5	hours	(consistent	with	the	duration	of	
an	 inhibitor/infection	 study).	 After	 this	 time,	 the	 cellular	 ATPase	 activity	 of	 cells	 were	
measured	using	a	 luciferase	based	ToxGlo	assay	 (Promega)	 (see	Chapter	2,	section	2.9.3).		
At	 concentrations	 higher	 than	 10μg/ml	 cytotoxicy	 was	 observed	 and	 therefore	 10μg/ml		
was	 the	 highest	 possible	 non-toxic	 concentration	 that	 could	 be	 used	 for	 BTV	 infection	
experiments	(Figure	5.6	(A)).	
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Figure	5.6	
	
	
	
Figure	5.6	Effects	of	Clathrin	inhibitor,	Chlorpromazine,	on	BTV-1	infection	of	BFA	cells	
(A)	 Cellular	 ATPase	 was	 measured	 for	 Chlorpromazine	 treated	 and	 untreated	 BFA	 cells	 using	 a	
luminesence	 assay	 and	 LOG10	 data	 and	 mean	 ±	 SD	 was	 plotted.	 The	 highest	 non-toxic	
concentration,	10μg/ml	was	used	to	test	effectiveness	in	blocking	CME.	(B)	Cells	were	treated	with	
the	 drug	 or	 control	 treated	 for	 30	minutes	 and	 allowed	 to	 take	 up,	 transferrin.	 Fluorescence	was	
measured	 using	 flow	 cytometry,	 determined	 from	 single,	 live	 cells	 and	 displayed	 as	 mean	
fluorescent	 intensity	 (MFI)	 indicating	 average	 fluorescent	 uptake	 of	 transferrin	 within	 cells.	 No	
inhibition	 of	 transferrin	 uptake	was	 observed	 in	 two	 repeat	 experiments	 carried	 out	 in	 triplicate,	
empty	 symbols	 =	 experiment	 1,	 solid	 symbols	 =	 experiment	 2.	 (C)	 The	 effect	 of	 10μg/ml	
Chlorpromazine	on	BTV	 infection	was	quantified	using	flow	cytometry.	The	%	of	 infected	cells	was	
determined	from	single,	 live	cells.	Three	repeat	experiments	carried	out	 in	triplicate	are	displayed,	
empty	symbols	=	experiment	1,	solid	symbols	=	experiment	2	and	half-filled	symbols	=	experiment	3.	
Chlorpromazine	 pre-treated	 cells	 show	 a	 significant	 effect	 on	 BTV	 infection	 when	 compared	 to	
control	treated	cells.		All	post	infection	treatments	show	no	significant	effect	on	infection.	
A	 B	
C	
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The	 inhibitory	 activity	 of	 the	 drug	 at	 10μg/ml	 was	 tested	 by	 using	 the	 control	 ligand,	
transferrin,	 which	 enters	 cells	 via	 CME	 (Harding	 et	 al.,	 1983,	 Harding	 and	 Stahl,	 1983,	
Hopkins	 et	 al.,	 1985,	 Hanover	 et	 al.,	 1984).	 If	 the	 drug	 inhibited	 CME	 there	 would	 be	 a	
decrease	in	transferrin	uptake.	BFA	cells	were	pre-treated	with	10μg/ml	Chlorpromzine	or	
control	treatment	for	30	minutes	at	37oC	and	then	incubated	with	transferrin	labelled	with	
Alexa-Fluor	647	for	15	minutes.	Control	treatment	for	all	pharmacological	inhibitors	in	this	
chapter	 is	 the	 drug	 diluent	 (e.g.	 DMSO)	 at	 dilution	 for	 the	 drug	 (see	 Chapter	 2,	 section		
2.9.1,	Table	2.2).	Cells	were	then	fixed	and	prepared	for	analysis	using	flow	cytometry	(see	
Chapter	 2,	 section	 2.7.1).	 At	 a	 concentration	 of	 10μg/ml,	 there	 was	 no	 inhibition	 of	
transferrin	uptake	 in	BFA	cells	 compared	 to	 control	 treatment	 indicating	 that	 the	highest	
possible	non-toxic	dose	was	not	effective	at	inhibiting	CME.	
	
	
	
Despite	 the	 drug	 being	 ineffective	 at	 inhibiting	 transferrin	 uptake	 the	 effects	 on	 BTV	
infection	 were	 still	 investigated.	 Cells	 were	 either	 pre-treated	 with	 10μg/ml		
Chlorpromazine	or	treated	with	the	drug	at	1,	3	or	6	hours	post	infection.	After	treatment	
the	drug	remained	present	throughout	the	assay.	Cells	were	harvested,	fixed	and	labelled	
for	 infection	 and	 prepared	 for	 flow	 cytometry	 analysis	 (see	 Chapter	 2,	 section	 2.7.1).	
Cultures	pre-treated	with	Chlorpromazine	showed	a	significant	inhibition	in	the	proportion	
of	 cells	 becoming	 infected	 with	 BTV	 compared	 to	 the	 control	 treated	 control	 cells.		
However,	 no	 significant	 inhibition	 of	 cell	 infection	was	 observed	 in	 cultures	 treated	with		
the	drug	at	1,	3	or	6	hours	post	infection.	As	Chlorpromazine	did	not	appear	to	inhibit	CME	
(i.e.	transferrin	uptake)	it	could	not	be	concluded	that	the	inhibitory	effect	on	infection	was	
due	 to	 preventing	 CME.	 Hence,	 these	 results	 might	 suggest	 that	 the	 inhibition	 of	 BTV	
infection	following	treatment	of	cells	with	Chlorpromazine	could	be	a	result	of	non-specific,	
off	target	effects	of	the	drug.	
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5.3.2 Clathrin	inhibitor,	Pitstop	2,	does	not	inhibit	BTV	infection	
	
	
As	Chlorpromazine	was	ineffective	at	inhibiting	CME,	an	alternative	inhibitor,	Pitstop	2,	was	
used	 to	 investigate	 the	 role	 of	 CME	 in	 BTV	 infection.	 Pitstop	 2	 has	 been	 shown	 to		
selectively	 inhibit	 the	uptake	of	 transferrin	 and	HIV,	which	 can	enter	 some	 cells	 via	 CME	
(Harding	et	al.,	1983,	Harding	and	Stahl,	1983,	Hanover	et	al.,	1984,	Hopkins,	1985,	Hopkins	
et	al.,	1985).	Pitstop	2	is	reported	to	interfere	with	clathrin	coated	pit	assembly,	specifically	
with	adapter	protein	2	(AP2)	binding	to	the	clathrin	lattice	(von	Kleist	et	al.,	2011).	
	
	
	
The	 cellular	ATPase	activity	was	measured	using	 a	 luciferase	based	assay	 (see	Chapter	 2,	
section	2.9.3)	 in	BFA	cells	when	exposed	to	a	range	of	Pitstop	2	concentrations	(2.5μM	to	
240µM)	 for	 12.5	 hours.	 Pitstop	 2	 was	 shown	 to	 be	 non-toxic	 to	 BFA	 cells	 up	 to	 	 and	
including	120µM	(Figure	5.7	(A)).	
	
	
	
Previous	studies	have	identified	an	effective	concentration	of	Pitstop	2	to	be	approximately	
30µM	(Schelhaas	et	al.,	2012).	Therefore,	30µM	Pitstop	2	was	tested	to	identify	whether	it	
was	able	to	inhibit	transferrin	uptake.	Cells	pre-treated	with	Pitstop	2	showed	a		statistically	
significant	 inhibition	 of	 transferrin	 uptake	 compared	 to	 the	 control	 treated	 control	 (see	
section	2.9.1				for	details	of	control	treatment)	(ANOVA,	Tukey’s	correction	p	=	
<0.0005)	(Figure	5.7	(B)).		This	confirmed	that	Pitstop	2	actively	inhibited	CME	in	BFA	cells	
at	a	concentration	of	30µM.	
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Figure	5.7	Effects	of	Clathrin	inhibitor,	Pitstop	2,	on	BTV-1	infection	of	BFA	cells	
(A)	Cellular	ATPase	of	Pitstop	2	treated	and	untreated	BFA	cells	was	measured	using	a	luminesence	
assay	 and	 LOG10	 data	 and	mean	 ±	 SD	 was	 plotted.	 (B)	 The	 highest	 non-toxic	 concentration	 was	
120µM.	 30µM	 was	 used	 to	 test	 effectiveness	 in	 blocking	 CME.	 Cells	 were	 treated	 with	 	 drug	 or	
control	 treated	 for	 30	 minutes	 and	 allowed	 to	 take	 up	 CME	 positive	 control	 ligand,	 transferrin.	
Fluoresence	was	measured	 using	 flow	 cytometry	 and	 determined	 from	 single,	 live	 cells.	 Pitstop	 2	
pre-treated	cells	displayed	a	significant	inhibition	of	transferrin	uptake	and	this	was	observed	in	two	
repeat	 experiments	 carried	 out	 in	 triplicate,	 empty	 symbols	 =	 experiment	 1,	 solid	 symbols	 =	
experiment	 2	 (ANOVA	 p	 =	 <0.0005)	 compared	 to	 control	 treated	 cells.	 (C)	 	 The	 effect	 of	 30µM		
Pitstop	2	on	BTV	infection	was	quantified	using	flow	cytometry	and	virus	antibody	labelling.		The	%		
of	 infected	 cells	 were	 determined	 from	 single,	 live	 cells.	 Two	 repeat	 experiments	 carried	 out	 in	
triplicate	are	displayed,	empty	symbols	=	experiment	1	and	solid	symbols	=	experiment	2.	Pitstop	2	
pre-treated	 cells	 and	 post	 infection	 treated	 cells	 had	 no	 significant	 effect	 on	 BTV	 infection	when	
compared	to	control	treated	cells.	
A	
Chapter	5:		Understanding	the	early	events	in	BTV	cell	entry	
198	
	
	
	
	
Next	 the	 effect	 of	 Pitsop-2	 on	 BTV	 infection	 was	 investigated.	 At	 30µM,	 Pistop2	 was	
ineffective	 at	 inhibiting	 BTV	 infection	 either	 upon	 pre-treatment	 of	 post-infection	
treatment	of	cells	with	the	drug	 (Figure	5.7	 (C)).	This	strongly	suggests	 that	BTV	does	not	
require	CME	for	infection	of	BFA	cells.	
	
	
	
5.3.3 Transient	expression	of	DN	Eps15	does	not	inhibit	BTV	infection	
	
	
	
To	 confirm	 the	observations	made	with	Pitstop	2,	DN	Epidermal	Growth	Factor	Receptor	
Substrate	Clone	15	(eps15)	mutants	were	used	to	see	further	investigate	the	role	of	CME	in	
BTV	infection.	
	
	
	
Eps15	facilitates	docking	of	the	adapter	protein-2	(AP-2)	at	the	plasma	membrane	to	allow	
correct	 assembly	of	 clathrin	 coated	pits	 (see	Chapter	1,	 section	1.11.1)	 (Benmerah	et	 al.,	
1999).	Mutations	of	the	EH	domains	of	eps15	result	 in	aberrant	targeting	of	eps15	to	the	
plasma	 membrane	 thereby	 preventing	 clathrin	 and	 AP-2	 recruitment	 to	 coated	 pit	
formation	(Benmerah	et	al.,	1999).	In	this	study,	two	DN	mutants	of	eps15	were	used	and	
compared	 to	 a	 control	 eps15	 construct	 to	 see	 the	 effects	 on	 BTV	 infection.	 The	 DN	
construct,	 DIII,	 lacks	 the	 eps15	 homology	 (EH)	 and	 the	 coil	 domain	 but	 retains	 the	 AP-2	
binding	 domains.	 The	 second	 DN	 construct,	 EH29,	 lacks	 part	 of	 the	 	 eps15	 	 homology	
domain	only.	Both	constructs	are	known	to	inhibit	clathrin	pit	formation	(Benmerah	et	al.,	
1999).	The	control	construct	D3Δ2,	has	EH,	coil	and	AP-2	binding	domain	missing	but	does	
not	 appear	 to	 impact	 on	 the	 formation	 of	 clathrin	 coated	 pits	 (Benmerah	 et	 al.,	 1999).	
These	 proteins	 were	 expressed	 as	 GFP	 fusions.	 A	 control	 plasmid,	 which	 expresses	 GFP	
alone	was	used	as	an	additional	control.	
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Figure	5.8	Effects	of	DN	eps15	expression	on	BTV-1	infection	of	BFA	cells	
Control	 plasmids	 peGFP	 backbone	 or	 D3Δ2	 and	 DN	 eps15	 constructs	 DIII	 and	 EH29	 were	 over	
expressed	 in	BFA	cells	and	the	effects	of	over	expression	of	these	constructs	on	transferrin	uptake	
and	 BTV	 infection.	 Panel	 (A)	 shows	 the	 effects	 of	 overexpression	 of	 control	 plasmid	 D3Δ2	 or	 DN	
eps15	 constructs	 DIII	 or	 EH29	 on	 transferrin	 uptake.	 Mean	 fluorescent	 intensity	 of	 internalised	
transferrin	 was	 ascertained	 from	 single,	 live	 cells	 using	 flow	 cytometry.	 Expressers	 of	 DN	 eps15	
constructs	DIII	and	EH29	observed	a	significant	decrease	in	transferrin	uptake	compared	to	control	
plasmid	D3Δ2.	Panel	(B)	shows	the	effects	of	DN	eps15	constructs	and	control	plasmids	D3Δ2,	peGFP	
and	 DN	 eps15	 constructs	 on	 BTV	 infection.	 Non-expressing	 and	 expressing	 populations	 can	 be	
observed.	Significant	differences	 in	 infection	are	observed	between	expressing	and	non-expressing	
populations	of	both	 control	 and	DN	constructs.	Panel	 (C)	displays	 infection	data	of	expressing	 cell	
populations	 only.	 There	 was	 no	 significant	 difference	 in	 infection	 between	 DN	 eps15	 constructs	
compared	 to	 the	control	plasmid	D3Δ2.	 Infected	cells	were	 labelled	 for	virus	by	using	an	antibody	
Orab	276	and	level	of	infection.	
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The	DN	eps15-GFP	fusions	were	overexpressed	in	BFA	cells	for	12	hours	and	their	effect	on	
the	uptake	of	transferrin	quantified	using	flow	cytometry.	The	expressing	cell	populations	
for	 the	DN	eps15	mutants,	DIII	 and	EH29,	were	 compared	 to	 the	expressing	 cells	 for	 the	
control	D3Δ2	(expression	determined	by	the	expression	of	the	GFP	fluorescent	signal	from	
the	 fusion	 protein).	 A	 significant	 inhibition	 of	 transferrin	 uptake	 was	 seen	 for	 the	 DN	
mutants	 (DIII	 and	 EH29)	 compared	 to	 the	 control	 cells	 (D3Δ2)	 (ANOVA	 with	 Tukey’s	
correction,	p	=	<0.005,	p	=	<0.005,	respectively)	(Fugure	5.8	(A)).	
	
	
	
GFP	 alone	 and	 the	 eps15	 control	 plus	 the	 DN	mutants	 were	 then	 overexpressed	 for	 12	
hours	 in	 BFA	 cells	 and	 their	 effects	 on	 BTV	 infection	 (for	 a	 12	 hours	 infection)	 was		
measured	using	flow	cytometry	(see	Chapter	2,	section	2.7).	For	each	transfection,	the	GFP	
expressing	 populations	 (indicated	 by	 GFP	 fluorescence)	 were	 compared	 with	 the	 non-	
expressing	 (i.e.	 non-fluorescent)	 population.	 This	 showed	 a	 significant	 inhibition	 of		
infection	for	the	GFP	transfected	cells	and	all	eps15	populations	regardless	of	whether	they	
express	a	DN	or	control	protein.	This	suggests	 that	DNA	transfection	of	BFA	cells	 reduces	
BTV	 infection	 (Figure	 5.8	 (B)).	 However,	 when	 infection	 was	 compared	 for	 the	 cell	
populations	 expressing	 the	 control	 eps15	 (D3Δ2)	 and	 DN	 mutants	 (DIII	 or	 EH29)	 no	
significant	 inhibition	 of	 infection	 was	 seen	 suggesting,	 that	 CME	 is	 not	 required	 for	 BTV	
infection	(Figure	5.8	(C)).	
5.4 Investigating	 the	 requirement	 of	 Caveolae-dependent	 endocytosis	
specific	cellular	factors	in	BTV	infection	
	
	
Cholesterol	 is	 involved	 in	 many	 endocytosis	 pathways	 most	 notably	 caveolae-	
dependent/lipid	raft	endocytosis	(Pelkmans	and	Helenius,	2003)	but	to	a	lesser	extent			 has	
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also	 been	 noted	 to	 be	 involved	 in	 macropinocytosis	 and	 CME	 as	 cholesterol	 	 provides	
fluidity	during	plasma	membrane	rearrangements	(Grimmer	et	al.,	2002).	
	
	
	
Many	 cholesterol-dependent	 endocytosis	 mechanisms	 are	 often	 associated	 with	 slow	
cellular	entry.	Therefore,	as	BTV	was	shown	to	reach	acidic	compartments	and	enter	cells	
relatively	slowly	the	requirement	of	cholesterol	for	BTV	infection	was	investigated.	
	
	
	
5.4.1 BTV	infection	in	BFA	cells	does	not	require	cholesterol	
	
	
Methyl-β-cyclodextrin	 selectively	 depletes	 cholesterol	 from	 the	 plasma	 membranes	
(Ormerod	et	al.,	2012,	Kilsdonk	et	al.,	1995).	
	
	
	
Measurement	 of	 cellular	 ATPase	 activity	 of	 cells	 in	 the	 presence	 of	 a	 range	 of	Methyl-β-	
cyclodextrin	 concentrations	 for	12.5	hours	 showed	 that	 concentrations	above	5mM	were	
toxic	to	BFA	cells	(Figure	5.9	(A)).	
	
	
	
	
To	identify	whether	5mM	was	sufficient	to	deplete	plasma	membrane	cholesterol	from	the	
cell,	 cells	were	 treated	with	 the	Methyl-β-cyclodextrin	 or	 control	 treated	 (see	Chapter	 2,	
section	 2.9.1,	 Table	 2.2)	 for	 30	 minutes.	 Cells	 were	 then	 fixed	 and	 cholesterol	 labelled		
using	Fillipin.	 Fillipin	allows	cholesterol	 to	be	visualised	as	 its	absorbance	properties	alter	
when	 it	 interacts	 and	 binds	 with	 cholesterol.	 Control	 treated	 cells	 showed	 bright	
fluorescence	indicating	the	presence	of	cholesterol	and	concentrated	labelling	was	seen	at	
the	 plasma	 membrane	 and	 in	 cytoplasmic	 puncta	 consistent	 with	 a	 vesicular	 location		
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(Figure	 5.9	 (B)).	 In	 contrast,	 upon	 treatment	with	 5mM	Methyl-β-cyclodextrin,	 very	 little	
fluorescence	was	observed	at	the	plasma	membrane	and	reduced	fluorescence	was	seen	in	
the	 cytoplasm	 indicating	 that	 plasma	 membrane	 cholesterol	 has	 been	 depleted	 with	
treatment	of	5mM	Methyl-β-cyclodextrin	(Figure	5.9	(B)).	
	
	
	
The	 effects	 of	 methyl-β-cyclodextrin	 on	 BTV	 infection	 were	 investigated	 next.	 BFA	 Cells	
were	 either	 pre-treated	 for	 30	minutes	 prior	 to	 BTV	 infection	 or	 at	 different	 time	points	
post	 infection.	 All	 conditions	 tested	 had	 no	 significant	 effect	 on	 the	 proportion	 of	 cells	
infected	with	BTV.	Some	reduction	in	infection	could	be	observed	in	pre-treated	cells	and	1	
hour	post	infection,	although	this	did	not	prove	to	be	statistically	significant	(Figure	5.9	C)	
which	might	indicate	that	cholesterol	plays	a	minor	role	in	BTV	infection.	
Chapter	5:		Understanding	the	early	events	in	BTV	cell	entry	
200
3	
	
	
A	
	
Figure	5.9	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Control	treated	 MβCD	treated	
B	 C	
D	
Chapter	5:		Understanding	the	early	events	in	BTV	cell	entry	
201
3	
	
	
	
	
Figure	5.9	Effects	of	Cholesterol	inhibitor,	Methyl-β-cyclodextrin,	on	BTV-1	infection	of	BFA	cells	
(A)	Cellular	ATPase	of	methyl-β-cyclodextrin	treated	and	untreated	BFA	cells	was	measured	using	a	
luminesence	 assay	 and	 LOG10	 data	 and	 mean	 ±	 SD	 was	 plotted.	 	 The	 	 highest	 	 non-toxic	
concentration	was	 5mM.	 (B)	 and	 (C)	 5mM	was	 used	 to	 test	 effectiveness	 in	 depleting	 cholesterol	
from	 the	 cell.	 Cells	were	 treated	with	drug	or	 control	 treated	 for	30	minutes	and	 fixed	 cells	were	
stained	with	Fillipin.	(B)	Control	treated	cells	stained	brightly	with	fillipin,	indicating	that	cholesterol	
was	present	 in	plasma	membrane,	ER	and	 in	vesicle-like	puncta	 throughout	 the	cell.	 (C)	However,	
little	fluoresence	was	detected	in	drug	treated	cells,	suggesting	cholesterol	had	been	depleted.	(D)	
The	effect	of	5mM	methyl-β-cyclodextrin	on	BTV	infection	was	quantified	using	flow	cytometry	and	
virus	antibody	 labelling.	The	%	of	 infected	cells	was	determined	 from	single,	 live	cells.	Two	repeat	
experiments	carried	out	in	triplicate	are	displayed,	empty	symbols	=	experiment	1	and	solid	 symbols	
=	experiment	2.	Methyl-β-cyclodextrin	pre-treated	and	post	infection	treated	cells	had	no	significant	
effect	on	BTV	infection	when	compared	to	control	treated	cells.	
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5.5 Investigating	 the	 requirement	 of	 macropinocytosis	 specific	 cellular	
factors	in	BTV	infection	
	
	
So	far	 investigations	have	suggested	that	the	dynamin-2	splice	variant	ba	(a	splice	variant	
known	 to	be	 involved	 in	macropinocytosis	 (Cao	et	al.,	2007)	 is	 required	 for	BTV	 infection	
(See	 Chapter	 4).	 In	 this	 chapter	 evidence	 has	 also	 shown	 that	 BTV	 entry	 and	 delivery	 to	
acidic	compartments	 is	relatively	slow	(which	is	also	consistent	with	macropinocytosis).	 In	
addition,	 as	 actin	 reorganisation	 is	 required	 for	 macropinocytosis	 the	 apparent	 actin	
reorganisation	observed	during	BTV	entry	further	supports	macropinocytosis	as	a	possible	
entry	mechanism.	
	
	
	
Macropinocytosis	 results	 in	 internalisation	 of	 large	 volumes	 of	 extracellular	 fluid	 and	
requires	 a	 number	 of	 cellular	 factors	 including	 sodium-proton	 exchangers,	 the	 actin	
cytoskeleton,	 kinases	 and	 small	 GTPases	 (reviewed	 in	 (Mercer	 and	 Helenius,	 2009)).	 A	
number	of	viruses	have	previously	been	found	to	utilize	macropinocytosis	to	gain	entry	to	
cells	 (Mercer	 and	 Helenius,	 2008,	 Mercer	 and	 Helenius,	 2010,	 Mercer	 et	 al.,	 2010a,	
Rossman	et	al.,	2012,	Aleksandrowicz	et	al.,	2011).	Many	pharmacological	 inhibitors	have	
been	 developed	 that	 are	 able	 to	 inhibit	 these	 cellular	 factors	 and	 thus	 inhibit	
macropinocytosis	 (Koivusalo	et	al.,	2010,	Deacon	et	al.,	2008).	The	use	of	 these	 inhibitors	
allows	 interrogation	 of	 the	macropinocytosis	 pathway	 and	 gives	 an	 insight	 into	 whether	
BTV	utilizes	macropinocytosis	for	entry.	
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5.5.1 BTV	infection	in	BFA	cells	requires	actin	
	
	
A	major	 reorganisation	of	actin	was	observed	during	BTV	entry	(Figure	5.2	 to	Figure	5.55),	
therefore,	the	role	actin	plays	in	BTV	infection	was	investigated.	
	
	
	
	
The	 inhibitory	effects	of	Cytochalasin	D	on	actin	polymerisation	and	elongation	have	 long	
been	known	(Brenner	and	Korn,	1980,	Flanagan	and	Lin,	1980).	 It	 is	now	understood	that	
activation	 of	 a	 signalling	 cascade	 by	 receptor	 tyrosine	 kinases	 is	 responsible	 for	 inducing	
actin	 remodelling	 during	 macropinocytosis,	 which	 subsequently	 generates	 plasma	
membrane	 ruffling,	 an	 indicative	 characteristic	 of	macropinocytosis	 (reviewed	 in	 (Mercer	
and	Helenius,	2009)).	Actin,	therefore,	plays	a	crucial	role	 in	the	macropinocytic	pathway,	
and	 localised	 actin	 reorganisation	 allows	 cargo	 to	 be	 engulfed	 by	 the	 remodelling	 of	 the	
plasma	 membrane	 and	 allows	 the	 formation	 of	 the	 macropinosome.	 	 Cytochalasin	 	 D	
inhibits	 macropinocytosis	 by	 causing	 mass	 disruption	 of	 the	 cytoskeletal	 organisation	 of	
actin	filaments	(Schliwa,	1982).	
	
	
	
In	order	to	ascertain	the	toxicity	of	Cytochalasin	D	on	BFA	cells,	cells	were	treated	with	a	
range	 of	 Cytochalasin	 D	 concentrations	 (from	 1.25µg/ml	 to	 160µg/ml)	 for	 12.5	 hours.	
Cellular	 ATPase	 measurements	 identified	 that	 all	 concentrations	 tested	 did	 not	 reduce	
cellular	ATPase	activity,	 indicating	 that	Cytochalasin	D	has	 little	 toxic	 effects	on	BFA	 cells	
(Figure	5.10	(A)).	A	concentration	of	10µg/ml	was	selected	to	investigate	whether	it	is	able	
to	successfully	disrupt	the	actin	cytoskeleton.	
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Figure	5.10		Effects	of	cytochalasin	D	on	BTV	infection	
(A)	 Cellular	 ATPase	 of	 cytochalasin	 D	 treated	 and	 untreated	 BFA	 cells	 was	 measured	 using	 a	
luminesence	 assay	 and	 LOG10	 data	 and	 mean	 ±	 SD	 was	 plotted.	 	 The	 	 highest	 	 non-toxic	
concentration	 was	 160µg/ml.	 10µg/ml	 was	 used	 to	 test	 effectiveness	 in	 disrupting	 the	 F-actin	
cytoskeleton.	 Cells	were	 treated	with	drug	or	 control	 treated	 for	 30	minutes	 and	 fixed	 cells	were	
stained	with	 Phalloidin-AF488.	 (B)	 Control	 treated	 cells	 stained	 brightly	with	 phalloidin	 at	 the	 cell	
periphery,	indicating	that	stable	actin	cytoskeleton	was	present.	(C)	However,	no	concentration	of	F-
actin	was	seen	in	Cytochalasin	D	treated	cells	instead	in	puncta	throughout	the	cytoplasm	indicating	
the	 cytoskeleton	 was	 disrupted.	 (D)	 The	 effect	 of	 10µg/ml	 cytochalasin	 D	 on	 BTV	 infection	 was		
quantified		using		flow		cytometry		and		virus		antibody		labelling.				The		%		of		infected	cells		was	
Control	treated	 Cytochalasin	D	treated	
B	 C	
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determined	 from	 single,	 live	 cells.	 Two	 repeat	 experiments	 carried	 out	 in	 triplicate	 are	 displayed,	
empty	symbols	=	experiment	1	and	solid	symbols	=	experiment	2.	Methyl-β-cyclodextrin	pre-treated	
and	post	infection	treated	cells	at	1	and	2hpi	had	significant	inhibitory	effect	on	BTV	infection	when	
compared	 to	 control	 treated	 cells.	 Cells	 treated	 at	 3	 and	 6	 hpi	 saw	 no	 significant	 difference	 in	
infection	compared	to	the	control	treatment.	
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BFA	 cells	 were	 treated	 with	 10µg/ml	 Cytochalasin	 D	 control	 treatment	 (see	 Chapter	 2	
section	 2.9.1,	 Table	 2.2)	 for	 30	 minutes.	 Cells	 were	 then	 fixed	 and	 processed	 for	
immunofluorescence	by	staining	F-actin	filaments	with	phalloidin,	AlexaFluor	488	and	DAPI	
nuclear	stain	(see	Chapter	2,	section	2.8).	Control	treated	cells	had	a	strong	labelling	at	the	
cell	periphery	and	some	cytomplasmic	signal	(Figure	5.10	(B)).	In	contrast,	in	Cytochalasin	
D	treated	cells	actin	appeared	to	be	disrupted	 in	the	cytosol	and	no	 labelling	was	seen	at	
the	cell	periphery	(Figure	5.10	(C)).	
	
	
	
Pre-treatment	 of	 BFA	 cells	 with	 10µg/ml	 Cytochalasin	 D	 inhibited	 BTV	 infection		
significantly.	 In	 order	 to	 determine	 whether	 actin	 was	 required	 for	 entry	 or	 during	
replication	 of	 BTV,	 Cytochalasin	 D	 was	 added	 at	 different	 time	 points	 post	 infection.	
Addition	 of	 Cytochalasin	 D	 at	 1	 and	 2	 hours	 post	 infection	 also	 resulted	 in	 a	 significant	
inhibition	 of	 infection.	 However,	 drug	 treatment	 at	 3	 and	 6	 hours	 post	 infection	 did	 not	
appear	 to	 inhibit	 infection	 (Figure	 5.10	 (D)),	 indicating	 that	 actin	 is	 required	 for	 an	 early	
stage	of	BTV	infection.	
	
	
	
5.5.2 BTV	infection	in	BFA	cells	requires	NHE1	
	
	
Amiloride,	 a	 pharmacological	 inhibitor	 of	 sodium-proton	 exchangers,	 has	 aided	 the	
understanding	 of	 the	 requirement	 of	 sodium-proton	 (Na+/H+)	 exchangers	 in	
macropinocytosis		(Koivusalo		et		al.,		2010).			However,		Amiloride		has		also		been	shown	to	
inhibit	 the	 sodium	 channel	 (Na+)	 and	 sodium-calcium	 (Na+/Ca	++)	 exchanger	 (Masereel	et	
	
al.,	 2003).	 Consequently,	 a	 number	of	more	 specific	 analogues	of	Amiloride	have	 been	
developed	that	target	sodium	proton	exchangers	with	higher	specificity.		One	such	inhibitor	
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is	known	as	EIPA,	(5-(N-Ethyl-N-isopropyl)amiloride)	has	been	shown	to	have	a	strong	
potency	and	selectivity	for	the	NHE1	and		reduced	off-target	selectivity	for	the	Na+			channel	
and			the			Na+/Ca	++				exchangers			(Masereel			et		 al.,		 2003).	 The			role			of			the			NHE1	 in	
	
macropinocytosis	 has	 been	 debated	 but	 it	 is	 widely	 believed	 that	 the	 role	 that	 sodium-	
proton	exchangers	play	in	the	homeostasis	of	cytosolic	and	sub-membranous	pH	allows	the	
small	GTPases	to	be	activated	when	the	right	pH	is	maintained.	Sodium-proton	exchanger	
inhibitors	 work	 by	 causing	 acidification	 of	 the	 sub-membranous	 pH,	 which	 actin	
remodelling	 GTPases	 are	 sensitive	 to	 and	 therefore	 inhibit	 the	 GTPase	 dependent-	
macropinocytosis	(Koivusalo	et	al.,	2010).	
	
	
	
Toxic	 effects	 of	 EIPA	were	 observed	when	 cells	 were	 treated	with	 concentrations	 above	
100µM	when	cellular	ATPase	activity	was	measured	after	different	concentrations	of	EIPA	
were	 present	 on	 cells	 for	 12.5hours	 (Figure	5.11	 (A)).	 Therefore,	 a	maximum	of	 100µM	
EIPA	was	used	for	subsequent	experiments.	
	
	
	
The	ability	of	EIPA	to	inhibit	macropinocytosis	was	tested	by	observing	the	effect	the	drug	
has	 on	 fluid	 phase	 uptake	 marker,	 Dextran.	 Fluorescently	 labelled	 dextran	 uptake	 was	
measured	 in	 untreated,	 control	 treated	 and	 EIPA	 treated	 cells	 by	 flow	 cytometry.	Mean	
fluorescent	 intensity	 of	 dextran	 uptake	 was	 determined.	 No	 statistically	 significant	
difference	in	dextran	uptake	was	observed	between	control	treated	and	EIPA	treated	cells	
despite	 being	 a	 slight	 reduction	 but	 non-significant	 in	 dextran	 uptake	 observed	 in	 EIPA	
treated	cells	(Figure	5.11	(B)).	
Chapter	5:		Understanding	the	early	events	in	BTV	cell	entry	
208
3	
	
	
	
	
	
Figure	5.11	
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Figure	5.11		Effects	of	EIPA	on	BTV	infection	
(A)	Cellular	ATPase	of	EIPA	treated	and	untreated	BFA	cells	was	measured	using	a	luminesence	assay	
and	LOG10	data	and	mean	±	SD	was	plotted.	The	highest	non-toxic	concentration	was	100µM.	 (B)	
100µM	was	used	to	test	effectiveness	in	blocking	fluid	phase	uptake.		Cells	were	treated	with	drug			
or	control	treated	for	30	minutes	and	allowed	to	take	up	fluid	phase	uptake	positive	control	ligand,	
dextran.	 Fluoresence	was	measured	 using	 flow	 cytometry	 and	 determined	 from	 single,	 	 live	 cells.	
Data	was	observed	in	two	repeat	experiments	carried	out	in	triplicate,	empty	symbols	=	experiment	
1,	solid	symbols	=	experiment	2.	A	small	but	non-significant	reduction	in	dextran	uptake	is	observed	
in	 EIPA	 treated	 cells.	 (C)	 The	 effect	 of	 100µM	 EIPA	 on	 BTV	 infection	 was	 quantified	 using	 flow	
cytometry	 and	 virus	 antibody	 labelling.	 The	 %	 of	 infected	 cells	 was	 determined	 from	 single,	 live		
cells.	Two	repeat	experiments	carried	out	in	triplicate	are	displayed,	empty	symbols	=	experiment	1	
and	solid	symbols	=	experiment	2.	EIPA	pre-treated	cells	and	cells	 treated	1,	2	and	3	hpi	observed	
significant	inhibitory	effect	on	BTV	infection	when	compared	to	control	treated	cells.	No	significant	
inhibition	in	BTV	infection	was	observed	in	cells	treated	at	6	hpi.	
B	
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To	 identify	whether	EIPA	had	an	effect	on	of	BTV	 infection,	 cells	were	either	pre-treated	
and	then	infected,	or	treated	at	different	time	points	post	infection	with	EIPA.	Cell	cultures	
that	were	 either	 pre-treated	or	 treated	1,	 2	 or	 3	 hours	 post	 infection,	 displayed	 a	highly	
significant	 inhibition	in	the	number	of	cells	 infected	compared	to	the	control	treated	cells		
at	the	equivalent	time	point	(ANOVA	with	Tukey’s	correction,	p	=	<	0.0005,	p	=	<0.0005,	p	=	
<0.0005	and	p	=	0.008,	respectively).	However,	when	cells	were	treated	with	the	drug	at	6	
hours	post	infection,	the	reduction	in	infection	observed	in	EIPA	treated	cells	compared	to	
the	 control	 treated	 cells	 from	 the	 same	 time	point	was	 not	 significant	 (Figure	5.11	 (C)).	
This	suggests	that	the	NHE1	is	required	for	an	early	step	in	BTV	infection,	most	likely	entry.	
	
	
	
5.5.3 BTV	infection	in	BFA	cells	requires	PAK1	
	
	
IPA-3	is	a	small	molecule	inhibitor	of	p21	activated	protein	kinase	1	(PAK1).	PAK1	is	one	of	
the	 most	 important	 kinases	 required	 for	 macropinocytosis	 (Deacon	 et	 al.,	 2008).	 It	 is		
known	to	regulate	cytoskeletal	dynamics	after	being	activated	by	Rac1	or	Cdc42	and	then	
relocates	 to	 the	plasma	membrane	where	 it	 activates	 effectors	 for	 ruffling,	 blebbing	 and	
macropinosome	 formation	 and	 aids	 macropinosome	 closure	 by	 activating	 CtBP-1	
(Dharmawardhane	 et	 al.,	 2000,	 Dharmawardhane	 et	 al.,	 1999,	 Dharmawardhane	 et	 al.,	
1997,	 Liberali	 et	 al.,	 2008).	 IPA-3	 causes	 macropinocytosis	 inhibition	 by	 binding	 to	
regulatory	 domain	 of	 PAK1	 and	 subsequently	 prevents	 the	 activator	 Cdc42	 from	 binding	
and	 activating	 PAK1,	 which	 therefore	 prevents	 PAK1	 from	 relocating	 to	 the	 plasma	
membrane	(Deacon	et	al.,	2008).	
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Figure	5.12		Effects	of	IPA-3	on	BTV	infection	
(A)	Cellular	ATPase	of	IPA-3	treated	and	untreated	BFA	cells	were	measured	using	a	luminesence	assay	
and	 LOG10	 data	 and	 mean	 ±	 SD	 was	 plotted	 as	 seen.	 The	 highest	 non-toxic	 concentration	 was	
100µM.	(B)100µM	was	used	to	test	effectiveness	in	blocking	fluid	phase	uptake.	Cells	were	treated	
with	 drug	 or	 control	 treated	 for	 30	 minutes	 and	 allowed	 to	 take	 up	 fluid	 phase	 uptake	 positive	
control	 ligand,	 dextran.	 Fluoresence	 was	 measured	 using	 flow	 cytometry	 and	 determined	 from	
single,	 live	 cells.	 IPA-3	 pre-treated	 cells	 did	 not	 show	 a	 significant	 difference	 in	 dextran	 uptake	
compared	 to	 control-treated	 cells.	 (C)	 The	effect	 of	 100µM	 IPA-3	on	BTV	 infection	was	quantified	
using	 flow	 cytometry	 and	 virus	 antibody	 labelling.	 The	%	 of	 infected	 cells	 were	 determined	 from	
single,	 live	 cells.	 Two	 repeat	 experiments	 carried	 out	 in	 triplicate	 are	 displayed,	 empty	 symbols	 =	
experiment	1	and	solid	symbols	=	experiment	2.	EIPA	pre-treated	cells	and	cells	treated	1,	2	and	3		
hpi	observed	significant	 inhibitory	effect	on	BTV	 infection	when	compared	to	control	 treated	cells.	
No	significant	inhibition	in	BTV	infection	was	observed	in	cells	treated	at	6	hpi.	
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IPA-3	concentrations	ranging	 from	3.25	to	400µM	were	tested	on	BFA	cells	 for	a	 total	of	
	
12.5	hours	to	determine	toxicity	limits	of	the	drug.	This	showed	that	concentrations	above	
100µM	were	toxic	to	BFA	cells	and	so	a	maximum	concentration	of	100µM	was	used	for	all	
further	experiments	(Figure	5.12	(A))	
	
	
	
The	 effect	 of	 IPA-3	 on	macropinocytosis	was	measured	 by	 using	 the	 fluid	 phase	marker,	
dextran	 as	 a	 positive	 control.	 The	 uptake	 of	 the	 fluorescently	 labelled	 dextran	 was	
measured	 using	 flow	 cytometry	 and	 the	 mean	 fluorescent	 intensity	 was	 determined.	
Although	a	small	inhibition	in	dextran	uptake	was	observed	in	IPA-3	treated	cells	compared	
to	control	treated	cells,	this	difference	was	not	statistically	significant	(Figure	5.12	(B)).	
	
	
	
The	 effect	 of	 IPA-3	on	BTV	 infection	was	 then	quantified	using	 flow	 cytometry.	 BFA	 cells	
were	either	pre-treated	with	IPA-3	or	control	treated	or	were	treated	at	1,	2,	3	or	6	hours	
post	 infection	 to	 determine	 the	 effects	 on	 infection.	 A	 significant	 inhibition	 of	 	 BTV		
infection	was	observed	in	IPA-3	treated	cells	that	were	either	pre-treated	or	treated	at	1,	2	
or	 3	 hours	 post	 infection	 compared	 to	 their	 matched	 control	 treated	 control	 (ANOVA,	
Tukeys	 correction,	p	=	<0.0005,	p	=	<0.0005,	p	=	0.0005,	p	=	0.001,	 respectively)	 (Figure	
5.12	 (C)).	 	 However,	 the	 level	 of	 infection	 recovers	 the	 later	 the	 drug	 is	 added	 post	
infection.	 	This	suggests	that	PAK1	is	required	for	BTV	infection	and	is	consistent	with	the	
time	of	virus	entry	observed	in	section	5.2.1.	
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5.5.4 BTV	infection	in	BFA	cells	require	rho	protein	signalling	
	
	
Many	viruses	are	known	to	manipulate	rho	protein	signalling	at	different	times	during	virus	
replication,	 such	 as,	 virus	 entry	 and	 egress	 (Van	 den	 Broeke	 et	 al.,	 2014).	 Rho	 protein	
signalling	 is	 known	 to	 play	 a	 role	 in	many	 endocytosis	 pathways,	 such	 as	 CME,	 caveolae	
dependent	endocytosis,	phagocytosis	and	macropinocytosis.		Specifically,	rho	proteins	play	
a	 crucial	 role	 in	 the	 regulation	 of	 the	 actin	 cytoskeleton,	 and	 viruses	 are	 often	 able	 to	
manipulate	rho	protein	signalling	for	internalisation	via	actin	dependent	mechanisms	such	
as	macropinocytosis	and	phagocytosis	(Van	den	Broeke	et	al.,	2014).	Herpes	Simples	Virus-	
1	and	Dengue	virus	have	been	shown	to	activate	formation	of	actin	filopodia	through	rho	
protein,	cdc42	and	rac1	signalling	(Zamudio-Meza	et	al.,	2009,	Oh	et	al.,	2010).	Rac1	is	also	
known	to	be	responsible	for	the	formation	of	the	three	types	of	characteristic	membrane	
ruffles	 associated	 with	 macropinocytosis,	 lamellipodia-like,	 circular	 ruffle	 or	 membrane	
blebs	 (Ridley	 et	 al.,	 1992,	 Mercer	 and	 Helenius,	 2008)	 (see	 Chapter	 1,	 section	 1.13.1).	
Therefore,	as	part	of	the	investigation	in	to	whether	BTV	was	utilizing	macropinocytosis	as		
a	 possible	 entry	mechanism,	 the	 role	 of	 rho	 proteins	were	 investigated	 by	 using	 the	 rho	
protein	inhibitor,	exoenzyme	C3	from	Clostridium	botulinum	(C3	Toxin).	
	
	
	
The	C3	toxin	is	known	to	cause	ADP-ribosylation	of	Rho	G-proteins.	Evidences	have	shown	
that	Rho	proteins	 regulate	 cytoskeletal	 activity	 and	 inhibition	of	Rho	via	C3	 toxin	 inhibits	
focal	adhesion	and	actin	stress	fibre	formation	(Ridley	and	Hall,	1992b,	Kozma	et	al.,	1995,	
Nobes	 and	 Hall,	 1995).	 C3	 has	 also	 shown	 to	 completely	 abolish	 actin	microfilaments	 in	
VERO	cells	and	subsequently	cause	actinmorphic	shape	of	cells	(Chardin	et	al.,	1989).	
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Doubling	 dilutions	 of	 C3	 toxin	 (0.125µg/ml	 to	 4µg/ml)	were	 tested	 on	 BFA	 cells	 for	 12.5	
hours	and	the	cellular	ATPase	measured	to	identify	toxicity.	This	showed	no	toxic	effects	at	
any	of	the	concentrations	used	(Figure	5.13	(A)).	A	concentration	of	1µg/ml	was	used	for	
subsequent	experiments.	
	
	
	
Cells	were	treated	with	1µg/ml	C3	toxin	or	control	treatment	(see	Chapter	2,	section	2.9.1,	
Table	 2.2	 for	 details	 of	 control	 treatment)	 30	 minutes	 and	 then	 chased	 with	 0.5mg/ml	
dextran.	No	statistical	significant	difference	was	seen	for	dextran	uptake	in	control	treated	
and	 C3	 toxin	 treated	 cells	 (Figure	 5.13	 (B)).	 Although,	 rho	 protein	 signalling	 is	 not	 an	
essential	 cellular	 factor	 required	 for	 all	 forms	of	macropinocytosis	 (Mercer	 and	Helenius,	
2009),	 therefore	 the	 effect	 on	 dextran	 uptake	 may	 be	 due	 to	 the	 fact	 that	 rho	 protein	
signalling	is	not	required	for	dextran	form	of	macropinocytosis.	Pre-treatment	of	cells	with	
C3	 toxin	 showed	 a	 statistically	 significant	 inhibition	 in	 infection	 when	 compared	 to	 the	
control	treated	control.	However,	all	treatments	post	infection	saw	no	significant	inhibition	
in	infection	(Figure	5.13	(C)),	suggesting	that,	rho	protein	signalling	is	required	at	an	early	
stage	of	infection.	
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Figure	5.13		Effects	of	C3	toxin	on	BTV	infection	
(A) Cellular	ATPase	of	C3	toxin	treated	and	untreated	BFA	cells	was	measured	using	a	luminesence	
assay	and	LOG10	data	and	mean	±	SD	was	plotted.		The	highest	non-toxic	concentration	was	4µg/ml.	
(B) 1µg/ml	was	 used	 to	 test	 effectiveness	 in	 blocking	 fluid	 phase	 uptake.	 Cells	were	 treated	with	
drug	or	control	 treated	 for	30	minutes	and	allowed	 to	 take	up	 fluid	phase	uptake	positive	control	
ligand,	dextran.	Fluoresence	was	measured	using	 flow	cytometry	and	determined	 from	single,	 live	
cells.	 C3	 toxin	pre-treated	 cells	presented	no	 significant	 inhibition	of	dextran	uptake	 compared	 to	
untreated	control	and	control-treated	cells	and	this	was	observed	in	two	repeat	experiments	carried	
out	 in	 triplicate,	 empty	 symbols	 =	 experiment	 1,	 solid	 symbols	 =	 experiment	 2.	 (C)	 The	 effect	 of	
1µg/ml	C3	toxin	on	BTV	infection	was	quantified	using	flow	cytometry	and	virus	antibody	labelling.	
The	%	of	infected	cells	were	determined	from	single,	live	cells.	Two	repeat	experiments	carried	out		
in	 triplicate	 are	 displayed,	 empty	 symbols	 =	 experiment	 1	 and	 solid	 symbols	 =	 experiment	 2.	 C3		
toxin	 pre-treated	 cells	 observed	 significant	 inhibitory	 effect	 on	 BTV	 infection	 when	 compared	 to	
control	treated	cells.	No	significant	inhibition	in	BTV	infection	was	observed	in	cells	treated	at	1,	2,	3	
or	6	hpi.	
A	 B	
C	
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5.5.5 Investigating	the	requirement	of	PI3-Kinase	in	BTV-1	infection	
	
	
At	nanomolar	concentrations,	Wortmannin	inhibits	the	function	of	phosphoinositide	(PI)	3-	
kinase	 (PI3-kinase),	 a	 key	 kinase	 required	 in	 macropinocytosis	 (Wymann	 et	 al.,	 1996,		
Hoeller	et	al.,	2013).	
	
	
	
The	effect	of	Wortmannin	on	cellular	ATPase	activity	was	investigated	by	exposing	cells	to	
Wortmannin	concentrations	ranging	from	6.25nM	to	800nM	for	12.5	hours	and	measuring	
cell	metabolism	as	above.		Wortmannin	displayed	no	toxic	effects	on	BFA	cells	when	used		
at	 nM	 concentrations	 (Figure	 5.14	 (A)).	 200nM	 concentration	 was	 selected	 for	 future	
experiments.	
	
	
	
The	 effect	 of	Wortmannin	 on	 dextran	 uptake	was	 investigated.	 There	was	 no	 significant	
difference	 in	 dextran	 uptake	 between	 control	 treated	 and	 Wortmannin	 treated	 cells	
(Figure	 5.14	 (B)).	 As	 PI3	 kinase	 has	 been	 heavily	 implicated	 in	 macropinocytosis,	 it	 is	
possible	 that	 the	 drug	 is	 not	 successfully	 inhibiting	 PI3	 kinase	 in	 BFA	 cells	 at	 a	 200nM	
concentration.	
	
	
	
Cells	 that	 were	 either	 pre-treated	 or	 treated	 post	 infection	 with	 200nM	 Wortmannin	
displayed	no	significant	effect	on	BTV	 infection	(Figure	5.14	(C)).	This	could	suggest	that,	
PI3	 kinase	 is	not	 required	 for	BTV	 infection.	However,	 as	 the	drug	 showed	 little	effect	 at	
inhibiting	 to	control	 ligand,	 it	 is	more	 likely	 that	 the	drug	was	 ineffective	at	 inhibiting	PI3	
kinase	at	the	tested	concentration	of	200nM.	
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Figure	5.14	
	
	
	
Figure	5.14		Effects	of	Wortmannin	on	BTV	infection	
(A)	Cellular	ATPase	of	Wortmannin	treated	and	untreated	BFA	cells	were	measured	using	a	luminesence	
assay	and	LOG10	data	and	mean	±	SD	was	plotted	as	seen.	The	highest	non-toxic	concentration	was	
800nM.	(B)	200nM	was	used	to	test	effectiveness	in	blocking	fluid	phase	uptake.	Cells	were	treated	
with	 drug	 or	 control	 treated	 for	 30	 minutes	 and	 allowed	 to	 take	 up	 fluid	 phase	 uptake	 positive	
control	 ligand,	 dextran.	 Fluoresence	 was	 measured	 using	 flow	 cytometry	 and	 determined	 from	
single,	live	cells.	Wortmannin	pre-treated	cells	presented	no	significant	inhibition	of	dextran	uptake	
compared	 to	control-treated	cells	and	 this	was	observed	 in	 two	repeat	experiments	carried	out	 in	
triplicate,	 empty	 symbols	 =	 experiment	 1,	 solid	 symbols	 =	 experiment	 2.	 (C)	 The	 effect	 of	 200nM	
Wortmannin	on	BTV	infection	was	quantified	using	flow	cytometry	and	virus	antibody	labelling.		The	
%	 of	 infected	 cells	was	 determined	 from	 single,	 live	 cells.	 Two	 repeat	 experiments	 carried	 out	 in	
triplicate	 are	 displayed,	 empty	 symbols	 =	 experiment	 1	 and	 solid	 symbols	 =	 experiment	 2.	
Wortmannin	 pre-treated	 and	 post-infection	 treated	 cells	 demonstrated	 no	 significant	 inhibitory	
effect	on	BTV	infection	when	compared	to	control	treated	cells.	
A	 B	
C	
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5.5.6 Investigating	the	requirement	of	Myosin	II	in	BTV-1	infection	
	
	
Blebbistatin	is	a	small	molecule	inhibitor	of	myosin	II.	Myosin	II	 is	a	cellular	motor	protein	
that	is	known	to	localise	to	membrane	ruffles	formed	during	macropinocytosis	(Mercer	and	
Helenius,	2009)	and	 is	believed	 to	aid	macropinosome	closure	 (Jiang	et	al.,	 2010,	Mercer	
and	Helenius,	2009).	
	
	
	
Blebbistatin	functions	by	preferentially	binding	to	ADP	and	phosphate	bound	at	the	active	
site	 of	myosin,	which	 in	 turn	 blocks	 the	myosin	 heads	 in	 a	 complex	 causing	myosin	 II	 to		
have	 low	 affinity	 with	 actin	 and	 thus	 preventing	 the	 motorised	 movement	 of	 actin	 via	
myosin	II	(Kovacs	et	al.,	2004).	
	
	
	
A	range	of	Blebbistatin	concentrations	(1.875µM	to	240µM)	were	tested	on	BFA	cells	for	a	
total	 of	 12.5	 hours	 and	 cellular	 ATPase	 activity	 of	 the	 cells.	 It	 was	 identified	 that	 no	
concentration	tested	adversely	affected	cellular	ATPase	activity	(Figure	5.15	(A))	indicating	
that	the	inhibitor	was	not	toxic	to	BFA	cells	at	the	concentrations	tested.
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Figure	5.15	
	
	
Figure	5.15		Effects	of	Blebbistatin	on	BTV	infection	
(A)	Cellular	ATPase	of	Blebbistatin	treated	and	untreated	BFA	cells	were	measured	using	a	luminesence	
assay	and	LOG10	data	and	mean	±	SD	was	plotted	as	seen.	The	highest	non-toxic	concentration	was	
240µM.	(B)	50µM	was	used	to	test	effectiveness	 in	blocking	fluid	phase	uptake.	Cells	were	treated	
with	 drug	 or	 control	 treated	 for	 30	 minutes	 and	 allowed	 to	 take	 up	 fluid	 phase	 uptake	 positive	
control	 ligand,	 dextran.	 Fluoresence	 was	 measured	 using	 flow	 cytometry	 and	 determined	 from	
single,	 live	cells.	Blebbistatin	pre-treated	cells	presented	no	significant	 inhibition	of	dextran	uptake	
compared	 to	control-treated	cells	and	 this	was	observed	 in	 two	repeat	experiments	carried	out	 in	
triplicate,	 empty	 symbols	 =	 experiment	 1,	 solid	 symbols	 =	 experiment	 2.	 (C)	 The	 effect	 of	 50µM	
Blebbistatin	on	BTV	infection	was	quantified	using	flow	cytometry	and	virus	antibody	labelling.			 The	
%	of	 infected	cells	were	determined	 from	single,	 live	 cells.	 Two	 repeat	experiments	 carried	out	 in	
triplicate	 are	 displayed,	 empty	 symbols	 =	 experiment	 1	 and	 solid	 symbols	 =	 experiment	 2.	
Blebbistatin	pre-treated	and	post-infection	treated	cells	observed	no	significant	inhibitory	effect	on	
BTV	infection	when	compared	to	control	treated	cells.	
A	 B	
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BFA	cells	pre-treated	with	50µM	Blebbistatin	displayed	no	significant	difference	in	dextran	
uptake	 when	 compared	 to	 control	 treated	 cells	 (Figure	 5.15	 (B))	 	 indicating	 	 that	
Blebbistatin	is	not	preventing	the	uptake	of	dextran	
	
	
	
Pre-treatment	and	 treatment	of	 cells	post	 infection	with	50µM	blebbistatin	do	not	effect	
BTV	 infection	when	 compared	 to	 the	 control	 treated	 controls	 of	 the	 same	 time	 point	 of	
inhibitor	 addition	 (Figure	 5.15	 (C)).	 However,	 as	 dextran	 was	 not	 inhibited	 at	 this	
concentration,	it	may	suggest	that	the	drug	at	50μM	was	insufficient	at	inhibiting	myosin	II.	
Although,	myosin	 II	 is	not	an	essential	cellular	 requirement	 for	macropinocytosis	and	 it	 is	
possible	that	uptake	of	dextran	does	not	require	myosin	II.	
	
	
	
5.5.7 BTV	stimulates	fluid	phase	uptake	in	BFA	cells	
	
	
Macropinocytosis	 is	 constitutively	active	 in	 some	cells	 such	as	dendritic	 cells	 (West	et	al.,	
2000).	 However,	 macropinocytosis	 can	 also	 be	 triggered	 by	 extracellular	 factors	 that	
activate	 signalling	 cascades	 that	 culminate	 in	 the	 generation	 of	 the	 classical	 membrane	
ruffling	 and	 macropinosome	 formation.	 Some	 viruses	 that	 utilize	 	 macropinocytosis	 	 for	
entry	stimulate	a	transient	elevation	in	fluid	phase	uptake	which	could	be	due	to	induction	
of	macropinocytosis,	(Mercer	and	Helenius,	2008).	Phorbol	12-myristate	13-acetate	(PMA)	
is	known	to	stimulate	macropinocytosis	and	increases	fluid	phase	uptake	(Swanson,	1989,	
Garcia-Perez	et	al.,	2012).		Therefore,	PMA	can	be	used	to	induce	macropinocytosis.	
BFA	 cells	 were	 control	 treated	 or	 treated	 with	 1ug/mL	 PMA	 for	 15	 minutes	 and	 then	
incubated	with	0.5mg/ml	AlexaFluor-647	labelled	dextran.	Cells	were	also	pre-treated	with	
BTV	for	15	minutes	and	then	incubated	with	labelled	dextran	as	above.			Two			 experiments	
Chapter	5:		Understanding	the	early	events	in	BTV	cell	entry	
220	
	
	
	
	
were	carried	out	 in	 triplicate	and	the	mean	fluorescent	 intensity	of	dextran	quantified	by	
flow	 cytometry	 (Figure	5.16).	 	 Statistically	 significant	 increases	 in	 the	 uptake	 of	 dextran		
was	 seen	 in	 both	 PMA	 and	 BTV	 stimulated	 cells	 when	 compared	 to	 the	 control	 cells	
(ANOVA	p	=	<0.05	p	=	<0.05,	respectively)	 indicating	that,	BTV	transiently	stimulates	fluid	
phase	uptake	in	BFA	cells.	
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Figure	5.16	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	5.16		Effects	of	BTV-1	stimulation	of	BFA	cells	on	fluid	phase	uptake	
Two	 repeat	 experiments	 carried	 out	 in	 triplicate	 are	 displayed	 in	 the	 graph,	 empty	 symbols		
represent	experiment	1	and	solid	symbols	experiment	2.	BFA	cells	were	either	stimulated	with	the	
macropinosome	 stimulator	 drug	 PMA,	 BTV-1	 or	 the	matched	 diluent	 and	 then	 cells	 were	 chased		
with	 fluorescently	 labelled	 dextran.	 Dextran	 uptake	 was	 quantified	 using	 flow	 cytometry	 and	
ascertained	 from	 single,	 live	 cells.	 Cells	 that	 were	 stimulated	 with	 either	 PMA	 or	 BTV-1	 saw	 a	
significant	increase	in	dextran	uptake	compared	to	the	matched	controls	(ANOVA	p	=	<0.05).	
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5.6	 Discussion	
	
	
This	chapter	investigated	the	effects	of	DN	proteins	and	specific	pharmacological	inhibitors	
of	cellular	 factors	 required	 for	different	endocytosis	mechanisms	on	BTV	 infection	of	BFA	
cells	using	a	purified	 low	 insect	cell	passage	 field	 isolate	virus.	The	use	of	 flow	cytometry	
allowed	 quantitative	 analysis	 of	 the	 effects	 of	 inhibitors	 at	 the	 early	 stages	 of	 infection	
without	 bias	 or	 inclusion	of	 dead	 cells	 or	 cell	 aggregates	 by	 utilizing	 gating	 strategies	 for	
analysing	single,	live	cell	populations.	This	is	the	first	time	cell	entry	has	been	investigated	
for	a	field	isolate	of	BTV	using	cells	derived	from	a	natural	host.	The	evidence	presented	in	
this	chapter	is	consistent	with	previous	reports	that	BTV	uses	a	macropinocytosis-like	entry	
mechanism	(Gold	et	al.,	2010)	for	productive	BTV	infection	in	BFA	cells.	
	
	
	
Previous	 publications	 have	 investigated	 entry	mechanisms	 of	 cell	 culture	 adapted	 BTV	 in	
non-host	derived	cells	and	their	findings	have	indicated	that	BTV	may	be	able	to	use	more	
than	 one	 entry	 pathway	 (Forzan	 et	 al.,	 2007,	 Gold	 et	 al.,	 2010).	 Although	 the	 main	
conclusions	reached	regarding	the	entry	mechanisms	used	by	cell	culture	adapted	viruses	
were	 different,	 there	were	 some	 common	 findings.	 Both	 studies	 demonstrated	 that	 BTV	
requires	 a	 low	 pH	 dependent	 step	 for	 infection	 and	 both	 agree	 that	 virus	 entry	 is	
independent	 of	 cholesterol.	 The	main	 difference	was	 one	 study	 concluded	 entry	was	 via	
CME	 (Forzan	et	 al.,	 2007)	while	 the	other	 identified	a	macropinocytosis	 –like	pathway	as		
the	main	entry	pathway	(Gold	et	al.,	2010).	
	
	
	
The	 entry	 kinetics	 of	 purified	 low	 insect	 cell	 passaged	 BTV-1	was	 shown	 to	 be	 relatively		
slow	in	BFA	cells.			Treatment	with	ammonium	chloride	pre-infection,	a	drug	that	is	able		 to	
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raise	endosomal	pH,	 identified	a	 significant	 inhibition	 in	BTV-1	 infection	 (approximately	a	
60%	drop	in	cells	infected)	in	BFA	cells	when	compared	to	untreated	cells.	This	observation	
suggests	that	the	major	entry	mechanism	used	by	BTV-1	requires	a	low	pH	dependent	step	
(see	 section	 5.2)	 to	 allow	 productive	 infection.	 Furthermore,	 the	 level	 of	 inhibition	 is	
consistent	 with	 the	 decrease	 in	 infection	 seen	 by	 Forzan	 and	 colleagues	 (Forzan	 et	 al.,	
2007).	
	
	
	
The	 observation	 that	 ammonium	 chloride	 added	 to	 cells	 1	 hour	 post	 infection	 still	
significantly	reduced	the	percentage	of	cells	infected	further	demonstrated	that	BTV-1	has		
a	 relatively	 slow	 rate	 of	 delivery	 to	 acidic	 compartments	 (section	 5.2).	 Together	 these	
observations	 suggest	 a	 non	 clathrin-mediated	 uptake	 mechanism.	 The	 rate	 of	 delivery	
observed	 (60	 minutes	 for	 50%	 of	 virus	 to	 be	 delivered	 to	 an	 acidic	 compartment)	 is	
comparable	to	that	observed	by	(Gold	et	al.,	2010)	using	mammalian	cell	culture	adapted	
BTV-1	 and	 BHK-21	 cells.	 Entry	 was	 also	 studied	 by	 visualising	 entry	 steps	 by	 confocal	
microscopy.	Internalisation	of	BTV-1	to	the	cytosol	was	not	observed	until	90	minutes	post	
entry	 (section	 5.2.1)	 and	 this	 confirmed	 entry	 mechanisms	 utilized	 by	 purified	 BTV-1	
particles	 display	 slow	 internalisation.	 CME	 is	 often	 described	 as	 a	 mechanism	 able	 to		
deliver	rapid	internalisation	of	cargo,	often	within	10	minutes	(Berryman	et	al.,	2005)	and	
so	this	entry	mechanism,	appeared	an	unlikely	cell	entry	route	for	BTV	into	BFA	cells.	
	
	
	
To	 further	 support	 the	 suggestion	 that	 BTV	 utilizes	 a	 clathrin-independent	 entry	
mechanism,	 known	 inhibitors	 of	 CME	 (i.e.	 Chlorpromazine,	 Pitstop	 2)	 and	 DN	 proteins	
eps15	were	used.	Chlorpromazine	was	used	by	(Forzan	et	al.,	2007)	to	conclude	that	BTV	
entered	cells	via	CME.		For	the	studies	presented	here	the	highest	non-toxic			concentration	
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of	Chlorpromazine	for	BFA	cells	10µg/mL	was	used.	This	concentration	is	the	same	as	used	
by	(Forzan	et	al.,	2007)	and	other	endocytosis	studies	(Schelhaas	et	al.,	2012,	Berryman	et	
al.,	 2005).	 However,	 when	 used	 at	 this	 concentration	 Chlorpromazine	 did	 not	 appear	 to	
inhibit	transferrin	uptake.	Interestingly,	Forzan	and	colleagues	did	not	present	the	effect	of	
Chlorpromazine	 on	 the	 control	 ligand,	 transferrin	 as	 supporting	 evidence	 and	 so	 the	
Chlorpromazine	data	presented	 in	 this	publication	should	be	viewed	with	caution	 (Forzan		
et	 al.,	 2007).	 Transferrin	 is	 an	established	positive	 control	 ligand	 for	CME	 (Harding	et	 al.,	
1983,	Harding	and	Stahl,	1983,	Hanover	et	al.,	1984,	Hopkins,	1985,	Hopkins	et	al.,	1985)	
and	 so	a	 lack	of	 inhibition	 suggests	a	 failure	of	 the	drug	 to	 inhibit	 the	CME	at	 the	 tested	
concentration.	 Despite	 this,	 this	 line	 of	 enquiry	 was	 pursued	 as	 the	 	 publication	 	 from	
(Forzan	 et	 al.,	 2007)	 used	 Chlorpromazine	 as	 the	 key	 piece	 of	 evidence	 that	 BTV	 used	 a		
CME	mechanism.	It	was	observed	that	Chlorpromazine	significantly	inhibited	BTV	infection	
upon	 pre-treatment	 of	 the	 cells	 with	 this	 drug	 but	 not	 upon	 treatment	 post	 infection,		
which	was	observed	 in	 three	 independent	experiments.	 This	 indicated	 that	 the	 inhibition		
to	 infection	 was	 most	 likely	 acting	 upon	 a	 step	 before	 BTV	 entry,	 as	 demonstrated	 in	
section	5.3.1.	BTV	does	not	enter	the	cytosol	until	90	minutes	post	infection.	However,	as	
Chlorpromazine	did	not	inhibit	transferrin	uptake	we	cannot	be	sure	the	drug	is	 inhibiting	
CME	and	any	effect	on	BTV	infection	could	be	an	indicator	of	off-target	non-specific	effects	
on	the	cell.	An	alternative	explanation	is	that	clathrin	is	also	used	in	a	number	of	trafficking	
events	(Sousa	and	Lafer,	2015)	and	so	the	inhibition	in	infection	observed	pre-entry	could	
be	 effects	 on	 the	 trafficking	 of	 the	 viruses’	 receptor	 to	 the	 cell	 surface.	However,	 as	 the	
receptor	of	BTV	is	unknown,	this	theory	could	not	be	tested.	
	
	
	
In	order	 to	clarify	 the	requirement	of	clathrin	 for	BTV	 infection	 further,	another	chemical	
inhibitor		of	clathrin,	Pitstop		2,	was		used	to		determine		the		role	that	clathrin	plays		in	BTV	
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infection.	 The	 results	 show	 that	 non-toxic	 concentrations	 of	 Pitstop	 2	 (30µM)	 inhibited	
transferrin	 uptake	 indicating	 that	 the	 drug	 was	 inhibiting	 CME.	 Interestingly,	 this	
concentration	 did	 not	 inhibit	 BTV	 infection	 during	 pre	 or	 post	 infection	 treatments,		
contrary	to	what	was	observed	with	Chlorpromazine	treatments	both	in	this	study	and	by	
the	(Forzan	et	al.,	2007)	study.	This	suggests	that	BTV	does	not	require	CME	for	infection	of	
BFA	cells.	
	
To	further	investigate	the	role	of	CME	in	BTV	infection,	over	expression	of	GFP-tagged	DN	
mutants	of	eps15	were	used.	Eps15	 is	an	 initiation	 factor	 required	 for	 clathrin	 coated	pit	
formation,	(see	Chapter	1,	section	1.11.1)	(Benmerah	et	al.,	1999).	Expression	of	DN	eps15	
inhibited	 uptake	 of	 transferrin,	 indicating	 that	 the	 constructs	were	 successfully	 inhibiting	
CME.	 Infection	 studies	 of	 BTV	 in	 combination	with	different	 control	 or	DN	eps15	mutant	
plasmids	showed	that	when	BFA	cells	were	transfected	with	any	construct	(controls	or	DN	
mutants)	 the	 expressing	 cell	 populations	 showed	 less	 infection	 compared	 to	 the	 non-	
expressing	cell	population	 in	the	same	sample.	 It	has	been	documented	that	use	of	some	
liposomal	 transfection	 reagents	 can	 induce	 interferon	 and	 cellular	 stress	 responses	 (Li	 et		
al.,	 1998,	 Fiszer-Kierzkowska	 et	 al.,	 2011),	 which	 could	 in	 turn	 inhibit	 BTV	 infection.	
However,	these	cell	responses	would	usually	impact	on	bystander	cells	too	but	in	this	study	
it	 appeared	 that	 only	 transfected	 gene	 expressing	 cells	 inhibited	 infection.	 Intracellular		
DNA	sensors,	such	as	IFI16,	are	known	to	induce	production	of	 interferon-β	(Unterholzner	
et	al.,	2010).	Furthermore,	 IFI16	is	also	known	to	act	as	a	viral	restriction	factor	 in	human	
cytomegalovirus	 infection	 (Gariano	 et	 al.,	 2012).	 Therefore,	 upregulation	 of	 such	 DNA	
sensors	 after	 transient	 transfection	 may	 restrict	 viral	 replication.	 However,	 investigating		
this	 possibility	 was	 not	 in	 the	 scope	 of	 this	 PhD.	 Despite	 this,	 when	 infection	 of	 cell	
populations	 expressing	 the	 control	 constructs	 were	 compared	 directly	 with	 the	 cells	
expressing	a	DN	eps15	construct,	no	significant	difference	 in	BTV	 infection	was	observed	
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indicating,	 that	 eps15	 activity	 was	 not	 required	 for	 BTV	 infection.	 These	 results	 further	
support	the	conclusion	that	BTV	infection	is	independent	of	CME.	
	
	
	
In	 agreement	 with	 previous	 studies	 (Forzan	 et	 al.,	 2007,	 Gold	 et	 al.,	 2010),	 cholesterol	
seemed	 not	 required	 for	 BTV	 infection	 of	 BFA	 cells.	 However,	 although	 not	 statistically	
significant,	 small	 decreases	 in	 infection	 were	 observed	 between	 control	 cells	 and	 those	
treated	with	methy-β-cyclodextrin	prior	to	and	1	hour	post	BTV	infection.	It	 is	known	that	
cholesterol	 is	 required	 for	membrane	rearrangements	 (e.g.	membrane	curvature),	 to	give	
essential	membrane	fluidity	needed	in	many	endocytosis	events	(Grimmer	et	al.,	2002).	
	
	
	
The	timing	of	the	small	decreases	in	infection	could	reflect	the	time	with	which	membrane	
rearrangements	 are	 likely	 to	 occur	 during	 BTV	 entry.	 However,	 as	 there	 is	 no	 statistical	
significance	 it	 is	difficult	 to	conclude	whether	 there	 is	a	minor	 role	 for	 cholesterol	during	
virus	entry.	
	
	
	
Observations	made	during	BTV	entry	experiment	 (section	5.2.1)	suggested	that	entry	was	
accompanied	by	a	major	 rearrangement	of	 actin.	 The	F-actin	 cytoskeletal	 structure	 could	
clearly	be	seen	at	the	cell	periphery	 in	cells	negative	for	BTV	labelling,	however,	the	actin	
rich	cortex	was	lost	in	BTV	positive	cells	(	
Figure	 5.2).	 Furthermore,	 in	 BTV	positive	 cells	 actin	 labelling	 appeared	more	 intense	 and	
disorganised	 in	 the	 cytosol.	 This	 suggested	 that	 actin	 reorganisation	 could	 play	 a	 	 role	
during	 BTV	 infection.	 This	 is	 not	 an	 unusual	 observation	 and	 many	 studies	 report	 actin	
rearrangements	during	virus	cell	entry.		For	example	HIV-1	induces	F-actin		 rearrangements	
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upon	virus	binding	to	CD4/CXCR4	complex	during	entry	 into	CD4	positive	T	cells	 (Gordon-	
Alonso	et	al.,	2013).	Also,	 Japanese	Encephalitis	Virus	binds	 to	neuronal	cells	and	triggers	
rapid	 actin	 rearrangements	 to	 facilitate	 virus	 entry	 (Kalia	 et	 al.,	 2013).	 To	 confirm	 the	
requirement	of	actin	during	BTV	infection	and	to	ensure	actin	rearrangements	were	not	an	
artefact	due	to	the	requirement	of	high	m.o.i.	to	allow	visualisation	of	virus	entry,	the	actin	
inhibitor	 Cytochalaisin	 D	 was	 used	 to	 identify	 whether	 it	 could	 inhibit	 BTV	 infection	 at		
lower	 m.o.i.	 (m.o.i.	 <1).	 Figure	 5.7	 show	 that	 Cytochalaisin	 D	 caused	 actin	 disruption.		
When	cells	were	pre-treated	with	Cytochalasin	D	or	treated	at	1	or	2	hours	post	infection,	a	
significant	 inhibition	of	cell	becoming	 infected	with	BTV	was	observed	when	compared	to	
the	 control	 treated	 controls.	 This	 coincides	 with	 the	 time	 it	 takes	 for	 virus	 to	 	 be		
internalised	and	suggests	that	actin	plays	a	key	role	during	BTV	entry.	The	confocal	images	
also	suggest	that	BTV	is	closely	associated	with	F-actin	structure	during	entry.	These	results	
suggest	that	actin	is	a	key	cellular	factor	during	BTV	entry.	
	
	
	
However,	 actin	 is	 known	 to	 be	 involved	 in	 many	 endocytosis	 pathways	 including	 CME,	
caveolae/lipid	 raft	 dependent	 endocytosis	 and	macropinocytosis	 (Smythe	 and	 Ayscough,	
2006).	Evidence	presented	 in	this	chapter	suggests	that	the	requirement	of	F-actin	during	
BTV	 infection	 is	 not	 linked	 to	 CME	 or	 cholesterol.	 Therefore,	 macropinocytosis	 was	
investigated	to	identify	any	role	in	BTV	infection.	
	
	
	
The	 two	 key	 cellular	 indicators,	 which	 many	 attribute	 as	 sole	 discriminators	 of	
macropinocytic	 endocytosis	 are	 the	 requirement	 of	 sodium	proton	 exchangers	 and	 PAK1	
(Deacon	et	al.,	 2008).	 To	 investigate	 the	NHE1	and	PAK1	 in	BTV	 infection,	 inhibitors	EIPA	
which	inhibit	NHE1	and	IPA-3	which,	inhibits	PAK1	(Deacon	et	al.,	2008)	were	used.					Upon	
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pre-treatment	or	treatment	at	1,	2	or	3	hours	post	 infection	with	either	of	these	drugs,	a	
highly	 significant	 inhibition	 in	 infection	 compared	 to	 control	 treatment	 was	 	 observed.	
These	 results	 are	 consistent	 with	 the	 slow	 entry	 mechanism	 observed	 in	 both	 confocal	
experiments	 and	 the	 rate	 of	 delivery	 of	 virus	 to	 acidic	 compartments	 (section	 5.2).	
However,	 neither	 inhibitor	 inhibited	 dextran	 uptake,	 a	 marker	 for	 fluid	 phase	
uptake/macropinocytosis.	As	dextran	is	a	marker	of	fluid	phase	uptake	and	not	specifically	
macropinocytosis,	this	could	suggest	that	most	dextran	uptake	occurs	by	mechanisms	that	
are	not	 inhibited	by	the	drugs	or	 that	 inhibition	of	macropinocytosis	stimulates	uptake	of	
dextran	 by	 compensating	 endocytosis	 mechanisms.	 Together,	 these	 results	 suggest	 that	
BTV	utilizes	a	macropinocytosis-like	entry	mechanism.	
The	 results	 reported	 in	 this	 Chapter	 also	 indicate	 that	 BTV	 has	 the	 ability	 to	 trigger	 up-	
regulation	 of	 fluid	 phase	 uptake	 (section	 5.5.7),	 in	 much	 the	 same	 manner	 as	
macropinosome	stimulating	drug	PMA	(Garcia-Perez	et	al.,	2012,	Yoshida	et	al.,	2015).	This	
suggests	 that	 BTV	may	 trigger	 signalling	 events	 and	 macropinocytosis	 during	 entry.	 This	
could	 include	 induction	 of	 filopodia	 extensions	 which	 protrude	 from	 the	 cell	 and	 are	
involved	 in	 ‘seeking’	 virions	 that	 are	 in	 close	 proximity	 to	 cells,	 such	 as	 that	 seen	 with	
Human	 Papillomavirus	 (Smith	 et	 al.,	 2008).	 Other	 possibilities	 include	 activation	 of	 RhoA	
induced	phagocytosis	as	seen	with	HSV	(Clement	et	al.,	2006).	Often	Rho	proteins	 (RhoA,	
Rac1	or	Cdc42)	are	involved	in	initiating	signalling	cascades	that	are	required	for	induction	
of	 increased	 virion	 uptake	 (Van	 den	 Broeke	 et	 al.,	 2014).	 Therefore,	 the	 role	 	 of	 	 Rho	
proteins	in	BTV	infection	was	also	investigated.	
	
	
	
Flow	 cytometry	 analysis	 of	 cell	 pre-treated	 with	 c3	 toxin	 from	 Clostridium	 botulinum,	 a	
known	rho	protein	inhibitor	 (Chardin	et	al.,	1989),	exhibited	a	significant	decrease	 in	BTV	
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infection	when	compared	to	the	control	treatment.	However,	cells	that	were	treated	at	1,		
2,	3	or	6	hours	post	 infection	did	not	see	a	decrease	 in	 infection.	This	 indicated	 that	Rho	
protein	signalling	is	activated	prior	to	virion	internalisation,	which	occurs	from	90	minutes	
post	virus	attachment.	Pre-entry	engagement	of	rho	protein	signalling	has	been	described	
to	 be	 used	 by	 many	 viruses	 including	 retroviruses,	 papillomaviruses,	 herpesviruses,	
poxviruses,	 dengue	 virus	 and	 vesicular	 stomatis	 virus	 (Van	 den	 Broeke	 et	 al.,	 2014).	 The	
three	main	mechanisms	governed	by	Rho	protein	signalling	that	occur	pre-entry	are	virus	
surfing	down	actin	filopodia	extensions	to	the	cell	body	as	seen	with	murine	leukemia	virus	
(Lehmann	et	 al.,	 2005)	 and	HPV	 (Schelhaas	et	 al.,	 2012),	 receptor	 clustering	 to	 virus	 ‘hot	
spots’	at	the	cell	periphery	to	facilitate	entry	as	seen	with	HPV	(Smith	et	al.,	2008)	and	HIV	
(Yoder	 et	 al.,	 2008,	 Iyengar	 et	 al.,	 1998,	 Jimenez-Baranda	 et	 al.,	 2007)	 and	 the	 last	
mechanism	is	filopodia	extensions	which	‘seek’	virions	close	to	but	not	bound	to	the	target	
cell	as	seen	with	HSV	(Clement	et	al.,	2006).	Observations	during	BTV	entry	(section	5.2.1)	
identified	small	filopodia	like-actin	rich	structures	protruding	from	the	cell	at	point	of	virus	
attachment,	 with	 virions	 often	 bound	 to	 the	 apical	 tips	 of	 these	 extensions	 and	 by	 30	
minutes	 uptake,	 virus	 could	 be	 seen	 at	 the	 periphery	 of	 the	 cell	 body	 (Figure	 5.2).	 In	
addition,	 virus	 clustering	 at	 specific	 locations	 could	 be	 seen	 after	 1	 hour	 virus	 uptake.	
Therefore,	 viral	 surfing	 or	 virus	 receptor	 clustering	 are	 possibilities	 for	 BTV	 but	 further	
investigation	is	required	for	the	specific	mechanism.	It	is	likely	that	live	cell	imaging	of	virus	
entry	 could	 shed	 light	 on	 whether	 virus	 can	 be	 seen	 ‘surfing’	 down	 actin	 filopodia	
projections,	 however,	 a	 fluorescently	 tagged	 virus	 is	 required	 for	 such	 imaging.	 It	 is	 also	
likely	 that	 receptor	 clustering	 could	 be	 visualised	 using	microscopy	 but	 this	 possibility	 is	
difficult	 when	 the	 attachment	 receptor	 of	 BTV	 in	 unknown.	 With	 this	 in	 mind	 and	 the	
understanding	 that	 myosin	 II	 is	 often	 involved	 in	 the	 retraction	 of	 actin	 filopodia		
projections	during	virus	surfing,	the	role	of	myosin	II	was	investigated.	
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Myosin	 II	motors	 are	 known	 to	 drive	 virus	 surfing,	working	with	 actin	 filaments	 to	move	
virions	 along	 filopodia	 (Van	 den	 Broeke	 et	 al.,	 2014).	 Blebbistatin	 is	 a	well	 characterised	
inhibitor	of	Myosin	II	(Limouze	et	al.,	2004)	and	was	used	in	this	study	to	identify	whether	
there	is	a	role	for	myosin	II	in	BTV	infection.	Blebbistatin	failed	to	inhibit	dextran	uptake	at	
the	 non-toxic	 concentration	 of	 50µM.	 However,	 myosin	 II	 whilst	 is	 a	 characteristic	 	 for		
some	 forms	 of	 macropinocytosis,	 it	 is	 not	 an	 essential	 cellular	 factor	 for	 all	 forms	 of	
macropinocytosis	 (Mercer	and	Helenius,	2009).	However	without	a	suitable	control	 it	was	
impossible	to	differentiate	if	Blebbistatin	was	an	effective	inhibitor	of	myosin	II	For	further	
clarification	the	effect	of	Blebbistatin	treatment	on	BTV	infection	was	still	investigated.	Pre-	
treatment	 or	 post	 infection	 treatments	 with	 Blebbistatin	 did	 not	 inhibit	 virus	 infection		
when	compared	to	matched	control	treatments.	It	is	possible	that	myosin	II	is	not	required	
for	 virus	 infection	 but	 equally	 plausible	 that	 50µM	 is	 not	 a	 sufficient	 concentration	 to		
inhibit	 myosin	 II	 in	 BFA	 cells.	 To	 draw	 any	 firm	 conclusions,	 a	 better	 control	 to	 identify	
whether	myosin	II	has	effectively	been	inhibited	is	required.	 In	addition,	as	toxicity	of	this	
drug	was	low	at	higher	concentration	than	50µM,	higher	concentrations	of	the	drug	could	
be	tested	to	see	whether	this	induces	myosin	II	inhibition.	
	
	
	
Phosphoinositide	 (PI)	 3-kinase	 (PI3-kinase)	 is	 a	 kinase	 that	 is	 frequently	 cited	 as	 being	
involved	in	macropinocytic	entry	of	viruses	and	in	the	transient	formation	of	actin	filopodia	
extensions	 during	 HPV	 entry	 (Smith	 et	 al.,	 2008).	 Therefore	 the	 PI3	 kinase	 inhibitor,	
Wortmannin	 was	 used	 to	 identify	 whether	 PI3	 kinase	 plays	 a	 role	 in	 BTV	 infection.	
Nanomolar	concentrations	of	wortmannin	 inhibit	PI3	kinase,	higher	concentrations	of	 the	
drug	then	inhibit	PI4	kinase	and	so	a	concentration	of	200nM	was	selected	as	 it	has	been	
highly	cited	as	being	the	maximum	concentration	effective	against	PI3	kinase	alone	(Park	et	
al.,		1997).					Wortmannin	did	not		inhibit		dextran	uptake	of		infection	at		any	of		the				time	
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points	 tested.	 This	 could	 suggest	 that	 BTV	 is	 entering	 independent	 of	 PI3	 	 kinase	 	 but	
without	 an	effective	 answer	 as	 to	whether	 the	drug	 is	 inhibiting	PI3	 kinase	 in	 these	 cells	
(due	to	lack	of	inhibition	of	the	dextran	control),	it	is	difficult	to	draw	conclusions.	
	
	
	
The	evidence	presented	 in	 this	chapter	demonstrate	 that	entry	and	 infection	of	BFA	cells	
with	 a	 purified,	 low	 insect	 cell	 passaged	 BTV-1	 is	 independent	 of	 CME	 and	 share	 many	
characteristics	of	macropinocytosis.	BTV-1	appears	to	initiate	rho	protein	signalling	prior	to	
virus	 entry,	 which	 subsequently	 results	 in	 cell	 signalling	 that	 triggers	 global	 actin	
reorganisation	and	a	transient	increase	in	fluid	phase	uptake,	which	appears	to	be	directly	
stimulated	 by	 the	 virus	 itself.	 In	 addition,	 kinases	 and	 other	 cellular	 factors	 which	 are	
essential	for	macropinocytosis	such	as	PAK1	and	the	NHE1	are	also	essential	for	productive	
BTV-1	 infection	 in	 BFA	 cells	 and	 appear	 to	 be	 required	 throughout	 the	 process	 of	 slow	
cellular	 entry	 by	 the	 virus.	 Taken	 together,	 the	 evidence	 in	 this	 chapter	 supports	
conclusions	 made	 by	 Gold	 et	 al.	 (2010)	 of	 macropinocytosis-like	 BTV-1	 entry	 in	 BHK-21		
cells.	However,	this	study	could	also	indicate	that	the	target	cell	of	the	virus	may	influence	
the	entry	mechanism	used	to	gain	entry.	
		
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Chapter	6	-	
	
Investigating	entry	mechanisms	
utilized	by	BTV	in	Culicoides	spp.	cells	
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6.1 Introduction	
	
	
Endocytosis	in	insect	cells	has	largely	been	neglected	as	a	research	area	with	only	a	handful	
of	publications	describing	endocytosis	of	major	human	arboviruses	in	mosquito	cells	(Lee	et	
al.,	2013,	Chu	et	al.,	2006,	Acosta	et	al.,	2011,	Acosta	et	al.,	2008)	or	the	endocytosis	of	the	
heavily	 used	 laboratory	 tool	 ‘Baculovirus’	 in	 Drosophila	 spp.	 cells	 (Long	 et	 al.,	 2006).	
However,	 in	 recent	 years,	 the	 emergence	 of	 Culicoides-borne	 viruses	 such	 as		
Schmallenberg	 virus	 (SBV)	 and	 multiple	 serotypes	 of	 BTV,	 plus	 the	 documentation	 of	
Oropouche	 virus,	 currently	 the	 only	 human	 midge	 transmitted	 virus	 ,	 strengthens	 the	
argument	 that	 the	 virus-vector	 interactions	 for	 Culicoides-borne	 viruses	 must	 be	 better	
understood	 (Carpenter	 et	 al.,	 2013).	 In	 particular,	 better	 understanding	 of	 insect	 	 cell	
biology	and	endocytic	processes	that	govern	entry	of	viruses	to	their	biological	vector	could	
elude	 to	 unique	 possibilities	 of	 preventing	 vector	 infection	 and	 thus	 transmission	 of	
arboviruses.	
	
	
	
In	addition,	many	viruses,	 including	arboviruses	have	been	reported	to	use	multiple	entry	
mechanisms	 (Boulant	 et	 al.,	 2015),	 although	 it	 is	 unknown	 if	 cell	 entry	 strategies	 are	
governed	by	the	cell	 type	being	 infected.	Therefore,	 the	possibility	remains	that	BTV	may	
adopt	 different	 cell-entry	 strategies	 in	 the	 Culicoides	 spp.	 host	 cells	 compared	 to	
mammalian	cellular	targets.	
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The	entry	of	BTV-1	into	Culicoides	derived	cells	(KC	cells),	was	investigated	in	more	detail	in	
this	chapter.	
	
	
	
In	 chapter	 4,	 data	 generated	 in	 Culicoides	 spp.	 cells	 identified	 a	 dynamin	 gene	 in	 the	
Culicoides	 spp.	 genome	 and	 results	 suggested	 that	 dynamin	 could	 be	 involved	 in	 BTV	
infection	but	could	not	be	confirmed	due	to	the	lack	of	an	insect	cell	characterised	positive	
control	 ligands.	 The	 dynamin-dependent	 CME	 pathway	 has	 been	 reported	 to	 operate	 in	
both	Drosophila	 cell	 lines	 (Chang	 et	 al.,	 2002)	 and	 Aedes	 cell	 lines	 (Acosta	 et	 al.,	 2008)	
suggesting	that	CME	is	an	evolutionary	conserved	endocytic	mechanism.	
	
	
	
As	the	full	Culicoides	spp.	genome	had	not	been	completed	or	published	at	the	start	of	this	
project,	 the	use	of	siRNA	and	dominant	negative	proteins	were	unable	to	be	used	due	to	
the	 lack	 of	 information	 regarding	 the	 vector’s	 genome.	 Therefore,	 the	 effects	 of	
pharmacological	inhibitors	targeting	cellular	factors	in	endocytosis	were	tested	with	control	
ligands	and	BTV	infections	were	characterised	in	Culicoides	spp.	cells.
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6.2 Investigating	 the	 requirement	 of	 acidic	 endosomal	 pH	 in	 BTV	 infection	 and		
the	rate	of	trafficking	to	acidic	compartments	within	KC	cells	
	
	
	
Many	viruses	require	an	acid	dependent	step	(Grove	and	Marsh,	2011)	to	initiate	infection.	
The	data	described	 in	Chapter	5	 confirmed	 that,	BTV	 requires	an	acid	dependent	 step	 to	
initiate	infection	in	bovine	endothelial	cells	and	this	was	also	further	documented	in	other	
mammalian	cell	lines	(Gold	et	al.,	2010,	Forzan	et	al.,	2007).	Therefore,	the	requirement	of	
an	acid-dependent	step	during	BTV	 infection	of	KC	cells	was	 investigated	by	treating	cells	
with	ammonium	chloride.	
	
	
	
Ammonium	chloride	neutralises	acid	compartments	(see	Chapter	5,	section	5.2).	Upon	pre-	
treatment	 with	 25mM	 Ammonium	 chloride,	 BTV-1	 infection	 of	 KC	 cells	 was	 significantly	
inhibited	compared	to	cells	that	were	untreated	(One-Way	ANOVA,	Tukey’s	correction,	p		 =	
<0.0005)	(Figure	6.1).	This	 finding	shows	that,	BTV	requires	an	acid-dependent	step	during	
infection	of	KC	cells.	The	addition	of	ammonium	chloride	to	cells	at	different	time	points	post	
infection	 allows	 inference	 of	 the	 rate	 with	 which	 virus	 reaches	 an	 acidic	 compartment.	
Statistically	significant	 inhibition	of	 infection	was	observed	 in	cells	 treated	with	ammonium	
chloride	up	to	8	hours	post	infection	(Figure	6.1),	however	the	level	of	significance	reduced	
in	accordance	with	time	post	infection.	This	is	indicative	of	a	relatively	slow	process	of	virus	
reaching	an	acidic	compartment	within	the	cell.	
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Figure	6.1	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	6.1		Rate	of	delivery	of	BTV	to	acidic	compartments	in	KC	cells	
KC	 cells	 were	 infected	 with	 purified	 BTV-1	 GIB2007/01	 KC3	 for	 a	 total	 of	 16	 hours.	 Ammonium	
chloride	(25mM)	was	added	to	cells	at	different	time	points	during	infection:	pre-treatment,	1,	2,	4,	
6,	8,	12	h.p.i.	and	during	the	last	5	minutes	of	 infection.	Cells	were	fixed	and	labelled	prior	to	flow	
cytometry	analysis.	Data	was	ascertained	by	gating	on	single,	 live	cells.	The	graph	shows	combined	
data	from	two	repeated	experiments	carried	out	in	triplicate	and	displays	mean	%	cells	infected	 and	
±	 SEM	 as	 error	 bars.	 ANOVA	 and	 Tukey’s	 analysis	 identified	 a	 statistically	 significant	 inhibition	 in	
infection	between	untreated	cells	and	cells	pre-treated	and	treated	at	1	h.p.i	,	2hpi,	4hpi,	6hpi	and	
8hpi	with	25mM	Ammonium	chloride	(p	=	<0.0005,	p	=	<0.0005,	p	=	<0.005,	p	=	<0.05,	p	=	<0.05,	p	 =	
<0.05,	respectively).	After	2	hours	of	internalisation,	approximately	50%	of	virus	has	been	delivered	
to	an	acidic	compartment.	
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6.3 Characterising	non-toxic	pharmacological	inhibitors	of	endocytosis	in	KC		cells	
	
As	previously	mentioned,	relatively	little	is	known	about	the	cellular	biology	of	insect	cells,	
and	 in	particular,	endocytosis	pathways	present.	As	a	 result,	 information	on	 the	 reagents	
and	tools	that	can	be	used	to	investigate	endocytosis	mechanisms	in	insect	cells	is	limited.	
Therefore,	the	potential	toxic	effects	of	common	pharmacological	inhibitors	of	mammalian	
cell	endocytosis	were	initially	determined	for	KC	cells.	
	
	
	
KC	 cells	 were	 incubated	 with	 one	 of	 six	 inhibitors	 for	 a	 duration	 of	 12.5	 hours.	 After	
incubation,	 cells	 were	 stained	 with	 Live/Dead	 stain	 (Life	 technologies).	 Cells	 were	 then		
fixed	and	single,	live	cells	were	analysed	using	flow	cytometry.	
	
	
	
Inhibitors	were	tested	at	concentrations	shown	to	inhibit	target	cellular	factors	in	BFA	cells	
and	previously	published	data,	concentrations	were	as	follows:	EIPA	(100µM),	Cytochalasin	
D	 (10µg/ml),	 IPA	 3	 (150µM),	 Methyl-β-cyclodextrin	 (5mM),	 Wortmannin	 (10µM)	 and		
Pitstop	 2	 (25µM).	 At	 the	 end-point	 of	 the	 experiment	 the	 only	 drug	 which	 displayed	 a	
substantial	 reduction	 in	 cell	 viability	were	KC	 cells	 incubated	with	 IPA	3	 (Figure	6.2).	 For		
this	 reason,	 IPA	 3	 was	 excluded	 from	 further	 experiments.	 Small	 but	 non-significant	
reductions	 in	 cell	 viability	 could	 also	 be	 seen	 in	 cells	 incubated	with	 Cytochalasin	 D	 and	
Pitstop	2.	However,	as	reduction	in	viability	was	minimal,	these	inhibitors	were	still	used	to	
further	investigate	endocytosis	mechanisms	utilised	in	KC	cells.	
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Figure	6.2		Toxicity	of	endocytosis	inhibitor	on	KC	cells	
Cells	were	 treated	with	one	of	 six	possible	endocytosis	 inhibitors	 for	12.5	hours	at	 concentrations	
shown	to	be	effective	 in	BFA	cells	and	 in	previously	published	works.	Cell	viability	was	determined		
by	 analysing	 the	 proportion	 of	 single,	 live	 cells.	 Panel	 (A)	 identifies	 toxicity	 data	 for	 100µM	 EIPA,	
panel	(B)	displays	toxicity	data	for	10µg/ml	Cytochalasin	D,	panel	(C)	exhibits	toxicity	data	for	150µM	
IPA	3,	panel	(D)	identifies	toxicity	data	for	5mM	methyl-β-cyclodextrin,	panel	(E)	depicts	toxicity	data	
for	25µM	Pitstop-2	and	 lastly	panel	 (F)	 shows	 toxicity	data	 for	10µM	Wortmannin.	Panel	C	 shows	
that	 there	 is	 a	 significant	 difference	 in	 cell	 viability	 in	 cells	 treated	with	 IPA-3	 compared	 to	mock	
control	treatment	and	untreated	cells	(ANOVA,	p	=	<0.0005,	p	=	<	0.0005,	respectively).	
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6.4 The	effect	of	macropinocytosis	inhibitors	on	BTV-1	infection	of	KC	cells	
	
	
	
Results	 presented	 in	 Chapter	 5,	 suggested	 that	 BTV	might	 utilize	 a	macropinocytosis-like	
mechanism	 to	 enter	 bovine	 endothelial	 cells.	 Therefore,	 pharmacological	 inhibitors	 EIPA,	
which	 inhibits	 NHE1	 and	 Cytochalasin	 D,	 which	 inhibits	 actin,	 both	 factors	 required	 for	
macropinocytosis,	were	used	 to	 identify	 their	 effects	on	 control	 ligand	uptake	and	BTV-1	
infection.	
	
	
	
As	 IPA-3	was	 toxic	 to	KC	cells	 (see	 section	6.2)	 the	 role	of	p21	activated	kinase	1	 (PAK1)	
could	not	be	investigated	in	KC	cells.	
	
	
	
Firstly,	the	effect	of	EIPA	on	control	 ligand	uptake	was	examined	as	 it	was	unknown	as	to	
whether	 macropinocytosis	 operates	 in	 the	 same	 manner	 in	 insect	 cells	 as	 it	 does	 in	
mammalian	cells	and	if	so,	whether	EIPA	would	act	on	NHE1	and	inhibit	macropinocytosis.	
KC	 cells	 were	 pre-treated	 with	 EIPA	 for	 30	 minutes	 or	 incubated	 with	 the	 equivalent	
dilution	of	the	drug	diluent,	DMSO.	Cells	were	then	allowed	to	internalise	the	fluorescently	
labelled	 macropinocytosis/fluid	 phase	 uptake	 marker	 dextran.	 After	 analysis	 using	 flow	
cytometry,	it	was	identified	that	there	was	a	significant	inhibition	in	dextran	uptake	in	EIPA	
treated	 cells	 compared	 to	 control	 treated	 and	 untreated	 cells	 (One-way	ANOVA,	 Tukey’s	
correction,	 p	 =	 <0.0005,	 p	 =	 <0.0005,	 respectively)	 (Figure	 6.3	 (A)),	 indicating,	
macropinocytosis	had	effectively	been	inhibited	with	EIPA.	
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The	effects	of	EIPA	on	BTV-1	infection	within	KC	cells	were	then	investigated.	KC	cells	were	
either	pre-treated	with	EIPA/control	treatment	or	treated	at	1,	2	or	4	hours	post	infection	
Cells	were	 labelled	 for	 viral	 proteins	 after	 fixation	 using	 an	 anti-virus	 antibody	Orab	 276		
(see	Chapter	2,	section	2.7)	and	analysed	using	flow	cytometry.	EIPA	successfully	inhibited	
uptake	of	dextran	in	KC	cell,	indicating	the	inhibitor	is	effective	at	blocking	MPC	(Figure	6.3	
(A))	 (ANOVA	 with	 Tukey’s	 correction	 p	 =	 <0.0005).	 Contrary	 to	 observation	 in	 bovine	
endothelial	cells	 (see	Chapter	5,	 section	5.5.2)	no	significant	effect	on	percentage	of	cells	
infected	was	observed	in	KC		cell	cultures	either	pre-treated	with	EIPA	or	treated	at	1,	2	or		
4	hours	post	infection	compared	to	the	matched	control	treatments	(Figure	6.3	(B)).	
	
	
	
The	 effect	 of	 actin	 inhibitor,	 Cytochalasin	 D	 was	 studied	 next	 to	 identify	 the	 effect	 on	
control	ligand	uptake	and	BTV-1	infection	of	KC	cells.	However,	pre-treatment	of	cells	with	
Cytochalasin	D	had	no	effect	on	dextran	uptake	(Figure	6.4	(A)).	
	
	
	
KC	cells	were	then	either	pre-treated	or	treated	at	1	or	2	hours	post	infection	with	10µg/ml	
Cytochalasin	D	or	an	equivalent	dilution	of	the	drug	diluent	and	the	effects	on	BTV	infection	
was	 observed.	 Cells	 either	 pre-treated	 or	 treated	 at	 1	 hour	 post	 infection	 displayed	 no	
significant	 effect	 on	 the	 proportion	 of	 cells	 infected	with	 BTV	 (Figure	 6.4	 (B)).	 Together,		
the	data	generated	 from	EIPA	and	Cytochalasin	D	experiments	suggests	BTV	may	not	use	
macropinocytosis	for	entry	in	KC	cells.	
Chapter	6:		Understanding	the	early	events	in	BTV	cell	entry	
243	
	
	
A	 B	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	6.3	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	6.3	The	effects	of	EIPA	inhibitor	on	BTV-1	infection	and	control	ligand	uptake	in	KC	cells	
KC	 cells	 were	 either	 pre-treated	 with	 100µM	 EIPA	 or	 an	 equivalent	 dilution	 of	 DMSO	 (the	 drug	
diluent)	 for	 30	 minutes	 or	 left	 untreated.	 Cells	 were	 then	 incubated	 with	 0.5mg/ml	 dextran-	
AlexaFluor-647	 for	 15	 minutes	 and	 live/dead	 stain.	 Cells	 were	 fixed	 and	 analysed	 using	 flow	
cytometry.	Data	 from	two	 individual	experiments,	empty	symbols	=	experiment	1,	 solid	 symbols	=	
experiment	2,	on	 the	effects	of	EIPA	on	dextran	uptake	can	be	seen	 in	panel	 (A).	Cells	either	pre-	
treated	with	EIPA	or	control	treatment	followed	by	BTV	infection,	or	infected	and	treated	with	drug	
or	control	treatment	at	1,	2	or	4hpi	can	be	seen	in	panel	(B).	Panel	(B)	shows	data	from	3	individual	
experiments,	empty	symbols	=	experiment	1,	solid	symbols	=	experiment	2	and	half-filled	symbols	=	
experiment	3.	EIPA	was	shown	to	inhibit	macropinocytosis	control	ligand	(ANOVA,	p	=	<0.0005)	but	
has	no	statistically	significant	effect	on	BTV	infection	at	any	of	the	time	points	for	treatment.	
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Figure	6.4		The	effects	of	actin	inhibitor,	Cytochalasin	D	on	BTV	infection	of	KC	cells	
	
KC	cells	were	either	pre-treated	with	10µg/ml	Cytochalasin	D	or	an	equivalent	dilution	of	the	drug	
diluent	 DMSO	 for	 30	 minutes	 or	 left	 untreated	 and	 then	 allowed	 to	 internalize	 0.5mg/ml	
fluorescently	 labelled	dextran	 for	15	minutes.	Cells	were	 fixed	and	analysed	using	 flow	cytometry.	
Graphs	 detail	 results	 from	 2	 experiments,	 empty	 symbols	 show	 experiment	 1	 and	 solid	 symbols		
show	 experiment	 2.	 Panel	 (A)	 details	 the	 effect	 of	 drug	 or	 control	 treatment	 on	 dextran	 uptake.		
Panel	 (B)	 identifies	 the	 effect	 of	 pre-treatment	 or	 post-infection	 treatment	 with	 EIPA	 on	 BTV	
infection	 compared	 to	 control	 treated	 and	 untreated	 cells.	 No	 significant	 difference	 in	 dextran	
uptake	 or	 BTV	 infection	 was	 observed	 in	 cells	 treated	 with	 Cytochalasin	 D	 compared	 to	 control	
treatments.	
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6.5 Investigating	the	role	of	clathrin	in	BTV-1	infection	of	KC	cells	
	
	
As	section	6.4	identified	that	BTV	infection	did	not	require	the	cellular	factors	NHE1	or	actin	
commonly	 required	 for	macropinocytosis,	 the	 role	of	 clathrin	 in	BTV	 infection	of	 KC	 cells	
was	further	investigated.	
	
	
	
Pitstop	2	inhibits	clathrin	(see	Chapter	5,	section	5.3.2).	 Initially,	the	effect	of	Pitstop	2	on	
the	control	ligand,	transferrin	uptake	in	KC	cells	was	quantified	using	flow	cytometry.	Upon	
pre-treatment	 with	 25µM	 Pitstop	 2	 (which	 was	 selected	 as	 was	 shown	 as	 previously	
effective	with	BFA	cells	and	in	previous	publications)	or	an	equivalent	dilution	of	the	drug	
diluent,	 DMSO	 for	 15	 minutes,	 cells	 treated	 with	 Pitstop2	 exhibited	 a	 highly	 significant	
decrease	 in	 transferrin	 uptake	 compared	 to	 control	 treatment	 and	 untreated	 cells	 (One-	
Way	ANOVA	with	Tukey’s	correction,	p	=	<0.0005,	p	=	 	<0.0005,	 respectively)	 (Figure	6.5		
A).	
	
	
	
The	role	of	clathrin	 in	BTV-1	 infection	of	KC	cells	was	then	 investigated.	Cells	were	either	
pre-treated	with	25µM	Pitstop	2	or	the	equivalent	dilution	of	DMSO	ore	treated	at	1,	2	or	3	
hours	post	infection	with	Pitstop	2/control	treatment.	The	level	of	infection	after	12	hours	
was	detected	using	an	anti-virus	antibody,	orab	276,	and	viral	protein	expression	quantified	
using	flow	cytometry	(see	Chapter	2,	section	2.7).	Statistically	significant	reductions	in	BTV-	
1	 infection	 could	 be	 observed	 in	 cells	 with	 pre-treated	 or	 treated	 at	 1hpi	 compared	 to	
matched	control	 treatments	 (One-Way	ANOVA,	Tukey’s	correction,	p	=	<0.005,	p	=	<0.05,	
respectively)	but	no	 significant	difference	 in	population	of	 cells	 infected	was	observed	 in	
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cells	treated	at	2	or	3	hpi	(Figure	6.5	(B)).	This	suggests	that	clathrin	may	play	a	role	in	the	
early	events	of	BTV	infection	of	KC	cells.	
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Figure	6.5	The	effects	of	clathrin	inhibitor,	Pitstop-2	on	BTV-1	infection	and	control	ligand	uptake	
in	KC	cells	
KC	 cells	 were	 either	 pre-treated	with	 25µM	 Pitstop-2	 or	 an	 equivalent	 dilution	 	 of	 drug	 	 diluent,	
DMSO	 and	 then	 allowed	 to	 internalise	 fluorescently	 labelled	 10µg/ml	 transferrin	 for	 15	minutes.	
After	fixation,	cells	were	analysed	using	flow	cytometery	and	data	from	single,	live	cells	can	be	seen	
in	panel	(A).	Panels	(A)	and	(B)	display	data	from	two	experiments,	where	empty	symbols	represent	
experiment	1	and	solid	symbols	experiment	2.	Panel	(B)	shows	KC	cells	that	were	either	pre-treated	
with	Pitstop-2	or	drug	diluent	as	a	control	treatment	and	then	infected	with	BTV-1	or	infected	and	
then	treated	with	Pitstop	2/control	treatment	at	1,	2	or	3hpi.	Cells	were	antibody	labelled	 for	BTV	
viral	 proteins	 and	 analysed	 by	 flow	 cytometry.	 (A)	 Statistically	 significant	 inhibition	 of	 transferrin	
uptake	was	 observed	 in	 cells	 treated	with	 Pitstop-2	 compared	 to	 control	 treatment	 (ANOVA,	 p	 =	
<0.0005).	 (B)	 shows	 statistically	 significant	 inhibition	 of	 infection	 in	 cells	 treated	 with	 Pitstop-2	
compared	 to	 control	 treatments	 in	 cells	 that	 were	 pre-treated	 or	 treated	 at	 1hpi	 (ANOVA,	 p	 =	
<0.005,	p	=	<0.05,	respectively).	.	
Figure	6.5	
A	 B	
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6.6 The	effect	of	Cholesterol	inhibitors	on	BTV-1	infection	of	KC	cells	
	
	
To	 determine	 if	 BTV-1	 utilizes	 more	 than	 one	 entry	 mechanism	 for	 KC	 cells,	 the	 role	 of	
cholesterol	 in	 BTV	 infection	 was	 investigated.	 Due	 to	 time	 restrictions,	 only	 one		
experiment	was	carried	out	in	triplicate.	Cells	were	either	pre-treated	with	5mM	Methyl-β-	
cyclodextrin	(see	Chapter	5,	section	5.4.1)	or	the	equivalent	dilution	of	drug	diluent,	serum	
free	media	 for	30	minutes.	Cells	were	then	 infected	with	BTV-1	for	12	hours	and	 labelled		
for	 viral	 proteins	 using	 an	 anti-virus	 antibody,	 orab	 276	 as	 previously	 described	 (see	
Appendix	C).	A	small	but	non-significant	reduction	in	BTV	infection	was	observed	in	MβCD	
treated	cells	compared	to	both	control	treatment	and	untreated	cells	(Figure	6.6).	
	
	
	
6.7 The	effect	of	phosphatidylinositol	3-kinase	and	phosphatidylinositol	4-kinase	
inhibitors	on	BTV-1	infection	of	KC	cells	
	
The	role	of	phosphatidylinositol	3-kinase	(PI3	Kinase)	and	phosphatidylinositol	4-kinase	(PI4	
Kinase)	 in	BTV-1	 infection	was	 investigated	 in	KC	cells	PI3-kinase	 is	known	to	be	a	critical	
kinase	 during	 macropinocytosis	 (Araki	 et	 al.,	 1996,	 Simonsen	 et	 al.,	 2001),	 PI4-kinase	 is	
thought	to	be	required	for	phospholipid	metabolism	and	endocytic	trafficking	(Simonsen	et	
al.,	 2001).	 PI3	 kinase	 and	 some	 forms	 of	 PI4	 kinase	 are	 inhibited	 by	Wortmannin	 at	 μM	
concentrations	(Simonsen	et	al.,	2001).	
	
	
	
Due	to	time	constraints,	only	a	single	experiment	was	carried	out	in	triplicate.	KC	cells	that	
were	 pre-treated	 with	 10µM	 Wortmannin	 displayed	 a	 significant	 inhibition	 in	 BTV-1	
infection	in	KC	cells	compared	to	the	control	treated	and	untreated	cells	(One-Way	ANOVA,	
p	=	<0.005,	p	=	<	0.005,	respectively	(Figure	6.7).	
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Figure	6.6	
	
Figure	6.6	The	effects	of	methyl-β-cyclodextrin	pre-treatment	on	BTV-1	infection	of	KC	cells	
KC	 cells	 were	 pre-treated	 with	 5mM	methyl-β-cyclodextrin	 or	 an	 equivalent	 of	 the	 drug	 diluent,	
serum	free	media	for	30	minutes.	Cells	were	then	infected	for	12	hours.	A	small	but	non-significant	
reduction	 can	be	 seen	 in	 cells	 treated	with	 the	drug	 compared	 to	 control	 treatment	or	untreated	
cells.		Data	is	from	one	experiment	carried	out	in	triplicate.	
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Figure	6.7	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	6.7	The	effects	of	phosphatidylinositol	4-kinase	inhibitor,	Wortmannin	pre-treatment	on	
BTV-1	infection	in	KC	cells	
KC	cells	were	either	pre-treated	with	10µM	Wortmannin	or	an	equivalent	of	the	drug	diluent,	DMSO	
for	30	minutes.	Cells	were	then	infected	with	BTV	for	12	hours.	A	significant	reduction	can	be	seen		
in	 cells	 treated	with	 the	drug	compared	 to	 control	 treatment	or	untreated	cells	 (One-way	ANOVA	
with	Tukey’s	correction,	p	=	<0.005,	p	=	<0.005,	respectively).	Data	 is	from	one	experiment	carried	
out	in	triplicate.	
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6.8 Discussion	
	
	
The	 endocytosis	 mechanisms	 used	 by	 viruses	 are	 relatively	 well	 characterised	 in		
mammalian	cells	 (Pelkmans	and	Helenius,	2003,	Sieczkarski	and	Whittaker,	2002)	but	 few	
studies	have	documented	entry	of	viruses	in	insect	cells	and	endocytosis	pathways	have	so	
far	not	been	studies	in	Culicoides	derived	KC	cells.	The	novel	data	generated	in	this	chapter	
details	the	first	investigation	of	BTV	endocytosis	in	KC	cells,	which	may	generate	knowledge	
to	inform	future	control	strategies.	
	
	
	
To	dissect	the	entry	route	of	BTV	in	KC	cells	a	diverse	range	of	pharmacological	 inhibitors	
targeting	cellular	factors	known	to	be	required	for	distinct	endocytic	pathways	were	used.	
BTV-1	infection	was	significantly	inhibited	(65%	reduction)	when	KC	cells	were	pre-treated	
with	ammonium	chloride,	a	drug,	which	immediately	raises	endosomal	pH	(	
Figure	6.1).	This	indicated	that	delivery	of	BTV-1	to	an	acidic	compartment	was	required	to	
initiate	 infection	 in	 Culicoides	 spp.	 cells.	 The	 requirement	 of	 low	 pH-dependent	 step	 is	
described	 for	many	non-enveloped	viruses	and	enveloped	viruses,	which	use	endocytosis		
as	 an	 entry	 route	 (Grove	 and	Marsh,	 2011).	 In	 the	 field	 of	 insect	 endocytosis,	 	 Dengue		
Virus,	Chikungunya	virus	and	West	Nile	Virus	have	been	described	to	require	a	low	pH	step	
when	 using	 a	 clathrin-mediated	 entry	 mechanism	 in	 Aedes	 albopictus	 mosquito	 cells	
(Acosta	 et	 al.,	 2011,	 Acosta	 et	 al.,	 2008,	 Chu	 et	 al.,	 2006,	 Lee	et	 al.,	 2013).			In	 addition,	
Baculovirus	 entering	 sf21	 (Spodoptera	 frugiperda)	 cells	 via	 a	 clathrin-dependent	 manner	
were	also	 found	 to	 require	an	acid-dependent	 step	 to	allow	 infection	 (Long	et	al.,	 2006).	
Addition	 of	 ammonium	 chloride	 at	 different	 time	 points	 post	 infection	 revealed	 that	
delivery	of	the	virus	to	an	acidic	compartment	is	an	extremely	slow	process	(	
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Figure	6.1).	 Statistically	 significant	 levels	of	 infection	 inhibition	were	observed	even	up	 to	
addition	of	ammonium	chloride	at	8	hours	post	 infection.	KC	cells	are	propagated	at	28°C	
and	 therefore,	 all	 entry	 experiments	 were	 carried	 out	 at	 this	 temperature.	 With	 the	
requirement	of	many	different	enzymes	for	both	endocytosis	mechanisms	and	trafficking,	it	
is	 impossible	 to	 rule	out	 that	 the	 low	 temperature	 these	experiments	were	 conducted	 in	
could	 slow	 enzymatic	 activity	 and	 therefore	 entry	 and	 trafficking	 processes.	 GTPases	 are	
required	 for	 both	 entry	 and	 trafficking	 of	 endocytic	 cargo	 (Van	 den	 Broeke	 et	 al.,	 2014,	
Stenmark,	2009,	Ferguson	and	De	Camilli,	2012).	GTPase	activity	in	other	cellular	processes	
have	 been	 reported	 to	 be	 reduced	 at	 low	 temperatures,	 such	 as	 that	 seen	 in	 human	
guanylate	 binding	 protein-1	 (hGBP-1),	 which	 is	 a	 dynamin	 related	 GTPase	 (Rani	 	 et	 	 al.,	
2012).	However,	 the	slow	delivery	of	BTV-1	 to	an	acidic	compartment	could	also	 indicate	
slow	 endocytosis	 mechanisms,	 such	 as,	 caveolae-dependent	 endocytosis	 or	
macropinocytsosis.	
	
	
	
Nevertheless,	 upon	 inhibition	 with	 non-toxic	 (Figure	 6.2	 (A)),	 macropinocytosis	 inhibitor	
EIPA,	no	significant	effect	on	BTV-1	infection	was	observed	either	at	pre-treatment	or	post	
infection	 treatments	 (Figure	 6.3	 (B)).	 In	 addition	 to	 this,	 it	 was	 confirmed	 that	 EIPA	 did	
induce	 inhibition	 of	 dextran	 uptake,	 implying	 macropinocytosis	 had	 successfully	 been	
inhibited	 (Figure	 6.3	 (A)).	 Furthermore,	 pre-treatment	 or	 treatment	 post	 infection	 with	
non-toxic	 (Figure	 6.2	 (B))	 actin	 inhibitor	 Cytochalasin	 D	 also	 had	 no	 effect	 on	 BTV-1	
infection	compared	mock	treated	cells	(Figure	6.4	(B)).	
	
	
	
The	 results	 might	 indicate	 that	 field	 isolate	 BTV-1	 can	 use	 an	 alternate	 endocytosis	
mechanism	in	Culicoides	spp.	cells	than	what	was	observed	in	bovine	endothelial	cells			(see	
Chapter	6:		Understanding	the	early	events	in	BTV	cell	entry	
253	
	
	
	
	
Chapter	 5)	 but	 interestingly,	 is	 consistent	 with	 the	 published	 endocytic	 mechanism	
described	by	Forzan	and	colleagues	(2007)	in	HeLa	and	Vero	cells.	
CME	 was	 successfully	 inhibited	 in	 KC	 cells	 with	 non-toxic	 concentrations	 of	 Pitstop	 2		
(Figure	6.2	(E)),	as	confirmed	by	the	statistically	significant	inhibition	in	transferrin	uptake	
(Figure	 6.5	 (A)).	 However,	 it	 has	 been	 reported	 that	 whilst	 transferrin	 does	 enter	 S2	
(Drosophilla	spp.	cells)	and	Sf9	(Spodoptera	frugiperda	cells)	cells	via	a	clathrin-dependent	
route,	 the	 ligand	 remains	 internalised	 in	 cellular	 compartments	 for	 hours	 and	 is	 not	
recycled	 back	 to	 the	 plasma	membrane	 as	 is	 seen	 in	mammalian	 cells	 (Van	 Hoof	 et	 al.,	
2005).	Therefore,	caution	must	be	used	when	using	mammalian	cell	characterised	 ligands		
in	insect	cells	as	positive	controls.	Moreover,	upon	pre-treatment	of	KC	cells	with	Pitstop	2	
and	treatment	of	cells	at	1	hour	post	infection,	a	significant	decrease	in	%	of	cells	infected	
was	 observed	 compared	 to	 control	 treated	 cells	 (Figure	 6.5	 (B)).	 This	 suggests	 that	 field	
isolate	BTV-1	infection	of	KC	cells	 is	reliant	on	clathrin	at	an	early	stage	of	 infection,	most	
likely	entry.	
	
	
	
Preliminary	 data	 was	 also	 generated	 in	 this	 chapter,	 which	 focused	 on	 the	 roles	 of	
cholesterol	and	PI4	kinase	 in	BTV-1	 infection	of	KC	cells.	Although,	no	conclusions	can	be	
drawn	from	this	data	as	it	was	only	generated	from	one	experiment	in	triplicate	and	does	
not	 include	control	 ligand	uptake	confirmation,	 it	did	suggest	 that	while	 	 cholesterol	may	
not	 be	 a	major	 factor	 in	 BTV-1	 infection,	 PI4	 kinase	might	 have	 a	 possible	 role	 in	 BTV-1	
replication	 in	KC	 cells.	However,	 further	 supporting	evidence	 is	 required	 to	 confirm	what	
the	preliminary	data	suggests.	
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In	 conclusion,	 data	 presented	 in	 this	 chapter	 suggests	 that	 BTV-1	 may	 utilize	 a	 pH	 and	
clathrin-dependent	 mechanism	 for	 infection	 in	 KC	 cells.	 However,	 confirmatory		
experiments	 with	 alternative	 pharmacological	 inhibitors	 of	 clathrin	 or	 expression	 of	 DN	
eps15	should	be	used	to	further	validate	the	observations	presented	in	this	chapter.	
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7.1		Final	Discussion	and	Future	Work	
	
	
BTV	has	evolved	to	replicate	in	ruminant	and	insect	hosts;	how	BTV	achieves	replication	in	
these	widely	different	 species	 is	poorly	understood.	Replication	begins	with	virus	binding		
to	attachment	receptors	at	the	plasma	membrane	of	target	cells,	which	 initiates	 infection	
and	 it	 is	 likely	 that	 the	 receptors	 and	 the	 entry	 pathway	 used	 by	 BTV	 are	 different	 for	
mammalian	 and	 insect	 cells.	 Target	 cells	 of	 BTV	 include	 endothelial	 cells	 and	 a	 subset	 of	
leukocytes	cells	in	the	ruminant	host	and	the	midgut	cells,	fat	body	cells	and	salivary	glands	
of	 the	midge.	 Following	 initial	 virus	 infections	 and	 once	 viral	 replication	 develops	 in	 the	
mammalian	 host	 and	 insect	 vector,	 the	major	 particle	 type	 present	 is	 likely	 to	 be	whole	
virions.	Therefore,	 this	 thesis	 focuses	on	 identifying	the	cell	entry	pathway	used	by	 intact	
BTV	 to	 infect	 host	 derived	 target	 cells	 from	 the	 ruminant	 host	 and	 insect	 vector	 cells.	
Previous	 studies	 in	 this	 area	 have	 used	 cell	 culture	 adapted	 BTV	 strains	 and	 standard	
mammalian	cell	 lines	derived	from	non-host	species.	Therefore,	the	aim	of	this	thesis	was	
to	elucidate	cell	entry	mechanisms	utilised	by	a	low	passage	KC	cell	generated	field	isolate	
BTV-1	in	host	derived	cells	(BFA	and	KC	cells).	Furthermore,	the	virus	used	in	this	study	was	
purified	 to	 eliminate	 the	 potential	 for	 cellular	 factors	 (possibly	 present	 in	 infected	 cell	
lysates)	that	may	influence	the	uptake	pathway.	
	
	
	
This	 thesis	 has	 identified	 the	 endocytosis	mechanism	used	by	 a	 field	 isolate	of	 BTV-1	 for	
entry	 into	 BFA	 cells	 as	 a	 macropinoctosis-like	 mechanism	 and	 presents	 preliminary		
evidence	 for	 an	 alternative	 endocytosis	 mechanism	 used	 by	 the	 same	 virus	 in	 KC	 cells.			
Thus,	 BTV-1	 is	 similar	 to	 other	 viruses	 and	 appears	 to	 use	 at	 least	 2	 endocytosis	
mechanisms,	which	may	 be	 dictated	 by	 target	 cell	 type	 or	 host.	 Furthermore,	 this	 thesis		
has		confirmed		that		dynamin-2		splice		variants		appear		to								 be		specific		for		differential	
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endocytosis	mechanisms	and	only	dynamin-2	ba	splice	variant	was	shown	to	play	a	role	in	
BTV-1	 endocytosis,	 which	 is	 the	 first	 time	 an	 individual	 dynamin	 splice	 variant	 has	 been	
confirmed	to	be	involved	in	pathogen	entry.	This	is	also	the	first	study	using	a	field	isolate		
of	 BTV,	 which	 has	 not	 been	 adapted	 to	 mammalian	 cell	 culture,	 to	 study	 cell	 entry.		
Evidence	 presented	 in	 this	 thesis	 (Chapter	 3)	 has	 also	 highlighted	 how	 cell	 culture	
adaptation	of	BTV	may	influence	infectivity,	which	could	alter	receptor	binding	preference	
and	 subsequent	 entry	 mechanisms.	 This	 thesis	 details	 an	 adapted	 method	 of	 BTV	
purification	 that	 negates	 the	 requirement	 of	 virus	 adaptation	 to	mammalian	 cell	 culture	
entirely	whilst	preserving	field	isolate	genotypic	and	phenotypic	characteristics.	
	
	
	
Historical	BTV	purification	methods	require	serial	passage	of	virus	in	BHK-21	cells	(Mertens	
et	 al.,	 1987)	 thereby	 generating	 purified	 particle	 likely	 to	 be	 adapted	 to	mammalian	 cell	
culture.	This	thesis	required	virus	that	retained	phenotypic	characteristics	resembling	field	
isolate	virus.	Therefore,	purification	methods	were	adapted	to	propagate	virus	 in	KC	cells	
only,	which	are	cells	derived	from	Culicoides	 larvae,	as	described	in	chapter	3.	 In	order	to	
identify	 whether	 this	method	would	 alter	 genotypic	 or	 phenotypic	 characteristics	 of	 the	
field	isolate,	BTV	was	serially	passaged	in	three	cell	lines	and	whole	genome	sequencing	of	
these	viruses	highlighted	possible	cell	culture	adaptation	changes,	which	were	then	related	
to	 the	 infectivity	 of	 these	 viruses.	 In	 chapter	 3,	 it	 was	 identified	 that	 viruses	 that	 were	
passaged	 in	KC	cells	 retained	 the	 same	 infectivity	as	 field	 isolate	BTV	 for	mammalian	cell	
culture	 and	 low	 passage	 KC	 viruses	 had	 infectivity	 akin	 to	 field	 isolate	 virus	 in	 KC	 cells.	
However,	virus	propagated	multiple	 times	 in	KC	cells	had	enhanced	 infectivity	 in	KC	cells,	
which	were	then	identified	as	having	genetic	changes	in	a	number	of	segments	of	the	viral	
genome.	 Viruses	 that	were	 passaged	 in	 BFA	 or	 BHK	 cells	were	 shown	 to	 have	 enhanced	
infectivity	in	mammalian	cell	culture	and	these	viruses	also	observed	genetic	changes	in	
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virus	segments.	Upon	serial	passaging	of	BTV	in	three	different	cell	lines,	the	occurrence	of	
sequence	changes	could	 indicate	cell	 culture	adaptation	had	occurred.	As	only	consensus	
level	 sequencing	was	carried	out,	 it	would	be	valuable	 to	assess	whether	 these	 sequence	
changes	 were	 a	 result	 of	 fixation	 of	 a	 sub	 consensus	 level	 virus	 sequence	 in	 the	 virus	
population	 or	 the	 generation	 of	 mutations.	 Follow	 up	 work	 investigating	 whether	 the	
identified	sequence	changes	 impact	on	virus	replication	and	entry	would	be	of	 interest	to	
future	studies	on	virus	host	 interactions.	 In	addition,	 investigating	 the	effect	of	passaging	
BTV	through	KC-BFA-KC-BFA	cells	could	highlight	a	natural	development	or	control	of	viral	
mutations.	
	
	
	
It	 was	 concluded	 that	 low	 passage	 virus	 generated	 in	 KC	 cells,	 would	 retain	 infectivity	
similar	 to	 the	 parental	 field	 isolate.	 Furthermore,	 sequencing	 of	 purified	 virus	 only	
identified	 a	 single	 nucleotide	 change	 in	 the	 whole	 genome.	 As	 this	 was	 not	 in	 any	 viral	
protein	 known	 to	 be	 required	 for	 BTV	 entry,	 it	 was	 concluded	 that	 field	 isolate	 entry	
kinetics	would	be	maintained.	BTV	was	 successfully	purified	after	 low	passage	 in	KC	 cells	
from	 an	 adapted	 established	 method	 (Mertens	 et	 al.,	 1987).	 This	 virus	 was	 used	 to	
investigate	the	mechanism	of	endocytosis	used	by	BTV	in	BFA	and	KC	cells.	
	
	
	
Previous	work	studying	endocytosis	mechanisms	of	cell	culture	adapted	BTV	identified	that	
dynamin	may	play	 a	 role	 in	BTV	 infection	 (Gold	et	 al.,	 2010).	However,	whilst	 a	dynamin	
inhibitor	 (Dynasore)	 blocked	 infection,	 expression	 of	 DN	 Dynamin-2	 aa	 did	 not	 inhibit	
infection	 (Gold	 et	 al.,	 2010).	 In	 chapter	 4,	 this	 conundrum	 was	 addressed	 by	 using	
additional	dynamin	inhibitors,	siRNA	targeting	dynamin-2	and	DN	dynamin-2	splice	variant	
proteins.					Pre-treatment		of			BFA		cells		with		a			pharmacological		inhibitor		of						 dynamin	
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(Dyngo4a)	 resulted	 in	 an	 inhibition	 of	 infection	 and	 blocked	 BTV	 entry	 into	 cells.	 siRNA	
targeting	 dynamin-2	 and	 expression	 of	 DN	 dynamin-2	 ba	 splice	 variant	 inhibited	 BTV	
infection.	 In	 contrast,	 no	 inhibition	 of	 infection	 was	 observed	 upon	 expression	 of	 DN	
dynmain-2	aa	and	bb.	Indicating	that,	BTV	entry	and	infection	is	dependent	on	dynamin-2	
ba	 splice	 variant.	 Theba	 splice	 variant	 of	 dynamin-2	 has	 been	 implicated	 to	 play	 a	major		
role	in	macropinocytosis	which	suggested	that	BTV	may	also	use	macropinocytosis	for	cell	
entry.	
	
	
	
In	 chapter	5	 it	was	 then	 identified	 that	BTV-1	entry	 in	 to	BFA	 cells	was	 slow	and	 took	at	
least	2	hours	before	virus	could	be	seen	in	the	cell	cytoplasm,	which	suggests	that	the	role	
dynamin	plays	in	BTV	infection	occurs	prior	to	virus	entry.	A	slow	rate	of	entry	was	further	
supported	 by	 demonstrating	 that	 virus	 trafficking	 to	 acidic	 endosomes	 was	 also	 slow	
(Chapter	5).	
	
	
	
It	was	further	identified	that	BTV-1	appeared	to	stimulate	enhanced	fluid-phase	uptake	and	
trigger	a	global	reorganisation	of	cellular	actin.	Evidence	was	also	presented	that	suggests	
this	 may	 be	 triggered	 by	 rho	 protein	 signalling.	 This	 suggests	 that	 BTV	 may	 be	 able	 to	
stimulate	 its	 own	 uptake	 by	 triggering	 endocytosis	 (e.g.	macropinocytosis).	 Rho	 proteins	
include	 Rac1,	 cdc42	 and	 Ras,	 all	 of	 which	 are	 known	 to	 play	 roles	 in	 macropinocytosis	
(Mercer	 and	 Helenius,	 2009).	 Future	 work	 should	 include	 identification	 of	 which	 	 rho	
protein	are	involved	in	signalling	during	BTV	entry	and	elucidate	the	downstream	signalling	
cascade	 responsible	 for	 actin	 reorganisation	and	 subsequent	 enhancement	 in	 fluid	phase	
uptake.	 The	 observation	 that	 accumulation	 of	 BTV	 at	 the	 cell	 surface	 over	 time	 could	
indicate	that	rho	protein	signalling	may	be	initiating	receptor	clustering,	in	a	similar	way		 to	
Chapter	7:		Understanding	the	early	events	of	Bluetongue	virus	cell	entry	
261	
	
	
	
	
what	 is	 observed	 with	 coxsackievirus	 B	 and	 its	 receptor	 ‘coxsackievirus	 and	 adenovirus	
receptor’	(CAR)	(Coyne	and	Bergelson,	2005).	
	
	
	
Due	to	the	early	involvement	of	dynamin	in	infection,	it	is	possible	that	dynamin	could	also	
act	 as	 a	 signalling	 molecule,	 which	 could	 work	 in	 concert	 with	 rho	 protein	 signalling	 to	
regulate	 cytoskeletal	 activity	 and	 subsequent	 enhancement	 of	 fluid-phase	 uptake.	
Dynamin-2	 has	 been	 shown	 to	 be	 recruited	 to	 sites	 of	 enteropathogenic	 Escherichia	 coli	
attachment	to	actin	rich	pedestals	of	epithelial	cells	and	initiate	signalling	that	 is	required	
for	 pedestal	 formation	 and	 actin	 polymerisation	 (Unsworth	 et	 al.,	 2007).	 Dynamin-2	 has	
also	been	shown	 to	 localise	at	actin	 tails	generated	by	Listeria	and	was	 shown	 to	control	
nucleation	 of	 actin	 from	membranes	 (Lee	 and	 De	 Camilli,	 2002).	 	 In	 addition,	 studies	 in		
yeast	have	identified	an	important	 link	between	dynamin	and	the	actin	cytoskeleton	(Geli	
and	Riezman,	 1998,	Wendland	 et	 al.,	 1998).	 	 This	 evidence	 along	with	 data	 generated	 in		
this	 thesis	 suggests	 that	 there	 is	 a	 strong	 functional	 link	 between	dynamin	 and	 the	 actin	
cytoskeleton.	From	evidence	presented	in	this	thesis,	it	is	possible	that	dynamin-2	ba	plays	
a	role	at	the	point	of	virus	attachment,	where	virus	was	seen	to	be	in	close	association	with	
F-actin	structures	at	the	cell	periphery.	
	
	
	
Future	 work	 should	 include	 studies	 to	 identify	 the	 location	 of	 endogenous	 	 dynamin-2	
during	BTV-1	attachment	and	entry	to	 identify	whether	Dynamin-2	 is	 recruited	to	sites	of	
virus	attachment.	In	addition,	an	experiment	to	investigate	whether	inhibition	of	dynamin-	
2	ba	 inhibits	actin	rearrangement	during	BTV-1	entry	to	 identify	whether	there	 is	a	direct	
link	between	this	dynamin	splice	variant	and	actin	during	BTV	entry.	The	role	of	dynamin	in	
actin	polymerisation	appears	to	be	linked	to	neural	Wiskott-Aldrich	syndrome	protein	(N-	
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WASP)	 –	WAVE	 and	 actin	 related	 protein	 2/3	 (ARP2/3),	 which	 along	with	 dynamin	 have	
been	found	to	localise	at	lamellipodia	(Schlunck	et	al.,	2004),	membrane	ruffles	(Krueger	et	
al.,	2003,	Gold	et	al.,	1999),	podosomes	(Ochoa	et	al.,	2000)	and	actin	comets	(Lee	and	De	
Camilli,	 2002,	 Orth	 et	 al.,	 2002)	 during	 bacteria	 cell	 entry	 (Unsworth	 et	 al.,	 2007).		
Therefore,	if	proposed	studies	identify	dynamin	localisation	at	sites	of	BTV	attachment	and	
inhibition	 of	 dynamin	 impacts	 actin	 reorganisation	 then	 the	 involvement	 of	N-WASP	 and	
ARP2/3	should	also	be	investigated.	
Expression	of	DN	dynamin-2	ba	 inhibited	 infection	but	 failed	to	 inhibit	 transferrin	uptake,	
indicating	 that	 BTV	 entry	 is	 dynamin-dependent	 but	 independent	 of	 clathrin.	 The	 role	 of	
clathrin	 in	BTV	 infection	was	evaluated	to	confirm	this	observation	and	because	CME	had	
been	previously	reported	as	an	endocytosis	mechanism	used	by	BTV-10	in	HeLa	and	VERO	
cells	 (Forzan	 et	 al.,	 2007).	 Pharmacological	 inhibitors	 of	 clathrin	 (Chlorpromazine	 and	
Pitstop	 2)	 were	 used	 to	 identify	 the	 involvement	 of	 clathrin	 during	 BTV	 infection.	 As	
Chlorpromazine	 was	 found	 not	 to	 inhibit	 the	 CME	 of	 the	 control	 ligand,	 transferrin,	 the	
results	generated	for	BTV	infection	might	therefore	be	a	result	of	off	target	effects	of	the	
drug.	However,	Pitstop	2	 inhibited	transferrin	uptake	 in	BFA	cell	but	did	not	 inhibit	BTV-1	
infection,	 suggesting	 CME	 is	 not	 required	 for	 infection	 in	 these	 cells.	 Furthermore,	
expression	of	DN	eps15	(Eps15	 is	a	clathrin	pit	 initiation	factor)	also	did	not	 inhibit	BTV-1	
infection	strengthening	the	observation	that	BTV	entry	and	infection	occurs	independent	of	
clathrin.	 In	 addition,	 depletion	 of	 cholesterol	 using	 Methyl-β-cyclodextrin	 also	 did	 not	
inhibit	BTV	infection,	suggesting	that	virus	infection	is	also	cholesterol-independent.	
	
	
	
One	 of	 the	 most	 striking	 characteristics	 of	 BTV	 entry	 into	 BFA	 cells	 was	 the	 slow	
internalisation			of			the			virus			and			trafficking			to			acidic			compartments			coupled					with	
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restructuring	 of	 the	 F-actin	 cytoskeleton	 to	 accommodate	 entry	 of	 the	 virus	 through	 the	
dense	 actin	 rich	 cortex	 that	 usually	 resides	 at	 the	 cell	 periphery.	 Furthermore,	 as	
mentioned	above,	 inhibition	of	rho	proteins,	 inhibited	BTV	 infection	when	cells	were	pre-	
treated	with	C3	toxin	but	not	when	cells	were	treated	post	infection.	This	may	suggest	rho	
protein	 signalling	may	 be	 involved	 in	 initiating	 enhancement	 of	 fluid-phase	 uptake	 upon	
virus	attachment.	 In	addition,	 inhibition	of	macropinocytosis	by	 targeting	NHE1	and	PAK1	
resulted	 in	 the	 inhibition	 of	 BTV-1	 infection.	 Together	 these	 observations	 support	 the	
conclusion	that	BTV	uses	a	macropinocytosis	like	mechanism	to	gain	entry	into	BFA	cells.	
Future	 work	 could	 include	 analysis	 of	 the	 actin	 reorganisation	 induced	 by	 BTV	 during	
attachment	and	entry	by	means	of	live	cell	microscopy.	This	would	help	elucidate	the	rate	
of	 extension	 and	 retractions	 of	 actin	 filaments	 and	 determine	 accurate	 timing	 of	 events,	
particularly	 if	BTV	was	successfully	 tagged	with	a	 fluorescent	probe.	Furthermore,	studies	
of	 the	 generation	 of	 membrane	 ruffles	 could	 be	 carried	 out	 with	 the	 use	 of	 scanning	
electron	microscopy	(SEM)	to	identify	whether	BTV	stimulates	lamellipodia,	circular	ruffles	
or	 blebs	 at	 the	 plasma	 membrane	 during	 virus	 internalisation.	 In	 addition,	 further	
investigation	into	the	trafficking	of	field	isolate	BTV	to	endosomal	compartments	should	be	
carried	out.	This	study	was	only	able	to	identify	a	cross	reactive	antibody	against	LAMP1	in	
bovine	 cells	 (data	 not	 shown),	 identification	 of	 other	 reagents	 that	 cross	 react	with	 host	
derived	cells	would	benefit	future	virus	trafficking	investigations.	
	
	
	
In	 summary,	 from	 evidence	 generated	 in	 Chapters	 4	 and	 5,	 using	 	 pharmacological	
inhibitors,	 siRNA	 and	DN	proteins,	 the	 proposed	model	 of	 entry	 for	 BTV-1	 in	 BFA	 cells	 is	
depicted	 in	 Figure	 7.1,	 which	 suggests	 that	 BTV-1	 uses	 a	 non-canonical,	 dynamin-	
dependent	macropinocytosis-like	entry	mechanism	is	used	for	cellular	entry	of	BFA	cells.	
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This	 thesis	 also	 investigated	entry	of	BTV	using	KC	 cells.	 Interestingly,	 inhibition	of	BTV-1	
infection	of	KC	cells	was	not	achieved	when	cells	were	treated	with	inhibitors	of	actin	and	
NHE1,	indicating	that	BTV-1	infection	is	independent	of	both	actin	and	NHE1.	This	suggests	
that	 BTV-1	 utilises	 an	 alternative	 route	 of	 cell	 entry	 in	 KC	 cells.	 Chapter	 6	 presented	
preliminary	evidence,	which	suggested	that	entry	for	KC	cells	is	clathrin-dependent.	This	is	
further	supported	by	the	inhibitory	effect	of	dynamin	inhibitors	on	BTV	infection	(Chapter	
4).	These	observations	suggest	that	a	clathrin-dependent	entry	mechanism	is	used	for	BTV-	
1	 entry	 in	 KC	 cells.	 It	 is	 possible	 that	 the	different	 entry	 pathways	 used	by	BTV	 to	 infect	
mammalian	 and	 KC	 cells	 results	 from	 differences	 in	 receptor	 usage.	 For	 example,	 it	 is		
known	 that	 BTV	 core	 particles	 can	 bind	 to	 KC	 cells	 via	 VP7	 but	 this	 does	 not	 occur	 in	
mammalian	 cells	 (Tan	 et	 al.,	 2001),	 which	 could	 influence	 the	 activation	 of	 alternative	
endocytosis	mechanisms.	 Interestingly,	 current	 literature	 suggests	 that	 all	 virus	 triggered	
endocytosis	mechanisms	 identified	 in	 insect	cells	have	been	via	CME	(Acosta	et	al.,	2011,	
Lee	et	al.,	2013,	Mosso	et	al.,	2008),	suggesting	that	this	may	be	an	endocytosis	mechanism	
used	specifically	for	virus	trafficking	in	insects.	
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Figure	7.1	
	
	
	
	
Figure	7.	1	Proposed	model	of	BTV	entry	into	BFA	cells	
	
Diagram	shows	the	early	requirements	of	NHE1,	rho	protein	and	Dynamin-2	ba	signalling,	which	are	
activated	upon	BTV-1	attachment	to	BFA	cells.	Actin	rearrangement	occurs	between	1	and	2	hours	
and	virus	begins	 to	be	 internalised	at	2	and	3	hours.	PAK1	signalling	 is	 required	throughout	BTV-1	
internalisation.	BTV	receptor,	trafficking	molecules	and	scission	protein	is	currently	unknown.	
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Investigations	into	endocytosis	in	Culicoides	spp.	derived	cells	were	challenging	due	to	the	
lack	of	knowledge	of	the	biology	of	Culicoides	spp.	derived	cells	and	therefore,	the	effects	
of	pharmacological	 inhibitors	were	 sometimes	difficult	 to	 interpret.	 	 Further	work	 should		
be	carried	out	to	confirm	the	entry	mechanism	BTV-1	uses	in	Culicoides	spp.	derived	cells.			
A	 valuable	 method	 to	 consider	 for	 studying	 this	 would	 be	 Proteomics	 Informed	 by	
Transcriptomics	 (PIT)	 (Evans	 et	 al.,	 2012,	 Wynne	 et	 al.,	 2014).	 This	 method	 	 allows		
detection	 and	quantification	of	 the	upregulation/	 downregulation	of	 RNA	 transcripts	 and	
quantifies	 expression	 of	 the	 proteome	 at	 different	 time	 points	 during	 infection.	 	 Whilst	
most	proteomic	methods	are	reliant	on	an	annotated	genome	and	proteome,	this	method	
allows	 detection	 of	 the	 transcriptome	 to	 generate	 a	 theoretical	 proteome	 from	 which	
proteins	detected	from	the	high	throughput	proteomics	can	be	evaluated	against	(Evans	et	
al.,	 2012).	 This	 method	 has	 generated	 invaluable	 results	 of	 Hendra	 virus	 replication	 in	
unannotated	 bat	 cell	 lines	 (Wynne	 et	 al.,	 2014)	 and	 this	 method	 would	 give	 a	 unique	
opportunity	 to	 identify	not	only	key	cellular	proteins	and	small	RNAs/transcripts	 required	
for	BTV	entry	 into	KC	cells	but	will	generate	a	wealth	of	data	that	could	contribute	to	the	
cell	biology	knowledge	of	these	cells/species.	
	
	
	
Arboviruses,	such	as	BTV,	need	to	enter	vertebrate	host	cells	and	cells	of	the	insect	vector.	
Dengue	 virus	 has	 been	 shown	 to	 use	 CME	 for	 productive	 entry	 into	 both	mosquito	 cells	
(Acosta	et	al.,	2011,	van	der	Schaar	et	al.,	2008,	Mosso	et	al.,	2008)	and	human	monocytes	
(Alhoot	 et	 al.,	 2011).	 In	 contrast,	whereas	 CHIKV	 uses	 CME	 for	 entry	 into	mosquito	 cells	
(Lee	et	al.,	2013)	this	virus	appears	to	use	a	clathrin-independent	mechanism	for	entry	 in	
mammalian	 cells	 (Bernard	 et	 al.,	 2010).	 Together	with	 observations	 from	 this	 study,	 this	
suggests	 that	 arboviruses	 are	 able	 to	 utilize	 different	 cell	 entry	 strategies	 to	 ensure	
productive	entry	into	the	insect	vector	and	mammalian	host	cells.	
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The	 findings	 from	 this	 thesis	 corroborates	 previous	 research	which	 identified	 cell	 culture	
adapted	 purified	 BTV1	 particles	 can	 enter	 cells	 using	 a	 macropinocytosis-like	 entry	
mechanism	(Gold	et	al.,	2010)	while	 tissue	culture	supernatant	BTV10	reportedly	entered		
by	CME	 (Forzan	et	 al.,	 2007).	 This	 thesis	has	 identified	 that	a	 field	 isolate	BTV-1	 can	also	
utilize	both	of	 these	entry	pathways	 and	has	 identified	 that	 the	differences	between	 the	
previous	 publications	may	 be,	 in	 part,	 due	 to	 the	 different	 cell	 lines	 used	 in	 each	 of	 the	
studies.	 Previous	 studies	 have	 identified	 that	 BTV	 can	 interact	with	 a	 number	 of	 cellular	
receptors,	such	as	Glycophorin	A	(Eaton	and	Crameri,	1989),	sialogycoprotein	(Hassan	and	
Roy,	 1999)	 and	 heparan	 sulphate	 (Mecham	 and	 McHolland,	 2010),	 indicating	 that	 it	 is	
possible	 that	 BTV	 can	 bind	 and	 use	multiple	 receptors.	 Use	 of	 the	 preferential	 receptor		
may	be	dependent	on	receptor	availability	on	the	target	cell,	which	could	explain,	 in	part,	
the	differences	in	endocytosis	mechanisms	used	in	different	cell	lines.	
	
	
	
Despite	the	contribution	the	research	presented	in	this	thesis	makes	to	the	field,	there	are	
still	 a	 number	 of	 key	 questions	 that	 are	 still	 to	 be	 addressed.	 There	 are	 at	 least	 three	
different	 infectious	 particles;	whole	 virion,	 ISVP	 (generated	by	 protease	 cleavage	of	 VP2)	
and	core	particles	(generated	by	low	pH	through	dissociation	of	VP2	and	VP5)	(Darpel	et	al.,	
2011,	Mertens	et	al.).	Transmission	of	BTV	to	and	from	mammalian	host	occurs	via	vector	
bite,	 in	 the	 presence	 of	 midge	 saliva	 (Mellor	 et	 al.,	 2000,	 Mellor	 et	 al.,	 1984b)	 which	
contains	 numerous	 pharmacological	 active	 substances	 including	 both	 proteases	 and	
protease	 inhibitors	 (Lehiy	 and	 Drolet,	 2014,	 Langner	 et	 al.,	 2007).	 Currently	 the	 exact	
structure	of	 the	 infectious	particle	 that	 is	 transmitted	between	 ruminant	 host	 and	 insect	
vector	 remains	 unknown,	 however	 particle	 type	might	 influence	 receptor	 use	 and	 entry	
pathways	 in	 each	 host	 and	 subsequently,	 cell	 tropism.	 Therefore,	 entry	 mechanisms	
employed	by	different	particle	types	in	host	derived	cells	and	identification	of	the	particle	
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type	transmitted	to	and	from	each	host	should	be	investigated.	Furthermore,	as	this	thesis	
has	identified	that	target	cell	type	can	influence	entry	strategies	of	BTV,	investigation	into	
primary	 target	 cells,	 such	 as	 microvascular	 endothelial	 cells	 and	 leukocytes	 would	 be	 a	
logical	 step	 to	 follow	 on	 from	 this	 research.	 In	 addition,	 comparisons	 of	 entry	 strategies	
between	ovine	and	bovine	cells	may	offer	difference	perspectives	to	BTV’s	versatility	when	
entering	host	cells.	
	
	
	
Taken	together,	this	thesis	provides	novel	insights	into	the	endocytosis	mechanisms	that	a	
low	insect	cell	passage	field	isolate	BTV	uses	during	entry	of	host-derived	cells	in	both	the	
mammalian	 and	 insect	 host.	 Identification	 of	 novel	 cellular	 factors	 involved	 in	 BTV	 entry	
were	made,	such	as	the	involvement	of	dynamin-2	ba	splice	variant,	rho	protein	signalling	
and	 PAK1,	 all	 of	 which	 were	 not	 known	 previously.	 Furthermore,	 this	 research	 not	 only	
contributes	to	the	field	of	BTV	cell	entry	but	also	to	the	field	of	endocytosis	as	this	thesis	
describes	a	variation	of	a	macropinocytosis-like	mechanism	that	involves	the	dynamin-2	ba	
splice	variant	prior	to	cargo	entry	and	appears	to	be	independent	of	PI3	kinase.	In	addition,	
it	provides	clarification	in	the	differences	in	endocytosis	mechanisms	that	were	previously	
observed	in	to	other	published	works,	which	could	be	partly	explained	by	usage	of	different	
target	 cells.	 Identification	 of	 key	 cellular	 factors	 required	 in	 both	 the	 insect	 	 and		
mammalian	host	cell	entry	could	influence	key	targets	for	future	drug	therapeutics.	
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Appendix	
9-A:	
Standard	Solutions	for	SDS	PAGE	Gel	
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Table	9-1		Table	of	composition	of	8%	SDS	PAGE	Resolving	Gel	
Reagent	 Concentration	 Volume	(µL)	
Deionised	
Water	
-	 4630	
Acrylamide	
(Sigma)	
30%	 2670	
Tris	pH	8.8	
(Sigma)	
1.5M	 2500	
SDS	
(Melford)	
10%	 100	
APS	
	
(Fisher)	
10%	 100	
TEMED	
(Invitrogen)	
-	 10	
	
	
	
Table	-9-2		Table	of	composition	of	5%	SDS	PAGE	Stacking	Gel	
Reagent	 Concentration	 Volume	(µL)	
Deionised	
Water	
-	 3400	
Acrylamide	
(Sigma)	
30%	 850	
Tris	pH	6.8	
(Sigma)	
1M	 600	
SDS	
(Melford)	
10%	 50	
APS	(Fisher)	 10%	 50	
TEMED	
(Invitrogen)	
-	 7.5	
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Appendix	
9-B:	
Flow	cytometry	compensation	and	
laser	configuration	settings	
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Table	9	-3		Table	showing	example	compensation	settings	
Fluorophores	 %	Compensation	
Alexa	Fluor	647	–	eGFP	 0.02%	
Live/Dead	Near	IR	633/775	–	eGFP	 0.00%	
eGFP	–	Alexa	Fluor	647	 0.19%	
Live/Dead	Near	IR	633/775	–	Alexa	Fluor	647	 0.64%	
eGFP	-	Live/Dead	Near	IR	633/775	 0.16%	
Alexa	Fluor	647	-	Live/Dead	Near	IR	633/775	 0.00%	
The	 table	 shows	 the	 %	 bleed	 through	 of	 one	 fluorescence	 channel	 into	 the	 other.	 Automatic	
compensation	 programme	 was	 run	 on	 FACS	 DIVA	 to	 establish	 compensation	 settings	 for	 single	
fluorescent	 dye	 stained	 samples.	 These	 are	 an	 example	 of	 the	 percentages	 that	 were	 used	 to	
compensate	 flow	 cytometry	 data.	 For	 each	 experiment	 compensation	 settings	 were	 adjusted	 to	
account	for	cell	autofluoresence.	
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Appendix	
9-C:	
Orab276	Dilution	series	staining	
index	and	western	blot	showing	viral	
protein	detection	
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Western	blot	showing	BTV	viral	proteins	detected	by	Orab276	antibody	
	
	
Optimal	Antibody	
Dilution	=	1/4000	
200kD	150kD	100kD	75kD	
50kD	 VP5	VP6	
	VP7	37kD	
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Appendix	
9-D	
Pipeline	for	multiple	sequence	
alignment	using	SAMtools	and	
BAMtools	
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Python	Script	to	carry	out	de	novo	sequence	alignment	
	
ls	{enter}	
	
bwa	index	[NAME	OF	FILE.fa]	{enter}	
	
bwa	mem	[NAME	OF	REFERENCE	FILE]	[NAME	OF	SEQUENCES	TO	BE	ALLIGNED			
FILE]	>	[NEW	NAME	OF	ALIGNMENT].sam	{enter}	
Samtools	view	–bS	[FILE	NAME.sam]	>	[FILE	NAME].bam	{enter}	
	
Samtools	sort	[FILE	NAME].bam	[NEW	NAME	OF	SORTED	FILE].sorted	{enter}	
samtools	index	[FILE	NAME].sorted.bam	{enter}	
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Appendix	
9-E	
Multiple	sequence	alignment	of	
passaged	BTV	
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Segment	1	Alignment	of	passaged	viruses	
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Segment	2	Alignment	of	passaged	viruses	
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Segment	3	alignment	of	passaged	viruses	
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Segment	4	alignment	of	passaged	viruses	
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Segment	5	alignment	of	passaged	viruses	
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Segment	6	alignment	of	passaged	viruses	
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Segment	7	alignment	of	passaged	viruses	
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Segment	8	alignment	of	passaged	viruses	
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Segment	9	alignment	of	passaged	viruses	
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Segment	10	alignment	of	passaged	viruses	
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Appendix	
9-F:	
Sequence	alignment	of	purified	BTV-1	
GIB2007/01	KC3	with	passaged	KC2	
virus	
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Segment	1	alignment	of	purified	BTV-1	and	KC2	
	
	
Chapter	9:		Understanding	the	early	events	of	Bluetongue	virus	cell	entry	
320	
	
	
	
	
Segment	2	alignment	of	purified	BTV-1	and	KC2	
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Segment	3	alignment	of	purified	BTV-1	and	KC2	
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Segment	4	alignment	of	purified	BTV-1	and	KC2	
	
	
Chapter	9:		Understanding	the	early	events	of	Bluetongue	virus	cell	entry	
323	
	
	
	
	
Segment	5	alignment	of	purified	BTV-1	and	KC2	
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Segment	6	alignment	of	purified	BTV-1	and	KC2	
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Segment	7	alignment	of	purified	BTV-1	and	KC2	
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Segment	8	alignment	of	purified	BTV-1	and	KC2	
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Segment	9	alignment	of	purified	BTV-1	and	KC2	
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Segment	10	alignment	of	purified	BTV-1	and	KC2	
	
	
